About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
3566 genotypes with 5064 annotations displayed of selected term and subterms
Searched Term: abnormal inflammatory response
Allelic Composition
(Genetic Background)		 Annotated Term Reference
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/Jdk) 		insulitis J:137009
5730403I07Rikem8Gpt/5730403I07Rikem8Gpt
(involves: C57BL/6JGpt) 		increased inflammatory response J:329871
9030622O22Rikem1Eem/9030622O22Rik+
Foxa2tm1.1Khk/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		respiratory system inflammation J:284174
9030622O22Rikem1Eem/9030622O22Rikem1Eem
(involves: C57BL/6 * CD-1) 		lung inflammation J:284174
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Tg(Myh6-2A)#Know/0
(involves: BALB/c * C57BL/6 * FVB/N) 		heart inflammation J:128060
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka) 		stomach inflammation J:184485
Ay/a
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl) 		abnormal inflammatory response J:177084
AA467197em1Nyam/AA467197em1Nyam
(C57BL/6J-AA467197em1Nyam) 		kidney inflammation J:347271
liver inflammation J:347271
lung inflammation J:347271
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J) 		glomerulonephritis J:64390
uterus inflammation J:64390
Abcb1atm1Bor/Abcb1atm1Bor
(FVB.129P2-Abcb1atm1Bor/TacImx) 		colitis J:51190
large intestinal inflammation J:51190
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N)) 		bile duct inflammation J:15531, J:21232
liver inflammation J:15531
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N) 		bile duct inflammation J:175015
liver inflammation J:175015
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J) 		bile duct inflammation J:105357
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c) 		bile duct inflammation J:168123
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB) 		decreased inflammatory response J:44110
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh) 		increased susceptibility to induced colitis J:117326
intestinal inflammation J:117326
small intestinal inflammation J:117326
Abcd1tm1Kds/Y
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		increased inflammatory response J:94583
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		lung inflammation J:132952
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB) 		liver inflammation J:201884
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA) 		liver inflammation J:199570
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J) 		lung inflammation J:72875
AbmmDBA/2J/?
(involves: BALB/cByJ * DBA/2J) 		myocarditis J:52296
Acantm2Afos/Acantm2Afos
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:122102
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc) 		brain inflammation J:299448
Ace2em1(ACE2)Yowa/Ace2em1(ACE2)Yowa
(C57BL/6-Ace2em1(ACE2)Yowa) 		interstitial pneumonia J:288243
Ace2em1Cya/Y
(C57BL/6J-Ace2em1Cya/Cya) 		increased susceptibility to induced colitis J:299383
intestinal inflammation J:299383
Ace2em2(ACE2)Gpt/Y
(C57BL/6JGpt-Ace2em2(ACE2)Gpt/Gpt) 		lung inflammation J:302150
Ace2em#Yngh/Y
(involves: Kunming) 		increased susceptibility to induced colitis J:221616
Ace2tm1a(KOMP)Wtsi/Y
Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac) 		lung inflammation J:282139
Ace2tm1a(KOMP)Wtsi/Ace2tm1a(KOMP)Wtsi
Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac) 		lung inflammation J:282139
Ace2tm1Cof/Ace2tm1Cof
(involves: 129S6/SvEvTac * C57BL/6) 		increased incidence of corneal inflammation J:289503
Ace2tm1Lex/Ace2tm1Lex
(B6;129S5-Ace2tm1Lex/Mmucd) 		lung inflammation J:264991
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6) 		heart inflammation J:124548
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd) 		lung inflammation J:282139, J:100334
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6J) 		lung inflammation J:277074
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd) 		lung inflammation J:282139, J:100334
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6J) 		lung inflammation J:277074
Acetm1Keb/Acetm1Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		kidney inflammation J:33018
Acetm1Mcf/Acetm1Mcf
(Not Specified) 		kidney inflammation J:32114
tubulointerstitial nephritis J:32114
Acetm1Unc/Acetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		kidney inflammation J:25284
Acetm9Keb/Acetm9Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		kidney inflammation J:185888
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi) 		skin inflammation J:235775
Ackr1tm1Scp/Ackr1tm1Scp
(involves: 129P2/OlaHsd * C57BL/6) 		increased inflammatory response J:64222
Ackr2tm1Gjg/Ackr2tm1Gjg
(involves: 129/Sv * C57BL/6) 		dermatitis J:97607
increased inflammatory response J:97806
Ackr3tm1Jgo/Ackr3+
(involves: 129S/SvEvBrd * C57BL/6) 		lung inflammation J:136246
Ackr3tm1Jgo/Ackr3tm1Jgo
(involves: 129S/SvEvBrd * C57BL/6) 		lung inflammation J:136246
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6) 		decreased inflammatory response J:182660
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J) 		liver inflammation J:174942
Acox2em1Jynz/Acox2em1Jynz
(involves: C57BL/6N) 		liver inflammation J:323193
Acss2em22Gpt/Acss2em22Gpt
(C57BL/6JGpt-Acss2em22Gpt/Gpt) 		decreased susceptibility to endotoxin shock J:346990
Actbtm4(cre/ERT2)Npa/Actb+
Sgpl1tm1.1Npa/Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6) 		abnormal type IV hypersensitivity reaction J:199525
Acvr1tm1Emsh/Acvr1+
(chimera involves: BALB/c * C57BL/6 * CD-1) 		increased inflammatory response J:194134
Adatm1Mw/Adatm1Mw
Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6) 		lung inflammation J:73418
Adam7tm1Tigm/Adam7tm1Tigm
(involves: C57BL/6) 		spermatic granuloma J:226260
Adam8tm1.1Mdz/Adam8tm1.1Mdz
(DBA/1LacJ-Adam8tm1.1Mdz) 		decreased susceptibility to induced arthritis J:155243
Adam17m1Btlr/Adam17m1Btlr
(C57BL/6J-Adam17m1Btlr) 		increased susceptibility to induced colitis J:166602
Adam17tm1.1Srj/Adam17tm1.1Srj
(involves: 129S/SvEv * C57BL/6 * SJL) 		increased susceptibility to induced colitis J:163380
skin inflammation J:163380
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Il17atm1Yiw/Il17atm1Yiw
Sox9tm3(cre)Crm/Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL) 		dermatitis J:229771
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Il23atm1Dnax/Il23atm1Dnax
Sox9tm3(cre)Crm/Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL) 		dermatitis J:229771
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+
(B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl) 		dermatitis J:229771
Adam17tm1Bbl/Adam17tm1Bbl
Lyz2tm1(cre)Ifo/0
(involves: 129P2/OlaHsd) 		decreased susceptibility to endotoxin shock J:139846
Adam17tm1Bbl/Adam17tm1Bbl
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased susceptibility to endotoxin shock J:139846
Adam17tm1Imx/Adam17tm1Imx
(involves: 129 * C57BL/6) 		increased incidence of corneal inflammation J:51053
Adam17woe/Adam17woe
(C57BL/6-Adam17woe) 		dermatitis J:160781
increased incidence of corneal inflammation J:160781
Adam29em1Otin/Adam29em1Otin
(C57BL/6-Adam29em1Otin) 		increased inflammatory response J:353244
Adamdec1tm1Dgen/Adamdec1+
(B6.129P2-Adamdec1tm1Dgen) 		increased susceptibility to induced colitis J:301741
Adamdec1tm1Dgen/Adamdec1tm1Dgen
(B6.129P2-Adamdec1tm1Dgen) 		increased susceptibility to colitis induced morbidity/mortality J:301741
increased susceptibility to induced colitis J:301741
intestinal inflammation J:301741
Adamts5tm1.1Eam/Adamts5+
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced arthritis J:97590
Adamts5tm1.1Eam/Adamts5tm1.1Eam
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced arthritis J:97590
Adamts5tm1Lex/Adamts5tm1Lex
Tg(CMV-cre)1Cgn/0
(involves: 129S5/SvEvBrd * BALB/cJ) 		osteoarthritis J:105138
Adamts5tm2.2Lex/Adamts5tm2.2Lex
(B6.129S5-Adamts5tm2.2Lex) 		decreased susceptibility to induced arthritis J:175366
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd
Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6) 		dermatitis J:271185
Adamts18tm1.1Wzha/Adamts18tm1.1Wzha
(involves: 129 * C57BL/6) 		increased acute inflammation J:258487
increased susceptibility to induced colitis J:258487
Adcy7tm1.1Pcst/Adcy7tm1.1Pcst
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J) 		peritoneal inflammation J:191067
Adm2em1Zhan/Adm2em1Zhan
(Not Specified) 		increased inflammatory response J:266495
liver inflammation J:266495
Admtm1Tfjt/Adm+
(involves: C57BL/6 * CBA) 		blood vessel inflammation J:102946
Adora2btm1Kra/Adora2btm1Kra
(involves: 129 * C57BL/6J) 		abnormal inflammatory response J:111715
Adora2btm1Till/Adora2btm1Till
(B6.129P2-Adora2btm1Till) 		increased susceptibility to type I hypersensitivity reaction J:125297
Adora3tm1Jbsn/Adora3tm1Jbsn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased acute inflammation J:120442
Adtrptm1.1Clu/Adtrptm1.1Clu
(involves: 129S4/SvJaeSor * C57BL/6) 		increased inflammatory response J:295059
Aec1NOD/Uf/Aec1NOD/Uf
Aec2NOD/Uf/Aec2NOD/Uf
(B6.NOD-Aec2NOD/Uf Aec1NOD/Uf) 		lacrimal gland inflammation J:129282
salivary gland inflammation J:129282
Agnm1MRL/MpJ/Agnm1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		glomerulonephritis J:97786
Agnm2C3H/HeJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		glomerulonephritis J:97786
Agnm2MRL/MpJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		glomerulonephritis J:97786
Agnm3C3H/HeJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		glomerulonephritis J:97786
Agnm3MRL/MpJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		glomerulonephritis J:97786
Agp1NZB/Agp1NZB
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Agp1NZB/Agp1NZW
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Agp2NZB/Agp2NZW
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Agp2NZW/Agp2NZW
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		brown adipose tissue inflammation J:186035
granulomatous inflammation J:186035
liver inflammation J:186035
Agr2tm1.1Lpkn/Agr2tm1.1Lpkn
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		colitis J:156704
Agr2tm1.2Erle/Agr2tm1.2Erle
(involves: 129S4/SvJae * FVB/N) 		increased susceptibility to induced colitis J:148339
Agr2tm1.2Lpkn/Agr2tm1.2Lpkn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		colitis J:156704
ileum inflammation J:156704
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA) 		tubulointerstitial nephritis J:46506
Agttm1Unc/Agttm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		tubulointerstitial nephritis J:24156
Agtr1atm1Unc/Agtr1atm1Unc
Agtr1btm1Cof/Agtr1btm1Cof
(involves: 129P2/OlaHsd * C57BL/6) 		kidney inflammation J:137944
Ahi1tm1Jgg/Ahi1tm1Jgg
Tg(TCF/Lef1-lacZ)34Efu/0
(involves: 129S1/Sv * 129X1/SvJ) 		kidney inflammation J:154321
Ahrb-1/Ahrb-1
(C57BL/6J) 		increased inflammatory response J:5244, J:5387
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:148870
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra/J) 		lung inflammation J:118646, J:100359
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N) 		bile duct inflammation J:25048
colitis J:44690
folliculitis J:44690
heart inflammation J:44690
increased inflammatory response J:25048
Ahrtm1Yfk/Ahrtm1Yfk
(involves: 129S/SvEv * C57BL/6J) 		urinary bladder inflammation J:179919
Aif1tm1Nsib/Aif1tm1Nsib
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to induced arthritis J:204462
Aim2tm1.2Arte/Aim2tm1.2Arte
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129 * BALB/c * C57BL/6 * C57BL/6J) 		rheumatoid arthritis J:238323
Aimp1Gt(OST58507)Lex/Aimp1Gt(OST58507)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased inflammatory response J:95974
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6) 		stomach inflammation J:119475
Airetm1.1Doi/Airetm1.1Doi
(B6.129S2-Airetm1.1Doi/Doi) 		increased incidence of corneal inflammation J:107432
lung inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi) 		increased incidence of corneal inflammation J:107432
liver inflammation J:107432
lung inflammation J:107432
ovary inflammation J:107432
pancreas inflammation J:107432
prostate gland inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
thyroid gland inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi) 		increased incidence of corneal inflammation J:107432
liver inflammation J:107432
lung inflammation J:107432
ovary inflammation J:107432
prostate gland inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi) 		liver inflammation J:107432
lung inflammation J:107432
ovary inflammation J:107432
pancreas inflammation J:107432
prostate gland inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6 * NOD) 		liver inflammation J:107432
lung inflammation J:107432
pancreas inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2-Airetm1.1Doi) 		chronic pancreas inflammation J:135154
insulitis J:135154
lacrimal gland inflammation J:135154
lung inflammation J:135154
salivary gland inflammation J:135154
stomach inflammation J:135154
thyroid gland inflammation J:135154
uveitis J:135154
Airetm1.1Doi/Airetm1.1Doi
H2b/H2b
(NOD.Cg-Airetm1.1Doi H2b/Doi) 		stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
Idd3C57BL/6/Idd3C57BL/6
Idd5C57BL/10SnJ/Idd5C57BL/10SnJ
(NOD.Cg-Idd3C57BL/6 Idd5C57BL/10SnJ Airetm1.1Doi/Doi) 		stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
Il1r1tm1Imx/Il1r1+
(involves: 129S2/SvPas * 129S7/SvEvBrd * NOD) 		keratoconjunctivitis J:163691
lacrimal gland inflammation J:163691
Airetm1.1Doi/Airetm1.1Doi
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S2/SvPas * 129S7/SvEvBrd * NOD) 		keratoconjunctivitis J:163691
lacrimal gland inflammation J:163691
Airetm1Mand/Aire+
(involves: 129P2/OlaHsd * C57BL/6) 		lacrimal gland inflammation J:135154
salivary gland inflammation J:135154
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand) 		chronic pancreas inflammation J:135154
CNS inflammation J:135154
increased inflammatory response J:188686
insulitis J:135154
lacrimal gland inflammation J:135154
salivary gland inflammation J:135154
thyroid gland inflammation J:135154
Airetm1Mand/Airetm1.1Doi
(NOD.129-Airetm1Mand/Airetm1.1Doi) 		chronic pancreas inflammation J:135154
insulitis J:135154
lacrimal gland inflammation J:135154
lung inflammation J:135154
salivary gland inflammation J:135154
stomach inflammation J:135154
thyroid gland inflammation J:135154
uveitis J:135154
Airetm1Mand/Airetm1Mand
(involves: 129P2/OlaHsd * C57BL/6) 		eye inflammation J:135154
lacrimal gland inflammation J:135154
salivary gland inflammation J:135154
Airetm1Mmat/Airetm1Mmat
(involves: C57BL/6 * CBA) 		lacrimal gland inflammation J:96580
pancreas inflammation J:96580
parotid gland inflammation J:96580
stomach inflammation J:96580
submandibular gland inflammation J:96580
Airetm1Mmat/Airetm1Mmat
(C.Cg-Airetm1Mmat) 		stomach inflammation J:96580
Airetm1Mmat/Airetm1Mmat
(B6.Cg-Airetm1Mmat) 		salivary gland inflammation J:96580
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6) 		liver inflammation J:77873
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn) 		liver inflammation J:115076
Airetm1Ptsn/Airetm1Ptsn
(C57BL/6-Airetm1Ptsn) 		parotid gland inflammation J:145910
sublingual gland inflammation J:145910
uveitis J:145910
vitreous body inflammation J:145910
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn) 		stomach inflammation J:174653
Ak7Gt(OST434404)Lex/Ak7Gt(OST434404)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		rhinosinusitis J:185566
Ak7Tg(tetO-Hmox1)67Sami/Ak7Tg(tetO-Hmox1)67Sami
(FVB/N-Ak7Tg(tetO-Hmox1)67Sami) 		respiratory system inflammation J:186062
rhinitis J:186062
Akap12tm1Ihg/Akap12tm1Ihg
(involves: 129S4/SvJae * C57BL/6) 		liver inflammation J:138882
Akip1em1Cya/Akip1em1Cya
(C57BL/6N-Akip1em1Cya) 		decreased susceptibility to endotoxin shock J:326919
Aknatm1Mak/Aknatm1Mak
(B6.129P2-Aknatm1Mak) 		alveolitis J:233952
increased acute inflammation J:233952
lung inflammation J:233952
Akr1b8tm1Dgen/Akr1b8tm1Dgen
(Not Specified) 		increased susceptibility to induced colitis J:301852
Akr1c21em1Wany/Akr1c21em1Wany
(involves: C57BL/6) 		increased acute inflammation J:322353
lung inflammation J:322353
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6N) 		kidney inflammation J:276210
liver inflammation J:276210
lung inflammation J:276210
peritoneal inflammation J:276210
Aldh18a1tm1a(KOMP)Wtsi/Aldh18a1+
(C57BL/6N-Aldh18a1tm1a(KOMP)Wtsi/Wtsi) 		skin inflammation J:232539
Aldobtm1(KOMP)Vlcg/Aldobtm1(KOMP)Vlcg
(C57BL/6NTac-Aldobtm1(KOMP)Vlcg) 		liver inflammation J:220330
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		tubulointerstitial nephritis J:100403
Alox5tm1Bhk/Alox5tm1Bhk
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)) 		abnormal inflammatory response J:68714
decreased acute inflammation J:68714
decreased susceptibility to type I hypersensitivity reaction J:68714
Alox5tm1Fun/Alox5tm1Fun
(involves: 129S2/SvPas * C57BL/6) 		decreased inflammatory response J:21372, J:75371
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased susceptibility to type I hypersensitivity reaction J:39229
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv) 		decreased acute inflammation J:39229
Alox5aptm1Jdm/Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm) 		decreased susceptibility to induced arthritis J:100736
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm) 		decreased inflammatory response J:100736
decreased susceptibility to induced arthritis J:100736
Alox8tm1a(KOMP)Wtsi/Alox8tm1a(KOMP)Wtsi
(C57BL/6N-Alox8tm1a(KOMP)Wtsi/MbpMmucd) 		lung inflammation J:277623
Alox15tm1Fun/Alox15tm1Fun
(B6.129S2-Alox15tm1Fun/J) 		dermatitis J:119405
Als2tm1Jei/Als2tm1Jei
(involves: 129P2/OlaHsd * C57BL/6J) 		CNS inflammation J:104446
amdA/J/amdA/J
(involves: A/J * C57BL/6J) 		myocarditis J:2843, J:11025
amdDBA/2J/amdDBA/2J
(B10.D2-H8b/(57N)SnJ) 		myocarditis J:11025
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm) 		liver inflammation J:221247
Ampd3tm1Tm/Ampd3tm1Tm
(Not Specified) 		lung inflammation J:201211
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J) 		glomerulonephritis J:199427
Ankank/Ankank
(involves: C3HeB/FeJ * C57BL/6J * JGBF/LeJ) 		autoimmune arthritis J:63420
Ankrd2tm1Krc/Ankrd2tm1Krc
(involves: 129 * Black Swiss) 		abnormal inflammatory response J:214867
Ano5em1Huyi/Ano5em1Huyi
(C57BL/6N-Ano5em1Huyi) 		periodontium inflammation J:294237
Ano5em2Huyi/Ano5em2Huyi
(C57BL/6-Ano5em2Huyi) 		osteomyelitis J:336715
Anta/Anta+
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		glomerulonephritis J:169366
anx/anx
(B6C3Fe a/a-anx/J) 		abnormal inflammatory response J:103396
Anxa1tm1Rjf/Anxa1+
(Not Specified) 		increased inflammatory response J:81498
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified) 		increased inflammatory response J:81498
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: BALB/c) 		increased susceptibility to induced colitis J:142735
Anxa5tm1Epo/Anxa5tm1Epo
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal inflammatory response J:117249
decreased susceptibility to type IV hypersensitivity reaction J:117249
Anxa7tm1Pll/Anxa7+
(Not Specified) 		pancreas inflammation J:58572
Aoc3tm1Salm/Aoc3tm1Salm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		decreased inflammatory response J:95656
Aod1aA/J/?
(involves: A/J * C57BL/6J) 		ovary inflammation J:83714
Aod1bC57BL/6J/?
(involves: A/J * C57BL/6J) 		ovary inflammation J:83714
Aod3A/J/?
(A/J) 		ovary inflammation J:78005
aol/aol
(involves: C3H * C57BL/6) 		osteoarthritis J:115238
Ap3b1pe/Ap3b1pe
Hps1ep/Hps1ep
(involves: C3H/He * C3HeB/FeJ * C57BL/6J) 		lung inflammation J:85431
Apba3tm1.1Ski/Apba3tm1.1Ski
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129-Apba3tm1.1Ski Lyz2tm1(cre)Ifo) 		decreased susceptibility to endotoxin shock J:176742
Apba3tm1.2Ski/Apba3tm1.2Ski
(B6.129-Apba3tm1.2Ski) 		decreased susceptibility to endotoxin shock J:176742
ApcMin/Apc+
Esr2tm1Mma/Esr2tm1Mma
(involves: 129S2/SvPas * C57BL/6J) 		colitis J:118600
Apctm1Tno/Apc+
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre/ERT)1Dwi/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA) 		peritoneal inflammation J:143082
Apctm2.1Cip/Apctm2.1Cip
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco) 		liver inflammation J:184496
Apctm2.1Cip/Apctm2.1Cip
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco) 		liver inflammation J:184496
Apcstm1Mpe/Apcs+
(B6.Cg-Apcstm1Mpe) 		glomerulonephritis J:90502
Apcstm1Mpe/Apcstm1Mpe
(B6.Cg-Apcstm1Mpe) 		glomerulonephritis J:90502
Apcstm1Mpe/Apcstm1Mpe
(129.Cg-Apcstm1Mpe) 		glomerulonephritis J:90502
Apcstm1Smae/Apcstm1Smae
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to endotoxin shock J:71194
Apex1tm1Ecf/Apex1+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6)) 		heart inflammation J:70397
myocarditis J:70397
pericarditis J:70397
Apoa4tm1Bres/Apoa4tm1Bres
(B6.129S4-Apoa4tm1Bres) 		increased susceptibility to induced colitis J:91357
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL) 		aortitis J:227165
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		blood vessel inflammation J:91058
decreased susceptibility to type IV hypersensitivity reaction J:61564
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		lung inflammation J:83615
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr) 		glomerulonephritis J:121671
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc) 		blood vessel inflammation J:91058
kidney inflammation J:200141
Apoetm1Unc/Apoetm1Unc
Gja5tm1Mchn/Gja5tm1Mchn
Tg(TIE2-lacZ)182Sato/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		alveolitis J:162224
Apoetm1Unc/Apoetm1Unc
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		lung inflammation J:83615
Apoetm1Unc/Apoetm1Unc
Klf15tm2Jain/Klf15tm2Jain
Tg(Tagln-cre)1Jjl/0
(involves: 129P2/OlaHsd * FVB/N) 		blood vessel inflammation J:203920
Apoetm1Unc/Apoetm1Unc
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129P2/OlaHsd * 129S2/SvPas) 		decreased acute inflammation J:123854
Apoetm1Unc/Apoetm1Unc
Nck1tm1Paw/Nck1tm1Paw
Nck2tm3Paw/Nck2tm3Paw
Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased inflammatory response J:326659
Apoetm1Unc/Apoetm1Unc
Soat1tm1Far/Soat1tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J) 		skin inflammation J:61147
Apoetm1Unc/Apoetm1Unc
Tg(MSR1-Plau)1Ddi/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		heart inflammation J:101486
Apol6em1Hsul/Apol6em1Hsul
(Not Specified) 		decreased inflammatory response J:344362
Apptm2.1Ldad/Apptm2.1Ldad
(involves: 129 * C57BL/6J) 		myositis J:166989
Apptm3.1Tcs/Apptm3.1Tcs
Mapttm1.1(MAPT)Tcs/Mapttm1.1(MAPT)Tcs
(involves: 129S/SvEv * C57BL/6) 		CNS inflammation J:278451
Aprttm1Dwm/Aprttm1Dwm
(129P2/OlaHsd-Aprttm1Dwm) 		pyelonephritis J:38450
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * Black Swiss) 		kidney inflammation J:33255
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * C57BL/6J) 		kidney inflammation J:33255
Aprttm1Vri/Aprttm1Vri
(involves: 129P2/OlaHsd * C57BL/6) 		kidney inflammation J:50874
Aqp3m1Btlr/Aqp3m1Btlr
(C57BL/6J-Aqp3m1Btlr) 		increased susceptibility to induced colitis J:153279
Aqp12tm1Rai/Aqp12tm1Rai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to induced pancreatitis J:155920
Artm1Verh/Y
Rnase10tm1(cre)Hht/Rnase10+
(involves: 129S7/SvEvBrd * C57BL/6) 		testis inflammation J:173897
Aregtm1Dle/Aregtm1Dle
Egftm1Dle/Egftm1Dle
Tgfatm1Unc/Tgfatm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		dermatitis J:54980
Arel1em1Bbc/Arel1+
(C57BL/6J-Arel1em1Bbc) 		decreased acute inflammation J:280563
Arel1em1Bbc/Arel1em1Bbc
(C57BL/6J-Arel1em1Bbc) 		decreased acute inflammation J:280563
Arhgap17Gt(RRN062)Byg/Arhgap17Gt(RRN062)Byg
(B6.129P2-Arhgap17Gt(RRN062)Byg) 		increased susceptibility to induced colitis J:277297
Arhgap25tm1a(KOMP)Wtsi/Arhgap25tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		increased acute inflammation J:240521
Arhgdiatm1Ytk/Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA) 		tubulointerstitial nephritis J:57995
Arid5bGt(ROSA)75Sor/Arid5bGt(ROSA)75Sor
(involves: 129S4/SvJaeSor) 		kidney inflammation J:117491
Arih2tm1Mak/Arih2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		dermatitis J:191066
heart inflammation J:191066
increased inflammatory response J:191066
liver inflammation J:191066
lung inflammation J:191066
Arih2tm1Mak/Arih2tm1Mak
(B6.129P2-Arih2tm1Mak) 		increased inflammatory response J:191066
Arl3Gt(OST263303)Lex/Arl3Gt(OST263303)Lex
(involves: 129S5/SvEvBrd) 		bile duct inflammation J:107331
Arpc4tm1c(EUCOMM)Wtsi/Arpc4tm1c(EUCOMM)Wtsi
Krt14tm1(cre)Wbm/Krt14+
(B6.Cg-Arpc4tm1c(EUCOMM)Wtsi Krt14tm1(cre)Wbm) 		dermatitis J:253986
Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6) 		increased acute inflammation J:112607
increased susceptibility to endotoxin shock J:112607
asa/asa
(either: A/J or BALB/c or DBA/2J) 		myocarditis J:2843
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6) 		lung inflammation J:285931
Ash1lGt(AL0395)Wtsi/Ash1lGt(AL0395)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J) 		blepharitis J:227516
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu) 		glomerulonephritis J:208213
increased susceptibility to endotoxin shock J:208213
increased susceptibility to induced arthritis J:208213
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
Il6tm1Kopf/Il6tm1Kopf
(B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf) 		abnormal inflammatory response J:208213
increased susceptibility to induced arthritis J:208213
Asm2MRL/MpJ/?
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		salivary gland inflammation J:66459
Asq1IQI/Asq1IQI
(involves: IQI * C57BL/6CrSlc) 		salivary gland inflammation J:127310
Atf2tm1Glm/Atf2tm1Glm
(involves: 129S2/SvPas) 		eye inflammation J:30611
Atf2tm1Glm/Atf2tm1Glm
(C.Cg-Atf2tm1Glm) 		increased susceptibility to endotoxin shock J:67176
Atf3tm1Dron/Atf3tm1Dron
(involves: 129X1/SvJ * C57BL/6) 		lung inflammation J:140112
Atg5tm1Myok/Atg5tm1Myok
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv) 		glomerulonephritis J:235399
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj) 		glomerulonephritis J:235399
Atg7tm1Tchi/Atg7tm1Tchi
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Defa6-icre)1Rsb/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		small intestinal inflammation J:206084
Atg7tm1Tchi/Atg7tm1Tchi
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		ileum inflammation J:206084
intestinal inflammation J:206084
Atg16l1tm1Aki/Atg16l1tm1Aki
(involves: 129/Sv * C57BL/6) 		increased susceptibility to induced colitis J:141420
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi
Tcrdtm1Mom/Tcrdtm1Mom
Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N * SJL) 		increased susceptibility to colitis induced morbidity/mortality J:340266
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi
Tg(Defa6-icre)1Rsb/0
(involves: C57BL/6) 		increased susceptibility to colitis induced morbidity/mortality J:340266
increased susceptibility to induced colitis J:340266
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi
Tg(Vil1-cre)997Gum/?
(involves: C57BL/6J * C57BL/6N * SJL) 		cecum inflammation J:221019
Atg16l1tm1Kuv/Atg16l1tm1Kuv
Tg(Vil1-cre)997Gum/0
(B6.Cg-Atg16l1tm1Kuv Tg(Vil1-cre)997Gum) 		increased susceptibility to induced colitis J:269933
small intestinal inflammation J:269933
Atg16l1tm1Kuv/Atg16l1tm1Kuv
Tg(Vil1-cre)997Gum/0
Xbp1tm2Glm/Xbp1tm2Glm
(B6.Cg-Atg16l1tm1Kuv Xbp1tm2Glm Tg(Vil1-cre)997Gum) 		small intestinal inflammation J:269933
Atg16l1tm1Kuv/Atg16l1tm1Kuv
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		ileum inflammation J:206084
intestinal inflammation J:206084
Atl1tm1.2Cbla/Atl1tm1.2Cbla
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6.Cg-Reep1Gt(OST398247)Tigm Atl1tm1.2Cbla) 		increased susceptibility to otitis media J:334532
Atp5if1em1Jpy/Atp5if1em1Jpy
(C57BL/6J-Atp5if1em1Jpy) 		decreased susceptibility to colitis induced morbidity/mortality J:312819
Atp7aMo-blo/Y
(B6.Cg-Atp7aMo-blo/J) 		osteoarthritis J:36378
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		kidney inflammation J:123200
AW112010em2Flv/AW112010em2Flv
(involves: C57BL/6N) 		decreased susceptibility to induced colitis J:267975
Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J) 		blepharitis J:308387
eye inflammation J:308387
Awat2tm1.2Golc/Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J) 		blepharitis J:308387
eye inflammation J:308387
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		joint inflammation J:70420
B2mtm1Jae/B2mtm1Jae
Foxp3sfOtcspf/Y
(involves: 129/Rl * 129S2/SvPas) 		dermatitis J:20865
B2mtm1Jae/B2mtm1Jae
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		small intestinal inflammation J:108572
B2mtm1Unc/B2mtm1Unc
(involves: 129P2/OlaHsd * NOD/Lt) 		insulitis J:93557
B2mtm1Unc/B2mtm1Unc
Il2tm1Hor/Il2tm1Hor
(involves: 129 * C57BL/6) 		colitis J:39981, J:51450
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to induced colitis J:123826
B3gnt6tm1Lx/B3gnt6tm1Lx
C1galt1tm1.1Rpmc/C1galt1tm1.1Rpmc
Tg(Vil1-cre)997Gum/0
(involves: 129S1/Sv * C57BL/6J * SJL) 		small intestinal inflammation J:239765
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased acute inflammation J:106669
decreased susceptibility to type IV hypersensitivity reaction J:106669
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		glomerulonephritis J:117891
B4gat1tm1Mifu/B4gat1tm1Mifu
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:120722
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal inflammatory response J:123547
colitis J:123547
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		colitis J:169839
liver inflammation J:169839
lung inflammation J:169839
B9d2/Tgfb1tm1Flv/B9d2/Tgfb1tm1Flv
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal inflammatory response J:123547
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		colitis J:169839
liver inflammation J:169839
lung inflammation J:169839
Bag4tm1Yeh/Bag4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6) 		increased inflammatory response J:83559
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		autoimmune arthritis J:100463
glomerulonephritis J:100463
Bap1tm1.1Geno/Bap1tm1.1Geno
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		heart inflammation J:187380
Bbaa1C3H/HeNCr/Bbaa1C3H/HeNCr
(involves: C3H/HeNCr * C57BL/6NCr) 		abnormal inflammatory response J:52017
Bbaa1C3H/HeNCr/Bbaa1C57BL/6NCr
(involves: C3H/HeNCr * C57BL/6NCr) 		abnormal inflammatory response J:52017
Bbaa3C3H/HeNCr/Bbaa3C3H/HeNCr
(involves: C3H/HeNCr * C57BL/6NCr) 		abnormal inflammatory response J:73060
Bbaa3C3H/HeNCr/Bbaa3C57BL/6NCr
(involves: C3H/HeNCr * C57BL/6NCr) 		abnormal inflammatory response J:52017
Bbaa10C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa11C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa12C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa13C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa14C3H/HeJ/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa16C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa17C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa18C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa20C3H/HeJ/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa22C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbaa23C3H/HeN/?
(involves: C3H/HeN * C57BL/6N) 		increased inflammatory response J:73060
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6) 		decreased inflammatory response J:189019
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased inflammatory response J:292505
Bcas1tm1Himo/Bcas1tm1Himo
(C57BL/6-Bcas1tm1Himo) 		brain inflammation J:242041
Bcl2a1atm1Prys/Bcl2a1atm1Prys
(involves: 129/Sv * C57BL/6J * SJL) 		decreased inflammatory response J:74478
Bcl2l11tm1.1Ast/Bcl2l11+
(involves: 129S1/Sv * C57BL/6) 		glomerulonephritis J:58641
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6) 		glomerulonephritis J:58641
increased inflammatory response J:58641
Bcl2l14tm1.1Boui/Bcl2l14tm1.1Boui
(involves: C57BL/6) 		abnormal susceptibility to induced colitis J:296081
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		white adipose tissue inflammation J:271078
Bcl6tm1Htno/Bcl6tm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		lung inflammation J:55952
myocarditis J:55952
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv) 		heart inflammation J:40769
increased inflammatory response J:40769
liver inflammation J:40769
lung inflammation J:40769
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv) 		heart inflammation J:40769
increased inflammatory response J:40769
liver inflammation J:40769
lung inflammation J:40769
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas) 		increased susceptibility to endotoxin shock J:23804
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp) 		liver inflammation J:273501
Bdkrb1tm1Bdr/Bdkrb1tm1Bdr
(involves: 129P2/OlaHsd) 		abnormal acute inflammation J:63271
decreased susceptibility to endotoxin shock J:135789
Bdkrb1tm2Bdr/Bdkrb1tm2Bdr
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to endotoxin shock J:135789
Becn1tm1Ebr/Becn1tm1Ebr
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd) 		glomerulonephritis J:235399
Best3tm1.1Zhoj/Best3tm1.1Zhoj
Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * SJL) 		aortitis J:338981
Bgntm1Mfy/Y
(involves: 129S4/SvJae * C57BL/6) 		osteoarthritis J:76203
Bgntm1Mfy/Y
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		osteoarthritis J:76203
Bgntm1Mfy/Y
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		accelerated temporomandibular joint osteoarthritis J:112779, J:117908
Bgntm1Mfy/Bgntm1Mfy
(involves: 129S4/SvJae) 		osteoarthritis J:222369
Bgntm1Mfy/Bgntm1Mfy
Epyctm1Mhok/Epyctm1Mhok
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		osteoarthritis J:222369
Bgntm1Mfy/Bgntm1Mfy
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		accelerated temporomandibular joint osteoarthritis J:117908
bhe/bhe
(Not Specified) 		chronic inflammation J:85113
Bidtm1Sjk/Bidtm1Sjk
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to endotoxin shock J:117693
Bin1tm1Gcp/Bin1tm2Gcp
Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL) 		endometrium inflammation J:117330
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6) 		liver inflammation J:133313
lung inflammation J:133313
Birc3tm1Rgk/Birc3tm1Rgk
(B6.129X1-Birc3tm1Rgk) 		decreased susceptibility to endotoxin shock J:144012
Bld/Bld+
(involves: BALB/cCi) 		increased incidence of corneal inflammation J:5076
Blmhtm1Geh/Blmhtm1Geh
(either: (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		dermatitis J:54585
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J) 		lung inflammation J:4098
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra) 		increased incidence of corneal inflammation J:110697
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		lung inflammation J:17712
Bmp5se-Ca/Bmp5+
(SEACGn.CB-Bmp5se-Ca) 		granulomatous inflammation J:5086
Bmp5se-Ca/Bmp5se-Ca
(CBA/Ca-Bmp5se-Ca) 		granulomatous inflammation J:5086
Bmp5se-Ca/Bmp5se-Ca
(SEACGn.CB-Bmp5se-Ca) 		granulomatous inflammation J:5086
Bmp5se/Bmp5se
(SEC/1Gn) 		granulomatous inflammation J:5086
Bmp5se/Bmp5se
(SEAC/Gn) 		granulomatous inflammation J:5086
Bmp7tm1.1Dgra/Bmp7tm1.1Dgra
Tg(Prrx1-cre)1Cjt/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * SJL/J) 		joint inflammation J:221175
osteoarthritis J:221175
Bmp7tm1Rob/Bmp7+
Bmp8atm1Blh/Bmp8atm1Blh
(involves: 129S/SvEv * 129S6/SvEvTac * Black Swiss * C57BL/6) 		granulomatous inflammation J:78867
Bmp8atm1Blh/Bmp8a+
Bmp8btm1Blh/Bmp8b+
(involves: 129/Sv * 129S6/SvEvTac * Black Swiss) 		granulomatous inflammation J:46927
Bmp8atm1Blh/Bmp8atm1Blh
(involves: 129S6/SvEvTac * Black Swiss) 		granulomatous inflammation J:46927
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		stomach inflammation J:163367
Bmpr1atm2.1Bhr/Bmpr1atm2.2Bhr
Tg(Gdf5-cre,-ALPP)1Kng/0
(involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng) 		osteoarthritis J:97780
Bmxtm1Ali/Bmxtm1Ali
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to induced arthritis J:173099
Bpitm1.1Buls/Bpitm1.1Buls
(involves: BALB/cJ * C57BL/6J) 		increased susceptibility to induced colitis J:346703
Bpifa1m1Ingm/Bpifa1m1Ingm
(involves: C3HeB/FeJ) 		increased susceptibility to otitis media J:221346
lung inflammation J:195535
Braftm1Mmcm/Braftm1Mmcm
Cd207tm2.1(cre)Bjec/Cd207+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		liver inflammation J:211690
lung inflammation J:211690
Braftm1Mmcm/Braftm1Mmcm
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		cytokine storm J:211690
granulomatous inflammation J:211690
increased inflammatory response J:211690
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		dermatitis J:155810
Brf1tm1Arte/Brf1tm1Arte
Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA) 		liver inflammation J:285667
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas * C57BL/6J) 		interstitial pneumonia J:46376
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129/Sv * 129S2/SvPas) 		interstitial pneumonia J:46376
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas) 		glomerulonephritis J:287636
Btbd8em1Lych/Btbd8em1Lych
(involves: C57BL/6) 		decreased susceptibility to induced colitis J:349252
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J) 		decreased acute inflammation J:92639
increased susceptibility to induced colitis J:92639
Btnl2em1Wche/Btnl2em1Wche
(C57BL/6-Btnl2em1Wche) 		large intestinal inflammation J:321348
Btrctm1Paga/Btrctm1Paga
Fbxw11tm1Ybn/Fbxw11tm1Ybn
Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		intestinal inflammation J:206654
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd) 		glomerulonephritis J:145903
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
X/Yaa
(B10.BXSB-(D13Mit3-D13Mit78) Yaa) 		glomerulonephritis J:145049
C1galt1ptl1/C1galt1ptl1
(C57BL/6-C1galt1ptl1) 		glomerulonephritis J:115272
kidney inflammation J:115272
C1galt1ptl1/C1galt1ptl1
Rag1tm1Bal/Rag1tm1Bal
(involves: 129S4/SvJae * C57BL/6) 		kidney inflammation J:115272
C1qatm1Mjw/C1qatm1Mjw
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		glomerulonephritis J:47315
C1qtnf3tm1Yiw/C1qtnf3tm1Yiw
(involves: C57BL/6NSlc) 		increased susceptibility to induced arthritis J:211893
joint inflammation J:211893
C1qtnf4em1Smoc/C1qtnf4em1Smoc
(C57BL/6JSmoc-C1qtnf4em1Smoc/Smoc) 		increased susceptibility to endotoxin shock J:302282
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw) 		increased susceptibility to induced arthritis J:227217
increased susceptibility to type III hypersensitivity reaction J:227217
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6) 		liver inflammation J:30152
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr) 		abnormal inflammatory response J:113463
brain inflammation J:123658
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae) 		glomerulonephritis J:44715
C3tm1Crr/C3tm1Crr
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6) 		insulitis J:122114
C3tm1Pkna/C3tm1Pkna
(D1.129P2-C3tm1Pkna) 		decreased susceptibility to induced arthritis J:88872
C3ar1tm1Raw/C3ar1tm1Raw
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to endotoxin shock J:68807
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw) 		increased susceptibility to type I hypersensitivity reaction J:80071
C3ar1tm1Raw/C3ar1tm1Raw
Cpn1tm1Raw/Cpn1tm1Raw
(B6.129-C3ar1tm1Raw Cpn1tm1Raw) 		increased acute inflammation J:148315
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6) 		liver inflammation J:30152
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J) 		glomerulonephritis J:111811
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae) 		glomerulonephritis J:44715
C5ar2tm1Cge/C5ar2tm1Cge
(B6.129S1-C5ar2tm1Cge) 		increased inflammatory response J:104092
C9em1Sjlg/C9em1Sjlg
(C57BL/6-C9em1Sjlg) 		decreased susceptibility to endotoxin shock J:301607
C9orf72tm1.1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N) 		dermatitis J:240357
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N) 		brain inflammation J:240357
dermatitis J:240357
liver inflammation J:240357
C9orf72tm1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N) 		dermatitis J:240357
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N) 		dermatitis J:240357
Cacna1ctm2Itl/Cacna1c+
(involves: 129S6/SvEvTac * C57BL/6NTac) 		dermatitis J:201506
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J) 		rhinitis J:92396
Camk2gtm1.1Irt/Camk2gtm1.1Irt
(involves: C57BL/6J) 		increased susceptibility to colitis induced morbidity/mortality J:243363
increased susceptibility to induced colitis J:243363
Camptm1Rlg/Camptm1Rlg
(involves: 129X1/SvJ * C57BL/6) 		increased incidence of corneal inflammation J:199719
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		eye inflammation J:234044
Car2tm1(KOMP)Vlcg/Car2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac) 		pyelonephritis J:216402
Card11m1Btlr/Card11m1Btlr
(C57BL/6J-Card11m1Btlr) 		dermatitis J:149767, J:139069
Card11tm1.1Litt/Card11tm1.1Litt
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129P2/OlaHsd * 129X1/SvJ) 		respiratory system inflammation J:180410
Card11tm1Xav/Card11tm1Xav
(involves: 129 * C57BL/6) 		lung inflammation J:132226
Card11unm/Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu) 		dermatitis J:84042
erythroderma J:84042
increased inflammatory response J:84042
Card14em1Tshu/Card14em1Tshu
(C57BL/6-Card14em1Tshu) 		decreased susceptibility to chemically induced skin inflammation J:289239
Card14em2Tshu/Card14+
(involves: C57BL/6) 		skin inflammation J:289239
Card14em3Tshu/Card14+
(involves: C57BL/6) 		skin inflammation J:289239
Card14em3Tshu/Card14+
Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6) 		decreased inflammatory response J:289239
Card14em9Lutzy/Card14+
(C57BL/6J-Card14em9Lutzy/J) 		skin inflammation J:262723
Card14tm1Lex/Card14tm1Lex
(B6.129S-Card14tm1Lex) 		decreased susceptibility to chemically induced skin inflammation J:253409
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to endotoxin shock J:43088
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
(B6.129S2-Casp1tm1Flv) 		increased susceptibility to induced colitis J:173245
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to endotoxin shock J:43088
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
Slc11a1s/Slc11a1s
(B6.129S2-Casp1tm1Flv) 		cecum inflammation J:124378
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6) 		abnormal inflammatory response J:80568
decreased susceptibility to endotoxin shock J:22964, J:40691
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
(B10.Cg-Casp1tm1Sesh Casp4del H2r H2-T18b) 		decreased inflammatory response J:63488
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
(B6.129S2(NOD)-Casp1tm1Sesh Casp4del) 		decreased susceptibility to endotoxin shock J:193522
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
Tg(Casp4)#Gne/0
(involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ) 		decreased susceptibility to endotoxin shock J:193522
Casp3tm1Mak/Casp3tm1Mak
(B6.129P2-Casp3tm1Mak) 		decreased inflammatory response J:97650, J:179279
Casp4tm1.1Vmd/Casp4tm1.1Vmd
(involves: C57BL/6) 		decreased susceptibility to endotoxin shock J:193522
Casp4tm1Yuan/Casp4tm1Yuan
(involves: 129S4/SvJae * C57BL/6J * DBA/2) 		decreased susceptibility to endotoxin shock J:46167
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		increased inflammatory response J:170815
Casp8tm1Clie/Casp8tm1Clie
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		liver inflammation J:218665
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0
(Not Specified) 		dermatitis J:167299
Casp12tm1Dwni/Casp12tm1Dwni
(involves: 129S1/SvImJ * C57BL/6) 		increased susceptibility to endotoxin shock J:144912
CasrNuf/CasrNuf
(involves: 102/El * C3H/He) 		tongue inflammation J:92612
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL) 		decreased susceptibility to endotoxin shock J:139304
lung inflammation J:87282
Cav1tm1Mls/Cav1tm1Mls
Cav3tm1Mls/Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL) 		heart inflammation J:77372
Cbfa2t2tm1Swh/Cbfa2t2tm1Swh
(either: B6.129S6-Cbfa2t2tm1Swh or (involves: 129S6/SvEvTac * C57BL/6)) 		small intestinal inflammation J:102172
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		lung inflammation J:125953
Cbltm1.1Hua/Cbltm1.1Hua
Lattm1Les/Lattm1Les
(involves: 129P2/OlaHsd) 		liver inflammation J:91369
lung inflammation J:91369
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		liver inflammation J:91369
lung inflammation J:91369
Cbltm2Hua/Cbltm2Hua
Cblbtm1Hua/Cblbtm1Hua
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR) 		dermatitis J:80427
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		liver inflammation J:101303
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm) 		increased susceptibility to otitis media J:147413
sinus inflammation J:147413
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp) 		decreased inflammatory response J:332421
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J) 		decreased susceptibility to endotoxin shock J:143853
Ccl1tm1Sman/Ccl1tm1Sman
(B6.129-Ccl1tm1Sman) 		abnormal inflammatory response J:138942
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:45920
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to induced colitis J:116878
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae) 		decreased inflammatory response J:155025
Ccl3tm1Unc/Ccl3tm1Unc
(involves: 129P2/OlaHsd) 		cecum inflammation J:107677
Ccl3tm1Unc/Ccl3tm1Unc
(B6.129P2-Ccl3tm1Unc/J) 		decreased susceptibility to type III hypersensitivity reaction J:94599
Ccl3tm1Unc/Ccl3tm1Unc
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		CNS inflammation J:90687
Ccl4em1Narl/Ccl4em1Narl
(C57BL/6JNarl-Ccl4em1Narl) 		decreased inflammatory response J:346348
Ccl5tm1Hso/Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:75842
Ccl11tm1Mer/Ccl11tm1Mer
Ccl24tm1Mer/Ccl24tm1Mer
(129S.129S6(Cg)-Ccl24tm1Mer Ccl11tm1Mer) 		abnormal inflammatory response J:102034
Ccl17tm1.1Ifo/Ccl17tm1.1Ifo
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:159098
Ccl21atm1Yout/Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		lacrimal gland inflammation J:244640
Ccl25tm1.1Mal/Ccl25tm1.1Mal
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		intestinal inflammation J:136667
Ccl27aem1Nax/Ccl27aem1Nax
Ccl27alem1Nax/Ccl27alem1Nax
Ccl27bem1Nax/Ccl27bem1Nax
(involves: C57BL/6) 		increased susceptibility to chemically induced skin inflammation J:330550
Ccl27aem1Nax/Ccl27aem1Nax
Ccl27alem1Nax/Ccl27alem1Nax
Ccl27bem1Nax/Ccl27bem1Nax
Ccr10tm1.1Nax/Ccr10+
(involves: C57BL/6) 		uterus inflammation J:330550
Ccl28tm1Takna/Ccl28tm1Takna
(C57BL/6J-Ccl28tm1Takna) 		increased susceptibility to induced colitis J:256896
Ccm2tm1Kwhi/Ccm2tm1.1Kwhi
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/?
(involves: C57BL/6 * CBA) 		CNS inflammation J:173947
Ccnt1Gt(RRR115)Byg/Ccnt1Gt(RRR115)Byg
(involves: 129P2/OlaHsd) 		lacrimal gland inflammation J:130071
salivary gland inflammation J:130071
Ccpg1tm1a(EUCOMM)Hmgu/Ccpg1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ccpg1tm1a(EUCOMM)Hmgu) 		pancreas inflammation J:256708
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae) 		glomerulonephritis J:115119
increased susceptibility to type IV hypersensitivity reaction J:115119
lung inflammation J:43569
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * C57BL/6) 		cecum inflammation J:107677
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129S4/SvJae * C57BL/6) 		granulomatous inflammation J:41324
Ccr1tm1Gao/Ccr1tm1Gao
(involves: C57BL/6) 		decreased susceptibility to type III hypersensitivity reaction J:94599
Ccr1tm1Gao/Ccr1tm1Gao
(B6.129S4-Ccr1tm1Gao) 		bronchiolitis J:162707
Ccr2tm1Blck/Ccr2tm1Blck
Faslpr/Faslpr
(MRL.Cg-Ccr2tm1Blck Faslpr) 		glomerulonephritis J:113343
kidney inflammation J:113343
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR) 		liver inflammation J:111517
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J) 		decreased acute inflammation J:106738
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6) 		decreased inflammatory response J:44345
decreased susceptibility to type I hypersensitivity reaction J:118971
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc) 		decreased susceptibility to induced colitis J:161138
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased inflammatory response J:110814
increased susceptibility to induced colitis J:110814
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae) 		bronchiolitis J:162707
Ccr4tm1Pwr/Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:70088
Ccr5tm1Brv/Ccr5tm1Brv
(either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR)) 		decreased susceptibility to endotoxin shock J:46941
increased susceptibility to type IV hypersensitivity reaction J:46941
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to induced colitis J:110814
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz) 		bronchiolitis J:162707
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd) 		decreased inflammatory response J:227458
Ccr6tm1.1Jmf/Ccr6tm1.1Jmf
(B6.129-Ccr6tm1.1Jmf) 		decreased inflammatory response J:152716
Ccr6tm1Gma/Ccr6tm1Gma
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased inflammatory response J:68191
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6) 		decreased inflammatory response J:124358
Ccr6tm1Lira/Ccr6tm1Lira
(B6.129-Ccr6tm1Lira) 		decreased susceptibility to type I hypersensitivity reaction J:71096
Ccr7tm1Dgen/Ccr7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		chronic inflammation J:101679
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c) 		decreased susceptibility to type IV hypersensitivity reaction J:57976
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor) 		increased inflammatory response J:110910
lacrimal gland inflammation J:110910
parotid gland inflammation J:110910
salivary gland inflammation J:110910
submandibular gland inflammation J:110910
Ccr9tm1.1Mal/Ccr9tm1.1Mal
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		intestinal inflammation J:136667
Ccrl2tm1Lex/Ccrl2tm1Lex
(involves: 129S/SvEvBrd * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:140110
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c) 		myocarditis J:126220
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J) 		lung inflammation J:177038
Cd1d1tm1Crw/Cd1d1tm1Crw
(B6.129S4-Cd1d1tm1Crw) 		decreased susceptibility to induced arthritis J:99107
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6) 		decreased acute inflammation J:93915
Cd1d1tm1Luc/Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc) 		glomerulonephritis J:121187
kidney inflammation J:121187
Cd2apem1Irgu/Cd2apem1Irgu
(C57BL/6-Cd2apem1Irgu) 		kidney inflammation J:294238
Cd3etm1Mal/Cd3etm1Mal
Nlrp1aNeut1/Nlrp1aNeut1
(involves: C57BL/6) 		skin inflammation J:191055
Cd4tm1Mak/Cd4tm1Mak
(PL.129S2(B6)-Cd4tm1Mak/Rdgz) 		brain inflammation J:92227
Cd4tm1Mak/Cd4tm1Mak
(SJL.129S2(B6)-Cd4tm1Mak/Rdgz) 		brain inflammation J:92227
Cd4tm1Mak/Cd4tm1Mak
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		small intestinal inflammation J:108572
Cd14hdl/Cd14hdl
(C57BL/6-Cd14hdl) 		decreased susceptibility to endotoxin shock J:98908
Cd14tm1Frm/Cd14tm1Frm
(involves: 129S4/SvJae) 		decreased susceptibility to endotoxin shock J:98908
Cd14tm1Smg/Cd14tm1Smg
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to endotoxin shock J:32729
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		arteritis J:147840
glomerulonephritis J:147840
kidney inflammation J:147840
Cd28tm1Jmg/Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg) 		increased susceptibility to type I hypersensitivity reaction J:149888
Cd28tm1Ltu/Cd28tm1Ltu
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		skin inflammation J:194503
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:149888
Cd28tm1Mak/Cd28tm1Mak
(B6.129S2-Cd28tm1Mak/J) 		brain inflammation J:57613
Cd28tm1Mak/Cd28tm1Mak
Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak) 		insulitis J:93421
Cd28tm1Mak/Cd28tm1Mak
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * 129S2/SvPas) 		esophageal inflammation J:205692
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:83722
Cd28tm1Pjl/Cd28tm1Pjl
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk) 		decreased susceptibility to type IV hypersensitivity reaction J:83722
Cd33tm1Avrk/Cd33tm1Avrk
(involves: 129X1/SvJ * C57BL/6) 		decreased inflammatory response J:83728
Cd36obl/Cd36obl
(C57BL/6-Cd36obl) 		endophthalmitis J:96018
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ) 		insulitis J:108097
Cd40tm1Kik/Cd40tm1Kik
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type II hypersensitivity reaction J:61673
Cd40tm1Kik/Cd40tm1Kik
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma) 		glomerulonephritis J:113556
Cd44tm1Hbg/Cd44+
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6) 		ileum inflammation J:145626
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ) 		increased acute inflammation J:131974
Cd44tm1Hbg/Cd44tm1Hbg
Tg(TNF)197Gkl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		autoimmune arthritis J:97992
Cd44tm1Mak/Cd44tm1Mak
(B6.129P2-Cd44tm1Mak) 		liver inflammation J:69351
lung inflammation J:111216, J:108245
Cd44tm1Mak/Cd44tm1Mak
(D1.129P2-Cd44tm1Mak) 		increased susceptibility to induced arthritis J:95275
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		decreased acute inflammation J:114341
peritoneal inflammation J:155691
Cd44tm2Kmz/Cd44tm2Kmz
(DBA/1LacJ-Cd44tm2Kmz) 		decreased susceptibility to induced arthritis J:74268
Cd44tm2Kmz/Cd44tm2Kmz
(involves: BALB/c * DBA/1) 		decreased susceptibility to type IV hypersensitivity reaction J:114317
Cd44tm2Kmz/Cd44tm2Kmz
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * BALB/c * DBA/1) 		decreased susceptibility to type IV hypersensitivity reaction J:114317
Cd55tm1Song/Cd55tm1Song
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm) 		myositis J:113567
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129) 		increased susceptibility to induced arthritis J:146711
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm) 		lung inflammation J:123582
myositis J:113567
Cd69tm1Naka/Cd69tm1Naka
(C.129P2-Cd69tm1Naka) 		decreased susceptibility to induced arthritis J:84940
Cd72c/Cd72c
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp) 		liver inflammation J:204782
lung inflammation J:204782
Cd72tm1Tsub/Cd72tm1Tsub
(involves: C57BL/6J) 		glomerulonephritis J:204782
lung inflammation J:204782
Cd72tm1Tsub/Cd72tm1Tsub
Faslpr/Faslpr
(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp) 		glomerulonephritis J:204782
liver inflammation J:204782
lung inflammation J:204782
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz) 		decreased susceptibility to type IV hypersensitivity reaction J:125654
Cd80tm1Shr/Cd80tm1Shr
Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr) 		brain inflammation J:57613
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * NOD) 		insulitis J:61905
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(involves: 129S4/SvJae * FVB/N * NOD) 		insulitis J:113109
Cd81tm1Lvy/Cd81tm1Lvy
(CByJ.129-Cd81tm1Lvy) 		decreased susceptibility to type I hypersensitivity reaction J:46171
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:92721
Cd83tm1Tft/Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:75700
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs) 		increased inflammatory response J:209990
increased susceptibility to endotoxin shock J:209990
Cd99l2tm1.1Dvst/Cd99l2tm1.1Dvst
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:193021
Cd109tm1Mat/Cd109tm1Mat
(involves: 129S6/SvEvTac * C57BL/6J) 		skin inflammation J:188696
Cd151tm1Nki/Cd151tm1Nki
(involves: 129P2/OlaHsd * FVB/N) 		tubulointerstitial nephritis J:114988
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		lung inflammation J:233977
Cd180tm1Kmiy/Cd180tm1Kmiy
Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr) 		blood vessel inflammation J:137066
glomerulonephritis J:137066
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods) 		increased susceptibility to induced arthritis J:65982
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6 * SJL) 		decreased susceptibility to type IV hypersensitivity reaction J:137517
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6) 		abnormal type IV hypersensitivity reaction J:179630
Cd207tm2.1(cre)Bjec/Cd207+
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal type IV hypersensitivity reaction J:179630
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(involves: C57BL/6) 		increased inflammatory response J:217719
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6) 		urinary bladder inflammation J:288225
Cd209btm1Anjm/Cd209btm1Anjm
(B6.129P2-Cd209btm1Anjm) 		decreased susceptibility to endotoxin shock J:159646
decreased susceptibility to induced colitis J:159646
Cd226tm1.1Cln/Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln) 		decreased inflammatory response J:209990
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc) 		increased susceptibility to induced arthritis J:165841
Cd276tm1Lpc/Cd276tm1Lpc
(B6.129-Cd276tm1Lpc) 		increased susceptibility to type I hypersensitivity reaction J:237700
Cd276tm1Lpc/Cd276tm1Lpc
(D1J.129-Cd276tm1Lpc) 		decreased susceptibility to induced arthritis J:237700
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased inflammatory response J:84973
Cd276tm1Mak/Cd276tm1Mak
(C.129P2-Cd276tm1Mak) 		increased inflammatory response J:84973
Cd300lftm1Toki/Cd300lftm1Toki
(Not Specified) 		increased susceptibility to type I hypersensitivity reaction J:190979
respiratory system inflammation J:190979
Cdcs1C3H/HeJBir/Cdcs1C57BL/6J
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn) 		colitis J:72978
Cdcs2C3H/HeJBir/Cdcs2C3H/HeJBir
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt) 		intestinal inflammation J:72978
Cdcs2C3H/HeJBir/Cdcs2C57BL/6J
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt) 		intestinal inflammation J:72978
Cdcs3C3H/HeJBir/Cdcs3C3H/HeJBir
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt) 		intestinal inflammation J:72978
Cdcs4C3H/HeJBir/Cdcs4C57BL/6J
(involves: C3H/HeJBir * C57BL/6J) 		intestinal inflammation J:72978
Cdcs4C57BL/6J/Cdcs4C57BL/6J
(involves: C3H/HeJBir * C57BL/6J) 		intestinal inflammation J:72978
Cdcs5C57BL/6J/Cdcs5C57BL/6J
(involves: C3H/HeJBir * C57BL/6J) 		intestinal inflammation J:72978
Cdcs6C57BL/6J/?
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt) 		intestinal inflammation J:72978
Cdcs7C3H/HeJBir/Cdcs7C3H/HeJBir
(involves: C3H/HeJBir * C57BL/6J) 		intestinal inflammation J:78917
Cdcs8C57BL/6J/Cdcs8C57BL/6J
(involves: C3H/HeJBir * C57BL/6J) 		intestinal inflammation J:78917
Cdcs9C3H/HeJBir/Cdcs9C3H/HeJBir
(involves: C3H/HeJBir * C57BL/6J) 		intestinal inflammation J:78917
Cdcs9C3H/HeJBir/Cdcs9C57BL/6J
(involves: C3H/HeJBir * C57BL/6J) 		intestinal inflammation J:78917
Cdcs10C3H/HeJBir/Cdcs10C3H/HeJBir
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn) 		intestinal inflammation J:78917
Cdcs10C3H/HeJBir/Cdcs10C57BL/6J
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn) 		intestinal inflammation J:72978
Cdh17M1Btlr/Cdh17M1Btlr
(C57BL/6J-Cdh17M1Btlr) 		increased susceptibility to induced colitis J:272090
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)) 		glomerulonephritis J:76041
increased inflammatory response J:76041
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J) 		decreased susceptibility to induced arthritis J:108569
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		glomerulonephritis J:60292, J:70894
Cdsntm1.1Ics/Cdsntm1.1Ics
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S2/SvPas) 		skin inflammation J:153292
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		liver inflammation J:136134
Cebpbtm1Aki/Cebpbtm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:153025
granulomatous inflammation J:153025
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1) 		decreased susceptibility to type IV hypersensitivity reaction J:25215
glomerulonephritis J:25215
Cebpbtm3Nerl/Cebpbtm3Nerl
(either: B6.129P2-Cebpbtm3Nerl or (involves: 129P2/OlaHsd * C57BL/6)) 		myositis J:153686
Cebpdtm1Pfj/Cebpdtm1Pfj
(involves: 129S1/Sv * C57BL/6) 		decreased inflammatory response J:192313
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss) 		colitis J:76024
conjunctivitis J:76024
increased inflammatory response J:76024
lung inflammation J:76024
osteomyelitis J:76024
peritoneal inflammation J:76024
rhinitis J:76024
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac) 		colitis J:76024
conjunctivitis J:76024
increased inflammatory response J:76024
lung inflammation J:76024
osteomyelitis J:76024
peritoneal inflammation J:76024
pleuritis J:76024
rhinitis J:76024
Celsr1ctb-2J/Celsr1ctb-2J
(STOCK Celsr1ctb-2J/GrsrJ) 		increased susceptibility to otitis media J:229303
Celsr1ctb/Celsr1ctb
(CByJ.Cg-Celsr1ctb/GrsrJ) 		increased susceptibility to otitis media J:229303
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N) 		decreased inflammatory response J:215519
Ces2atm1(KOMP)Vlcg/Ces2atm1(KOMP)Vlcg
(C57BL6/N-Ces2atm1(KOMP)Vlcg) 		liver inflammation J:335459
Cfbtm1Pkna/Cfbtm1Pkna
(D1.129P2-Cfbtm1Pkna) 		decreased susceptibility to induced arthritis J:88872
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129/Sv * C57BL/6) 		glomerulonephritis J:78193
increased susceptibility to type III hypersensitivity reaction J:78193
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129) 		glomerulonephritis J:131403
Cfmq1129X1/SvJ/Cfmq1C57BL/6J
Cftrtm1Unc/Cftrtm1Unc
(involves: 129X1/SvJ * C57BL/6J) 		intestinal inflammation J:101842
Cfmq2129X1/SvJ/Cfmq2129X1/SvJ
Cftrtm1Unc/Cftrtm1Unc
(involves: 129X1/SvJ * C57BL/6J) 		intestinal inflammation J:101842
Cfmq3129X1/SvJ/Cfmq3C57BL/6J
Cftrtm1Unc/Cftrtm1Unc
(involves: 129X1/SvJ * C57BL/6J) 		intestinal inflammation J:101842
Cfptm1Song/Cfptm1Song
(involves: 129 * C57BL/6) 		decreased susceptibility to induced arthritis J:165497
Cfptm2.1Song/Cfptm2.1Song
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL) 		decreased susceptibility to induced arthritis J:165497
Cftrtm1Bay/Cftrtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		acute pancreas inflammation J:15244
Cftrtm1Cam/Cftrtm1Cam
(involves: 129S/SvEv) 		peritoneal inflammation J:23850
Cftrtm1Hgu/Cftrtm1Hgu
(involves: 129P2/OlaHsd) 		lung inflammation J:24119
Cftrtm1Kth/Cftrtm1Kth
(involves: 129S7/SvEvBrd * C57BL/6J) 		peritoneal inflammation J:29074
Cftrtm1Kth/Cftrtm1Kth
(B6.129S7-Cftrtm1Kth) 		lung inflammation J:112450
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc/J) 		lung inflammation J:58571, J:112450
Cftrtm1Unc/Cftrtm1Unc
(involves: 129P2/OlaHsd) 		peritoneal inflammation J:2079
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc) 		lung inflammation J:44904
Cftrtm1Unc/Cftrtm1Unc
Tg(FABPCFTR)1Jaw/0
Tg(Scgb1a1-Scnn1b)6608Bouc/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N) 		respiratory system inflammation J:191673
Cftrtm2Cam/Cftrtm2Cam
(involves: 129S/SvEv) 		peritoneal inflammation J:27734
Cftrtm2Mrc/Cftrtm2Mrc
(B6.129S6-Cftrtm2Mrc) 		lung inflammation J:112450
Cftrtm3Hgu/Cftrtm3Hgu
(involves: 129P2/OlaHsd) 		gallbladder inflammation J:32766
peritoneal inflammation J:32766
Cftrtm3Mrc/Cftrtm3Mrc
(B6.129S6-Cftrtm3Mrc) 		lung inflammation J:112450
Cgnz1NZM2328/J/Cgnz1NZM2328/J
(involves: C57L/J * NZM2328/J) 		kidney inflammation J:71397
Chchd10em8Lutzy/Chchd10+
(C57BL/6NJ-Chchd10em8Lutzy/J) 		increased susceptibility to otitis media J:272524
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		arteritis J:146176
heart inflammation J:146176
interstitial pneumonia J:146743
liver inflammation J:146743
myocarditis J:146743
Chd7Flo/Chd7+
(involves: C3HeB/FeJ) 		keratoconjunctivitis sicca J:104123
Chd7Looper/Chd7+
(BALB/c-Chd7Looper) 		blepharitis J:252089
conjunctivitis J:252089
Chd7Ome/Chd7+
(involves: BALB/cByJ * C57BL/6J) 		increased susceptibility to otitis media J:187200
Chd7Trooper/Chd7+
(BALB/c-Chd7Trooper) 		blepharitis J:262283
conjunctivitis J:262283
Chd7Whi/Chd7+
(involves: C3HeB/FeJ) 		keratoconjunctivitis sicca J:104123
Chrna3tm1Bay/Chrna3tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		urinary bladder inflammation J:54994
Chrnb2tm1Mdb/Chrnb2tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(involves: 129S7/SvEvBrd * C57BL/6J) 		urinary bladder inflammation J:73590
Chsy1skt/Chsy1skt
Pde6b+/Pde6b+
(mixed) 		kidney inflammation J:286529
Chsy1tm1Lex/Chsy1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		autoimmune arthritis J:171883
Chuktm1Mpa/Chuktm1Mpa
Ikbkbtm2Cgn/Ikbkbtm2Cgn
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		increased susceptibility to endotoxin shock J:137861
Chuktm2Yhu/Chuktm2Yhu
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		skin inflammation J:197037
Chuktm2Yhu/Chuktm2Yhu
Tg(Lor-CHUK)8Yhu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		lung inflammation J:197037
Cia2DBA/1J/Cia2DBA/1J
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:116665
Cia5C57BL/10/Cia5C57BL/10
(involves: B10.RIII * RIIIS/J) 		abnormal inflammatory response J:50472
Cia5bRIIIS/J/?
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia5bRIIIS/J/Cia5bRIIIS/J
Cia32B10.RIII/Cia32RIIIS/J
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia5cRIIIS/J/?
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia6C57BL/10SnSg/Cia6C57BL/10SnSg
(involves: B10.Q * DBA/1) 		abnormal inflammatory response J:57012
Cia6C57BL/10SnSg/Cia6DBA/1J
(involves: B10.Q * DBA/1) 		abnormal inflammatory response J:57012
Cia6DBA/1J/Cia6DBA/1J
(involves: B10.Q * DBA/1) 		decreased inflammatory response J:57012
Cia7DBA/1J/Cia7C57BL/10SnSg
(involves: B10.Q * DBA/1) 		increased inflammatory response J:57012
Cia7DBA/1J/Cia7DBA/1J
(involves: B10.Q * DBA/1) 		increased inflammatory response J:57012
increased susceptibility to induced arthritis J:122130
Cia8DBA/1J/Cia8DBA/1J
(involves: B10.Q * DBA/1) 		increased inflammatory response J:57012
Cia9C57BL/10SnSg/Cia9NOD/ShiLtJ
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd) 		increased inflammatory response J:69981
Cia10C57BL/10/Cia10C57BL/10
(involves: C57BL/10 * RIIIS/J) 		abnormal inflammatory response J:50472
Cia10C57BL/10/Cia10C57BL/10
Cia5C57BL/10/Cia5C57BL/10
(involves: C57BL/10 * RIIIS/J) 		abnormal inflammatory response J:50472
Cia23C57BL/10SnSg/Cia23C57BL/10SnSg
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd) 		abnormal inflammatory response J:69981
Cia23C57BL/10SnSg/Cia23NOD/ShiLtJ
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd) 		abnormal inflammatory response J:69981
Cia23C57BL/10SnSg/Cia23NOD/ShiLtJ
Cia9C57BL/10SnSg/Cia9C57BL/10SnSg
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd) 		decreased inflammatory response J:69981
Cia26RIIIS/J/Cia26RIIIS/J
Cia30B10.RIII/?
(involves: B10.RIII * RIIIS/J) 		autoimmune arthritis J:95848
Cia30RIIIS/J/Cia30RIIIS/J
Cia5B10.RIII/Cia5B10.RIII
(involves: B10.RIII * RIIIS/J) 		decreased susceptibility to induced arthritis J:95848
Cia31B10.RIII/Cia31RIIIS/J
Cia5B10.RIII/Cia5B10.RIII
(involves: B10.RIII * RIIIS/J) 		autoimmune arthritis J:95848
Cia31B10.RIII/Cia31RIIIS/J
Cia5RIIIS/J/Cia5RIIIS/J
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia32B10.RIII/Cia32RIIIS/J
Cia5B10.RIII/Cia5B10.RIII
(involves: B10.RIII * RIIIS/J) 		autoimmune arthritis J:95848
Cia34DBA/1J/Cia34DBA/1J
(involves: C57BL/10 * DBA/1J) 		decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35C57BL/10SnSg
Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
Cia35DBA/1J/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
Cia36DBA/1J/Cia36DBA/1J
(involves: C57BL/10 * DBA/1J) 		decreased susceptibility to induced arthritis J:122130
Cia37C57BL/10SnSg/Cia37DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased susceptibility to induced arthritis J:122130
Cia38DBA/1J/Cia38DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased susceptibility to induced arthritis J:122130
Cia39C57BL/10Sn/Cia39C57BL/10Sn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r) 		decreased susceptibility to induced arthritis J:97801
Cia39RIII/WySn/Cia39RIII/WySn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r) 		autoimmune arthritis J:97801
Cia40C57BL/10SnSg/Cia40C57BL/10SnSg
(involves: C57BL/10SnSg * DBA/1J * NFS/N) 		increased susceptibility to induced arthritis J:106522
Cia43DBA/1J/Cia43FVB/N
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:146242
Cia43FVB/N/Cia43FVB/N
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:146242
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum) 		abnormal inflammatory response J:106081
insulitis J:107051
pancreas inflammation J:106081
periinsulitis J:106081
Cishtm1.1Cdon/Cishtm1.1Cdon
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased susceptibility to type I hypersensitivity reaction J:204829
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon) 		increased susceptibility to type I hypersensitivity reaction J:204829
lung inflammation J:204829
Clca1tm1.1Lex/Clca1tm1.1Lex
(involves: 129S/SvEvBrd) 		increased inflammatory response J:125158
lung inflammation J:125158
Clca1tm1Dgen/Clca1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal inflammatory response J:112942
Clcnkam1Btlr/Clcnkam1Btlr
(C57BL/6J-Clcnkam1Btlr) 		increased susceptibility to induced colitis J:271974
Clec2htm1.1Apma/Clec2htm1.1Apma
(B6(Cg)-Clec2htm1.1Apma) 		kidney inflammation J:322835
Clec2htm1.1Apma/Clec2htm1.1Apma
Rag1tm1Mom/Rag1tm1Mom
(B6.Cg-Rag1tm1Mom Clec2htm1.1Apma) 		kidney inflammation J:322835
Clec4a2tm1.1Cfg/Clec4a2tm1.1Cfg
(involves: C57BL/6) 		increased inflammatory response J:217719
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		enthesitis J:217720
increased inflammatory response J:217720
increased susceptibility to induced arthritis J:217720
joint inflammation J:217720
salivary gland inflammation J:217720
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6) 		lung inflammation J:203221
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:203159
granulomatous inflammation J:203159
lung inflammation J:203159
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to type IV hypersensitivity reaction J:203159
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe) 		liver inflammation J:200968
Clec5atm1Cua/Clec5atm1Cua
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:158811
Clec7atm1Gdb/Clec7atm1Gdb
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal inflammatory response J:116669
Clec7atm1Gdb/Clec7atm1Gdb
(B6.129S6-Clec7atm1Gdb) 		lung inflammation J:179011
Clec10am1/Clec10am1
(NC/Nga) 		dermatitis J:283174
Clec10atm1Hed/Clec10atm1Hed
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		dermatitis J:283174
Clec12atm1Jrld/Clec12atm1Jrld
(B6J.129-Clec12atm1Jrld) 		increased inflammatory response J:210326
Clic4tm1.1Aidi/Clic4tm1.1Aidi
(involves: C57BL/6 * C57BL/6J) 		decreased susceptibility to endotoxin shock J:175404
ClppGt(IST11134F10)Tigm/ClppGt(IST11134F10)Tigm
(involves: C57BL/6N) 		dermatitis J:203140
ClppGt(IST13563G11)Tigm/ClppGt(IST13563G11)Tigm
(involves: C57BL/6N) 		dermatitis J:203140
Clutm1Jakh/Clutm1Jakh
(involves: Black Swiss * FVB/N) 		heart inflammation J:65660
myocarditis J:65660
Cmastm1.1Bwei/Cmastm1.1Bwei
Tg(NPHS2-cre)295Lbh/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		tubular nephritis J:286022
Cmklr1tm1Dgen/Cmklr1tm1Dgen
(B6.Cg-Cmklr1tm1Dgen) 		increased susceptibility to endotoxin shock J:157190
lung inflammation J:157190
Cmtm4tm1d(EUCOMM)Wtsi/Cmtm4tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		decreased inflammatory response J:333836
decreased susceptibility to chemically induced skin inflammation J:333836
Col1a1Aga2/Col1a1+
(C3HeB/FeJ-Col1a1Aga2) 		lung inflammation J:185988
Col1a1M1Jrt/Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ) 		osteoarthritis J:216423
Col1a1M1Jrt/Col1a1+
(involves: C57BL/6 * FVB/N) 		autoimmune arthritis J:228439
Col1a1tm1(tetO-Fos)Wag/Col1a1+
Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		skin inflammation J:201145
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		liver inflammation J:210545
Col2a1tm1Prc/Col2a1+
Col9a1tm1Jae/Col9a1tm1Jae
(involves: 129/Sv * 129S2/SvPas) 		osteoarthritis J:117910
Col3a1m1Btlr/Col3a1m1Btlr
(C57BL/6J-Col3a1m1Btlr) 		increased susceptibility to induced colitis J:271973
Col3a1Tsk2/Col3a1+
(C3H101H-Col3a1Tsk2/H) 		adipose tissue inflammation J:31216
skin inflammation J:31216
Col4a1tm1.1Ics/Col4a1+
(involves: 129S2/SvPas * C57BL/6) 		kidney inflammation J:240798
Col4a1tm1.1Ics/Col4a1tm1.1Ics
(involves: 129S2/SvPas * C57BL/6) 		kidney inflammation J:240798
Col4a3tm1.1Rkl/Col4a3+
(involves: C57BL/6) 		glomerulonephritis J:167404
Col4a3tm1Dec/Col4a3tm1Dec
(involves: 129X1/SvJ * C57BL/6) 		glomerulonephritis J:37963
Col4a3tm1Dec/Col4a3tm1Dec
(129-Col4a3tm1Dec/J) 		glomerulonephritis J:158731
Col4a3tm1Dec/Col4a3tm1Dec
(B6.129X1-Col4a3tm1Dec) 		glomerulonephritis J:167404
Col4a3tm1Dec/Col4a3tm1Dec
Itga1tm1Gdnr/Itga1tm1Gdnr
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c) 		tubular nephritis J:71378
Col4a3tm1Dec/Col4a3tm1Dec
Sostdc1tm1Myan/Sostdc1tm1Myan
(involves: 129X1/SvJ) 		glomerulonephritis J:158731
Col4a3tm1Jhm/Col4a3tm1Jhm
(involves: 129S1/Sv * 129X1/SvJ) 		glomerulonephritis J:37017
Col4a3tm1Jhm/Col4a3tm1Jhm
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) 		glomerulonephritis J:63137
Col4a4bwk/Col4a4bwk
(NON;NZO-Col4a4bwk/J) 		kidney inflammation J:223185
tubulointerstitial nephritis J:223185
Col4a4bwk/Col4a4bwk
(D2.NON(NZO)-Col4a4bwk/GrsrJ) 		kidney inflammation J:223185
Col4a4bwk/Col4a4bwk
(129S1.NON(NZO)-Col4a4bwk/PgnJ) 		kidney inflammation J:223185
Col4a5tm1Yseg/Y
(B6.Cg-Col4a5tm1Yseg) 		tubulointerstitial nephritis J:102306
Col9a1tm1Jae/Col9a1tm1Jae
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL)) 		osteoarthritis J:18628
Col9a1tm1Jae/Col9a1tm1Jae
(involves: 129S2/SvPas) 		osteoarthritis J:117910
Col11a1cho/Col11a1+
(involves: C57BL/6Fr) 		osteoarthritis J:106282
Col13a1tm1Pih/Col13a1tm1Pih
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		myositis J:71939
Col17a1em1Dcr/Col17a1em1Dcr
Lamc2jeb/Lamc2jeb
(B6.Cg-Lamc2jeb Col17a1em1Dcr/Dcr) 		ear inflammation J:352187
Col17a1em2Dcr/Col17a1em2Dcr
Lamc2jeb/Lamc2jeb
(C57BL/6J-Col17a1em2Dcr/Dcr) 		ear inflammation J:352187
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6) 		skin inflammation J:220622
Comptm1Mbri/Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		osteoarthritis J:125086
Copatm1.1Shum/Copa+
(B6(CBA)-Copatm1.1Shum) 		bronchiolitis J:288425
lung inflammation J:288425
Coro1aLmb3-C57BL/6Scr/Coro1aLmb3-C57BL/6Scr
(MRL.Cg-Coro1aC57BL/6Scr Faslpr) 		glomerulonephritis J:125557
Coro1atm1Achn/Coro1atm1Achn
Coro1btm1.1Nfoe/Coro1btm1.1Nfoe
(involves: 129X1/SvJ * C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:177785
Cox4i2tm1Hutt/Cox4i2+
(B6.129-Cox4i2tm1Hutt) 		lung inflammation J:187640
Cox4i2tm1Hutt/Cox4i2tm1Hutt
(B6.129-Cox4i2tm1Hutt) 		lung inflammation J:187640
Cptm1Hrs/Cptm1Hrs
Hephsla/Y
(involves: 129X1/SvJ * C57BL/6) 		eye inflammation J:136925
Cpa1tm1.1Satom/Cpa1tm1.1Satom
(involves: C57BL/6NCrl * FVB/N) 		pancreas inflammation J:300042
Cpa3tm3(icre)Hrr/Cpa3+
(B6.129P2-Cpa3tm3(icre)Hrr) 		abnormal inflammatory response J:178942
Cpa3tm3(icre)Hrr/Cpa3+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:178942
Cpa3tm3(icre)Hrr/Cpa3+
Fgfr1tm1Upir/Fgfr1tm1Upir
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J) 		skin inflammation J:221184
Cpb2tm1Efp/Cpb2+
Plgtm1Dco/Plg+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:80114
Cpb2tm1Efp/Cpb2tm1Efp
Plgtm1Dco/Plg+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:80114
Cpb2tm1Nok/Cpb2tm1Nok
(involves: 129P2/OlaHsd * BALB/c) 		increased inflammatory response J:93733
Cpn1tm1Raw/Cpn1tm1Raw
(B6.129S1-Cpn1tm1Raw) 		increased acute inflammation J:148315
Cr1ltm1Hmo/Cr1ltm1Hmo
(involves: 129X1/SvJ) 		increased inflammatory response J:59432
Creb3l3tm1.1Sad/Creb3l3tm1.1Sad
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		decreased acute inflammation J:140018
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		abnormal inflammatory response J:98419
decreased inflammatory response J:90690, J:72196
Crim1Gt(KST264)Byg/Crim1Gt(KST264)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		kidney inflammation J:172334
Crlf2tm1Jni/Crlf2tm1Jni
(involves: 129P2/OlaHsd) 		respiratory system inflammation J:187770
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: BALB/c) 		lung inflammation J:107431
Crlf2tm1Wjl/Crlf2tm1Wjl
(Not Specified) 		colitis J:175844
Crocctm1Tili/Crocctm1Tili
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		lung inflammation J:98885
Crotem1Akw/Crotem1Akw
Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Crotem1Akw Ldlrtm1Her) 		blood vessel inflammation J:331161
Crsl/Crsl+
(involves: C3HeB/FeJ) 		keratoconjunctivitis sicca J:104123
Cry1tm1Jhjh/Cry1tm1Jhjh
Cry2tm1Jhjh/Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced arthritis J:159504
Csf1op/Csf1op
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6) 		interstitial pneumonia J:19089
lung inflammation J:19089
Csf1op/Csf1op
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J) 		liver inflammation J:117880
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6) 		lung inflammation J:18747
Csf2tm1Dran/Csf2tm1Dran
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased inflammatory response J:83086
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli) 		decreased susceptibility to type IV hypersensitivity reaction J:67404
glomerulonephritis J:83086
lung inflammation J:67404
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(C.129S2-Csf2tm1Dran Il3tm1Glli) 		decreased susceptibility to type IV hypersensitivity reaction J:67404
lung inflammation J:67404
Csf2raem1Szut/Csf2raem1Szut
(C57BL/6-Csf2raem1Szut) 		lung inflammation J:322934
Csf2rbtm1Cgb/Csf2rbtm1Cgb
(involves: 129S1/Sv * C57BL/6) 		lung inflammation J:29737
Csf2rbtm1Clsc/Csf2rbtm1Clsc
Csf2rb2tm1Cgb/Csf2rb2tm1Cgb
(C.129S1-Csf2rb2tm1Cgb Csf2rbtm1Clsc) 		decreased susceptibility to type I hypersensitivity reaction J:130939
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd * C57BL/6) 		lung inflammation J:35829
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd) 		lung inflammation J:24122
Csf2rbtm1Mur/Csf2rbtm1Mur
Il3tm1Tyb/Il3tm1Tyb
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		lung inflammation J:35829
Csgalnact1tm1.1Migar/Csgalnact1tm1.1Migar
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj) 		periodontium inflammation J:269621
Csktm1Tara/Csktm2Tara
Elanetm1(cre)Roes/Elane+
(involves: 129P2/OlaHsd * CB20 * C57BL/6) 		increased acute inflammation J:89716
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased incidence of corneal inflammation J:50587
uveitis J:50587
Ct55em1Xdzg/Ct55em1Xdzg
(involves: C57BL/6) 		decreased susceptibility to induced colitis J:280149
ctl/ctl
(A/WySnJ-ctl/GrsrJ) 		autoimmune arthritis J:91389
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD) 		increased acute inflammation J:109887
Ctla4tm1All/Ctla4tm1All
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD * SJL) 		increased acute inflammation J:109887
insulitis J:109887
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		increased inflammatory response J:140085
lung inflammation J:140085
myocarditis J:140085
salivary gland inflammation J:140085
stomach inflammation J:140085
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		joint inflammation J:30393
lung inflammation J:30393
myocarditis J:30393
pancreas inflammation J:30393
salivary gland inflammation J:30393
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6) 		conjunctivitis J:71744
increased inflammatory response J:71744
increased susceptibility to otitis media J:71744
keratoconjunctivitis sicca J:71744
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(CMV-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		increased inflammatory response J:71744
increased susceptibility to otitis media J:71744
keratoconjunctivitis sicca J:71744
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm
Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * FVB/N) 		pancreas inflammation J:119908
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Tg(Cd4-cre)1Cwi/0
Foxp3sf/Y
Rag1tm1Mom/Rag1+
(mixed) 		decreased inflammatory response J:348981
Ctrb1em1Toth/Ctrb1em1Toth
(C57BL/6N-Ctrb1em1Toth) 		increased susceptibility to induced pancreatitis J:294171, J:294035
Ctrcm1/Ctrcm1
(C57BL/6-Ctrcm1) 		increased susceptibility to induced pancreatitis J:291240
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde) 		insulitis J:153355
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde) 		insulitis J:153355
salivary gland inflammation J:153355
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6) 		dermatitis J:108745
Ctsgtm1.1Roes/Ctsgtm1.1Roes
Elanetm1(cre)Roes/Elanetm1(cre)Roes
(involves: 129P2/OlaHsd) 		decreased susceptibility to endotoxin shock J:77597
Ctslnkt/Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2)) 		dermatitis J:54856
increased inflammatory response J:54856
liver inflammation J:54856
lymph node inflammation J:54856
Ctslnkt/Ctslnkt
(B6.Cg-Ctslnkt) 		dermatitis J:78460
Ctslnkt/Ctslnkt
(C.Cg-Ctslnkt) 		dermatitis J:78460
Ctsltm1Alpk/Ctsltm1Alpk
(involves: 129P2/OlaHsd * C57BL/6) 		dermatitis J:99755
folliculitis J:99755
granulomatous inflammation J:99755
Ctsltm1Alpk/Ctsltm1Alpk
(B6.129P2-Ctsltm1Alpk) 		granulomatous inflammation J:99755
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr) 		insulitis J:153355
Ctsltm1Cptr/Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr) 		salivary gland inflammation J:153355
Ctsstm1Eae/Ctss+
(NOD.D1-Ctsstm1Eae) 		insulitis J:153355
Ctsstm1Eae/Ctsstm1Eae
(involves: C57BL/6 * DBA/1LacJ) 		decreased susceptibility to induced arthritis J:53399
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae) 		insulitis J:153355
salivary gland inflammation J:153355
Cuedc2tm1Qxia/Cuedc2tm1Qxia
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased susceptibility to induced colitis J:211782
Cux1tm2Ejn/Cux1tm2Ejn
(involves: 129S4/SvJae * C57BL/6) 		rhinitis J:74660
Cuzd1tm1Ljm/Cuzd1tm1Ljm
(involves: 129S6/SvEvTac * Black Swiss) 		increased susceptibility to induced pancreatitis J:80980
Cx3cl1tm1.1Yono/Cx3cl1tm1.1Yono
(involves: C57BL/6J) 		decreased inflammatory response J:271242
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd) 		decreased inflammatory response J:271242
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt) 		brain inflammation J:129712
Cxcl5tm1Gscw/Cxcl5tm1Gscw
(involves: 129) 		decreased susceptibility to endotoxin shock J:162629
Cxcl9tm1Jmf/Cxcl9tm1Jmf
(B6.129S4-Cxcl9tm1Jmf) 		decreased inflammatory response J:120743
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * 129X1/SvJ) 		decreased susceptibility to type IV hypersensitivity reaction J:75584
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl) 		CNS inflammation J:87076
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J) 		decreased susceptibility to induced arthritis J:142880
Cxcr3tm1Raks/Cxcr3tm1Raks
(B6.129P2-Cxcr3tm1Raks) 		kidney inflammation J:152790
Cxcr3tm1Wwh/Y
(B6.Cg-Cxcr3tm1Wwh) 		lung inflammation J:91359
Cxcr3tm1Wwh/Cxcr3tm1Wwh
(B6.Cg-Cxcr3tm1Wwh) 		lung inflammation J:91359
Cxcr4tm1Yiw/Cxcr4tm1Yiw
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:164872
Cybanmf333/Cybanmf333
(A.B6 Tyr+-Cybanmf333/J) 		increased inflammatory response J:132359
lung inflammation J:132359
Cybatm1Dgh/Cybatm1Dgh
(B6.Cg-Cybatm1Dgh) 		decreased inflammatory response J:231269
Cybbtm1Din/Y
(involves: 129S/SvEv * C57BL/6) 		increased inflammatory response J:22868
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din) 		granulomatous inflammation J:146231
increased acute inflammation J:110181
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J) 		glomerulonephritis J:235399
Cyldtm1.1Mpa/Cyldtm1.1Mpa
Faddtm1Mpa/Faddtm1Mpa
Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Cyldtm1.1Mpa Tg(Vil1-cre)997Gum) 		cecum inflammation J:175865
Cyldtm1.1Mpa/Cyldtm1.1Mpa
Ikbkgtm1.1Mpa/Y
Tg(Vil1-cre)997Gum/0
(B6.Cg-Cyldtm1.1Mpa Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum) 		colitis J:175865
Cyldtm1.1Mpa/Cyldtm1.1Mpa
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Vil1-cre)997Gum/0
(B6.Cg-Cyldtm1.1Mpa Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum) 		colitis J:175865
Cyldtm1Lex/Cyldtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal inflammatory response J:114972
increased susceptibility to induced colitis J:114972
Cyp2c70em1Sjka/Cyp2c70em1Sjka
(C57BL/6-Cyp2c70em1Sjka) 		liver inflammation J:330641
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2c70em1Utr) 		liver inflammation J:302190
Cyp2ctm1104Arte/Cyp2ctm1104Arte
(B6NTac(Cg)-Cyp2ctm1104Arte/Arte) 		liver inflammation J:241121
Cyp2ctm1897.1(Alb-CYP2C9)Arte/Cyp2ctm1897.1(Alb-CYP2C9)Arte
(B6(Cg)-Cyp2ctm1897.1(Alb-CYP2C9)Arte/Arte) 		liver inflammation J:241121
Cyp2g1tm1(rtTA)Lane/Cyp2g1+
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: 129 * C57BL/6 * SJL) 		rhinitis J:157842
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6) 		kidney inflammation J:92438
salivary gland inflammation J:92438
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv) 		lacrimal gland inflammation J:216958
salivary gland inflammation J:216958
Cys1cpk/Cys1cpk
(129.B6-Cys1cpk) 		liver inflammation J:116210
Cysltr1tm1Ykn/Cysltr1tm1Ykn
(involves: C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:77087
respiratory system inflammation J:88647
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C57BL/6-Cysltr2tm1Ykn) 		decreased susceptibility to type I hypersensitivity reaction J:94488
Cyth2tm1d(EUCOMM)Wtsi/Cyth2tm1d(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased susceptibility to type I hypersensitivity reaction J:307633
Cytl1tm1Chun/Cytl1tm1Chun
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to induced arthritis J:175377
DbaclC57BL/6Jcl/DbaclC57BL/6Jcl
(NOD.B6-(D4Mit193-D4Mit17)) 		insulitis J:144964
Dcntm1Ioz/Dcntm1Ioz
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		tubular nephritis J:75298
Ddctm1.1Rhrs/Ddctm1.1Rhrs
Tg(Ggt1-cre)M3Egn/0
(involves: 129 * C57BL/6 * SJL) 		tubulointerstitial nephritis J:175630
Ddctm1.1Rhrs/Ddctm1.1Rhrs
Tg(Ggt1-cre)M3Egn/0
(129.Cg-Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn) 		tubulointerstitial nephritis J:175630
Ddit3tm1Dron/Ddit3tm1Dron
Tg(Col2a1-rtTA,tetO-COMP*)2Jath/0
(involves: 129X1/SvJ * 129S1/Sv * C57BL/6) 		decreased inflammatory response J:233238
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J) 		white adipose tissue inflammation J:214136
Defb3tm1Xen/Defb3tm1Xen
(involves: C57BL/6) 		increased incidence of corneal inflammation J:199719
Del(1Aim2-Ifi205)1Stsn/+
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		heart inflammation J:234263
increased inflammatory response J:234263
kidney inflammation J:234263
myositis J:234263
stomach inflammation J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		stomach inflammation J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		heart inflammation J:234263
increased inflammatory response J:234263
kidney inflammation J:234263
myositis J:234263
stomach inflammation J:234263
Del(6Ephb6-Trpv6)1Mhed/+
(involves: 129S/SvEv) 		dermatitis J:133151
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed
(involves: 129S/SvEv) 		dermatitis J:133151
Del(6Snca)1Slab/Del(6Snca)1Slab
Tg(Th-SNCA*)1Mgsp/0
(involves: C57BL/6J * C57BL/6JOlaHsd * CBA/Ca) 		brain inflammation J:108310
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae) 		osteoarthritis J:72926
Del(10Prmt2-Col6a1)1Yah/+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		lung inflammation J:167506
respiratory system inflammation J:167506
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce
(involves: C57BL/6) 		decreased inflammatory response J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce
Nlrc4em2Vnce/Nlrc4em2Vnce
(involves: C57BL/6) 		decreased inflammatory response J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6J * C57BL/6N) 		decreased inflammatory response J:294930
Del(14Ltb4r2-Ltb4r1)1Bodd/+
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:131779
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:131779
Del(19Poll-Dcpd)1Nmt/Del(19Poll-Dcpd)1Nmt
(involves: 129P2/OlaHsd) 		sinus inflammation J:75779
Derm1NC/Nga/Derm1NC/Nga
(involves: MSM/Ms * NC/Nga) 		dermatitis J:68698
DermsBALB/cByJ/?
(involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J) 		dermatitis J:80574
DermsDBA/2J/?
(involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J) 		dermatitis J:80574
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:293120
decreased susceptibility to induced arthritis J:293120
Dh/Dh+
H2d/H2d
(NZB.Cg-Dh) 		glomerulonephritis J:12036
Diaph1tm1Asal/Diaph1tm1Asal
(involves: 129S1/Sv * C57BL/6) 		dermatitis J:124319
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ) 		blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ) 		blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Foxp3-EGFP/icre)1aJbs/0
(involves: 129 * NOD/ShiLt) 		liver inflammation J:138808
lung inflammation J:138808
Dicer1tm1Tara/Dicer1tm1Tara
Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd) 		increased susceptibility to induced arthritis J:180783
Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		liver inflammation J:328215
Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		lung inflammation J:81054
Dlk1tm1.1Jvs/Dlk1+
Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased inflammatory response J:167124
Dmbt1tm1Janm/Dmbt1tm1Janm
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced colitis J:130258
Dmdem1Eno/Y
(involves: C57BL/6J) 		myositis J:253191
Dmdem4Eno/Y
(C57BL/6-Dmdem4Eno) 		myositis J:285447
Dmdem4Eno/Dmdem4Eno
(C57BL/6-Dmdem4Eno) 		myositis J:285447
Dmdmdx/Y
(involves: C57BL/10ScSn) 		diaphragmitis J:140282
myositis J:140282
Dmdmdx/Y
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL) 		myositis J:167294
Dmdmdx/Y
Tg(DMD*)#Spc/0
(involves: 129P2/OlaHsd * C57BL/10ScSn * DBA/2) 		myositis J:280218
Dmdmdx/Y
Utrntm1Jrs/Utrn+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn) 		diaphragmitis J:140282
myositis J:140282
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx/J) 		myositis J:226314
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx/J) 		heart inflammation J:226314
myositis J:226314
Dmdmdx/Dmdmdx
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn) 		myositis J:162340
Dmdtm1.1Know/Dmdtm1.1Know
(involves: C3H) 		myocarditis J:207775
Dmdtm1Kmf/Y
(involves: C57BL/6) 		myositis J:233298
Dnaaf5em1Slb/Dnaaf5em1Slb
(C57BL/6-Dnaaf5em1Slb) 		sinus inflammation J:342770
Dnaaf5em1Slb/Dnaaf5em2Slb
(C57BL/6-Dnaaf5em1Slb Dnaaf5em2Slb) 		sinus inflammation J:342770
Dnah5Tg1Htz/Dnah5Tg1Htz
(involves: C57BL/6 * CBA/J) 		increased susceptibility to otitis media J:76189
sinus inflammation J:76189
Dnai1tm1.1Leo/Dnai1tm1.1Leo
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6) 		rhinosinusitis J:155730
Dnajc3m1Btlr/Dnajc3m1Btlr
(C57BL/6J-Dnajc3m1Btlr) 		increased susceptibility to induced colitis J:265248
Dnase1tm1Tmo/Dnase1+
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:62549
kidney inflammation J:62549
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:62549
kidney inflammation J:62549
Dnase1tm2092.1Arte/Dnase1tm2092.1Arte
(involves: C57BL/6) 		glomerulonephritis J:277126
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		joint inflammation J:238323, J:114982
rheumatoid arthritis J:238323, J:114982
Dnase2atm1Osa/Dnase2atm2Osa
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA) 		joint inflammation J:114982
rheumatoid arthritis J:114982
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd) 		glomerulonephritis J:144035
Dock8tm1Ysfk/Dock8tm1Ysfk
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL) 		dermatitis J:305132
Dpcd/PollGt(OST280355)Lex/Dpcd/PollGt(OST280355)Lex
(involves: 129S5/SvEvBrd * C57BL/6Brd) 		increased susceptibility to otitis media J:185566
Dpp4em1Rba/Dpp4+
(C57BL/6J-Dpp4em1Rba) 		lung inflammation J:279834
Dpp4em1Rba/Dpp4em1Rba
(C57BL/6J-Dpp4em1Rba) 		lung inflammation J:279834
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6NTac) 		interstitial pneumonia J:223728
lung inflammation J:223728
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		lung inflammation J:238079
pleuritis J:238079
Dpp4tm1.1(DPP4)Pbmj/Dpp4tm1.1(DPP4)Pbmj
(involves: C57BL/6 * C57BL/6NTac) 		lung inflammation J:242025
Drd1tm1Jcd/Drd1tm1Jcd
Drd2tm1Ebo/Drd2+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		small intestinal inflammation J:91781
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		intestinal inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Dsc1tm1Dga/Dsc1tm1Dga
(involves: C57BL/6J) 		dermatitis J:73102
Dsg2m1Btlr/Dsg2m1Btlr
(C57BL/6J-Dsg2m1Btlr) 		increased susceptibility to induced colitis J:271975
Dsg2m2Btlr/Dsg2m2Btlr
(C57BL/6J-Dsg2m2Btlr) 		increased susceptibility to induced colitis J:271976
Dsg2m3Btlr/Dsg2m3Btlr
(C57BL/6J-Dsg2m3Btlr) 		increased susceptibility to induced colitis J:271977
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		heart inflammation J:235770
Dsg2tm3.1Leu/Dsg2tm3.1Leu
Tg(Vil1-cre)20Syr/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased susceptibility to colitis induced morbidity/mortality J:302333
increased susceptibility to induced colitis J:302333
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk) 		conjunctivitis J:219200
Dsg3tm1Stan/Dsg3tm1Stan
(involves: 129X1/SvJ * C57BL/6J) 		conjunctivitis J:40804
Dsg4lah-J/Dsg4lah-J
(involves: DBA/1LacJ) 		dermatitis J:83117
Dsg4lah/Dsg4lah
(LAH/Pas) 		dermatitis J:33849
Dspptm1Kul/Dspptm1Kul
(B6;129-Dspptm1Kul/Mmnc) 		periodontium inflammation J:241990
Dssc1C3H/HeJ/Dssc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		colitis J:52852
Dssc1C57BL/6J/Dssc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		colitis J:52852
Dssc2C3H/HeJ/Dssc2C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		colitis J:52852
Dssc2C3H/HeJ/Dssc2C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		colitis J:52852
DstTg4/DstTg4
(involves: C57BL/6 * CD-1) 		conjunctivitis J:209161
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl) 		glomerulonephritis J:151605
liver inflammation J:151605
lung inflammation J:151605
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas) 		lung inflammation J:118832
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to endotoxin shock J:118833
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * various) 		increased susceptibility to type I hypersensitivity reaction J:125919
Dusp1tm1Brv/Dusp1tm1Brv
(C3.129S2-Dusp1tm1Brv) 		lung inflammation J:164929
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to endotoxin shock J:126383
increased susceptibility to induced arthritis J:126383
Dusp2tm1Cmac/Dusp2tm1Cmac
(B6.Cg-Dusp2tm1Cmac) 		decreased susceptibility to induced arthritis J:112609
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac) 		increased susceptibility to type I hypersensitivity reaction J:92104
Dusp11Gt(BB0198)Wtsi/Dusp11Gt(BB0198)Wtsi
(B6.129P2-Dusp11Gt(BB0198)Wtsi) 		increased susceptibility to endotoxin shock J:301503
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht) 		increased inflammatory response J:213253
kidney inflammation J:213253
liver inflammation J:213253
lung inflammation J:213253
Dysfim/Dysf+
Large1myd/Large1myd
(involves: C57BL/6 * SJL/J) 		myositis J:221523
Dysfim/Dysfim
Fktntm1Ttd/Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J) 		myositis J:221523
Dysfim/Dysfim
Large1myd/Large1myd
(involves: C57BL/6 * SJL/J) 		myositis J:221523
Dysftm1Kcam/Dysftm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		myositis J:171870
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg) 		insulitis J:93708
salivary gland inflammation J:93708
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6) 		glomerulonephritis J:76318
increased inflammatory response J:76318
liver inflammation J:76318
lung inflammation J:76318
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J) 		increased inflammatory response J:76318
E2f3tm1Lees/E2f3tm1Lees
(involves: 129S2/SvPas * C57BL/6) 		lung inflammation J:75765
E2f4tm1Lees/E2f4tm1Lees
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to otitis media J:64193
rhinitis J:64193
Eae2B10.RIII/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J) 		autoimmune arthritis J:95848
Eae2RIIIS/J/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J) 		decreased susceptibility to induced arthritis J:95848
Eae2bC57BL/10SnSg/Eae2bC57BL/10SnSg
(involves: B10.RIII * RIIIS/J) 		CNS inflammation J:96204
Eae7B10.S/DvTe/Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J) 		brain inflammation J:49054
Eae7B10.S/DvTe/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J) 		brain inflammation J:49054
Eae7SJL/J/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J) 		brain inflammation J:49054
Eae16SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased inflammatory response J:67840
Eae21SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased inflammatory response J:67840
Eae22SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased inflammatory response J:67840
Eae23SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased inflammatory response J:67840
Eae25SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased inflammatory response J:69083
Eae27C57BL/10SnSg/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J) 		CNS inflammation J:96204
Eae27RIIIS/J/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J) 		CNS inflammation J:96204
Eae39C57BL/10SnSg/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J) 		CNS inflammation J:96204
Eae39RIIIS/J/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J) 		CNS inflammation J:96204
Eae41C57BL/10SnSg/Eae41C57BL/10SnSg
(involves: B10.RIII * RIIIS/J) 		CNS inflammation J:96204
Eae44aB10.S/DvTe/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J) 		brain inflammation J:49054
Eae44aSJL/J/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J) 		brain inflammation J:49054
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow
Eaf2tm1Zhow/Eaf2tm1Zhow
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * DBA/2) 		prostate gland inflammation J:288972
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow
Tg(Pbsn-cre)4Prb/0
(B6(Cg)-Eaf1tm1.1Zhow Tg(Pbsn-cre)4Prb) 		prostate gland inflammation J:288972
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd) 		prostate gland inflammation J:288972
Eamcd1A/WySn/Eamcd1A/WySn
(B10.A-(D1Mit65-D1Mit334)) 		myocarditis J:145043
Eamcd2A/WySn/Eamcd2A/WySn
(involves: A.SW-H2s/J * B10.S-H2s/J) 		myocarditis J:96562
Ebi3Gt716Lex/Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		brain inflammation J:286951
Ebi3tm1Rsb/Ebi3tm1Rsb
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to induced colitis J:81014
Ecm1tm1Bsun/Ecm1tm1Bsun
(involves: 129 * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:168252
EdaTa-6J/Y
(C57BL/6J Aw-J-EdaTa-6J/J) 		blepharitis J:99510
conjunctivitis J:99510
corneal limbitis J:99510
eye inflammation J:99510
increased incidence of corneal inflammation J:99510
Edil3Tg(lacZ)1Tq/Edil3Tg(lacZ)1Tq
(Not Specified) 		increased susceptibility to induced arthritis J:254384
Ednrbtm1Nrd/Ednrbtm1Nrd
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J) 		large intestinal inflammation J:233811
Ednrbtm1Ywa/Ednrb+
(involves: 129S/SvEvBrd) 		decreased acute inflammation J:103977
Ednrbtm1Ywa/Ednrbtm1Ywa
(involves: 129S5/SvEvBrd) 		decreased acute inflammation J:103977
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J) 		decreased susceptibility to type IV hypersensitivity reaction J:6766
Efstm1Kale/Efs+
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J)) 		increased inflammatory response J:103757
small intestinal inflammation J:103757
Efstm1Kale/Efstm1Kale
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J)) 		increased inflammatory response J:103757
kidney inflammation J:103757
liver inflammation J:103757
lung inflammation J:103757
small intestinal inflammation J:103757
Egfrtm1Dwt/Egfrtm1Dwt
Sox9tm3(cre)Crm/Sox9+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		dermatitis J:229771
Egr1tm1Jmi/Egr1tm1Jmi
(B6.129-Egr1tm1Jmi) 		liver inflammation J:128421
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6) 		decreased inflammatory response J:152898
Egr1tm1Jmi/Egr1tm1Jmi
Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1*)1Eli/?
(involves: 129 * C57BL/6) 		lung inflammation J:92469
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:66112
Eif2ak3tm1.1Drc/Eif2ak3tm1.1Drc
Tg(Ela1-cre)16Eps/0
(involves: 129S6/SvEvTac) 		acute pancreas inflammation J:129974
Eif4btm1.1Smoc/Eif4btm1.1Smoc
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6) 		increased susceptibility to induced colitis J:311140
lung inflammation J:311140
Elac2em1Afi/Elac2em1Afi
(C57BL/6N-Elac2em1Afi) 		prostate gland inflammation J:336403
Elanetm1Sds/Elanetm1Sds
(involves: 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:113463
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo) 		increased susceptibility to endotoxin shock J:184388
increased susceptibility to induced colitis J:184388
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to endotoxin shock J:184388
Elavl1tm1Lix/Elavl1tm1Lix
Tg(Scgb1a1-rtTA)2Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6) 		decreased inflammatory response J:204952
lung inflammation J:204952
Elf4tm1Nim/Elf4tm1Nim
(B6.129S1-Elf4tm1Nim) 		abnormal inflammatory response J:79568
Elovl3tm1Jaco/Elovl3tm1Jaco
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		dermatitis J:88477
Elp1tm1.1Id/Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		conjunctivitis J:188923
Elp1tm1.2Id/Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		conjunctivitis J:188923
Enpp1asj/Enpp1asj
(C57BL/6J-Enpp1asj/GrsrJ) 		increased susceptibility to otitis media J:251638
joint inflammation J:174912
osteoarthritis J:174912
osteomyelitis J:174912
Enpp1ttw/Enpp1ttw
(involves: ICR) 		osteoarthritis J:19124, J:37369
Enpp2tm1Lex/Enpp2+
(involves: 129S/SvEvBrd * C57BL/6J) 		decreased susceptibility to endotoxin shock J:103485
Enpp3tm1Ktak/Enpp3tm1Ktak
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6)) 		increased susceptibility to type I hypersensitivity reaction J:223825
intestinal inflammation J:223825
lung inflammation J:223825
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		liver inflammation J:163795
Entpd8tm1Ktak/Entpd8tm1Ktak
(C.Cg-Entpd8tm1Ktak) 		increased susceptibility to induced colitis J:311564
Entpd8tm1Ktak/Entpd8tm1Ktak
P2rx4tm1Ando/P2rx4tm1Ando
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		abnormal susceptibility to induced colitis J:311564
Epcamtm1.1Mcu/Epcamtm1.1Mcu
Tg(CD207-cre)1Dhka/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL/J) 		increased susceptibility to type IV hypersensitivity reaction J:182665
Epcamtm1.2Msiv/Epcamtm1.2Msiv
(involves: C57BL/6 * FVB/N * SJL) 		small intestinal inflammation J:210901
Epha1tm1Sld/Epha1tm1Sld
(involves: 129 * C57BL/6J) 		endometrium inflammation J:142722
vaginal inflammation J:142722
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129) 		decreased susceptibility to type IV hypersensitivity reaction J:94701
Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+
Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * CBA/J * SJL) 		pancreas inflammation J:107545
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		dermatitis J:213427
Epyctm1Mhok/Epyctm1Mhok
(involves: 129S7/SvEvBrd * C57BL/6J) 		osteoarthritis J:222369
Erbb3tm1.1Dwt/Erbb3tm2.1Dwt
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased susceptibility to induced colitis J:152703
Erbb4tm1Grl/Erbb4tm1Grl
Tg(Myh6-ERBB4)HT2Gass/0
(involves: 129S1/Sv * 129X1/SvJ) 		lung inflammation J:132190
Eregtm1Dwt/Eregtm1Dwt
(129S6/SvEvTac-Eregtm1Dwt) 		increased susceptibility to induced colitis J:93327
Eregtm1Sawa/Eregtm1Sawa
(involves: 129X1/SvJ * C57BL/6J) 		dermatitis J:92618
Ergtm1.1Iwamo/Ergtm1.1Iwamo
Tg(Gdf5-cre,-ALPP)1Kng/?
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased susceptibility to induced arthritis J:243715
osteoarthritis J:243715
Ern1tm2.1Tiw/Ern1tm2.1Tiw
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL) 		small intestinal inflammation J:206084
Ern2m1Btlr/Ern2m1Btlr
(C57BL/6J-Ern2m1Btlr) 		increased susceptibility to induced colitis J:216045
Ern2M2Btlr/Ern2M2Btlr
(C57BL/6J-Ern2M2Btlr) 		increased susceptibility to induced colitis J:234237
Ern2m3Btlr/Ern2m3Btlr
(C57BL/6J-Ern2m3Btlr) 		increased susceptibility to induced colitis J:236686
Ern2tm1Dron/Ern2tm1Dron
(either: 129S6/SvEvTac-Ern2tm1Dron or B6.129S6-Ern2tm1Dron) 		increased susceptibility to induced colitis J:67934
Errfi1tm1Gvw/Errfi1tm1Gvw
(Not Specified) 		accelerated temporomandibular joint osteoarthritis J:100927
osteoarthritis J:100927
Errfi1tm1Gvw/Errfi1tm1Gvw
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv) 		osteoarthritis J:100927
Errfi1tm3.1Gvw/Errfi1tm3.1Gvw
Tg(CMV-cre)1Cgn/0
(involves: 129 * 129S4/SvJaeSor * BALB/cJ) 		osteoarthritis J:206807
Errfi1tm3.1Gvw/Errfi1tm3.1Gvw
Tg(Col2a1-cre)1Asz/0
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6 * CBA) 		osteoarthritis J:206807
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		glomerulonephritis J:88156
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd) 		spermatic granuloma J:60490
Esr1tm1Ksk/Esr1tm1Ksk
Inhatm1Bay/Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd) 		liver inflammation J:84989
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd) 		colitis J:107308
urinary bladder inflammation J:122274
exf/exf
(involves: C3H/HeN(MTV-)) 		conjunctivitis J:5649
Exph5tm1Tiz/Exph5tm1Tiz
(B6NJcl.Cg-Exph5tm1Tiz/Tiz) 		increased susceptibility to type I hypersensitivity reaction J:313415
Extl1em1Caox/Extl1em1Caox
Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * CBA) 		chronic inflammation J:333437
decreased acute inflammation J:333437
Eya4tm1Jse/Eya4tm1Jse
(involves: 129S6/SvEvTac * CBA/J) 		increased susceptibility to otitis media J:131873
F2tm2Jld/F2+
(B6.129P2-F2tm2Jld) 		decreased susceptibility to endotoxin shock J:174629
F2tm2Jld/F2+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J) 		decreased susceptibility to induced arthritis J:174629
F2rtm1Ajc/F2rtm1Ajc
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to endotoxin shock J:132733
F2rtm1Pago/F2rtm1Pago
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:124648
decreased susceptibility to induced colitis J:94420
F2rtm1Pago/F2rtm1Pago
(involves: 129P2/OlaHsd) 		decreased susceptibility to endotoxin shock J:133917
F2rl1tm1Bpd/F2rl1tm1Bpd
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:124648
increased inflammatory response J:96196
increased susceptibility to induced pancreatitis J:96196
F2rl1tm1Bpd/F2rl1tm1Bpd
(B6.129P2-F2rl1tm1Bpd) 		decreased susceptibility to endotoxin shock J:88245
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6) 		glomerulonephritis J:124303
F2rl1tm1Jkaw/F2rl1tm1Jkaw
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:106127
F2rl1tm1Mslb/F2rl1tm1Mslb
(involves: 129X1/SvJ * C57BL/6) 		decreased inflammatory response J:79757
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to induced arthritis J:81119
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd) 		liver inflammation J:102762
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss) 		decreased susceptibility to endotoxin shock J:91165
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/0
(B6.Cg-F3tm1Dco Tg(F3)1Nmk) 		decreased susceptibility to endotoxin shock J:88245
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		lung inflammation J:67398
F11rtm1.1Dej/F11rtm1.1Dej
(Not Specified) 		increased susceptibility to type IV hypersensitivity reaction J:92592
Faddtm1Mpa/Faddtm1Mpa
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		liver inflammation J:118336
Faddtm1Mpa/Faddtm1Mpa
Myd88tm1Aki/Myd88tm1Aki
Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Myd88tm1Aki Tg(Vil1-cre)997Gum) 		cecum inflammation J:175865
Faddtm1Mpa/Faddtm1Mpa
Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Tg(Vil1-cre)997Gum) 		cecum inflammation J:175865
colitis J:175865
Faddtm1Mpa/Faddtm1Mpa
Tnftm1Gkl/Tnftm1Gkl
Tg(Vil1-cre)997Gum/0
(B6.Cg-Faddtm1Mpa Tnftm1Gkl Tg(Vil1-cre)997Gum) 		cecum inflammation J:175865
colitis J:175865
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J) 		dermatitis J:153293
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * PT) 		kidney inflammation J:77295
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL) 		liver inflammation J:27735
Fahtm1Mgo/Fahtm1Mgo
Hgdaku/Hgd+
(involves: 129S7/SvEvBrd * NB) 		kidney inflammation J:77295
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6) 		liver inflammation J:164184
Fam3dem1Wko/Fam3dem1Wko
(C57BL/6-Fam3dem1Wko) 		colitis J:300819
increased susceptibility to colitis induced morbidity/mortality J:300819
increased susceptibility to induced colitis J:300819
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi) 		white adipose tissue inflammation J:258290
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi
Tg(Col1a1-cre)2Bek/0
(involves: 129S6/SvEvTac * CD-1) 		dental pulp inflammation J:225679
periodontium inflammation J:225679
Fam76bGt(IST14004H1)Tigm/Fam76bGt(IST14004H1)Tigm
(C57BL/6-Fam76bGt(IST14004H1)Tigm) 		increased inflammatory response J:358021
Fam210bem1Cya/Fam210bem1Cya
(involves: C57BL/6N) 		glomerulonephritis J:351618
Fan1tm1a(KOMP)Wtsi/Fan1tm1a(KOMP)Wtsi
(129S1.B6-Fan1tm1a(KOMP)Wtsi) 		tubulointerstitial nephritis J:242198
Faslpr/Fas+
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp) 		liver inflammation J:72817
Faslpr/Faslpr
(MRL/Mp-Faslpr) 		abnormal type III hypersensitivity reaction J:28885
blood vessel inflammation J:28885
glomerulonephritis J:27634, J:13757, J:28885
lacrimal gland inflammation J:18512
salivary gland inflammation J:18512
submandibular gland inflammation J:21965
thyroid gland inflammation J:28171
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J) 		CNS inflammation J:14151
conjunctivitis J:123192
glomerulonephritis J:92084, J:122315, J:127199, J:7454
salivary gland inflammation J:92084
Faslpr/Faslpr
(involves: C3H * MRL/Mp) 		increased susceptibility to type III hypersensitivity reaction J:34296
Faslpr/Faslpr
(B6.MRL-Faslpr/J) 		brain inflammation J:120427
CNS inflammation J:120427
Faslpr/Faslpr
(MRL-Faslpr) 		glomerulonephritis J:126261
Faslpr/Faslpr
(MRL.Cg-Irf1tm1Mak Faslpr) 		glomerulonephritis J:114771
Faslpr/Faslpr
(C3.MRL-Faslpr/J) 		glomerulonephritis J:7454
Faslpr/Faslpr
(B6.MRL-Faslpr) 		glomerulonephritis J:135036, J:7454
Faslpr/Faslpr
(AK.MRL-Faslpr) 		glomerulonephritis J:7454
Faslpr/Faslpr
(C3.MRL-Faslpr) 		lacrimal gland inflammation J:1028
salivary gland inflammation J:1028
Faslpr/Faslpr
(MRL/MpJ-Faslpr) 		blood vessel inflammation J:137066
glomerulonephritis J:125114, J:132514, J:137066
Faslpr/Faslpr
(involves: 129P2/OlaHsd * MRL) 		glomerulonephritis J:45448
kidney inflammation J:45448
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr) 		arteritis J:106188
decreased susceptibility to type III hypersensitivity reaction J:106188
glomerulonephritis J:106188
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
(MRL.Cg-Ifnar1tm1Agt Faslpr) 		glomerulonephritis J:92084
salivary gland inflammation J:92084
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr) 		glomerulonephritis J:92084
salivary gland inflammation J:92084
Faslpr/Faslpr
Ifngtm1Ts/Ifng+
(MRL.Cg-Ifngtm1Ts Faslpr) 		glomerulonephritis J:123834
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts
(MRL.Cg-Ifngtm1Ts Faslpr) 		kidney inflammation J:123834
lung inflammation J:123834
Faslpr/Faslpr
Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Faslpr) 		glomerulonephritis J:92084
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn
(MRL.Cg-Il4tm1Cgn Faslpr) 		glomerulonephritis J:132514
lacrimal gland inflammation J:132514
Faslpr/Faslpr
Il27ratm1Mak/Il27ratm1Mak
(MRL.Cg-Il27ratm1Mak Faslpr) 		glomerulonephritis J:122148
Faslpr/Faslpr
Irf1tm1Mak/Irf1+
(MRL.Cg-Irf1tm1Mak Faslpr) 		glomerulonephritis J:114771
Faslpr/Faslpr
Irf1tm1Mak/Irf1tm1Mak
(MRL.Cg-Irf1tm1Mak Faslpr) 		glomerulonephritis J:114771
Faslpr/Faslpr
Selptm1Bay/Selptm1Bay
(MRL.Cg-Selptm1Bay Faslpr) 		dermatitis J:127199
glomerulonephritis J:127199
Faslpr/Faslpr
Selplgtm1Fur/Selplgtm1Fur
(MRL.Cg-Selplgtm1Fur Faslpr) 		dermatitis J:127199
glomerulonephritis J:127199
Faslpr/Faslpr
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp) 		kidney inflammation J:73396
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * MRL) 		kidney inflammation J:45448
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp) 		kidney inflammation J:122222
liver inflammation J:122222
lung inflammation J:122222
salivary gland inflammation J:122222
Faslpr/Faslpr
Tg(INS-Il10)#Sar/0
(NOD.Cg-Faslpr Tg(INS-Il10)#Sar) 		insulitis J:64051
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr) 		glomerulonephritis J:135036
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr) 		glomerulonephritis J:113557
kidney inflammation J:113557
Faslpr/Faslpr
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Faslpr/Faslpr
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr) 		lacrimal gland inflammation J:126929
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn) 		alveolitis J:114948
increased inflammatory response J:114948
kidney inflammation J:114948
liver inflammation J:114948
lung inflammation J:114948
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J) 		interstitial pneumonia J:7306
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J) 		brain inflammation J:120427
CNS inflammation J:120427
eye inflammation J:136745
liver inflammation J:135830
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6) 		dermatitis J:153501
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		dermatitis J:153501
glomerulonephritis J:153501
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6) 		glomerulonephritis J:87990
Fasltm1.1Lest/Fasltm1.1Lest
(B6.129-Fasltm1.1Lest) 		glomerulonephritis J:87990
Fat1Gt(KST249)Byg/Fat1Gt(KST249)Byg
Tg(Myl1-lacZ)1Ibdml/0
(involves: 129P2/OlaHsd) 		myositis J:199157
Fat1tm1.2Fhel/Fat1tm1.2Fhel
Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J * SJL) 		myositis J:199157
Fbn1tm1Lper/Fbn1+
(involves: 129/Sv * CD-1) 		lung inflammation J:167276
Fbn1tm2Rmz/Fbn1tm2Rmz
(involves: 129S1/Sv * 129X1/SvJ) 		aortitis J:54081
lung inflammation J:91815
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk) 		alveolitis J:15018, J:30961, J:6566
increased susceptibility to type IV hypersensitivity reaction J:7185
lung inflammation J:30961, J:6566
Fbxl4tm1.2Lrsn/Fbxl4tm1.2Lrsn
(involves: C57BL/6N) 		liver inflammation J:303084
Fbxl5tm2.1Kei/Fbxl5tm2.1Kei
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		liver inflammation J:176655
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl * C3H/HeN) 		increased susceptibility to otitis media J:85263
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl * C3H/HeN * C57BL/6J) 		increased susceptibility to otitis media J:114851
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl) 		increased susceptibility to otitis media J:250208
Fbxo11Jf/Fbxo11Mutt
(involves: BALB/c * C3H/HeN) 		increased susceptibility to otitis media J:114851
Fcer1atm1Knt/Fcer1atm1Knt
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2)) 		decreased susceptibility to type I hypersensitivity reaction J:113572, J:39250
Fcer1atm1Knt/Fcer1atm1Knt
(involves: 129 * BALB/c) 		increased susceptibility to type I hypersensitivity reaction J:78659
Fcer1atm1Knt/Fcer1atm1Knt
Fcer2atm1Max/Fcer2atm1Max
Fcgr1tm1Jsv/Fcgr1tm1Jsv
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.Cg-Fcgr2btm1Ttk Fcgr3tm1Jsv Fcer1atm1Knt Fcgr1tm1Jsv Fcer2atm1Max) 		increased susceptibility to type I hypersensitivity reaction J:144620
Fcer1atm1Knt/Fcer1atm1Knt
Tg(SV40/HTLV-FCER1A)1Bhk/0
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2)) 		abnormal type I hypersensitivity reaction J:113572
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:78659, J:39248
Fcer1gtm1Tks/Fcer1gtm1Tks
(involves: C57BL/6) 		decreased inflammatory response J:50023
decreased susceptibility to type IV hypersensitivity reaction J:112160
Fcer2atm1Max/Fcer2atm1Max
(involves: C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:57738
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1+
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J) 		increased susceptibility to type I hypersensitivity reaction J:198154
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J) 		increased susceptibility to type I hypersensitivity reaction J:198154
Fcgr1tm1Hoga/Fcgr1tm1Hoga
(involves: 129S1/Sv * 129X1/SvJ) 		decreased inflammatory response J:86281
Fcgr1tm1Jsv/Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c) 		abnormal type I hypersensitivity reaction J:83995
decreased susceptibility to induced arthritis J:83995
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv
Sle16C57BL/6/Sle16C57BL/6
(involves: C57BL/6 * FVB/N) 		increased susceptibility to induced arthritis J:179175
kidney inflammation J:179175
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6) 		increased susceptibility to induced arthritis J:190890
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(involves: 129S4/SvJae) 		increased susceptibility to type I hypersensitivity reaction J:31133
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk) 		glomerulonephritis J:64152
increased inflammatory response J:64152
kidney inflammation J:64152
liver inflammation J:64152
lung inflammation J:64152
pancreas inflammation J:64152
salivary gland inflammation J:64152
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(Not Specified) 		increased susceptibility to induced arthritis J:106191
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Il17atm1Yiw/Il17a+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		glomerulonephritis J:191090
kidney inflammation J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas * 129S4/SvJae * BALB/c) 		urinary bladder inflammation J:207275
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Sle21129P2/Ola/Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk) 		increased susceptibility to induced arthritis J:179175
kidney inflammation J:179175
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6) 		kidney inflammation J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm2Sbn/Traf3ip2tm2Sbn
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		glomerulonephritis J:191090
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal type I hypersensitivity reaction J:83995
decreased susceptibility to type II hypersensitivity reaction J:35057
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J) 		decreased susceptibility to induced arthritis J:106191
Fcgr3tm1Ttk/Fcgr3tm1Ttk
(involves: 129X1/SvJ) 		decreased susceptibility to type I hypersensitivity reaction J:107371
Fcgr4tm1.1Rav/Fcgr4tm1.1Rav
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:167375
Fcgr4tm1Rav/Fcgr4tm1Rav
Tg(Ctsk-cre)1Rda/0
(involves: C57BL/6) 		autoimmune arthritis J:197378
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch) 		chronic liver inflammation J:244082
Fem1atm1Seno/Fem1atm1Seno
(C57BL/6-Fem1atm1Seno) 		increased susceptibility to colitis induced morbidity/mortality J:228893
increased susceptibility to induced colitis J:228893
Fen1tm3.1Bhsh/Fen1+
(Not Specified) 		chronic inflammation J:231218
glomerulonephritis J:231218
interstitial pneumonia J:231218
lung inflammation J:231218
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified) 		chronic inflammation J:231218
glomerulonephritis J:231218
interstitial pneumonia J:231218
lung inflammation J:231218
Fermt1tm1Ref/Fermt1tm1Ref
(involves: 129S1/Sv * 129X1/SvJ) 		ileum inflammation J:142913
large intestinal inflammation J:142913
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ) 		conjunctivitis J:64748
Festm2Pag/Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased susceptibility to endotoxin shock J:98590
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6) 		increased susceptibility to induced arthritis J:153951
increased susceptibility to induced colitis J:153951
lung inflammation J:153951
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal inflammatory response J:157383
decreased susceptibility to induced colitis J:157383
large intestinal inflammation J:157383
Fgfr1Hspy/Fgfr1+
(C3HeB/FeJ-Hspy) 		increased susceptibility to otitis media J:95895
Fgfr1tm1Upir/Fgfr1tm1Upir
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J) 		dermatitis J:221184
skin inflammation J:158802, J:221184
Fgfr2tm1Dsn/Fgfr2tm1Dsn
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		adipose tissue inflammation J:119723
skin inflammation J:119723
Fgfr2tm1Ewj/Fgfr2+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		bronchiolectasis J:101174
Fgl1tm1b(EUCOMM)Hmgu/Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N) 		dermatitis J:269578
Fgl2tm1Pam/Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam) 		glomerulonephritis J:130895
FgrMhdaali18/Fgr+
(C3HeB/FeJ-FgrMhdaali18) 		dermatitis J:112868
increased inflammatory response J:112868
FgrMhdaali18/FgrMhdaali18
(C3HeB/FeJ-FgrMhdaali18) 		autoimmune arthritis J:112868
dermatitis J:112868
Fgrtm1Hev/Fgrtm1Hev
(B6.129S7-Fgrtm1Hev) 		abnormal inflammatory response J:113463
Fgrtm1Hev/Fgrtm1Hev
Hcktm1Hev/Hcktm1Hev
Lyntm1Sor/Lyntm1Sor
(B6.Cg-Hcktm1Hev Fgrtm1Hev Lyntm1Sor) 		abnormal inflammatory response J:113463
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6) 		increased susceptibility to induced colitis J:285283
liver inflammation J:302658
Fignfi/Fignfi
(mixed) 		conjunctivitis J:13035
eye inflammation J:13035
Fkbp11Gt(OST298786)Lex/Fkbp11Gt(OST298786)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased inflammatory response J:103485
Fkrptm1Scbr/Fkrptm1Scbr
Sox1tm1(cre)Take/Sox1+
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		myositis J:207119
Fkrptm1Scbr/Fkrptm1Scbr
Sox1tm1(cre)Take/Sox1+
Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj) 		myositis J:207119
Flgft/Flgft
(involves: C57BL/6) 		skin inflammation J:151110
Flgft/Flgft
(Not Specified) 		dermatitis J:198332
Flgft/Flgft
(STOCK a/a Tmem79ma Flgft/J) 		dermatitis J:204304
Flgft/Flgft
Tmem79ma/Tmem79ma
(involves: CBA/CaGr) 		blepharitis J:202453
skin inflammation J:202453
Flgtm1Amag/Flgtm1Amag
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac) 		dermatitis J:198332
increased inflammatory response J:229771
increased susceptibility to type IV hypersensitivity reaction J:198332
Flgtm1Amag/Flgtm1Amag
Tg(CD207-Dta)312Dhka/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac * FVB) 		decreased inflammatory response J:229771
Flicrem1Doi/Flicrem1Doi
(NOD/ShiLtDoi-Flicrem1Doi) 		insulitis J:241346
Flvcr2tm1.2Tda/Flvcr2tm1.2Tda
(involves: C57BL/6J) 		brain inflammation J:287134
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		osteoarthritis J:79115
Fmodtm1Aol/Fmodtm1Aol
Lumtm1Chak/Lumtm1Chak
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		osteoarthritis J:79115
Fndc4tm1.1Mabo/Fndc4tm1.1Mabo
(involves: C57BL/6 * BALB/c) 		increased susceptibility to induced colitis J:236896
Fostm3.1Wag/Fostm3.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm4.1Wag/Fostm4.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm5.1Wag/Fostm5.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm6.1Wag/Fostm6.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm7Wag/Fostm7Wag
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:175064
Foxa2tm1.1Khk/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		respiratory system inflammation J:284174
Foxf1em1Vvk/Foxf1+
(involves: C57BL/6 * DBA/2) 		lung inflammation J:296328
Foxm1tm1Rhc/Foxm1tm1Rhc
Tg(Tek-cre)1Ywa/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		lung inflammation J:167773
Foxn1nu/Foxn1+
(involves: BALB/c) 		blepharitis J:12543
increased incidence of corneal inflammation J:12543
Foxn1nu/Foxn1nu
(involves: BALB/c) 		blepharitis J:12543
Foxn1nu/Foxn1nu
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * BALB/c * CF-1) 		decreased inflammatory response J:99033
Foxo1tm1Flv/Foxo1tm1Flv
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) 		abnormal inflammatory response J:189962
Foxo1tm1Flv/Foxo1tm1Flv
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased susceptibility to induced colitis J:147057
Foxo3Gt(XAO26)Byg/Foxo3Gt(XAO26)Byg
(involves: 129P2/OlaHsd) 		increased inflammatory response J:93593
kidney inflammation J:93593
lung inflammation J:93593
salivary gland inflammation J:93593
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		dermatitis J:118179
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR)) 		blepharitis J:11262
dermatitis J:11262
increased inflammatory response J:11262
liver inflammation J:11262
Foxp3sf/Y
(involves: 101/H * C3H/HeH * STOCK MR) 		conjunctivitis J:10398
Foxp3sf/?
(Not Specified) 		liver inflammation J:138808
lung inflammation J:138808
Foxp3sf/Y
(B6.Cg-Foxp3sf/J) 		lung inflammation J:125129
salivary gland inflammation J:125129
skin inflammation J:125129
Foxp3tm1(CD2/CD52)Shori/Foxp3tm1(CD2/CD52)Shori
(involves: C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:171378
Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		stomach inflammation J:140085
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ) 		skin inflammation J:82560
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		dermatitis J:117743
liver inflammation J:117743
lung inflammation J:117743
lymph node inflammation J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		dermatitis J:117743
liver inflammation J:117743
lung inflammation J:117743
lymph node inflammation J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		blepharitis J:167922
conjunctivitis J:167922
dermatitis J:167922
Foxp3tm1Ayr/Y
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		dermatitis J:97029
Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch) 		abnormal inflammatory response J:117165
dermatitis J:117165
respiratory system inflammation J:117165
Foxp3tm1Tch/Y
(B6.129X1-Foxp3tm1Tch) 		abnormal inflammatory response J:117165
dermatitis J:117165
respiratory system inflammation J:117165
Foxp3tm2.1(EGFP/cre)Shori/Y
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6) 		pancreas inflammation J:234397
Foxp3tm2Flv/Y
(involves: C57BL/6) 		blepharitis J:118631
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		conjunctivitis J:117743
dermatitis J:117743
liver inflammation J:117743
lung inflammation J:117743
lymph node inflammation J:117743
Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch) 		colitis J:120636
Foxp3tm4(YFP/icre)Ayr/Y
Zfp91tm1Smoc/Zfp91tm1Smoc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to induced colitis J:306129
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
Ikzf4tm1Djr/Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ) 		chronic inflammation J:294549
glomerulonephritis J:294549
granulomatous inflammation J:294549
small intestinal inflammation J:294549
Foxq1sa/Foxq1sa
Lystbg/Lystbg
(involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl) 		interstitial pneumonia J:15166, J:5311
Foxq1sa/Foxq1sa
Lystbg/Lystbg
(involves: 101/Rl * C3H/Rl * C57BL10/Rl) 		interstitial pneumonia J:5311
lung inflammation J:5311
Fpr2tm1.1Jimw/Fpr2tm1.1Jimw
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ) 		decreased susceptibility to induced colitis J:197568
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(B6.129X1-Fpr2tm1.2Jimw) 		decreased inflammatory response J:160074
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(involves: 129X1/SvJ) 		colitis J:197568
decreased acute inflammation J:197568
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6) 		increased acute inflammation J:159658
increased susceptibility to induced arthritis J:159658
Frmd8em2Smoc/Frmd8em2Smoc
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL) 		increased susceptibility to colitis induced morbidity/mortality J:338904
increased susceptibility to induced colitis J:338904
FrylGt(Ayu21-T312)Imeg/FrylGt(Ayu21-T312)Imeg
(B6J.Cg-FrylGt(Ayu21-T312)Imeg) 		kidney inflammation J:260667
Fth1tm1.1Lck/Fth1tm1.1Lck
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Fth1tm1.1Lck Tg(Mx1-cre)1Cgn) 		liver inflammation J:166515
Ftotm1.2Pzg/Ftotm1.2Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		dermatitis J:166984
Ftotm1.3Pzg/Ftotm1.3Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		dermatitis J:166984
Fut4tm1Jbl/Fut4tm1Jbl
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl Fut4tm1Jbl) 		decreased susceptibility to type IV hypersensitivity reaction J:79388
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl) 		decreased susceptibility to type IV hypersensitivity reaction J:79388, J:74776
Fxntm1Mkn/Fxntm1Mkn
Tg(FXN)YG8Pook/0
(involves: 129/Sv * C57BL/6 * CBA) 		brain inflammation J:216422
Fxntm1Mkn/Fxntm1Pand
(involves: 129/Sv * C57BL/6) 		brain inflammation J:216422
Fyntm1Rmp/Fyntm1Rmp
(B6.129S2-Fyntm1Rmp) 		increased susceptibility to type I hypersensitivity reaction J:114287
Gab2tm1Hhg/Gab2tm1Hhg
(involves: 129S4/SvJae) 		decreased susceptibility to type I hypersensitivity reaction J:70424
Gab2tm3.1Thir/Gab2tm3.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl) 		decreased susceptibility to type I hypersensitivity reaction J:178045
Gab2tm4.1Thir/Gab2tm4.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl) 		decreased susceptibility to type I hypersensitivity reaction J:178045
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya) 		pancreas inflammation J:88785
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6)) 		glomerulonephritis J:76041
increased inflammatory response J:76041
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv) 		glomerulonephritis J:118837
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6) 		glomerulonephritis J:118837
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv) 		abnormal type IV hypersensitivity reaction J:69475
Galctwi/Galctwi
(involves: CE/J) 		CNS inflammation J:78223
GaltGt(E285B04)Wrst/GaltGt(E285B04)Wrst
(involves: 129P2/OlaHsd * C57BL/6J) 		brain inflammation J:234753
liver inflammation J:234753
Gasa1BALB/cCrSlc/Gasa1BALB/cCrSlc
(involves: BALB/cCrSlc * C57BL/6) 		stomach inflammation J:54699
Gasa1BALB/cCrSlc/Gasa1C57BL/6
(involves: BALB/cCrSlc * C57BL/6) 		stomach inflammation J:54699
Gasa2BALB/cCrSlc/Gasa2BALB/cCrSlc
(involves: BALB/cCrSlc * C57BL/6) 		stomach inflammation J:54699
Gasa2BALB/cCrSlc/Gasa2BALB/cCrSlc
Gasa4BALB/cCrSlc/Gasa4C57BL/6
(involves: BALB/cCrSlc * C57BL/6) 		stomach inflammation J:75277
Gasa2BALB/cCrSlc/Gasa2C57BL/6
(involves: BALB/cCrSlc * C57BL/6) 		stomach inflammation J:54699
Gasa3BALB/cCrSlc/Gasa3C57BL/6
(involves: BALB/cCrSlc * C57BL/6) 		stomach inflammation J:75277
Gasa4BALB/cCrSlc/Gasa4C57BL/6
(involves: BALB/cCrSlc * C57BL/6) 		stomach inflammation J:75277
Gasttm1Lcs/Gasttm1Lcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		stomach inflammation J:97527
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(Not Specified) 		kidney inflammation J:227997
Gata5tm1Eno/Gata5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6) 		urethritis J:63036
vaginal inflammation J:63036
Gatmem1Btlr/Gatmem1Btlr
(C57BL/6J-Gatmem1Btlr) 		increased susceptibility to induced colitis J:252049
Gatmem1Btlr/Gatmm1Btlr
(C57BL/6J-Gatmem1Btlr/Gatmm1Btlr) 		increased susceptibility to induced colitis J:252049
Gatmm1Btlr/Gatm+
(C57BL/6J-Gatmm1Btlr) 		increased susceptibility to induced colitis J:252049
Gatmm1Btlr/Gatmm1Btlr
(C57BL/6J-Gatmm1Btlr) 		increased susceptibility to induced colitis J:252049
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		abnormal inflammatory response J:76409
liver inflammation J:76409
lung inflammation J:76409
lymph node inflammation J:76409
skin inflammation J:76409
Gcatm1Roes/Gcatm1Roes
(involves: 129P2/OlaHsd * 129S2/SvPas) 		decreased susceptibility to endotoxin shock J:81436
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129/Sv * C57BL/6) 		abnormal acute inflammation J:86387
abnormal inflammatory response J:86387
Gcnt3tm1.1Jxm/Gcnt3tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to induced colitis J:149909
Gdnftm1Lmgd/Gdnf+
(B6.129-Gdnftm1Lmgd) 		tubulointerstitial nephritis J:103081
Gfaptm1Pkny/Gfaptm1Pkny
Ppt1tm1Hof/Ppt1tm1Hof
Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		brain inflammation J:177265
Gfaptm1Pkny/Gfaptm1Pkny
Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased inflammatory response J:123278
Gfertm1.1Crg/Gfertm1.1Crg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		liver inflammation J:227242
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to endotoxin shock J:75143
Gfustm1Jbl/Gfustm1Jbl
(involves: 129S2/SvPas * C57BL/6J) 		large intestinal inflammation J:82239
Ggt5tm1Mwl/Ggt5tm1Mwl
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased acute inflammation J:77691
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J) 		colitis J:160090
intestinal inflammation J:160090
Git2tm1Hsb/Git2tm1Hsb
(involves: C57BL/6 * CBA) 		lung inflammation J:112663
Gja1M1Jrt/Gja1+
(involves: C3H/HeJ * C57BL/6J) 		heart inflammation J:101733
Gjb1tm1Kwi/Y
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		optic nerve inflammation J:219594
spinal cord inflammation J:219594
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		optic nerve inflammation J:219594
spinal cord inflammation J:219594
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac) 		stomach inflammation J:234656
Glis2tm1Amj/Glis2tm1Amj
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:134208
GlmpGt(P084H04)Wrst/GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas * C57BL/6) 		liver inflammation J:208774
Glmptm1Lex/Glmptm1Lex
(B6;129S5-Glmptm1Lex/Mmucd) 		liver inflammation J:171883
Gm16685em1Osb/Gm16685em1Osb
(C57BL/6N-Gm16685em1Osb) 		decreased susceptibility to colitis induced morbidity/mortality J:303079
Gm41610em1Scrp/Gm41610em1Scrp
(C57BL/6-Gm41610em1Scrp) 		decreased susceptibility to endotoxin shock J:302605
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd) 		decreased susceptibility to type I hypersensitivity reaction J:146132
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm2Soff/Gnaqtm2Soff
Tg(Tek-icre/ERT2)1Soff/?
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		decreased susceptibility to type I hypersensitivity reaction J:146132
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased susceptibility to type IV hypersensitivity reaction J:149560
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd * C57BL/6J) 		colitis J:24434
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd) 		colitis J:24434
increased inflammatory response J:30507
large intestinal inflammation J:30507
peritoneal inflammation J:30507
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd * C57BL/6) 		colitis J:91100
Gnai2tm2.1Lbi/Gnai2tm2.1Lbi
Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA) 		increased susceptibility to induced colitis J:194587
GnasOedsml/Gnas+
(involves: 101/H * C3H/HeH) 		abnormal inflammatory response J:65007
Gnb1lGt(OST35527)Lex/Gnb1l+
(B6;129S5-Gnb1lGt(OST35527)Lex/Orl) 		glomerulonephritis J:82809
Gnetm1.1Masn/Gnetm1.1Masn
(involves: 129P2/OlaHsd * C57BL/6) 		kidney inflammation J:184315
Gnptabnym/Gnptabnym
(involves: BALB/cAnNHsd * C3H/HeNHsd) 		brain inflammation J:218156
Golm1Gt(KST273)Byg/Golm1Gt(KST273)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		kidney inflammation J:151282
liver inflammation J:151282
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(B6.129-Gpa33tm1Jkhh) 		increased susceptibility to induced colitis J:224768
increased susceptibility to type IV hypersensitivity reaction J:224768
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(involves: 129 * C57BL/6) 		increased susceptibility to colitis induced morbidity/mortality J:231808
increased susceptibility to induced colitis J:231808
Gpc3tm1Fil/Y
(B6.Cg-Gpc3tm1Fil) 		lung inflammation J:73877
rhinitis J:73877
Gpc3tm1Fil/Gpc3tm1Fil
(B6.Cg-Gpc3tm1Fil) 		lung inflammation J:73877
Gpdc1C3H/HeN/Gpdc1C3H/HeN
(involves: C3H/HeN-Gnai2tm1Uru * C57BL/6J-Gna2tm1Uru) 		colitis J:95140
Gpdc2C3H/HeN/Gpdc2C3H/HeN
(involves: C3H/HeN-Gnai2tm1Uru * C57BL/6J-Gna2tm1Uru) 		colitis J:95140
Gpdc3C3H/HeN/?
(involves: C3H/HeN-Gnai2tm1Uru * C57BL/6J-Gna2tm1Uru) 		colitis J:95140
Gpr15tm1.1Litt/Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt) 		increased susceptibility to induced colitis J:199126
Gpr31btm1Ktak/Gpr31btm1Ktak
(B6.Cg-Gpr31btm1Ktak) 		decreased inflammatory response J:271242
Gpr34tm1.1Shbg/Gpr34tm1.1Shbg
(B6.Cg-Gpr34tm1.1Shbg) 		increased susceptibility to type IV hypersensitivity reaction J:168120
Gpr35em1Niess/Gpr35em1Niess
(C57BL/6N-Gpr35em1Niess) 		increased susceptibility to induced colitis J:300275
Gpr35em2Niess/Gpr35em2Niess
Cx3cr1tm2.1(cre/ERT2)Litt/Cx3cr1+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to induced colitis J:300275
Gpr35tm1(KOMP)Vlcg/Gpr35tm1(KOMP)Vlcg
(C57BL/6N-Gpr35tm1(KOMP)Vlcg/MbpMmucd) 		decreased susceptibility to colitis induced morbidity/mortality J:306520
decreased susceptibility to induced colitis J:306520
Gpr89tm1.1Ymae/Gpr89tm1.1Ymae
Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6) 		dermatitis J:189574
Gpr108tm1.1Brs/Gpr108tm1.1Brs
(involves: 129S6/SvEvTac) 		increased susceptibility to endotoxin shock J:266821
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c) 		increased inflammatory response J:69473
kidney inflammation J:69473
liver inflammation J:69473
lung inflammation J:69473
Gprc5atm1Rlo/Gprc5atm1Rlo
(involves: 129 * C57BL/6) 		lung inflammation J:127821
Gpsm3Gt(IST12408A1)Tigm/Gpsm3Gt(IST12408A1)Tigm
(involves: C57BL/6N) 		decreased susceptibility to induced arthritis J:193270
Gpx1tm1Kola/Gpx1tm1Kola
(involves: 129S2/SvPas * BALB/c * CF-1) 		increased inflammatory response J:79183
Gpx1tm1Ysh/Gpx1+
Gpx2tm2Coh/Gpx2tm2Coh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		intestinal inflammation J:71506
Gpx1tm1Ysh/Gpx1tm1Ysh
Gpx2tm2Coh/Gpx2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		intestinal inflammation J:71506
Gpx1tm1Ysh/Gpx1tm1Ysh
Gpx2tm2Coh/Gpx2tm2Coh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		colitis J:71506
intestinal inflammation J:71506
small intestinal inflammation J:71506
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:193993
Gpx8tm1Lex/Gpx8tm1Lex
(B6;129S5-Gpx8tm1Lex/Mmucd) 		dermatitis J:171883
Grem2em1Stpg/Grem2em1Stpg
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J) 		ovary inflammation J:318711
Grem2tm1Akh/Grem2tm1Akh
(involves: 129/Sv * C57BL/6) 		increased inflammatory response J:250034
GrhprGt(OST383093)Lex/GrhprGt(OST383093)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		urinary bladder inflammation J:181969
Grk6tm1.1Mca/Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca) 		glomerulonephritis J:225063
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6J) 		kidney inflammation J:268827
Gsdma3Ae/Gsdma3+
(involves: C57BL/6J * CAST/Ei) 		skin inflammation J:180149
Gsdma3M2Btlr/Gsdma3M2Btlr
(involves: C57BL/6J) 		dermatitis J:209203
Gsntm1Djk/Gsntm1Djk
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		decreased inflammatory response J:24346
Gstk1tm1Pgb/Gstk1tm1Pgb
(BALB/c-Gstk1tm1Pgb) 		glomerulonephritis J:177201
urethritis J:177201
urinary bladder inflammation J:177201
Gstt2em1Rmah/Gstt2em1Rmah
(Not Specified) 		increased inflammatory response J:358834
Gstz1tm1Pgb/Gstz1tm1Pgb
(BALB/c-Gstz1tm1Pgb/AnuApb) 		chronic inflammation J:91519
liver inflammation J:91519
Gt(ROSA)26Sortm1(B4galt1)Clib/Gt(ROSA)26Sortm1(B4galt1)Clib
Tg(Nes-cre)Wme/?
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased acute inflammation J:209737
decreased susceptibility to induced colitis J:209737
Gt(ROSA)26Sortm1(CAG-CAMK2G*T287D,-EGFP)Whua/Gt(ROSA)26Sor+
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6) 		decreased susceptibility to induced colitis J:243363
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Malt1tm1c(EUCOMM)Hmgu/Malt1tm1c(EUCOMM)Hmgu
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1) 		skin inflammation J:292094
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1) 		skin inflammation J:292094
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		CNS inflammation J:234435
lymph node inflammation J:234435
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Trpv1-cre)1Hoon/0
(involves: 129S1/Sv) 		decreased inflammatory response J:169256
Gt(ROSA)26Sortm1(DUX4)Sqh/Gt(ROSA)26Sor+
Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: 129S6/SvEvTac * C3H * C57BL/6) 		abnormal acute inflammation J:268959
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA) 		increased susceptibility to induced pancreatitis J:289183
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		dermatitis J:157757
Gt(ROSA)26Sortm1(HA)Libl/Gt(ROSA)26Sortm1(HA)Libl
Mogtm1(cre)Gkl/?
Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: 129/Sv * BALB/c * C57BL/6) 		brain inflammation J:137838
optic nerve inflammation J:137838
spinal cord inflammation J:137838
Gt(ROSA)26Sortm1(MAML1)Wsp/Gt(ROSA)26Sor+
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6 * FVB) 		conjunctivitis J:194073
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J) 		glomerulonephritis J:260047
increased inflammatory response J:260047
joint inflammation J:260047
small intestinal inflammation J:260047
Gt(ROSA)26Sortm1(Ptpn22*)Draw/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:201448
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		lung inflammation J:205858
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6) 		increased acute inflammation J:256652
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sortm1.1(DUX4*)Plj
(B6(Cg)-Gt(ROSA)26Sortm1.1(DUX4*)Plj) 		preputial gland inflammation J:256652
Gt(ROSA)26Sortm1.1(Loxl2)Acan/Gt(ROSA)26Sortm1.1(Loxl2)Acan
(Not Specified) 		epididymis inflammation J:220689
increased inflammatory response J:220689
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		increased inflammatory response J:202090
intestinal inflammation J:202090
kidney inflammation J:202090
liver inflammation J:202090
meningitis J:202090
stomach inflammation J:202090
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA) 		increased inflammatory response J:202090
intestinal inflammation J:202090
kidney inflammation J:202090
liver inflammation J:202090
meningitis J:202090
stomach inflammation J:202090
Gt(ROSA)26Sortm2(CAG-Nr5a1)Fjd/Gt(ROSA)26Sor+
Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ) 		uterus inflammation J:269597
Gt(ROSA)26Sortm2(cre/ERT2)Brn/0
Tg(Sftpc-Grem1)105Mmyl/0
(involves: 129P2/OlaHsd * C57BL/6N) 		lung inflammation J:82809
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased inflammatory response J:207306
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR) 		increased inflammatory response J:207306
Gt(ROSA)26Sortm3.1(CAG-Il17a)Awai/Gt(ROSA)26Sor+
(involves: BALB/c * C57BL/6) 		skin inflammation J:144710
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sortm4(HIF2A*)Kael
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased susceptibility to colitis induced morbidity/mortality J:307422
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Ripk3tm1Arte/Ripk3tm1Arte
(involves: C57BL/6NTac) 		intestinal inflammation J:209137
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N) 		peritoneal inflammation J:121321
Gy/Y
(involves: 101/H * C3H/HeH) 		blepharitis J:8335
H2-Ab1b-tm1Doi/H2-Ab1+
(involves: 129S2/SvPas * C57BL/6 * NOD/Lt) 		insulitis J:93557
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129S2/SvPas * C57BL/6 * NOD/Lt) 		insulitis J:93557
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Ighmtm1Cgn/Ighmtm1Cgn
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-Ighmtm1Cgn H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		heart inflammation J:113267
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Rag1tm1Mom/Rag1tm1Mom
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		heart inflammation J:113267
myocarditis J:113267
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Rag1tm1Mom/Rag1tm1Mom
Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl) 		myocarditis J:88055
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		heart inflammation J:87013, J:86540
lung inflammation J:86540
myositis J:86540
salivary gland inflammation J:86540
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell) 		thyroid gland inflammation J:113509
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL) 		salivary gland inflammation J:68641
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv) 		salivary gland inflammation J:59245
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)70Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl) 		heart inflammation J:88055
insulitis J:88055
myocarditis J:88055
salivary gland inflammation J:88055
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl) 		heart inflammation J:88055
insulitis J:88055
myocarditis J:88055
salivary gland inflammation J:88055
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL) 		salivary gland inflammation J:68641
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
Tg(HLA-A/H2-D/B2M)1Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-A/H2-D/B2M)1Dvs/Dvs) 		insulitis J:257229
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
Tg(HLA-B39/H2-D/B2m)2Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-B39/H2-D/B2M)2Dvs/Dvs) 		insulitis J:257229
H2-D1bm14/H2-D1bm14
(C57BL/6) 		spinal cord inflammation J:97717
H2-DMatm1Luc/H2-DMatm1Luc
(B6.129S4-H2-Dmatm1Luc) 		decreased susceptibility to type IV hypersensitivity reaction J:125654
H2-T18b/H2-T18b
H2-T3tm1Luc/H2-T3tm1Luc
Tcratm1Mom/Tcratm1Mom
(B6.Cg-Tcratm1Mom H2-T3tm1Luc) 		colitis J:142515
H2b/H2b
(NOD.B10SnJ-H2b) 		periinsulitis J:14178
H2b/H2g7
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL) 		mitral valve inflammation J:275827
rheumatoid arthritis J:36815, J:275827
H2dlAb1-Ea/H2dlAb1-Ea
Rag1tm1Mom/Rag1tm1Mom
Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		brain inflammation J:189816
H2dlAb1-Ea/H2dlAb1-Ea
Rag1tm1Mom/Rag1tm1Mom
Tg(HLA-DRA,HLA-DRB5*0101)loKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		brain inflammation J:189816
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6) 		brain inflammation J:189816
CNS inflammation J:189816
increased inflammatory response J:189816
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)loKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6) 		brain inflammation J:189816
H2g7/H2g7
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		insulitis J:111874
H2g7/H2g7
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		insulitis J:111874
H2h2/H2h2
(NOD.Cg-H2h2) 		insulitis J:14178
periinsulitis J:14178
H2h4/H2h4
(NOD.Cg-H2h4) 		insulitis J:14178
periinsulitis J:14178
thyroid gland inflammation J:54563
H2i5/H2i5
(NOD.Cg-H2i5) 		periinsulitis J:14178
H2i7/H2g7
((NOD x NOD.Cg-H2i7)F1) 		insulitis J:14178
H2i7/H2i7
(NOD.Cg-H2i7) 		periinsulitis J:14178
H2k/H2k
(NOD.Cg-H2k) 		periinsulitis J:14178
H2q/?
Ncf1m1J/Ncf1m1J
(B6.Cg-Ncf1m1J H2q) 		increased susceptibility to induced arthritis J:92437
increased susceptibility to type IV hypersensitivity reaction J:92437
rheumatoid arthritis J:92437
Habp2tm1Lex/Habp2tm1Lex
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		liver inflammation J:207454
Hapstr1tm1.1Menm/Hapstr1tm1.1Menm
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * C57BL/6J * CBA) 		large intestinal inflammation J:348964
Havcr1tm1Vlcg/Havcr1tm1Vlcg
(C.129-Havcr1tm1Vlcg) 		respiratory system inflammation J:187793
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow
Slc12a4Rbc10/Slc12a4+
(involves: 129 * BALB/c * C57BL/6J) 		liver inflammation J:227339
Hbnr2CBA/Hbnr2SWR
(involves: CBA * SWR) 		granulomatous inflammation J:85787
Hbnr2SWR/Hbnr2SWR
(involves: CBA * SWR) 		granulomatous inflammation J:85787
Hc0/Hc0
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		decreased susceptibility to induced arthritis J:134111
Hc1/?
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6) 		lung inflammation J:111432
Hcktm1Hev/Hcktm1Hev
(B6.129S7-Hcktm1Hev) 		abnormal inflammatory response J:113463
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		CNS inflammation J:90687
Hfgi1C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla) 		stomach inflammation J:123483
Hfgi2C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla) 		stomach inflammation J:123483
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6) 		dermatitis J:81448
Hif1atm3Rsjo/Hif1atm3Rsjo
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Hprt1tm1(Pck1-cre)Vhh/Y
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ) 		kidney inflammation J:130751
Hif1atm3Rsjo/Hif1atm3Rsjo
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6) 		kidney inflammation J:106705
Hif1atm3Rsjo/Hif1atm3Rsjo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased inflammatory response J:107682
decreased susceptibility to induced arthritis J:107682
Hif1atm3Rsjo/Hif1atm3Rsjo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to endotoxin shock J:148597
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Fabp1-cre)1Jig/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB/N) 		increased susceptibility to induced colitis J:93476
Hivep2tm1Sis/Hivep2tm1Sis
(either: (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj) or (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)) 		CNS inflammation J:263351
Hmgb1tm1.1Dltg/Hmgb1tm1.1Dltg
Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6 * FVB/N) 		increased susceptibility to induced pancreatitis J:225260
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd) 		increased susceptibility to endotoxin shock J:205499
Hmgxb4tm1.2Zhji/Hmgxb4tm1.2Zhji
(B6(Cg)-Hmgxb4tm1.2Zhji) 		decreased susceptibility to endotoxin shock J:302603
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N) 		decreased inflammatory response J:214639
Hmox1tm1.2Gkl/Hmox1tm1.2Gkl
(involves: 129 * BALB/cJ * C57BL/6) 		increased inflammatory response J:148498
liver inflammation J:148498
Hmox1tm1Poss/Hmox1tm1Poss
(involves: 129S2/SvPas * C57BL/6) 		chronic inflammation J:79254
glomerulonephritis J:79254
liver inflammation J:79254
lung inflammation J:79254
Hnf1btm1Mya/Hnf1btm3Mya
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		liver inflammation J:75935
Hnf1btm2Ics/Hnf1b+
(involves: 129 * C57BL/6N) 		chronic pancreas inflammation J:306082
Hnrnpdtm1Rjsc/Hnrnpdtm1Rjsc
(involves: 129S6/SvEvTac * C57BL/6J) 		increased susceptibility to endotoxin shock J:116112
Hoxa5tm1Rob/Hoxa5tm1Rob
(involves: 129S/SvEv * C57BL/6 * MF1) 		lung inflammation J:113378
Hoxa11osem1Kaf/Hoxa11osem1Kaf
(C57BL/6-Hoxa11osem1Kaf) 		increased susceptibility to induced colitis J:344661
intestinal inflammation J:344661
Hptm1Skl/Hptm1Skl
Hpxtm1Altr/Hpxtm1Altr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J) 		liver inflammation J:80539
Hpgdstm1Urad/Hpgdstm1Urad
(B6.129-Hpgdstm1Urad) 		increased acute inflammation J:107651
increased inflammatory response J:107651
increased susceptibility to type I hypersensitivity reaction J:197334
Hpi1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal inflammatory response J:69153
Hpi1C57BL/6J/Hpi1C57BL/6J
Hpi2C57BL/6J/Hpi2C57BL/6J
(involves: A/J * C57BL/6J) 		abnormal inflammatory response J:69153
Hpi2C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal inflammatory response J:69153
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6) 		kidney inflammation J:106705
Hps1ep/Hps1ep
(B6.C3Fe-Hps1ep/J) 		alveolitis J:110157
Hpsetm1.2Mdh/Hpsetm1.2Mdh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased acute inflammation J:209913
Hrhr/Hrhr
Tg(CD2-Stat6*V625A*T626A)78Mhk/0
(involves: C3H * SKH1) 		blepharitis J:230018
eye inflammation J:230018
Meibomian gland inflammation J:230018
uveitis J:230018
Hrm1Enu/Hrm1Enu
(BALB/cJ-Hrm1Enu) 		granulomatous inflammation J:108173
Hrrh/Hrrh
(Not Specified) 		eye inflammation J:16021
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2)) 		glomerulonephritis J:21316
lymph node inflammation J:21316
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn) 		decreased inflammatory response J:110367
Hrh4tm1Lex/Hrh4tm1Lex
(involves: 129S/SvEv * BALB/c) 		decreased inflammatory response J:131785
Hsd17b13tm1Lex/Hsd17b13tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		liver inflammation J:273927
Hsp90b1tm1Zhli/Hsp90b1tm1.1Zhli
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv) 		abnormal inflammatory response J:118427
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
(involves: 129 * C57BL/6) 		increased susceptibility to endotoxin shock J:302787
Hspb1tm1.1Jdn/Hspb1tm1.1Jdn
(B6.129S2(Cg)-Hspb1tm1.1Jdn) 		increased inflammatory response J:209117
Hspg2tm1Rdgr/Hspg2tm1Rdgr
(involves: 129S1/Sv * 129X1/SvJ) 		osteoarthritis J:121855
Htr3atm1Ckn/Htr3atm1Ckn
(involves: 129S1/Sv * C57BL/6J * DBA/2) 		kidney inflammation J:90942
prostate gland inflammation J:90942
pyelonephritis J:90942
seminal vesiculitis J:90942
tubulointerstitial nephritis J:90942
Hyal1tm1Stn/Hyal1tm1Stn
(involves: 129X1/SvJ * C57BL/6J) 		osteoarthritis J:136860
Hydinhyrh/Hydinhyrh
(involves: C57BL/6J * C57BL/10J * RIII) 		rhinitis J:137815
Ibdq1C57BL/6J/Ibdq1SAMP1/YitFcs
(involves: C57BL/6J * SAMP1/YitFc) 		ileum inflammation J:84661
Ibdq1SAMP1/YitFcs/Ibdq1SAMP1/YitFcs
(involves: C57BL/6J * SAMP1/YitFc) 		ileum inflammation J:84661
Ibdq2SAMP1/YitFcs/Ibdq2SAMP1/YitFcs
(involves: AKR/J * SAMP1/YitFcs) 		small intestinal inflammation J:105411
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:14565
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay) 		decreased susceptibility to endotoxin shock J:123460
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to induced colitis J:111227
large intestinal inflammation J:111227
Icam1tm1Bay/Icam1tm1Bay
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased acute inflammation J:112286
Icam1tm1Bay/Icam1tm1Bay
Selltm1Tft/Selltm1Tft
(B6.129-Selltm1Tft Icam1tm1Bay) 		abnormal inflammatory response J:124291
Icam1tm1Jcgr/Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased susceptibility to type IV hypersensitivity reaction J:18743
Icam1tm1Jcgr/Icam1tm1Jcgr
Tg(INS-Il10)#Sar/0
(NOD.Cg-Icam1tm1Jcgr Tg(INS-Il10)#Sar) 		periinsulitis J:66103
IchsC57BL/6J/IchsC57BL/6J
(involves: A/J * C57BL/6J * C57BL/6JOlaHsd) 		abnormal type I hypersensitivity reaction J:63737
IchsC57BL/6JOlaHsd/IchsC57BL/6JOlaHsd
(involves: A/J * C57BL/6J * C57BL/6JOlaHsd) 		abnormal type I hypersensitivity reaction J:63737
Icostm1Flv/Icos+
(NOD.129S1-Icostm1Flv) 		insulitis J:131529
Icostm1Flv/Icostm1Flv
(NOD.129S1-Icostm1Flv) 		insulitis J:131529
Icosltm1Mak/Icosltm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:84668
Id1tm1Zhu/Id1+
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor) 		increased susceptibility to otitis media J:311050
Id1tm1Zhu/Id1tm1Zhu
Id3tm1Zhu/Id3+
(involves: 129S1/Sv * 129S4/SvJaeSor) 		increased susceptibility to otitis media J:311050
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S4/SvJaeSor) 		lacrimal gland inflammation J:93916
salivary gland inflammation J:93916
Id3tm2.1Zhu/Id3tm2.1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J) 		parotid gland inflammation J:172701
submandibular gland inflammation J:172701
Idc/Idc+
(involves: 101 * C3H) 		blepharitis J:6686
Idd1NOD/Uf/Idd1NOD/Uf
(involves: C57BL/6 * NOD/Uf) 		periinsulitis J:33172
Idd3C57BL/10SnJ/Idd3C57BL/10SnJ
Idd5.2C57BL/10SnJ/Idd5.2C57BL/10SnJ
(involves: C57BL/10SnJ * NOD/MrkTac) 		insulitis J:143549
Idd3C57BL/10SnJ/Idd3C57BL/10SnJ
Idd5C57BL/10SnJ/Idd5C57BL/10SnJ
(involves: C57BL/10 * NOD/MrkTac) 		pancreas inflammation J:88667
Idd3NOD/?
(involves: C57BL/10 * NOD) 		pancreas inflammation J:17906
Idd4C57BL/6J/?
(involves: C57BL/6J * NOD) 		pancreas inflammation J:73763
Idd4NOD/Jsd/?
(involves: NOD/Jsd * NOR/LtJ) 		pancreas inflammation J:99002
Idd4NOD/Jsd/Idd4NOD/Jsd
Idd9NOD/Jsd/Idd9NOD/Jsd
(involves: NOD/Jsd * NOR/LtJ) 		pancreas inflammation J:99002
Idd4NOR/LtJ/?
(involves: NOD/Jsd * NOR/LtJ) 		pancreas inflammation J:99002
Idd5NOD/Uf/Idd5NOD/Uf
(involves: C57BL/6 * NOD/Uf) 		periinsulitis J:33172
Idd9NOD/Jsd/?
(involves: NOD/Jsd * NOR/LtJ) 		pancreas inflammation J:99002
Idd9NOR/LtJ/?
(involves: NOD/Jsd * NOR/LtJ) 		pancreas inflammation J:99002
Idd16.1ALR/LtJ/Idd16.1ALR/LtJ
(involves: ALR/LtJ * NOD/LtJ) 		pancreas inflammation J:98187
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * BALB/c) 		epididymis inflammation J:170565
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased susceptibility to type IV hypersensitivity reaction J:211949
Ido2em1Lamn/Ido2em1Lamn
(involves: BALB/c * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:342726
Ido2em1Lamn/Ido2em1Lamn
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * C57BL/6J * SJL) 		autoimmune arthritis J:342726
Ido2em2Lamn/Ido2em2Lamn
(involves: BALB/c * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:342726
Ido2em2Lamn/Ido2em2Lamn
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * C57BL/6J * SJL) 		autoimmune arthritis J:342726
Ido2tm1.2Gcp/Ido2tm1.2Gcp
(involves: C57BL/6J * FVB/N) 		decreased susceptibility to type IV hypersensitivity reaction J:211949
Iduatm1Efn/Iduatm1Efn
(involves: C57BL/6) 		increased susceptibility to otitis media J:123676
Ier3tm1Mxw/Ier3tm1Mxw
(involves: C57BL/6) 		decreased susceptibility to induced colitis J:194587
Ier3tm1Mxw/Ier3tm1Mxw
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to induced colitis J:194587
Ifi35em1Hhl/Ifi35em1Hhl
(C57BL/6-Ifi35em1Hhl) 		decreased susceptibility to endotoxin shock J:298909
Ifi204tm1.1Cjul/Ifi204tm1.1Cjul
(B6.129(Cg)-Ifi204tm1.1Cjul) 		decreased susceptibility to endotoxin shock J:270123
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422) 		chronic liver inflammation J:209917
glomerulonephritis J:209917
increased inflammatory response J:209917
skin inflammation J:209917
Ifih1Rgsc422/Ifih1+
Ifnar1tm1Agt/Ifnar1+
(involves: 129S2/SvPas * C57BL/6JJcl * DBA/2JJcl) 		glomerulonephritis J:209917
Ifih1Rgsc422/Ifih1+
Mavstm1Aki/Mavs+
(involves: C57BL/6JJcl * DBA/2JJcl) 		glomerulonephritis J:209917
Ifih1Rgsc422/Ifih1Rgsc422
(D2JJcl.B6JJcl-Ifih1Rgsc422) 		glomerulonephritis J:209917
Ifit1tm1(KOMP)Vlcg/Ifit1tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac) 		brain inflammation J:205203
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas) 		abnormal inflammatory response J:114555
Ifnar1tm1Agt/Ifnar1tm1Agt
Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu
Tg(KRT14-cre)1Cgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N * DBA/2) 		dermatitis J:312394
Ifnar1tm1Agt/Ifnar1tm1Agt
Tg(CD46)373Zbz/Tg(CD46)373Zbz
(involves: 129S2/SvPas * C3H/He * C57BL/6) 		brain inflammation J:160878
lung inflammation J:160878
meningitis J:160878
Ifnar2tm1Pjh/Ifnar2tm1Pjh
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv) 		increased susceptibility to endotoxin shock J:168781
Ifnb1tm1Tl/Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl) 		CNS inflammation J:83021
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal type IV hypersensitivity reaction J:55740
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd) 		decreased susceptibility to type IV hypersensitivity reaction J:29170
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J) 		abnormal type IV hypersensitivity reaction J:45665
glomerulonephritis J:118730
increased susceptibility to type IV hypersensitivity reaction J:118730
stomach inflammation J:120556
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * BALB/c) 		decreased inflammatory response J:114213
Ifngtm1Ts/Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J) 		abnormal inflammatory response J:115144
Ifngtm1Ts/Ifngtm1Ts
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S7/SvEvBrd * C57BL/6) 		brain inflammation J:191055
Ifngtm1Ts/Ifngtm1Ts
Tg(SFTPC-Il18)AThos/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N * DBA/2) 		lung inflammation J:147547
Ifngtm1Ts/Ifngtm1Ts
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129-Ifngtm1Ts Tgfb1tm1Doe) 		liver inflammation J:69346
Ifngtm1Ts/Ifngtm1Ts
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6J) 		small intestinal inflammation J:108572
Ifngtm1Ts/Ifngtm1Ts
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		lung inflammation J:119206
Ifngtm1Yiw/Ifngtm1Yiw
(involves: 129X1/SvJ * C57BL/6) 		decreased inflammatory response J:41632, J:88226
Ifngtm1Yiw/Ifngtm1Yiw
(B6.129X1-Ifngtm1Yiw) 		liver inflammation J:50405
peritoneal inflammation J:50405
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd) 		aortitis J:115139
arteritis J:115139
decreased susceptibility to endotoxin shock J:17878
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * DBA/1OlaHsd) 		increased susceptibility to induced arthritis J:40634
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(involves: 129S1/Sv) 		decreased susceptibility to type IV hypersensitivity reaction J:48016
Ifnktm1.1(KOMP)Vlcg/Ifnktm1.1(KOMP)Vlcg
(C57BL/6NTac-Ifnktm1.1(KOMP)Vlcg) 		decreased susceptibility to chemically induced skin inflammation J:322130
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb Igf1rtm1Jcbr) 		decreased susceptibility to type I hypersensitivity reaction J:241924
Igfbp1tm1Taub/Igfbp1tm1Taub
(involves: 129X1/SvJ * C57BL/6) 		liver inflammation J:81123
Igh-Jtm1(CB20)Riho/Igh-J+
(involves: C57BL/10 * DBA/1) 		increased susceptibility to induced arthritis J:179456
Igh-Jtm1(CB20)Riho/Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1) 		increased susceptibility to induced arthritis J:179456
Igh-Jtm1Aigl/Igh-J+
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		CNS inflammation J:151335
Igh-Jtm1Aigl/Igh-J+
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		CNS inflammation J:151335
Igh-Jtm1Dhu/Igh-J+
Il2tm1Hor/Il2tm1Hor
(involves: 129/Sv * C57BL/6) 		colitis J:29999
Igh-Jtm1Dhu/Igh-Jtm1Dhu
Il2tm1Hor/Il2tm1Hor
(involves: 129/Sv * C57BL/6) 		colitis J:29999
Ightm1.1(Igh564)Tik/Ightm1.1(Igh564)Tik
Igktm1(Igk564)Tik/Igktm1(Igk564)Tik
(B6.129S4-Igktm1(Igk564)Tik Ightm1(Igh564)Tik) 		glomerulonephritis J:113555
Ighg1tm1.1Pyu/Ighg1+
(B6.C(Cg)-Ighg1tm1.1Pyu) 		increased susceptibility to type I hypersensitivity reaction J:198154
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(B6.C(Cg)-Ighg1tm1.1Pyu) 		increased susceptibility to type I hypersensitivity reaction J:198154
Ighg2cem1Wliu/Ighg2cem1Wliu
(C57BL/6J-Ighg2cem1Wliu) 		decreased susceptibility to induced colitis J:322180
Ighmtm1Cgn/Ighm+
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		insulitis J:91865
Ighmtm1Cgn/Ighm+
Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V281)3Jwt) 		insulitis J:91865
Ighmtm1Cgn/Ighmtm1Cgn
(NODCaj.129S2-Ighmtm1Cgn) 		insulitis J:93190
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas) 		decreased susceptibility to type IV hypersensitivity reaction J:112160
increased susceptibility to induced arthritis J:157619
Ighmtm1Cgn/Ighmtm1Cgn
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		insulitis J:91865
Ighmtm1Cgn/Ighmtm1Cgn
Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V281)3Jwt) 		insulitis J:91865
Ighmtm1Cgn/Ighmtm1Cgn
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ) 		insulitis J:80859
Ighmtm1Cgn/Ighmtm1Cgn
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * C57BL/6 * CF-1) 		abnormal inflammatory response J:99033
Ighmtm1Cgn/Ighmtm1Cgn
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		small intestinal inflammation J:108572
Ighmtm1Cgn/Ighmtm1Cgn
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased inflammatory response J:181257
kidney inflammation J:181257
myocarditis J:181257
tubular nephritis J:181257
Ighmtm1Msn/Ighmtm1Msn
(involves: 129S/SvEv * C57BL/6) 		kidney inflammation J:111817
Igktm1Dhu/Igktm1Dhu
Tg(H2-Ea-HA)HACIIAjca/0
Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo) 		autoimmune arthritis J:209872
Ignpq3BALB/cAJcl/Ignpq3HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc) 		glomerulonephritis J:116904
Ignpq3HIGA/Nsc/Ignpq3HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc) 		glomerulonephritis J:116904
Ikbipem1Bcgen/Ikbipem1Bcgen
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd) 		increased susceptibility to induced colitis J:282971
lung inflammation J:282971
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Il20ratm1Rsab/Il20ratm1Rsab
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2) 		skin inflammation J:208995
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Il22tm1Jcrd/Il22tm1Jcrd
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2) 		skin inflammation J:208995
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Il22ra1tm1Rsab/Il22ra1tm1Rsab
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2) 		skin inflammation J:208995
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2) 		skin inflammation J:208995
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Tnfrsf1atm2Gkl/Tnfrsf1atm2Gkl
Tg(KRT14-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		skin inflammation J:208995
Ikbkbtm2Mka/Ikbkbtm2.1Mka
Tg(Vil-cre)1Mka/0
(involves: 129/Sv * C57BL/6) 		decreased acute inflammation J:83313
Ikbketm1Tman/Ikbketm1Tman
(B6.Cg-Ikbketm1Tman) 		lung inflammation J:119791
Ikbkgtm1.1Chtr/Y
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		liver inflammation J:151485
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		liver inflammation J:151485
Ikbkgtm1.1Dwat/Y
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		liver inflammation J:202106
Ikbkgtm1.1Mpa/Y
Tg(Vil1-cre)997Gum/0
(B6.Cg-Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum) 		colitis J:175865
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		abnormal inflammatory response J:118336
increased susceptibility to endotoxin shock J:137861
liver inflammation J:118336
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Vil1-cre)997Gum/0
(B6.Cg-Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum) 		colitis J:175865
Ikbkgtm1Dwb/Ikbkgtm1Dwb
(Not Specified) 		decreased susceptibility to endotoxin shock J:136353
Ikbkgtm1Mka/Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		erythroderma J:63054
Ikbkgtm1Mpa/Ikbkg+
(involves: C57BL/6) 		skin inflammation J:63055
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		lung inflammation J:20671
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c) 		lung inflammation J:20671
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		abnormal type III hypersensitivity reaction J:81805
glomerulonephritis J:81805
Ikzf4tm1.1Etms/Ikzf4tm1.1Etms
(Not Specified) 		chronic inflammation J:294549
Ikzf4tm1Djr/Ikzf4tm1Djr
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		chronic inflammation J:294549
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:165513
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw
Tg(KRT14-CASP1)1Miz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		dermatitis J:78602
Il1atm1Yiw/Il1atm1Yiw
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:191055
Il1btm1Dch/Il1btm1Dch
(involves: 129S2/SvPas) 		decreased susceptibility to type IV hypersensitivity reaction J:33465
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased acute inflammation J:27234
decreased inflammatory response J:27234
Il1r1em1Qizh/Il1r1em1Qizh
(C57BL/6-Il1r1em1Qizh) 		increased susceptibility to induced arthritis J:338375
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129 * C57BL/6) 		osteomyelitis J:58851
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J) 		increased susceptibility to induced arthritis J:125570
Il1r1tm1Imx/Il1r1tm1Imx
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		interstitial pneumonia J:126652
lung inflammation J:126652
osteomyelitis J:58851
Il1r1tm1Imx/Il1r1tm1Imx
Vsig4tm1Gne/Vsig4tm1Gne
(B6.Cg-Il1r1tm1Imx Vsig4tm1Gne) 		increased susceptibility to induced colitis J:281762
Il1r1tm1Quan/Il1r1tm1Quan
(involves: C57BL/6) 		abnormal inflammatory response J:219864
Il1r1tm1Quan/Il1r1tm1Quan
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal inflammatory response J:219864
Il1r1tm1Quan/Il1r1tm1Quan
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6) 		abnormal inflammatory response J:219864
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:42373
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv) 		decreased susceptibility to induced arthritis J:120707
Il1r1tm1Roml/Il1r1tm1Roml
Nlrp3tm1Hhf/Nlrp3+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6) 		skin inflammation J:150054
Il1r2tm1.2Mchc/Il1r2tm1.2Mchc
(involves: BALB/cJ * C57BL/6J * C57BL/6NTac) 		increased inflammatory response J:347877
Il1r2tm1Yiw/Il1r2tm1Yiw
(B6.129P2-Il1r2tm1Yiw) 		increased susceptibility to induced arthritis J:274653
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:61108
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(C.129P2-Il1rl1tm1Anjm) 		increased susceptibility to induced pancreatitis J:184801
Il1rl2tm1Hblu/Il1rl2tm1Hblu
(involves: 129) 		decreased susceptibility to induced colitis J:256437
Il1rntm1.1Cga/Il1rntm1.1Cga
Lyz2tm1(cre)Ifo/Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo) 		increased susceptibility to induced arthritis J:162760
Il1rntm1Dih/Il1rn+
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to endotoxin shock J:36387
Il1rntm1Dih/Il1rntm1Dih
(involves: 129S/SvEv * C57BL/6J) 		increased acute inflammation J:61600, J:88605
increased susceptibility to endotoxin shock J:36387
Il1rntm1Nick/Il1rn+
(involves: 129P2/OlaHsd * MF1) 		aortitis J:59410
Il1rntm1Nick/Il1rntm1Nick
(involves: 129P2/OlaHsd * MF1) 		aortitis J:59410
chronic inflammation J:59410
Il1rntm1Nick/Il1rntm1Nick
(involves: 129P2/OlaHsd * MF1 * BALB/cAnNHsd) 		aortitis J:89034
skin inflammation J:89034
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd) 		aortitis J:89034
rheumatoid arthritis J:89034
skin inflammation J:89034
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd * C57BL/6) 		aortitis J:89034
rheumatoid arthritis J:89034
Il1rntm1Sush/Il1rntm1Sush
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:97684
Il1rntm1Yiw/Il1rntm1Yiw
(C.129-Il1rntm1Yiw) 		rheumatoid arthritis J:143719
Il1rntm1Yiw/Il1rntm1Yiw
Il17atm1Yiw/Il17a+
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to induced arthritis J:83408
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6) 		colitis J:37220, J:29999, J:15223
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor) 		heart inflammation J:29799
increased inflammatory response J:29799
liver inflammation J:29799
lung inflammation J:29799
pancreas inflammation J:29799
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J) 		lacrimal gland inflammation J:125129
large intestinal inflammation J:125129
salivary gland inflammation J:125129
Il2tm1Hor/Il2tm1Hor
Rag2tm1Fwa/Rag2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		colitis J:29999
Il2ratm1Dw/Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6) 		colitis J:64279
Il2ratm1Dw/Il2ratm1Dw
(B6.129S4-Il2ratm1Dw/J) 		lacrimal gland inflammation J:125129
large intestinal inflammation J:125129
lung inflammation J:125129
salivary gland inflammation J:125129
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak) 		liver inflammation J:113547
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6) 		cecum inflammation J:24117
Il2rgtm1Wjl/Il2rgtm1Wjl
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S4/SvJae) 		lung inflammation J:140483
Il3tm1Glli/Il3tm1Glli
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6)) 		decreased susceptibility to type IV hypersensitivity reaction J:80640
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c) 		decreased inflammatory response J:60609, J:165513
ileum inflammation J:60609
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c) 		decreased inflammatory response J:60609, J:165513
ileum inflammation J:60609
Il4tm1Cgn/Il4tm1Cgn
(NOD.Cg-H2b Il4tm1Cgn) 		lacrimal gland inflammation J:105803
salivary gland inflammation J:105803
Il4tm1Cgn/Il4tm1Cgn
(either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD)) 		insulitis J:85924
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il4tm1Cgn/Il4tm1Cgn
(MRL.129P2-Il4tm1Cgn) 		lacrimal gland inflammation J:132514
Il4tm1Cgn/Il4tm1Cgn
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd) 		esophageal inflammation J:205692
increased inflammatory response J:205692
lung inflammation J:205692
Il4tm1Cgn/Il4tm1Cgn
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		insulitis J:85924
Il4tm1Nnt/Il4tm1Nnt
(C57BL/6-Il4tm1Nnt/J) 		CNS inflammation J:125605
granulomatous inflammation J:37196
stomach inflammation J:120556
Il4tm2Nnt/Il4tm2Nnt
(BALB/c-Il4tm2Nnt) 		ileum inflammation J:60609
Il4tm2Nnt/Il4tm2Nnt
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.Cg-Tgfb1tm1Doe Il4tm2Nnt) 		liver inflammation J:69346
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/cJ) 		granulomatous inflammation J:114751
liver inflammation J:114751
Il4ratm1Fbb/Il4ratm2Fbb
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/c) 		granulomatous inflammation J:114751
liver inflammation J:114751
Il4ratm1Tch/Il4ratm1Tch
(involves: 129X1/SvJ * BALB/c) 		respiratory system inflammation J:86215
Il4ratm2Tch/Il4ratm2Tch
(C.129X1-Il4ratm2Tch) 		increased susceptibility to type I hypersensitivity reaction J:152376
respiratory system inflammation J:152376
Il4ratm2Tch/Il4ratm2Tch
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/?
(B6.Cg-Il4ratm2Tch Tg(Scgb1a1-rtTA,tetO-IL13)1Eli) 		respiratory system inflammation J:152376
Il4ratm3.1Tch/Il4ratm3.1Tch
(C.129X1-Il4ratm3.1Tch) 		increased susceptibility to type I hypersensitivity reaction J:160806
Il5tm1Anjm/Il5tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il5tm1Anjm/Il5tm1Anjm
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il5tm1Kopf/Il5tm1Kopf
(C57BL/6-Il5tm1Kopf) 		granulomatous inflammation J:107418
Il5tm2Anjm/Il5tm2Anjm
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il5tm3Anjm/Il5tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il5tm3Anjm/Il5tm3Anjm
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il5ratm1Ktk/Il5ratm1Ktk
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:91089
Il6tm1Kopf/Il6+
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw) 		esophageal inflammation J:180282
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to induced colitis J:79073
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J) 		decreased susceptibility to induced arthritis J:208213
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas) 		abnormal inflammatory response J:160966
Il6tm1Kopf/Il6tm1Kopf
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * 129S2/SvPas) 		decreased susceptibility to endotoxin shock J:168781
Il6tm1Kopf/Il6tm1Kopf
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6) 		skin inflammation J:155575
Il6tm1Kopf/Il6tm1Kopf
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Il6tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw) 		esophageal inflammation J:180282
Il6tm1Mur/Il6tm1Mur
(involves: 129/Sv * C57BL/6) 		brain inflammation J:40579
Il6tm1Mur/Il6tm1Mur
(B6.129P2(B6)-Il6tm1Mur) 		abnormal inflammatory response J:85581
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * C57BL/6) 		decreased inflammatory response J:68063
Il6tm1Poli/Il6tm1Poli
(CAnNCrl.129S(Cg)-Il6tm1Poli) 		decreased inflammatory response J:42869
Il6ratm1.1Drew/Il6ratm1.1Drew
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased acute inflammation J:160966
Il6ratm1.2Drew/Il6ratm1.2Drew
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL) 		abnormal inflammatory response J:160966
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6) 		liver inflammation J:202764
Il6sttm1Ard/Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6) 		cecum inflammation J:79555
conjunctivitis J:79555
increased inflammatory response J:79555
increased susceptibility to induced colitis J:79073
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6) 		abnormal inflammatory response J:139226
decreased susceptibility to induced colitis J:79073
increased susceptibility to induced arthritis J:142883
stomach inflammation J:87206
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv) 		increased susceptibility to endotoxin shock J:168781
Il6sttm1Ern/Il6sttm1Ern
Stat1tm1Rds/Stat1tm1Rds
(involves: 129S1/Sv) 		abnormal inflammatory response J:139226
Il6sttm1Ern/Il6sttm1Ern
Stat3tm1Aki/Stat3+
(involves: 129P2/OlaHsd * 129S1/Sv) 		decreased susceptibility to endotoxin shock J:168781
Il6sttm1Ern/Il6sttm1Ern
Tiraptm1.1Pjh/Tiraptm1.1Pjh
(involves: 129S1/Sv) 		decreased susceptibility to endotoxin shock J:168781
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6) 		rheumatoid arthritis J:133059
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:82881, J:113543
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd * C57BL/6) 		intestinal inflammation J:94537
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd) 		increased susceptibility to endotoxin shock J:151551
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal type IV hypersensitivity reaction J:35510
cecum inflammation J:35020
chronic inflammation J:15222
colitis J:68476
increased susceptibility to type IV hypersensitivity reaction J:51636
intestinal inflammation J:35020, J:107077, J:15222
large intestinal inflammation J:35020
small intestinal inflammation J:35020
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd) 		abnormal inflammatory response J:117122
increased susceptibility to endotoxin shock J:117122, J:118833
intestinal inflammation J:113376
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J) 		cecum inflammation J:157787
increased susceptibility to induced colitis J:157787
large intestinal inflammation J:149347
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/1) 		colitis J:84100
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * 129S/SvEv) 		colitis J:59872
Il10tm1Cgn/Il10tm1Cgn
Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		colitis J:136179
decreased susceptibility to induced colitis J:136179
Il10tm1Cgn/Il10tm1Cgn
Nfil3tm1Look/Nfil3tm1Look
(involves: 129P2/OlaHsd * 129X1/SvJ) 		colitis J:209365
Il10tm1Cgn/Il10tm1Cgn
Nfil3tm1Pbro/Nfil3tm1Pbro
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		colitis J:209365
Il10tm1Cgn/Il10tm1Cgn
Tg(MUC1)79.24Gend/0
(B6.Cg-Il10tm1Cgn Tg(MUC1)79.24Gend) 		large intestinal inflammation J:149347
Il10tm1Cgn/Il10tm1Cgn
Tg(Vil1-cre)997Gum/?
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac * SJL) 		colitis J:229155
Il10tm1Cgn/Il10tm1Cgn
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac) 		colitis J:229155
Il10tm1Cgn/Il10tm1Cgn
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		colitis J:107077
intestinal inflammation J:107077
Il10tm1Mhry/Il10tm1Mhry
(involves: 129P2/OlaHsd * C57BL/6) 		intestinal inflammation J:117628
Il10tm1Roer/Il10tm1Roer
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal type IV hypersensitivity reaction J:134513
colitis J:134513
lung inflammation J:134513
Il10tm1Roer/Il10tm1Roer
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2) 		intestinal inflammation J:94537
liver inflammation J:94537
peritoneal inflammation J:94537
Il10tm2Roer/Il10tm2Roer
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal inflammatory response J:117122
increased susceptibility to endotoxin shock J:117122
Il10tm2Roer/Il10tm2Roer
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		abnormal inflammatory response J:117122
increased susceptibility to endotoxin shock J:117122
Il10ram1Jskg/Il10ram1Jskg
(B6.Cg-Il10ram1Jskg) 		colitis J:146644
Il10ratm1.2Jack/Il10ratm1.2Jack
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2) 		cecum inflammation J:157787
increased susceptibility to induced colitis J:157787
Il10rbtm1Agt/Il10rbtm1Agt
(involves: 129S2/SvPas * C57BL/6) 		colitis J:134156
large intestinal inflammation J:45917
Il10rbtm1Agt/Il10rbtm1Agt
Tg(Cd4-TGFBR2)16Flv/?
(involves: 129S2/SvPas * C3H * C57BL/6) 		colitis J:134156
liver inflammation J:134156
lung inflammation J:134156
proctitis J:134156
Il11ra1tm1Wehi/Il11ra1tm1Wehi
Il6tm1Kopf/Il6tm1Kopf
(involves: 129/Sv * C57BL/6) 		increased susceptibility to induced colitis J:79073
Il12atm1Jm/Il12atm1Jm
(129S1/Sv-Il12atm1Jm) 		decreased susceptibility to type IV hypersensitivity reaction J:34164
Il12atm1Jm/Il12atm1Jm
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv * 129S6/SvEvTac) 		lung inflammation J:140483
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J) 		decreased susceptibility to type IV hypersensitivity reaction J:120806
Il12btm1Jm/Il12btm1Jm
(129S1/Sv-Il12btm1Jm) 		decreased susceptibility to type IV hypersensitivity reaction J:34164
Il12btm1Jm/Il12btm1Jm
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv) 		lung inflammation J:140483
Il12btm1Jm/Il12btm1Jm
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		small intestinal inflammation J:108572
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J) 		glomerulonephritis J:106805
liver inflammation J:106805
parotid gland inflammation J:106805
salivary gland inflammation J:106805
submandibular gland inflammation J:106805
Il13tm1Anjm/Il13tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:82881, J:113543
Il13tm1Anjm/Il13tm1Anjm
Il5tm3Anjm/Il5tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6) 		granulomatous inflammation J:113543
Il13tm2Anjm/Il13tm2Anjm
(C.129P2(B6)-Il13tm2Anjm) 		abnormal type I hypersensitivity reaction J:123772
increased susceptibility to type I hypersensitivity reaction J:123772
Il13ra2tm1Gru/Il13ra2tm1Gru
(C.Cg-Il13ra2tm1Gru) 		decreased susceptibility to endotoxin shock J:82376
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:87137
Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6) 		chronic inflammation J:136279
increased susceptibility to induced colitis J:136279
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:79127
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:79127
Il17atm1Yiw/Il17atm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to induced arthritis J:83408
Il17atm1Yiw/Il17atm1Yiw
Il17ftm1Yiw/Il17ftm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129 * BALB/c) 		rheumatoid arthritis J:143719
Il17atm1Yiw/Il17atm1Yiw
Il17ftm2Yiw/Il17ftm2Yiw
(involves: 129P2/OlaHsd * BALB/c) 		nasal inflammation J:143719
Il17bem1Cya/Il17bem1Cya
(C57BL/6-Il17bem1Cya) 		increased susceptibility to induced colitis J:339366
Il17bGt(371C12)Cmhd/Il17bGt(371C12)Cmhd
(B6.129-Il17bGt(371C12)Cmhd) 		increased susceptibility to induced colitis J:229778
Il17ftm1Cdon/Il17ftm1Cdon
(involves: C57BL/6) 		chronic inflammation J:136279
decreased acute inflammation J:136279
decreased susceptibility to induced colitis J:136279
Il17ftm1Yiw/Il17ftm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129 * BALB/c) 		rheumatoid arthritis J:143719
Il17ratm1.2Kurs/Il17ratm1.2Kurs
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL) 		skin inflammation J:196483
Il17ratm1Koll/Il17ratm1Koll
(involves: 129 * C57BL/6) 		decreased inflammatory response J:139080
Il17rbtm1Bud/Il17rbtm1Bud
(B6.129-Il17rbtm1Bud) 		decreased inflammatory response J:139080
Il17rbtm1Tgi/Il17rb+
(Not Specified) 		decreased susceptibility to induced colitis J:229778
Il17rbtm1Tgi/Il17rbtm1Tgi
(Not Specified) 		decreased susceptibility to induced colitis J:229778
Il17rctm1Lex/Il17rctm1Lex
(involves: C57BL/6) 		decreased inflammatory response J:159874
Il17retm1Lex/Il17retm1Lex
(B6.129S5-Il17retm1Lex) 		increased susceptibility to induced colitis J:178967
Il18tm1Aki/Il18tm1Aki
(C.129P2-Il18tm1Aki) 		stomach inflammation J:120594
Il18tm1Aki/Il18tm1Aki
(B6.129P2-Il18tm1Aki) 		increased susceptibility to induced colitis J:173245
Il18tm1Aki/Il18tm1Aki
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal inflammatory response J:191055
myocarditis J:191055
Il18tm1Khe/Il18tm1Khe
(involves: 129P2/OlaHsd) 		decreased susceptibility to endotoxin shock J:62263
Il19tm2Vlcg/Il19tm2Vlcg
(B6.Cg-Il19tm2Vlcg) 		increased susceptibility to colitis induced morbidity/mortality J:229575
increased susceptibility to induced colitis J:229575
Il20tm1Lex/Il20tm1Lex
(B6;129S5-Il20tm1Lex/Mmucd) 		abnormal type IV hypersensitivity reaction J:171883
Il20rbtm1Uwe/Il20rbtm1Uwe
(C.129P2-Il20rbtm1Uwe) 		increased susceptibility to type IV hypersensitivity reaction J:143497
Il21rtm1Day/Il21rtm1Day
(involves: BALB/c * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:144708
Il21rtm1Kopf/Il21rtm1Kopf
(B6.129-Il21rtm1Kopf) 		granulomatous inflammation J:137508
Il22tm1.1Lex/Il22tm1.1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		ear inflammation J:118261
Il22tm1.1Lex/Il22tm1.1Lex
(involves: 129S5/SvEvBrd) 		colitis J:161073
lung inflammation J:179011
Il22tm1Flv/Il22+
(B6.Cg-Il22tm1Flv) 		increased susceptibility to endotoxin shock J:126103
Il22tm1Flv/Il22tm1Flv
(B6.Cg-Il22tm1Flv) 		increased susceptibility to endotoxin shock J:126103
liver inflammation J:126103
Il22tm1Flv/Il22tm1Flv
(involves: 129/Sv * C57BL/6) 		increased susceptibility to induced colitis J:189217
Il22ra2tm2Vlcg/Il22ra2tm2Vlcg
(B6.Cg-Il22ra2tm2Vlcg) 		colitis J:189217
Il23atm1Gdy/Il23a+
(B6.Cg-Il23atm1Gdy) 		increased susceptibility to induced colitis J:139557
Il23atm1Gdy/Il23atm1Gdy
(B6.Cg-Il23atm1Gdy) 		increased susceptibility to induced colitis J:139557
Il23atm1Ngh/Il23atm1Ngh
(involves: 129 * C57BL/6) 		decreased susceptibility to induced colitis J:216867
granulomatous inflammation J:120806
Il23rtm1.1Ngh/Il23rtm1.1Ngh
(involves: C57BL/6) 		decreased susceptibility to induced colitis J:216867
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac) 		decreased susceptibility to induced colitis J:229778
increased susceptibility to type I hypersensitivity reaction J:158594
lung inflammation J:158594
Il25tm1Cdon/Il25tm1Cdon
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6N * SJL) 		decreased susceptibility to induced colitis J:229778
Il25tm1Dart/Il25tm1Dart
(C57BL/6-Il25tm1Dart) 		intestinal inflammation J:123808
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua) 		increased susceptibility to type IV hypersensitivity reaction J:147706
Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced arthritis J:151552
Il31ratm1Ngh/Il31ratm1Ngh
(involves: C57BL/6) 		granulomatous inflammation J:123198
Il33tm1Snak/Il33tm1Snak
(involves: C57BL/6 * CBA) 		decreased inflammatory response J:165513
decreased susceptibility to endotoxin shock J:165513
increased susceptibility to induced colitis J:165513
lung inflammation J:165513
Il34tm1b(EUCOMM)Wtsi/Il34tm1b(EUCOMM)Wtsi
(involves: BALB/cJ * C57BL/6N) 		decreased susceptibility to type IV hypersensitivity reaction J:187643
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced colitis J:256437
Il36rntm1Hblu/Il36rn+
Tg(KRT14-Il1f6)1Hblu/?
(involves: 129 * C57BL/6 * DBA/2) 		skin inflammation J:126327
Il36rntm1Hblu/Il36rntm1Hblu
(C.129(B6)-Il36rntm1Hblu) 		increased susceptibility to chemically induced skin inflammation J:260118
Il36rntm1Hblu/Il36rntm1Hblu
Tg(KRT14-Il1f6)1Hblu/?
(involves: 129 * C57BL/6 * DBA/2) 		skin inflammation J:126327
Il36rntm1Kopf/Il36rntm1Kopf
(B6.129S5-Il36rntm1Kopf) 		dermatitis J:193548
Ilktm1Star/Ilktm1Star
Tg(KRT14-cre)1Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		skin inflammation J:172934
Ilktm1Star/Ilktm1Star
Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		tubulointerstitial nephritis J:129286, J:129244
In(2a;Itch)18H/In(2a;Itch)18H
(involves: 101/H * C3H/HeH) 		chronic inflammation J:24934
increased inflammatory response J:45910
interstitial pneumonia J:24934
lung inflammation J:24934
Inavatm1.1Itl/Inavatm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac) 		increased susceptibility to induced colitis J:257317
Inhatm1Bay/Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		chronic liver inflammation J:20450
Inhbbtm1Jae/Inhbbtm1Jae
(either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		increased incidence of corneal inflammation J:16995
Inpp5dm1Anu/Inpp5dm1Anu
(C57BL/6JAnu-Inpp5dm1Anu) 		lung inflammation J:104190
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		ileum inflammation J:173301
intestinal inflammation J:173301
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)1Ell) 		salivary gland inflammation J:98583
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)3Ell) 		salivary gland inflammation J:98583
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Mnt/Ins2tm1Mnt
Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		pancreas inflammation J:152798
Ins2tm1Jja/Ins2tm1Jja
(NOD.129S2-Ins2tm1Jja) 		insulitis J:85309
Insrm1Btlr/Insrm1Btlr
(C57BL/6J-Insrm1Btlr) 		increased susceptibility to induced colitis J:267534
Insrtm1Khn/Insrtm1Khn
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N) 		liver inflammation J:192274
ovary inflammation J:192274
white adipose tissue inflammation J:192274
Irak1tm1Jth/Y
Irak2tm1Aki/Irak2tm1Aki
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to endotoxin shock J:136290
Irak1tm1Jth/Y
Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL) 		myocarditis J:84829
Irak1tm1Jth/Irak1tm1Jth
Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL) 		myocarditis J:84829
Irak2tm1Aki/Irak2tm1Aki
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to endotoxin shock J:136290
Irak2tm1Jth/Irak2tm1Jth
(involves: 129 * C57BL/6) 		decreased susceptibility to endotoxin shock J:149258
Irak3tm1Flv/Irak3tm1Flv
(involves: 129S1/Sv * C57BL/6) 		abnormal inflammatory response J:78189
increased susceptibility to endotoxin shock J:78189
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv) 		insulitis J:229884
Irak4tm1Aki/Irak4tm1Aki
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to endotoxin shock J:125729
Irak4tm1Lix/Irak4tm1Lix
(involves: C57BL/6) 		decreased acute inflammation J:125732
decreased susceptibility to endotoxin shock J:125732
Irak4tm1Yeh/Irak4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to endotoxin shock J:76098
Irak4tm2Aki/Irak4tm2Aki
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to endotoxin shock J:125729
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to induced arthritis J:43086
Irf2tm1Mak/Irf2tm1Mak
(involves: 129S2/SvPas * C57BL/6) 		dermatitis J:66034
Irf3tm1Ttg/Irf3tm1Ttg
Sting1em1Jmin/Sting1em1Jmin
(involves: 129S/SvEv * C57BL/6N) 		lung inflammation J:251372
Isg20em1Cya/Isg20em1Cya
Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6N * ICR) 		kidney inflammation J:343183
Isl1Drsh/Isl1+
(C3HeB/FeJ-Isl1Drsh) 		increased susceptibility to otitis media J:202214
Itchtm1.1Alta/Itchtm1.1Alta
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		dermatitis J:204685
increased inflammatory response J:204685
lung inflammation J:204685
Itchtm1.1Alta/Itchtm1.1Alta
Gt(ROSA)26Sortm1Hjf/Gt(ROSA)26Sor+
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased inflammatory response J:204685
Itga3tm1Son/Itga3tm1Son
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * FVB/N) 		skin inflammation J:145988
Itga3tm1Son/Itga3tm1Son
Tg(KRT5-cre)5132Jlj/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		skin inflammation J:145988
Itga5tm1Hyn/Itga5+
Nischedsn/Nisch+
(C3H.Cg-Nischedsn Itga5tm1Hyn) 		increased susceptibility to otitis media J:244907
Itga5tm1Hyn/Itga5+
Nischedsn/Nischedsn
(C3H.Cg-Nischedsn Itga5tm1Hyn) 		increased susceptibility to otitis media J:244907
Itgaltm1Bll/Itgaltm1Bll
(B6.129S7-Itgaltm1Bll/J) 		abnormal inflammatory response J:113463
Itgaltm1Mak/Itgal+
(B6.129P2-Itgaltm1Mak) 		decreased susceptibility to endotoxin shock J:123460
Itgaltm1Mak/Itgaltm1Mak
(B6.129P2-Itgaltm1Mak) 		decreased susceptibility to endotoxin shock J:123460
Itgamtm1Myd/Itgamtm1Myd
(B6.129S4-Itgamtm1Myd) 		abnormal inflammatory response J:113463
Itgavtm2Hyn/Itgavtm2.1Hyn
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB) 		colitis J:125508
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL) 		colitis J:125508
increased inflammatory response J:125508
large intestinal inflammation J:125508
Itgb1tm1Ref/Itgb1tm1Ref
Tg(KRT5-cre)5132Jlj/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J) 		skin inflammation J:65038
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd) 		decreased inflammatory response J:13599
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * PL/J) 		dermatitis J:109598, J:32126
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J * PL/J) 		dermatitis J:84126
Itgb2tm1Bay/Itgb2tm1Bay
Psrs1PL/J/Psrs1PL/J
(B6.Cg-(D10Mit126-D10Mit38) Itgb2tm1Bay) 		rheumatoid arthritis J:134251
Itgb2tm1Bay/Itgb2tm1Bay
Psrs1PL/J/Psrs1PL/J
(B6.Cg-(D10Mit75-D10Mit271) Itgb2tm1Bay) 		rheumatoid arthritis J:134251
Itgb2tm1Bay/Itgb2tm2Bay
(PL.129S7-Itgb2tm1Bay Itgb2tm2Bay) 		dermatitis J:84126
Itgb2tm1Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J * PL/J) 		dermatitis J:84126
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		conjunctivitis J:48542
dermatitis J:48542
increased inflammatory response J:48542
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased acute inflammation J:112286
Itgb2tm2Bay/Itgb2tm2Bay
(PL.129S7-Itgb2tm2Bay) 		decreased susceptibility to type IV hypersensitivity reaction J:109598
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		dermatitis J:52262
myositis J:119666
Itgb4tm2Son/Itgb4tm2Son
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		ear inflammation J:96543
Itgb6tm1Des/Itgb6tm1Des
(involves: 129S4/SvJae * C57BL/6J) 		respiratory system inflammation J:33139
Itgb6tm1Des/Itgb6tm1Des
(involves: 129S4/SvJae * C57BL/6 * SJL) 		respiratory system inflammation J:51592
Itgb6tm1Des/Itgb6tm1Des
Mmp12tm1Sds/Mmp12tm1Sds
(involves: 129/Sv * 129T2/SvEms) 		lung inflammation J:89578
Itgb6tm1Des/Itgb6tm1Des
Tg(SFTPC-ITGB6)1Des/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		respiratory system inflammation J:51592
Itgb7tm1Cgn/Itgb7tm1Cgn
(C57BL/6-Itgb7tm1Cgn/J) 		colitis J:127413
Itgb7tm1Cgn/Itgb7tm1Cgn
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6) 		abnormal inflammatory response J:136667
autoimmune arthritis J:136667
Itgb7tm1Mshi/Itgb7tm1Mshi
(involves: C57BL/6) 		colitis J:127413
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda) 		ear inflammation J:199153
skin inflammation J:199153
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae) 		chronic inflammation J:56629
Jak3wil/Jak3wil
(C57BL/6JSfdAnu-Jak3wil/Anu) 		large intestinal inflammation J:104190
Jam3tm1Rha/Jam3tm1Rha
(involves: 129P2/OlaHsd * C57BL/6) 		lung inflammation J:121841
Jmjd8em1Kaso/Jmjd8em1Kaso
(C57BL/6-Jmjd8em1Kaso) 		decreased inflammatory response J:319518
Juntm1Rsjo/Juntm1Rsjo
Tg(KRT14-cre)8Brn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased incidence of corneal inflammation J:84743
Juntm4Wag/Juntm4Wag
Junbtm3Wag/Junbtm3Wag
Tg(Krt1-5-cre/ERT)1Ipc/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		autoimmune arthritis J:116380
increased inflammatory response J:116380
skin inflammation J:116380
Juntm4Wag/Juntm4Wag
Tg(Sftpc-cre)1Blh/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		lung inflammation J:179883
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6) 		dermatitis J:155575
glomerulonephritis J:155575
increased inflammatory response J:155575
tubulointerstitial nephritis J:155575
Jundtm1Mya/Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		increased susceptibility to endotoxin shock J:65879
liver inflammation J:65879
Juptm1.1Glr/Juptm1.1Glr
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL) 		heart inflammation J:170618
Kcna1mceph/Kcna1mceph
(BALB/cByJ-Kcna1mceph/J) 		ear inflammation J:119491
eye inflammation J:119491
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * BALB/cByJ * C3HeB/FeJ) 		ear inflammation J:119491
eye inflammation J:119491
Kcne2tm1a(EUCOMM)Wtsi/Kcne2tm1a(EUCOMM)Wtsi
(C57BL/6N-Kcne2tm1a(EUCOMM)Wtsi) 		stomach inflammation J:230226
Kcne3tm1Gwab/Kcne3tm1Gwab
(involves: C57BL/6) 		increased inflammatory response J:210381
Kcnj8mydy/Kcnj8mydy
(involves: C57BL/6J) 		increased susceptibility to endotoxin shock J:126658
Kcnj8sos/Kcnj8sos
(C57BL/6J-Kcnj8sos) 		increased susceptibility to endotoxin shock J:149353
Keratm1Cyl/Keratm1Cyl
(involves: 129S6/SvEvTac) 		abnormal inflammatory response J:128992
Kif1cOrch3-BALB/cByJ/Kif1cOrch3-BALB/cByJ
(involves: BALB/cByJ * DBA/2) 		testis inflammation J:35331
Kif1cOrch3-BALB/cByJ/Kif1cOrch3-DBA/2J
(involves: BALB/cByJ * DBA/2) 		decreased inflammatory response J:35331
Kif1cOrch3-DBA/2J/Kif1cOrch3-DBA/2J
(involves: BALB/cByJ * DBA/2) 		decreased inflammatory response J:35331
Kif27Gt(OST441915)Lex/Kif27Gt(OST441915)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased susceptibility to otitis media J:185566
maxillary sinus inflammation J:185566
KitW-sh/KitW-sh
(involves: C57BL/6J) 		decreased susceptibility to type I hypersensitivity reaction J:197334
KitW-sh/KitW-sh
(B6.Cg-KitW-sh/HNihrJaeBsmGlliJ) 		decreased susceptibility to type I hypersensitivity reaction J:275367
KitW-sh/KitW-sh
Lyntm1Ard/Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH) 		glomerulonephritis J:161523
KitW/KitW-v
((WB/ReJ x C57BL/6J-KitW-v/J)F1-KitW/KitW-v/J) 		decreased inflammatory response J:131785
kidney inflammation J:113500
KitW/KitW-v
((WB KitW x B6.Cg-KitW-v)F1) 		decreased susceptibility to induced arthritis J:178942
decreased susceptibility to type I hypersensitivity reaction J:197334
KitlSl/KitlSl-d
(involves: C57BL/6 * WC) 		dermatitis J:5758
stomach inflammation J:2777
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J) 		lung inflammation J:229255
Klf4tm1Khk/Klf4tm1Khk
Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S6/SvEvTac * FVB/N) 		blepharitis J:117671
Klf5M1Btlr/Klf5M1Btlr
(C57BL/6J-Klf5M1Btlr) 		increased susceptibility to induced colitis J:265229
Klf5tm1Jaw/Klf5tm1Jaw
Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB) 		lacrimal gland inflammation J:175263
Klf15tm1Jain/Klf15tm1Jain
(involves: 129X1/SvJ) 		blood vessel inflammation J:203920
Klhdc10tm1Hijo/Klhdc10tm1Hijo
(B6J.B6N-Klhdc10tm1Hijo) 		decreased inflammatory response J:251158
Klk5em1Mer/Klk5em1Mer
(BALB/c-Klk5em1Mer) 		abnormal acute inflammation J:344772
Klk6tm1Gsot/Klk6+
(involves: C57BL/6) 		decreased inflammatory response J:270051
decreased susceptibility to chemically induced skin inflammation J:270051
Klk6tm1Gsot/Klk6tm1Gsot
(involves: C57BL/6) 		decreased inflammatory response J:270051
decreased susceptibility to chemically induced skin inflammation J:270051
Klk6tm1Gsot/Klk6tm1Gsot
Spink5tm1Drh/Spink5tm1Drh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:289877
Klrc1tm1Mmka/Klrc1tm1Mmka
(B6.129-Klrc1tm1Mmka) 		liver inflammation J:222503
lung inflammation J:222503
Kmt2etm1Apa/Kmt2etm1Apa
(129S6/SvEvTac-Kmt2etm1Apa) 		blepharitis J:145445
Kprptm1Msug/Kprp+
(involves: C57BL/6) 		increased susceptibility to chemically induced skin inflammation J:286659
Krastm4Tyj/Kras+
Krt19tm1(cre/ERT)Ggu/Krt19+
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac) 		lung inflammation J:254370
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Scgb1a1tm1.1(cre)Fjd/Scgb1a1+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		lung inflammation J:131721
Krastm4Tyj/Kras+
Tg(Scgb1a1-cre)1Kkw/?
(involves: 129 * C57BL/6 * FVB/N) 		increased inflammatory response J:107260
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae) 		lung inflammation J:191425
Krastm4Tyj/Krastm4Tyj
Trim33tm1Los/Trim33tm1Los
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * DBA/2) 		pancreas inflammation J:151781
Krt2tm1a(KOMP)Wtsi/Krt2tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		skin inflammation J:214772
Krt8tm1Rgo/Krt8tm1Rgo
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		chronic inflammation J:86719, J:98058
Krt18tm1Tmm/Krt18+
(involves: 129P2/OlaHsd) 		liver inflammation J:309021
Krt18tm1Tmm/Krt18tm1Tmm
(involves: 129P2/OlaHsd) 		liver inflammation J:309021
Krt76tm1a(KOMP)Wtsi/Krt76tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		skin inflammation J:232539
Ksr1tm1Shaw/Ksr1tm1Shaw
(Not Specified) 		decreased susceptibility to induced arthritis J:140520
Lacc1em1Arkr/Lacc1em1Arkr
(C57BL/6NTac-Lacc1em1Arkr) 		decreased susceptibility to endotoxin shock J:244365
Lacc1em2Arkr/Lacc1em2Arkr
(C57BL/6NTac-Lacc1em2Arkr) 		decreased susceptibility to endotoxin shock J:244365
Lacc1em3Arkr/Lacc1em3Arkr
(C57BL/6NTac-Lacc1em3Arkr) 		increased susceptibility to endotoxin shock J:244365
Lacc1em4Arkr/Lacc1em4Arkr
(C57BL/6NTac-Lacc1em4Arkr) 		increased susceptibility to endotoxin shock J:244365
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		increased susceptibility to endotoxin shock J:244365
Lama2tm1Eeng/Lama2tm1Eeng
(involves: 129S1/Sv) 		myositis J:170192
Lama3tm1.1Grsb/Lama3tm1.1Grsb
(involves: C57BL/6) 		lung inflammation J:235712
Lama3tm1Arte/Lama3tm1Arte
Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6 * CD-1) 		skin inflammation J:240054
Lama5tm2Jhm/Lama5tm1Jhm
Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		tubulointerstitial nephritis J:185850
Lamb2tm1Jrs/Lamb2tm1Jrs
(involves: 129S1/Sv * 129X1/SvJ) 		glomerulonephritis J:23783
Lamc2jeb/Lamc2jeb
(129X1/SvJ-Lamc2jeb) 		ear inflammation J:158873
Lancl1tm1.1Pfw/Lancl1tm1.1Pfw
(involves: 129 * C57BL/6) 		brain inflammation J:214805
Lao1tm1Oka/Lao1tm1Oka
(involves: 129S2/SvPas * C57BL/6J) 		mastitis J:260668
Laptm5tm1Jow/Laptm5tm1Jow
(C57BL/6-Laptm5tm1Jow) 		abnormal type IV hypersensitivity reaction J:137841
Large1myd/Large1myd
(MYD/Le-Os +/+ Largemyd/J) 		myositis J:5670
Large1myd/Large1myd
(B6C3Fe a/a-Large1myd/J) 		myositis J:27793
Lat2tm1Wz/Lat2tm1Wz
(Not Specified) 		increased susceptibility to endotoxin shock J:181866
Lat2tm3.1Wz/Lat2tm3.1Wz
(B6.Cg-Lat2tm3.1Wz) 		increased susceptibility to endotoxin shock J:181866
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas) 		chronic inflammation J:77098
glomerulonephritis J:125722
increased inflammatory response J:262891
kidney inflammation J:262891
liver inflammation J:125722
lung inflammation J:125722
pancreas inflammation J:262891
phlebitis J:262891
salivary gland inflammation J:262891
Lbptm1Buru/Lbptm1Buru
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		decreased susceptibility to type I hypersensitivity reaction J:67090
Lbptm1Buru/Lbptm1Buru
(B6.129-Lbptm1Buru) 		abnormal acute inflammation J:129411
Lbw2NZB/BlScr/Lbw2NZB/BlScr
(involves: NZB * NZW) 		glomerulonephritis J:45708
Lbw2NZB/BlScr/Lbw2NZW/LacScr
(involves: NZB * NZW) 		glomerulonephritis J:20991
Lctlp1FVB/NJ/Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:122919
Lctlp2FVB/NJ/Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:122919
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		liver inflammation J:175559
Ldlrtm1Her/Ldlrtm1Her
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		skin inflammation J:61147
Lect2tm1Ymg/Lect2tm1Ymg
(involves: 129P2/OlaHsd * C57BL/6J) 		liver inflammation J:90961
Lepob/Lepob
(B6.Cg-Lepob/J) 		lung inflammation J:115772
Lepob/Lepob
(B6.Cg-Lepob/OlaHsd) 		abnormal acute inflammation J:124815
increased susceptibility to endotoxin shock J:124815
liver inflammation J:124815
Lepob/Lepob
(B6.Cg-Lepob/JRj) 		liver inflammation J:277927
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J) 		pancreas inflammation J:118305
periinsulitis J:118305
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl) 		white adipose tissue inflammation J:171755
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J) 		lung inflammation J:115772
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/OlaHsd) 		abnormal acute inflammation J:124815
increased susceptibility to endotoxin shock J:124815
liver inflammation J:124815
Leprdb/Leprdb
(B6.BKS(D)-Leprdb/JOrlRj) 		liver inflammation J:277927
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb) 		kidney inflammation J:346348
Leprottm1.2Damj/Leprottm1.2Damj
(involves: 129S2/SvPas * C57BL/6N * FVB/N) 		decreased inflammatory response J:349250
Lgals2tm1.1Cfg/Lgals2tm1.1Cfg
(involves: C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:217719
Lgals3tm1Ftl/Lgals3tm1Ftl
(B6.129S2-Lgals3tm1Ftl) 		brain inflammation J:109126
lung inflammation J:109126
small intestinal inflammation J:109126
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * C57BL/6) 		peritoneal inflammation J:60741
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1) 		liver inflammation J:221030
Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * SJL) 		lung inflammation J:131407
Lgals3bptm1Megt/Lgals3bptm1Megt
(involves: 129P2/OlaHsd * C57BL/Ka) 		increased susceptibility to endotoxin shock J:94936
Lgals9tm1Glp/Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp) 		increased susceptibility to induced arthritis J:132889
lgr/lgr
(Not Specified) 		eye inflammation J:13879
Lgr4Gt(LST020)Byg/Lgr4Gt(LST020)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased incidence of corneal inflammation J:134299
Lhcgrtm1Hht/Lhcgrtm1Hht
(involves: 129S7/SvEvBrd * C57BL/6J) 		epididymis inflammation J:105533
prostate gland inflammation J:105533
reproductive system inflammation J:105533
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6) 		increased acute inflammation J:119777
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * BALB/c) 		increased susceptibility to endotoxin shock J:136940
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		intestinal inflammation J:157574
liver inflammation J:157574
Lilrb4atm1Eol/Lilrb4atm1Eol
(B6.129P2-Lilrb4atm1Eol) 		increased inflammatory response J:129969
Lilrb4atm1Hrk/Lilrb4atm1Hrk
(involves: 129/Sv * BALB/c) 		increased susceptibility to type I hypersensitivity reaction J:70491
Limk2Gt(OST80053)Lex/Limk2Gt(OST80053)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased incidence of corneal inflammation J:192231
Limk2whe/Limk2whe
(B6.Cg-Lepob Limk2whe/GrsrJ) 		increased incidence of corneal inflammation J:127016
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		liver inflammation J:270182
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1) 		chronic inflammation J:101217
lung inflammation J:101217
Litaftm1Samr/Litaftm1Samr
(involves: 129S4/SvJae) 		decreased susceptibility to endotoxin shock J:113750
LmnaDhe/Lmna+
(B6(D2)-LmnaDhe/TyGrsrJ) 		increased susceptibility to otitis media J:188496
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6NTac) 		keratoconjunctivitis sicca J:261974
Lmo4tm1Slp/Lmo4tm1Slp
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca) 		abnormal acute inflammation J:282740
Lmo4tm1Slp/Lmo4tm1Slp
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca) 		abnormal acute inflammation J:282740
Lncucc1em1Bwu/Lncucc1em1Bwu
(C57BL/6-Lncucc1em1Bwu) 		abnormal susceptibility to colitis induced morbidity/mortality J:340220
increased susceptibility to induced colitis J:340220
Loricrintm1Der/Loricrintm1Der
(FVB.129S7-Loricrintm1Der) 		erythroderma J:65187
Loxl2tm1.2Acan/Loxl2tm1.2Acan
(Not Specified) 		decreased inflammatory response J:220689
Lpar2tm1Dgen/Lpar2tm1Dgen
(B6.Cg-Lpar2tm1Dgen) 		increased susceptibility to type I hypersensitivity reaction J:184061
lung inflammation J:184061
Lpn1NZB/Lpn1NZB
(involves: NZB * NZW) 		kidney inflammation J:6026
Lpn1NZB/Lpn1NZW
(involves: NZB * NZW) 		kidney inflammation J:6026
Lpn2NZB/Lpn2NZW
(involves: NZB * NZW) 		kidney inflammation J:6026
Lpn2NZW/Lpn2NZW
(involves: NZB * NZW) 		kidney inflammation J:6026
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL) 		aortitis J:307289
arteritis J:307289
blood vessel inflammation J:307289
cardiovalvulitis J:307289
gallbladder inflammation J:307289
glomerulonephritis J:307289
increased inflammatory response J:307289
intestinal inflammation J:307289
liver inflammation J:307289
lung inflammation J:307289
mastitis J:307289
myocarditis J:307289
myositis J:307289
pancreas inflammation J:307289
stomach inflammation J:307289
Lprm3MRL/MpJ/Lprm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		glomerulonephritis J:44625
Lrbaem1Btlr/Lrbaem1Btlr
(C57BL/6J-Lrbaem1Btlr) 		increased susceptibility to induced colitis J:274652
Lrbaem2Btlr/Lrbaem2Btlr
(C57BL/6J-Lrbaem2Btlr) 		increased susceptibility to induced colitis J:274652
Lrbaem3Btlr/Lrbaem3Btlr
(C57BL/6J-Lrbaem3Btlr) 		increased susceptibility to induced colitis J:274652
Lrbam1Btlr/Lrbam1Btlr
(C57BL/6J-Lrbam1Btlr) 		increased susceptibility to induced colitis J:274652
Lrbam2Btlr/Lrbam2Btlr
(C57BL/6J-Lrbam2Btlr) 		increased susceptibility to induced colitis J:274652
Lrdm1MRL/MpJ/?
(involves: CAST/Ei * MRL/MpJ-Faslpr/J) 		kidney inflammation J:3304
Lrdm2MRL/MpJ/?
(involves: CAST/Ei * MRL/MpJ-Faslpr/J) 		kidney inflammation J:3304
Lrig2tm1.1Hhed/Lrig2tm1.1Hhed
(involves: 129 * C57BL/6 * FVB/N) 		increased inflammatory response J:205929
Lrp1tm2Her/Lrp1tm2Her
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL) 		brain inflammation J:167724
Lrp6tm1Arma/Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma) 		liver inflammation J:225450
Lrp12em1Gpt/Lrp12em1Gpt
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JGpt * DBA/2) 		increased susceptibility to induced colitis J:338432
Lrrc25em1Cya/Lrrc25em1Cya
(C57BL/6J-Lrrc25em1Cya/Cya) 		heart inflammation J:270157
Lrrk2tm2.1Shn/Lrrk2tm2.1Shn
(involves: 129 * C57BL/6) 		kidney inflammation J:160542
Lse/Lse+
(B6C3Fe a/a-Lse/J) 		keratoconjunctivitis sicca J:338204
Lta4htm1Bhk/Lta4htm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv) 		decreased acute inflammation J:58985
decreased susceptibility to type I hypersensitivity reaction J:58985
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug) 		decreased susceptibility to induced arthritis J:115034
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug) 		decreased susceptibility to induced arthritis J:115034
Lta/Tnftm1Fda/Lta/Tnftm1Fda
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to endotoxin shock J:39519
Lta/Tnftm1Fda/Lta+
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to endotoxin shock J:39519
Lta/Tnftm1Fda/Lta/Tnftm1Fda
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to endotoxin shock J:39519
Lta/Tnftm1Fda/Tnf+
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to endotoxin shock J:39519
Ltahlb382/Ltahlb382
(C57BL/6J-Ltahlb382/J) 		liver inflammation J:134498
lung inflammation J:134498
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor) 		decreased susceptibility to induced arthritis J:131779
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6)) 		decreased susceptibility to induced arthritis J:163271
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(B6.Cg-Ltb4r1tm1Tksh) 		decreased susceptibility to type I hypersensitivity reaction J:197334
lung inflammation J:118995
Ltb4r2tm1Bodd/Ltb4r2tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:163271
Ltb4r2tm1Tksh/Ltb4r2tm1Tksh
(B6.Cg-Ltb4r2tm1Tksh) 		decreased susceptibility to type I hypersensitivity reaction J:197334
Ltbtm1Kpf/Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf) 		colitis J:158663
Ltbp3tm1Bdvc/Ltbp3tm1Bdvc
(involves: 129S6/SvEvTac) 		osteoarthritis J:76213, J:79920
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(B6.129S2-Ltbp4Gt(U3Cre)1Vmel) 		colitis J:78819
proctitis J:78819
Ltc4stm1Blam/Ltc4stm1Blam
(involves: 129S7/SvEvBrd * C57BL/6) 		respiratory system inflammation J:88647
Ltc4stm1Blam/Ltc4stm1Blam
(involves: 129S7/SvEvBrd * BALB/c) 		abnormal type I hypersensitivity reaction J:87909
Ltc4stm1Blam/Ltc4stm1Blam
(B6.129S7-Ltc4stm1Blam) 		decreased susceptibility to type I hypersensitivity reaction J:197334
Lumtm1Wwk/Lumtm1Wwk
(involves: 129P2/OlaHsd) 		abnormal inflammatory response J:128992
Lxw2NZW/LacScr/Lxw2NZW/LacScr
(involves: BXSB/Scr * NZW/LacScr) 		glomerulonephritis J:86924
Ly6etm1c(EUCOMM)Hmgu/Ly6etm1c(EUCOMM)Hmgu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio) 		decreased inflammatory response J:291868
Ly96tm1Kmiy/Ly96tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:92494
Lynmld4/Lynmld4
(involves: C57BL/6) 		glomerulonephritis J:144799
peritoneal inflammation J:144799
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		glomerulonephritis J:200745
increased inflammatory response J:200745
liver inflammation J:200745
lung inflammation J:200745
skin inflammation J:200745
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd) 		glomerulonephritis J:161523
Lyntm1Ard/Lyntm1Ard
(B6.129P2-Lyntm1Ard) 		glomerulonephritis J:144799
peritoneal inflammation J:144799
Lyntm1Sor/Lyntm1Sor
(B6.129S4-Lyntm1Sor) 		abnormal inflammatory response J:113463
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor) 		glomerulonephritis J:146161, J:200745
liver inflammation J:146161
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		glomerulonephritis J:71174
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:29751
Lynweeb/Lynweeb
(C57BL/6-Lynweeb) 		glomerulonephritis J:146161
liver inflammation J:146161
Lynf1C57BL/10J/Lynf1C57BL/10J
Lynf3C57BL/10J/Lynf3C57BL/10J
(involves: B10.O20 * O20/A) 		abnormal acute inflammation J:128728
Lynf2C57BL/10J/Lynf2C57BL/10J
Lynf3C57BL/10J/Lynf3C57BL/10J
(involves: B10.O20 * O20/A) 		abnormal acute inflammation J:128728
Lynf2O20/A/Lynf2O20/A
(involves: B10.O20 * O20/A) 		abnormal acute inflammation J:128728
Lynf4C57BL/10J/Lynf4C57BL/10J
(involves: B10.O20 * O20/A) 		abnormal acute inflammation J:128728
Lynf4C57BL/10J/Lynf4O20/A
(involves: B10.O20 * O20/A) 		abnormal acute inflammation J:128728
Lypd8tm2Ktak/Lypd8tm2Ktak
(B6.Cg-Lypd8tm2Ktak) 		increased susceptibility to colitis induced morbidity/mortality J:232706
increased susceptibility to induced colitis J:232706
Lystbg/Lystbg
(B6.C3Rl-Lystbg) 		alveolitis J:110157
Lyz2tm1(cre)Ifo/Lyz2+
Pikfyvetm1b(EUCOMM)Hmgu/Pikfyvetm1b(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:244776
Lyz2tm1(cre)Ifo/Lyz2+
St18tm1c(KOMP)Wtsi/St18tm1c(KOMP)Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased inflammatory response J:298828
Lyz2tm1.1Graf/Lyz2tm1.1Graf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased inflammatory response J:82642
Macroh2a1tm1Peh/Macroh2a1tm1Peh
Macroh2a2tm1.1Peh/Macroh2a2tm1.1Peh
(129S6.Cg-Macroh2a2tm1.1Peh Macroh2a1tm1Peh) 		blepharitis J:220524
MafOfl/MafOfl
(either: 102/ElH or C3H/HeH) 		tubular nephritis J:82475
Magi2tm1Key/Magi2tm1Key
(involves: 129S4/SvJae) 		tubulointerstitial nephritis J:213553
Malat1tm1.2Dlsp/Malat1tm1.2Dlsp
(B6J.Cg-Malat1tm1.2Dlsp) 		brain inflammation J:239375
Man2a1tm1Jxm/Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		glomerulonephritis J:74579
liver inflammation J:74579
lung inflammation J:74579
Man2a1tm1Jxm/Man2a1tm1Jxm
Rag1tm1Mom/Rag1tm1Mom
(B6.129-Rag1tm1Mom Man2a1tm1Jxm) 		kidney inflammation J:124348
Map3k1tm1Glj/Map3k1tm1Glj
(involves: 129S/SvEv) 		heart inflammation J:78068
Map3k7tm1.1Gkl/Map3k7tm1.1Gkl
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased inflammatory response J:211916
increased susceptibility to endotoxin shock J:211916
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		liver inflammation J:160521
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd) 		colitis J:112837
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd * C57BL/6) 		colitis J:238318
Map3k8tm1Pnt/Map3k8tm1Pnt
(involves: 129S1/Sv * C57BL/6J) 		decreased susceptibility to endotoxin shock J:66503
Map3k8tm1Pnt/Map3k8tm1Pnt
Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J) 		small intestinal inflammation J:108572
Map3k14aly/Map3k14aly
(involves: C57BL/6J) 		bile duct inflammation J:48224
increased inflammatory response J:38580, J:48224
kidney inflammation J:38580
lacrimal gland inflammation J:38580
liver inflammation J:48224
lung inflammation J:48224
pancreas inflammation J:48224
Mapk8tm1Rjd/Mapk8tm1Rjd
Mapk9tm2.1Rjd/Mapk9tm2.1Rjd
Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd) 		decreased inflammatory response J:192551
Mapk9tm1Flv/Mapk9tm1Flv
Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J) 		small intestinal inflammation J:108572
Mapk11tm1Jda/Mapk11tm1Jda
Mapk14tm1Jda/Mapk14tm1Jda
(involves: 129 * C57BL/6) 		decreased susceptibility to induced arthritis J:165966
Mapk11tm1Jsca/Mapk11tm1Jsca
Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		autoimmune arthritis J:107771
ileum inflammation J:107771
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to endotoxin shock J:59678
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J) 		granulomatous inflammation J:108572
small intestinal inflammation J:108572
Marchf2em1Cnu/Marchf2em1Cnu
(C57BL/6-Marchf2em1Cnu) 		increased susceptibility to endotoxin shock J:297482
Marcotm1Ktry/Marcotm1Ktry
(B6.129S6-Marcotm1Ktry) 		increased inflammatory response J:115081
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		glomerulonephritis J:68830
kidney inflammation J:68830
lung inflammation J:68830
salivary gland inflammation J:68830
Mat1atm1Jmm/Mat1atm1Jmm
(involves: 129/Sv * C57BL/6) 		liver inflammation J:69408
Matn3tm1Brd/Matn3tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		osteoarthritis J:112002
Mavstm1Aki/Mavstm1Aki
(involves: 129S/SvEv * C57BL/6) 		brain inflammation J:162888
CNS inflammation J:162888
Mavstm1Itl/Mavstm1Itl
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6) 		increased inflammatory response J:181257
myocarditis J:181257
myositis J:181257
skin inflammation J:181257
stomach inflammation J:181257
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh) 		insulitis J:323838
salivary gland inflammation J:323838
Mbd3tm2Bh/Mbd3tm2Bh
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased susceptibility to induced colitis J:167984
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt) 		increased susceptibility to induced colitis J:146454
Mc3rtm1Butl/Mc3rtm1Butl
(B6.Cg-Mc3rtm1Butl) 		increased inflammatory response J:178147
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J) 		liver inflammation J:177386
white adipose tissue inflammation J:177386
Mc4rtm1Matsu/Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu) 		liver inflammation J:285412
Mcemp1em1Jngj/Mcemp1em1Jngj
(C57BL/6-Mcemp1em1Jngj) 		abnormal type I hypersensitivity reaction J:335318
Mcl1tm3Sjk/Mcl1tm3Sjk
Tg(Cpa3-cre)3Glli/0
(involves: 129X1/Sv * C57BL/6) 		decreased inflammatory response J:179080
decreased susceptibility to type I hypersensitivity reaction J:179080
Mdktm1Tmu/Mdktm1Tmu
(129S2-Mdktm1Tmu) 		tubular nephritis J:93637
MecomJbo/Mecom+
(C3N.C-MecomJbo) 		increased susceptibility to otitis media J:113445
respiratory system inflammation J:113445
MecomJbo/Mecom+
(involves: BALB/c) 		increased susceptibility to otitis media J:250208
Mecp2tm1.1Bird/Y
SqleSum3-Jus/Sqle+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		dermatitis J:198551
Mecp2tm1.1Bird/Y
Sum2M1Jus/Sum2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		dermatitis J:198551
eye inflammation J:198551
Mecp2tm1.1Bird/Y
Sum4M1Jus/Sum4+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		dermatitis J:198551
eye inflammation J:198551
Mecp2tm1.1Bird/Y
Sum5M1Jus/Sum5+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		eye inflammation J:198551
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-icre/ERT2)1Soff/0
(involves: C57BL/6J * C57BL/6N) 		white adipose tissue inflammation J:298822
Mefvtm1Chae/Mefvtm1Chae
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)) 		increased inflammatory response J:82763
increased susceptibility to endotoxin shock J:82763
Mefvtm3.1(MEFV)Chae/Mefvtm3.1(MEFV)Chae
(B6.129S6-Mefvtm3.1(MEFV)Chae) 		autoimmune arthritis J:172117
dermatitis J:172117
increased inflammatory response J:172117
Mefvtm4.1(MEFV)Chae/Mefvtm4.1(MEFV)Chae
(B6.129S6-Mefvtm4.1(MEFV)Chae) 		autoimmune arthritis J:172117
dermatitis J:172117
increased inflammatory response J:172117
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
(B6.129S6-Mefvtm5.1(MEFV)Chae) 		autoimmune arthritis J:172117
dermatitis J:172117
increased inflammatory response J:172117
joint inflammation J:172117
liver inflammation J:172117
skin inflammation J:172117
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
Nlrp3tm1Tsc/Nlrp3tm1Tsc
(involves: 129S6/SvEvTac * C57BL/6) 		increased inflammatory response J:172117
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased inflammatory response J:172117
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		pancreas inflammation J:67128
Mep1atm1Bond/Mep1atm1Bond
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to induced colitis J:145685
urinary bladder inflammation J:145037
Mep1btm1Bond/Mep1btm1Bond
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased inflammatory response J:132021
Mertktm1Gkm/Mertktm1Gkm
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased susceptibility to endotoxin shock J:53423
Mertktm1Gkm/Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm) 		insulitis J:147153
Mettm1Gvw/Met+
(involves: 129 * C57BL/6J) 		glomerulonephritis J:94722
Mettm2Gvw/Met+
(involves: 129 * C57BL/6J) 		glomerulonephritis J:94722
Mettm4Gvw/Met+
(involves: 129 * C57BL/6J) 		glomerulonephritis J:94722
Metrnltm1d(KOMP)Wtsi/Metrnltm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		increased susceptibility to endotoxin shock J:268270
kidney inflammation J:268270
liver inflammation J:268270
uterus inflammation J:268270
Mfge8Gt(KST227)Byg/Mfge8Gt(KST227)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		mastitis J:107106
Mfge8tm1Shur/Mfge8tm1Shur
(B6.129-Mfge8tm1Shur) 		spermatic granuloma J:145962
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi) 		increased susceptibility to type I hypersensitivity reaction J:250123
Mfsd8tm1a(EUCOMM)Hmgu/Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		CNS inflammation J:211608
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		glomerulonephritis J:80661
Mgat5tm1Jwd/Mgat5tm1Jwd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal inflammatory response J:60960
Mgat5btm1Nta/Mgat5btm1Nta
(Not Specified) 		brain inflammation J:199165
Miftm1Dvd/Miftm1Dvd
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to endotoxin shock J:52300
Miftm1Mky/Miftm1Mky
(C.129-Miftm1Mky) 		abnormal inflammatory response J:106380
Milr1tm1Shib/Milr1tm1Shib
(involves: C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:161854
Mir10bem1Rosay/Mir10bem1Rosay
(C57BL/6J-Mir10bem1Rosay) 		large intestinal inflammation J:342486
Mir21atm1.1Mer/Mir21atm1.1Mer
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased susceptibility to type I hypersensitivity reaction J:179235
Mir21atm1.1Mer/Mir21atm1.1Mer
(B6.129S1-Mir21atm1.1Mer) 		increased susceptibility to type IV hypersensitivity reaction J:179235
Mir34atm1.1Pisc/Mir34atm1.1Pisc
Mirc21tm1.1Pisc/Mirc21tm1.1Pisc
Mirc34tm1.1Pisc/Mirc34tm1.1Pisc
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		nasal inflammation J:256929
Mir100em1Nju/Mir100em1Nju
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		liver inflammation J:281439
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6) 		liver inflammation J:190066
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ) 		liver inflammation J:190067
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		liver inflammation J:190067
Mir126atm2.1Smoc/Mir126atm2.1Smoc
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6J * C57BL/6N * DBA/2) 		dermatitis J:355195
Mir139em1Jwli/Mir139em1Jwli
(C57BL/6J-Mir139em1Jwli) 		increased susceptibility to colitis induced morbidity/mortality J:280467, J:248779
increased susceptibility to induced colitis J:248779
Mir140tm1.1Asah/Mir140tm1.1Asah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased susceptibility to induced arthritis J:160358
osteoarthritis J:160358
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N) 		increased susceptibility to endotoxin shock J:173671
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased acute inflammation J:173671
increased susceptibility to endotoxin shock J:173671
Mir149em1Ydw/Mir149em1Ydw
(C57BL/6J-Mir149em1Ydw) 		increased susceptibility to endotoxin shock J:294318
Mir155tm1Brd/Mir155tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		intestinal inflammation J:121095
lung inflammation J:121095
Mir216aem1Uf/Mir216aem1Uf
(C57BL/6-Mir216aem1Uf) 		increased susceptibility to induced pancreatitis J:278847
Mir216aem2Uf/Mir216aem2Uf
(C57BL/6-Mir216aem2Uf) 		increased susceptibility to induced pancreatitis J:278847
Mir216bem1Uf/Mir216bem1Uf
(C57BL/6-Mir216bem1Uf) 		increased susceptibility to induced pancreatitis J:278847
Mir217em1Uf/Mir217em1Uf
(C57BL/6-Mir217em1Uf) 		increased susceptibility to induced pancreatitis J:278847
Mir217em2Uf/Mir217em2Uf
(C57BL/6-Mir217em2Uf) 		increased susceptibility to induced pancreatitis J:278847
Mir223tm1Fcam/Mir223tm1Fcam
(involves: 129S4/SvJae * C57BL/6) 		increased acute inflammation J:140009
lung inflammation J:140009
Mir497em1Hgyu/Mir497em1Hgyu
(C57BL/6-Mir497em1Hgyu) 		increased susceptibility to induced colitis J:357958
Mir511em1Clib/Mir511em1Clib
(C57BL/6J-Mir511em1Clib) 		decreased susceptibility to induced colitis J:345580
Mirc32tm1.1Jtm/Mirc32tm1.1Jtm
Tg(Myh11-cre,-EGFP)2Mik/?
(B6.Cg-Mirc32tm1.1Jtm Tg(Myh11-cre,-EGFP)2Mik) 		increased susceptibility to induced colitis J:214382
Mirc32tm1.1Jtm/Mirc32tm1.1Jtm
Twist2tm1(cre)Dor/Twist2+
(B6.129(Cg)-Twist2tm1.1(cre)Dor Mirc32tm1.1Jtm) 		increased susceptibility to induced colitis J:214382
Mirc32tm1.2Jtm/Mirc32tm1.2Jtm
(B6.129(Cg)-Mirc32tm1.2Jtm) 		increased susceptibility to induced colitis J:214382
Mispem1Nsas/Mispem1Nsas
(FVB/NJcl-Mispem1Nsas) 		increased susceptibility to induced colitis J:333842
MitfTg(Tff3-Tmem207)2Tamo/Mitf+
(involves: C57BL/6) 		kidney inflammation J:244533
Mlklm1Btlr/Mlkl+
(C57BL/6J-Mlklm1Btlr) 		decreased inflammatory response J:225934
Mlklm1Btlr/Mlklm1Btlr
(C57BL/6J-Mlklm1Btlr) 		decreased inflammatory response J:225934
Mlklm2Btlr/Mlkl+
(C57BL/6J-Mlklm2Btlr) 		decreased inflammatory response J:234252
Mlklm2Btlr/Mlklm2Btlr
(C57BL/6J-Mlklm2Btlr) 		decreased inflammatory response J:234252
Mlklm3Btlr/Mlkl+
(C57BL/6J-Mlklm3Btlr) 		decreased inflammatory response J:234251
Mlklm3Btlr/Mlklm3Btlr
(C57BL/6J-Mlklm3Btlr) 		decreased inflammatory response J:234251
Mlkltm1.1Wsa/Mlkltm1.1Wsa
Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2) 		dermatitis J:312394
Mmdtm1Beij/Mmdtm1Beij
(Not Specified) 		decreased susceptibility to induced arthritis J:304637
Mmetm1Cge/Mmetm1Cge
(B6.129S4-Mmetm1Cge) 		dermatitis J:66854
increased susceptibility to type I hypersensitivity reaction J:66854
Mmp1atm1Otin/Mmp1atm1Otin
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased inflammatory response J:198586
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal inflammatory response J:46091
brain inflammation J:94099
decreased inflammatory response J:46091
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd) 		autoimmune arthritis J:121780
Mmp2tm1Ito/Mmp2tm1Ito
Timp3tm1Osya/Timp3tm1Osya
(involves: 129P2/OlaHsd * C57BL/6) 		aortitis J:193744
Mmp3tm1Mrl/Mmp3tm1Mrl
(either: (129S7/SvEvBrd X B10.RIII)N2 or ((involves: 129S7/SvEvBrd * C57BL/6) X B10.RIII)N2) 		autoimmune arthritis J:46038
joint inflammation J:46038
osteoarthritis J:46038
Mmp3tm1Mrl/Mmp3tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/10ScSn * RIII) 		decreased susceptibility to type IV hypersensitivity reaction J:55723
Mmp7tm1Lmm/Mmp7tm1Lmm
(B6.129-Mmp7tm1Lmm) 		increased susceptibility to induced colitis J:149388
Mmp8tm1Otin/Mmp8tm1Otin
(involves: 129X1/SvJ * C57BL/6J) 		abnormal inflammatory response J:86393
chronic inflammation J:86393
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac) 		decreased inflammatory response J:84293
myocarditis J:148442
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.129S6-Mmp9tm1Tvu) 		decreased susceptibility to induced colitis J:104644
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129/Sv * 129S6/SvEvTac) 		increased susceptibility to type IV hypersensitivity reaction J:55723
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6) 		lung inflammation J:88065
Mmp9tm1Tvu/Mmp9tm1Tvu
(C3N.129S6-Mmp9tm1Tvu) 		decreased susceptibility to induced arthritis J:150311
joint inflammation J:150311
Mmp10tm1Jkmg/Mmp10tm1Jkmg
(B6.129X1-Mmp10tm1Jkmg) 		lung inflammation J:153651
Mmp14tm1Hbh/Mmp14tm1Hbh
(involves: 129P2/OlaHsd * Black Swiss) 		autoimmune arthritis J:57969
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase) 		decreased inflammatory response J:137128
decreased susceptibility to type IV hypersensitivity reaction J:137128
Mmp25Gt(IST14198E10)Tigm/Mmp25Gt(IST14198E10)Tigm
(involves: C57BL/6N) 		decreased susceptibility to endotoxin shock J:347009
Mmuttm1Cpv/Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		tubulointerstitial nephritis J:147313
Mmuttm1Cpv/Mmuttm1Cpv
Tg(Alb-Mut)#Cpv/0
(involves: C57BL/6) 		tubulointerstitial nephritis J:200689
Mocosem2(IMPC)Ics/Mocosem2(IMPC)Ics
(involves: C57BL/6N) 		kidney inflammation J:336718
tubulointerstitial nephritis J:336718
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6) 		CNS inflammation J:151335
Mol2DBA/2N/Mol2DBA/2N
(involves: BALB/cAnFcr * DBA/2N) 		increased inflammatory response J:58921
mpc253H/mpc253H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		colitis J:234901
Mpdk2C57BL/6J/Mpdk2CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk2CAST/Ei/Mpdk2CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk7C57BL/6J/Mpdk7CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk7CAST/Ei/Mpdk7CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk8C57BL/6J/Mpdk8CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk8CAST/Ei/Mpdk8CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J) 		decreased inflammatory response J:102688
Mpzl3rc/Mpzl3rc
(C57BL/6J-Mpzl3rc/J) 		dermatitis J:93038
liver inflammation J:93038
Mpzl3tm1(KOMP)Mbp/Mpzl3tm1(KOMP)Mbp
(C57BL/6-Tyrc-Brd Mpzl3tm1(KOMP)Mbp) 		seborrheic dermatitis J:210832
skin inflammation J:210832
Mrgprb2em1Xzd/Mrgprb2em1Xzd
(C57BL/6-Mrgprb2em1Xzd) 		decreased inflammatory response J:219209
Mrs2em1Muma/Mrs2em1Muma
(B6.Cg-Mrs2em1Muma) 		decreased susceptibility to endotoxin shock J:298361
Ms4a2tm1Chr/Ms4a2tm1Chr
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to type I hypersensitivity reaction J:53106
Ms4a2tm1Knt/Ms4a2tm1Knt
(involves: 129 * BALB/c) 		decreased susceptibility to type I hypersensitivity reaction J:47138
Ms4a2tm1Knt/Ms4a2tm1Knt
Tg(SV40/HTLV-FCER1A)1Bhk/0
(involves: 129 * BALB/c) 		decreased susceptibility to type I hypersensitivity reaction J:47138
Ms4a6dem1Cya/Ms4a6dem1Cya
(involves: C57BL/6) 		decreased susceptibility to endotoxin shock J:342776
Ms4a6dem1Ywch/Ms4a6dem1Ywch
(C57BL/6-Ms4a6dem1Ywch) 		decreased susceptibility to endotoxin shock J:342776
Ms4a6dem2Ywch/Ms4a6dem2Ywch
(C57BL/6-Ms4a6dem2Ywch) 		decreased susceptibility to endotoxin shock J:342776
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd) 		abnormal inflammatory response J:80893
Msmpem1Jzx/Msmpem1Jzx
(C57BL/6-Msmpem1Jzx) 		liver inflammation J:311042
Mst1tm1Jab/Mst1tm1Jab
(involves: 129P2/OlaHsd * Black Swiss) 		increased susceptibility to induced colitis J:46185
Mst1rtm1.1Sew/Mst1rtm1.1Sew
(involves: 129/Ola * CD-1 * NIH Black Swiss) 		abnormal type IV hypersensitivity reaction J:75503
increased acute inflammation J:75503
increased susceptibility to endotoxin shock J:75503
Mst1rtm1Ber/Mst1rtm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal type IV hypersensitivity reaction J:76451
increased inflammatory response J:76451
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		kidney inflammation J:126620
lung inflammation J:120196
mt-Co1m1Jiha
(involves: C57BL/6J * M. m. domesticus) 		heart inflammation J:132659
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		dermatitis J:137101
glomerulonephritis J:137101
liver inflammation J:137101
panniculitis J:137101
skin inflammation J:137101
MtapGt(RRK081)Byg/Mtap+
(129P2/OlaHsd-MtapGt(RRK081)Byg) 		arteritis J:123675
Mtfmtem1Heb/Mtfmt+
(C57BL/6-Mtfmtem1Heb) 		decreased inflammatory response J:334467
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg) 		increased inflammatory response J:186118
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:212144
insulitis J:212144
salivary gland inflammation J:212144
Mtv7BALB/c/Mtv7BALB/c
(involves: B10.Q * BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:27701
Mtv7BALB/c/Mtv7DBA/2
(involves: B10.Q * BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:27701
Mtv7DBA/2/Mtv7DBA/2
(C.D2-Mtv7DBA/2) 		decreased susceptibility to induced arthritis J:27701
Muc2eey/Muc2eey
(C57BL/6-Muc2eey) 		ileum inflammation J:194148
increased susceptibility to induced colitis J:194148
Muc2M1Btlr/Muc2+
(C57BL/6J-Muc2M1Btlr) 		increased susceptibility to induced colitis J:150326
Muc2M1Btlr/Muc2M1Btlr
(C57BL/6J-Muc2M1Btlr) 		increased susceptibility to induced colitis J:150326
Muc2m2Btlr/?
(C57BL/6J-Muc2m2Btlr) 		increased susceptibility to induced colitis J:159359
Muc2m3Btlr/Muc2m3Btlr
(C57BL/6J-Muc2m3Btlr) 		increased susceptibility to induced colitis J:254906
Muc2tm1Avel/Muc2tm1Avel
(involves: 129P2/OlaHsd * C57BL/6) 		colitis J:216831
large intestinal inflammation J:216831
Muc2wnn/Muc2+
(C57BL/6-Muc2wnn) 		increased susceptibility to induced colitis J:194148
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn) 		colitis J:194148
ileum inflammation J:194148
increased susceptibility to induced colitis J:194148
Muc4tm1Skb/Muc4tm1Skb
(involves: 129 * C57BL/6J) 		decreased susceptibility to colitis induced morbidity/mortality J:234205
decreased susceptibility to induced colitis J:234205
Muc5btm1.2Evns/Muc5btm1.2Evns
(B6.129S1-Muc5btm1.2Evns) 		increased susceptibility to otitis media J:207159
respiratory system inflammation J:207159
Muc13tm1.1Mamg/Muc13tm1.1Mamg
(involves: 129 * C57BL/6) 		increased susceptibility to colitis induced morbidity/mortality J:313870
increased susceptibility to induced colitis J:313870
large intestinal inflammation J:313870
small intestinal inflammation J:313870
Mug1tm1Vln/Mug1tm1Vln
(B.129P2-Mug1tm1Vln) 		liver inflammation J:57485
Mug1tm2Vln/Mug1tm2Vln
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln Mug1tm2Vln) 		liver inflammation J:57485
Mus81tm1Esse/Mus81+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased inflammatory response J:222498
Mus81tm1Esse/Mus81tm1Esse
(involves: 129P2/OlaHsd * C57BL/6J) 		lung inflammation J:222498
Mxra8em1Diam/Mxra8em1Diam
(C57BL/6J-Mxra8em1Diam) 		decreased inflammatory response J:280585
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki) 		bronchiolitis J:162707
decreased inflammatory response J:123946
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd) 		increased susceptibility to induced colitis J:167340
Myd88tm1Aki/Myd88tm1Aki
(C.129P2-Myd88tm1Aki) 		decreased susceptibility to induced arthritis J:178054
Myd88tm1Aki/Myd88tm1Aki
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl
Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to induced colitis J:163410
Mydgftm1Kcw/Mydgftm1Kcw
(BALB/c-Mydgftm1Kcw) 		decreased inflammatory response J:216795
Myh4arl/Myh4arl
(involves: C3H/HeH * C57BL/6J) 		myositis J:181892
Myh6tm1Jse/Myh6+
Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6) 		liver inflammation J:153302
lung inflammation J:153302
Myh9tm1.1(MYH9*)Mjk/Myh9+
(B6.Cg-Myh9tm1.1(MYH9*)Mjk) 		increased incidence of corneal inflammation J:175367
Myh10tm7Rsad/Myh10tm7Rsad
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N) 		heart inflammation J:170148
Myl3tm1a(EUCOMM)Hmgu/Myl3tm1a(EUCOMM)Hmgu
Tg(Col2a1-cre)1Xya/0
(involves: C57BL/6J * C57BL/6N) 		osteoarthritis J:343166
Myl3tm1a(EUCOMM)Hmgu/Myl3tm1a(EUCOMM)Hmgu
Tg(Col2a1-cre/ERT)KA3Smac/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		increased susceptibility to induced arthritis J:343166
Mylktm1Mzhu/Mylktm1Mzhu
Taglntm1(cre/ERT2)Feil/?
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		small intestinal inflammation J:141907
Myo1dem1Btlr/Myo1dem1Btlr
(C57BL/6J-Myo1dem1Btlr) 		increased susceptibility to colitis induced morbidity/mortality J:267525
increased susceptibility to induced colitis J:267525
Myo1dm1Btlr/Myo1dm1Btlr
(C57BL/6J-Myo1dm1Btlr) 		increased susceptibility to induced colitis J:267525
Myo1dm1Btlr/Myo1dm2Btlr
(C57BL/6J-Myo1dm1Btlr/Myo1dm2Btlr) 		increased susceptibility to induced colitis J:267525
Myo1dm2Btlr/Myo1dm2Btlr
(C57BL/6J-Myo1dm2Btlr) 		increased susceptibility to induced colitis J:267525
Myo1dm3Btlr/Myo1dm3Btlr
(C57BL/6J-Myo1dm3Btlr) 		increased susceptibility to induced colitis J:267525
Myo1dm4Btlr/Myo1dm4Btlr
(C57BL/6J-Myo1dm4Btlr) 		increased susceptibility to induced colitis J:267525
N4bp1tm1.2Vmd/N4bp1tm1.2Vmd
(involves: C57BL/6) 		lung inflammation J:297419
Naglutm1Efn/Naglutm1Efn
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to otitis media J:129390
Naipctm1.1Kmma/Naipctm1.1Kmma
(involves: BALB/cJ * C57BL/6) 		decreased susceptibility to induced colitis J:222114
Naipctm1Kmma/Naipctm1Kmma
Lyz2tm1(cre)Ifo/Lyz2+
(B6.Cg-Lyz2tm1(cre)Ifo Naipctm1Kmma) 		decreased susceptibility to induced colitis J:222114
Naipctm1Kmma/Naipctm1Kmma
Tg(Vil1-cre)997Gum/0
(B6.Cg-Naipctm1Kmma Tg(Vil1-cre)997Gum) 		decreased susceptibility to induced colitis J:222114
Nba4NZB/Nba4NZB
(involves: NZB * SWR) 		glomerulonephritis J:96060
Nba5NZB/Nba5NZB
(C57BL/6-Nba5 Yaa) 		glomerulonephritis J:95829
increased susceptibility to type III hypersensitivity reaction J:95829
Nba8NZB/Nba8NZB
(involves: NZB * SWR) 		glomerulonephritis J:73097
Nba10NZB/?
(involves: C57BL/6 * NZB * SB/Le) 		glomerulonephritis J:95829
increased susceptibility to type III hypersensitivity reaction J:95829
Nba10NZB/Nba10NZB
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB) 		glomerulonephritis J:134128
Nba10NZB/Nba10NZB
Tlr7tm1Aki/Y
X/Yaa
(B6.Cg-Nba10NZB Tlr7tm1Aki Yaa) 		glomerulonephritis J:137656
Nba10NZB/Nba10NZB
X/Yaa
(C57BL/6-Nba2 Yaa) 		glomerulonephritis J:95829, J:137656
increased susceptibility to type III hypersensitivity reaction J:95829
Nba11NZB/Nba11NZB
(involves: NZB * SWR) 		glomerulonephritis J:96263
Nba11NZB/Nba11SWR
(involves: NZB * SWR) 		glomerulonephritis J:96263
Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi
(C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi) 		increased inflammatory response J:220801
Nbr1tm1.1Jmos/Nbr1tm1.1Jmos
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6J) 		decreased inflammatory response J:165438
Nbwa2NZB/?
(involves: BALB/c * NZB * NZW) 		glomerulonephritis J:88464
Ncapd2em1Cya/Ncapd2+
(C57BL/6N-Ncapd2em1Cya) 		decreased susceptibility to induced colitis J:310248
Ncf1tm1Hbd/Ncf1tm1Hbd
(involves: 129) 		granulomatous inflammation J:74593
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J) 		increased acute inflammation J:28267
Ncf1tm1Shl/Ncf1tm1Shl
(B6.129S2-Ncf1tm1Shl) 		abnormal inflammatory response J:142617
granulomatous inflammation J:111142
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi) 		lung inflammation J:260777
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6) 		heart inflammation J:141377
liver inflammation J:141377
lung inflammation J:141377
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6) 		increased susceptibility to endotoxin shock J:120086
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6) 		chronic liver inflammation J:207622
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		dermatitis J:116617
increased inflammatory response J:116617
lung inflammation J:116617
Ndfip1tm1.1Pmo/Ndfip1tm1.1Pmo
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		esophageal inflammation J:205692
skin inflammation J:205692
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N) 		esophageal inflammation J:267519
small intestinal inflammation J:267519
Ndrg2tm1.1Hori/Ndrg2tm1.1Hori
(B6.129-Ndrg2tm1.1Hori) 		decreased inflammatory response J:214686
Ndst1tm1Je/Ndst1tm1Je
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased inflammatory response J:100456
Ndst2tm1Rls/Ndst2tm1Rls
(B6.Cg-Ndst2tm1Rls) 		decreased susceptibility to induced arthritis J:142880
Nedd4ltm1.1Hkb/Nedd4ltm1.1Hkb
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		lung inflammation J:169296
Nedd4ltm1Shkr/Nedd4ltm1Shkr
(involves: C57BL/6 * C57BL/6J) 		lung inflammation J:205657
Nedd4ltm1Shkr/Nedd4ltm1Shkr
(involves: 129 * C57BL/6 * C57BL/6J) 		lung inflammation J:205657
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6) 		joint inflammation J:106077
Neil2tm1.1Tkhz/Neil2tm1.1Tkhz
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl) 		lung inflammation J:225791
Nek7M1Btlr/Nek7+
(C57BL/6J-Nek7M1Btlr) 		decreased inflammatory response J:226677
Nek7M1Btlr/Nek7M1Btlr
(C57BL/6J-Nek7M1Btlr) 		decreased inflammatory response J:226677
Nek8m1Btlr/Nek8m1Btlr
(C57BL/6J-Nek8m1Btlr) 		increased susceptibility to induced colitis J:267544
Nf1tm1.1Kest/Nf1tm1c(KOMP)Wtsi
Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N) 		dermatitis J:234172
Nf1tm1c(KOMP)Wtsi/Nf1tm1c(KOMP)Wtsi
Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * FVB/N) 		dermatitis J:234172
Nf2tm1Gth/Nf2tm2Gth
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased susceptibility to otitis media J:63264
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)1Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased susceptibility to otitis media J:63264
Nf2tm2Gth/Nf2tm2Gth
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased susceptibility to otitis media J:63264
Nfat5tm1Rao/Nfat5tm1Rao
(B6.129-Nfat5tm1Rao) 		tubulointerstitial nephritis J:88636
Nfatc1tm3Glm/Nfatc1tm3Glm
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		liver inflammation J:144598
lung inflammation J:144598
lymph node inflammation J:144598
stomach inflammation J:144598
Nfatc2tm1Glm/Nfatc2tm1Glm
Nfatc3tm1Glm/Nfatc3tm1Glm
(involves: 129S2/SvPas) 		blepharitis J:51339
increased inflammatory response J:51339
interstitial pneumonia J:51339
Nfe2l1tm1Jefc/Nfe2l1tm1Ywk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		liver inflammation J:97188
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR) 		glomerulonephritis J:104016
lung inflammation J:118068
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to induced colitis J:116676
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * CD-1) 		increased acute inflammation J:122813
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6) 		liver inflammation J:136120
Nfil3tm1.1Kubo/Nfil3tm1.1Kubo
(B6.Cg-Nfil3tm1.1Kubo) 		increased susceptibility to induced colitis J:172134
Nfil3tm1Pbro/Nfil3tm1Pbro
(B6.129S6-Nfil3tm1Pbro) 		colitis J:209365
Nfkb1M3Btlr/Nfkb1M3Btlr
(C57BL/6J-Nfkb1M3Btlr) 		increased susceptibility to induced colitis J:254821
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6) 		cecum inflammation J:67107
large intestinal inflammation J:67107
peritoneal inflammation J:67107
Nfkb1tm1Bal/Nfkb1tm1Bal
Relatm1Bal/Rela+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		cecum inflammation J:67107
large intestinal inflammation J:67107
peritoneal inflammation J:67107
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv) 		abnormal inflammatory response J:46912
liver inflammation J:46912
lung inflammation J:46912
Nfkb2Lym1/Nfkb2+
(BALB/c-Nfkb2Lym1) 		liver inflammation J:154812
lung inflammation J:154812
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c) 		liver inflammation J:154812
lung inflammation J:154812
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6) 		chronic inflammation J:163686
Nfkbiatm1Stw/Nfkbiatm1Stw
(involves: 129S1/Sv) 		dermatitis J:32527
Nfkbibtm1Bal/Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal) 		decreased susceptibility to endotoxin shock J:163302
decreased susceptibility to induced arthritis J:163302
Nfkbidtm1Ktak/Nfkbidtm1Ktak
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:113334
increased susceptibility to induced colitis J:113334
Nfkbiztm1.1Muta/Nfkbiztm1.1Muta
Tg(CAG-cre)13Miya/?
(involves: C57BL/6) 		dermatitis J:194832
Nfkbiztm1.1Muta/Nfkbiztm1.1Muta
Tg(KRT5-cre)1Tak/?
(involves: C3H * C57BL/6) 		dermatitis J:194832
Nfkbiztm1Aki/Nfkbiz+
Stat6tm1Aki/Stat6tm1Aki
(C.129P2-Stat6tm1Aki Nfkbiztm1Aki) 		skin inflammation J:141704
Nfkbiztm1Aki/Nfkbiztm1Aki
(involves: 129P2/OlaHsd) 		blepharitis J:96363
conjunctivitis J:96363
corneal limbitis J:96363
dermatitis J:194832, J:91297
eye inflammation J:96363
interstitial pneumonia J:194832
lacrimal gland inflammation J:194832
periocular dermatitis J:194832
Nfkbiztm1Aki/Nfkbiztm1Aki
(C.129P2-Nfkbiztm1Aki) 		blepharitis J:141704
conjunctivitis J:141704
dermatitis J:141704
eye inflammation J:141704
perioral dermatitis J:141704
skin inflammation J:141704
Nfkbiztm1Aki/Nfkbiztm1Aki
Stat6tm1Aki/Stat6tm1Aki
(C.129P2-Stat6tm1Aki Nfkbiztm1Aki) 		blepharitis J:141704
dermatitis J:141704
eye inflammation J:141704
skin inflammation J:141704
Nfkbiztm1Aki/Nfkbiztm1Aki
Tnftm1Sek/Tnftm1Sek
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj) 		conjunctivitis J:194832
dermatitis J:194832
Nfkbiztm1Mamo/Nfkbiztm1Mamo
(involves: 129S7/SvEvBrd) 		dermatitis J:95040
Nid2Gt(GST011)Byg/Nid2Gt(GST011)Byg
(involves: 129P2/OlaHsd) 		osteoarthritis J:229684
Ninj2em1Cqxu/Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu) 		white adipose tissue inflammation J:332575
NipblGt(RRS564)Byg/Nipbl+
(involves: 129P2/OlaHsd * CD-1) 		abnormal inflammatory response J:154117
eye inflammation J:154117
Nischedsn/Nischedsn
(C3H.B6-Nischedsn) 		increased susceptibility to otitis media J:244907
Nischedsn/NischV33A
(involves: BALB/c * C3H/HeH * C57BL/6J) 		increased susceptibility to otitis media J:244907
NischV33A/NischV33A
(involves: BALB/c * C57BL/6J) 		increased susceptibility to otitis media J:244907
Nlrc3tm1Bhk/Nlrc3tm1Bhk
(B6.129S6-Nlrc3tm1Bhk) 		increased susceptibility to endotoxin shock J:187586
Nlrc4em1Vnce/Nlrc4em1Vnce
(C57BL/6-Nlrc4em1Vnce) 		decreased inflammatory response J:294930
Nlrc4em1Vnce/Nlrc4em1Vnce
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6J * C57BL/6N) 		decreased inflammatory response J:294930
Nlrc4em2Vnce/Nlrc4em2Vnce
(C57BL/6-Nlrc4em2Vnce) 		decreased inflammatory response J:294930
Nlrc4em2Vnce/Nlrc4em2Vnce
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6J * C57BL/6N) 		decreased inflammatory response J:294930
Nlrp1aNeut1/Nlrp1a+
(C.B6-Nlrp1aNeut1) 		increased inflammatory response J:191055
liver inflammation J:191055
lung inflammation J:191055
meningitis J:191055
myocarditis J:191055
pancreas inflammation J:191055
Nlrp1aNeut1/Nlrp1aNeut1
(C.B6-Nlrp1aNeut1) 		increased inflammatory response J:191055
liver inflammation J:191055
lung inflammation J:191055
meningitis J:191055
myocarditis J:191055
pancreas inflammation J:191055
Nlrp1aNeut1/Nlrp1aNeut1
Pycardtm1Vmd/Pycardtm1Vmd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:191055
Nlrp3tm1Bhk/Nlrp3tm1Bhk
(B6.129S6-Nlrp3tm1Bhk/J) 		white adipose tissue inflammation J:256504
Nlrp3tm1Flv/Nlrp3tm1Flv
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased susceptibility to endotoxin shock J:113333
decreased susceptibility to type IV hypersensitivity reaction J:113333
Nlrp3tm1Flv/Nlrp3tm1Flv
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced colitis J:173245
Nlrp3tm1Flv/Nlrp3tm1Hhf
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6) 		increased inflammatory response J:150054
Nlrp3tm1Hhf/Nlrp3+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		increased inflammatory response J:150054
Nlrp3tm1Hhf/Nlrp3+
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129/Sv * C57BL/6 * CBA) 		skin inflammation J:150054
Nlrp3tm1Hhf/Nlrp3+
Tg(Zp3-cre)3Mrt/?
(involves: 129/Sv * FVB/N) 		increased inflammatory response J:150054
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6N) 		decreased susceptibility to endotoxin shock J:106976
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(B6.B6N-Nlrp3tm1Vmd) 		decreased susceptibility to endotoxin shock J:193522
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6) 		chronic inflammation J:150053
dermatitis J:150053
increased susceptibility to type IV hypersensitivity reaction J:150053
Nlrp3tm2Hhf/Nlrp3+
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129/Sv * C57BL/6 * CBA) 		skin inflammation J:150054
Nlrp3tm3.1Hhf/Nlrp3+
(involves: 129) 		increased inflammatory response J:202147
joint inflammation J:202147
meningitis J:202147
osteomyelitis J:202147
Nlrp6tm1Flv/Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv) 		increased susceptibility to induced colitis J:173245
Nlrp6tm1Macha/Nlrp6tm1Macha
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased susceptibility to induced colitis J:173352
Nlrp10tm1Seis/Nlrp10tm1Seis
(B6.Cg-Nlrp10tm1Seis) 		decreased susceptibility to endotoxin shock J:183989
Nlrp12tm1Jpyt/Nlrp12tm1Jpyt
(B6.Cg-Nlrp12tm1Jpyt) 		decreased susceptibility to type IV hypersensitivity reaction J:164725
Nlrp12tm1Tdk/Nlrp12tm1Tdk
(B6.Cg-Nlrp12tm1Tdk) 		increased inflammatory response J:178951
increased susceptibility to induced colitis J:178951
Nlrx1tm1Jpyt/Nlrx1tm1Jpyt
(involves: C57BL/6 * C57BL/6J) 		increased susceptibility to endotoxin shock J:173995
Nme5tm1Lex/Nme5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		maxillary sinus inflammation J:185566
nasal inflammation J:185566
nmf370/nmf370
(C57BL/6J-nmf370/J) 		ear inflammation J:87349
nmf391/nmf391
(C57BL/6J-nmf391/J) 		ear inflammation J:87349
Nmiem1Hhl/Nmiem1Hhl
(C57BL/6-Nmiem1Hhl) 		decreased susceptibility to endotoxin shock J:298909
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased susceptibility to endotoxin shock J:226234
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to endotoxin shock J:96035
Nod2tm1Flv/Nod2tm1Flv
(C.129S1-Nod2tm1Flv) 		decreased susceptibility to induced arthritis J:178054
Nod2tm1Jhgt/Nod2tm1Jhgt
(B6.Cg-Nod2tm1Jhgt) 		increased susceptibility to induced colitis J:124575
Nod2tm1Mka/Nod2tm1Mka
(involves: C57BL/6) 		increased susceptibility to induced colitis J:96128
Nod2tm1Pmu/Nod2tm1Pmu
(involves: BALB/c * C57BL/6) 		decreased susceptibility to endotoxin shock J:86264
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh/J) 		decreased inflammatory response J:103018
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6) 		skin inflammation J:64036
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		decreased susceptibility to induced colitis J:87601
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau/J) 		abnormal inflammatory response J:103018
decreased inflammatory response J:103018
Nos2tm1Liew/Nos2tm1Liew
(involves: 129P2/Ola * MF1) 		decreased inflammatory response J:25755
decreased susceptibility to endotoxin shock J:25755
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd) 		decreased susceptibility to endotoxin shock J:25511
increased inflammatory response J:51635
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6) 		pancreas inflammation J:65562
Nos3m1Btlr/Nos3m1Btlr
(C57BL/6J-Nos3m1Btlr) 		increased susceptibility to induced colitis J:225268
Nos3M2Btlr/Nos3M2Btlr
(C57BL/6J-Nos3M2Btlr) 		increased susceptibility to induced colitis J:272392
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J) 		increased inflammatory response J:103018
kidney inflammation J:148626
Notch1tm1Con/Notch1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		aortic valve inflammation J:187551
Notch1tm2Rko/Notch1tm3(cre)Rko
(involves: 129X1/SvJ * C57BL/6) 		chronic liver inflammation J:171829
NotumGt(OST172035)Lex/NotumGt(OST172035)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		chronic inflammation J:274615
periodontium inflammation J:266040
Nox1tm1.1Anrt/Nox1tm1.1Anrt
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL) 		colitis J:194294
Nox4tm1Syb/Nox4tm1Syb
(involves: 129S4/SvJae) 		decreased susceptibility to endotoxin shock J:298830
Npas3tm1Mesu/Npas3tm1Mesu
(B6.129S6-Npas3tm1Mesu) 		bronchiectasis J:150793
Npc1m1N/Npc1m1N
(BALB/cNctr-Npc1m1N/J) 		nasal inflammation J:209834
Nphp3pcy/Nphp3pcy
(KK-Nphp3pcy) 		kidney inflammation J:8302
Nphp3pcy/Nphp3pcy
(either: D2.KK-Nphp3pcy or (involves: DBA/2Fg * DBA/2J * KK)) 		kidney inflammation J:11399
Nphp3pol/Nphp3pol
(C57BL/6JSfdAnu-Nphp3pol/Anu) 		kidney inflammation J:104190
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:118850
decreased susceptibility to type IV hypersensitivity reaction J:118850
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		lung inflammation J:234268
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		increased inflammatory response J:158168
Nr1h3tm1Wexi/Nr1h3tm1Wexi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to endotoxin shock J:155709
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj) 		liver inflammation J:200842
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6) 		liver inflammation J:118204
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj) 		decreased inflammatory response J:169333
Nr3c1tm1.1Jaci/Nr3c1tm1.1Jaci
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N) 		heart inflammation J:201995
Nr3c1tm2Ljm/Nr3c1tm2Ljm
Tg(Lck-cre)548Jxm/?
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		cecum inflammation J:97484
increased susceptibility to endotoxin shock J:97484
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to endotoxin shock J:239509
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Tg(Lck-cre)1Jtak/0
(Not Specified) 		increased susceptibility to induced colitis J:205658
Nr5a2tm1Auw/Nr5a2+
(involves: 129P2/OlaHsd) 		increased susceptibility to induced colitis J:123697
Nr5a2tm1Sjns/Nr5a2tm1Sjns
Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL) 		increased susceptibility to induced colitis J:123697
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129X1/SvJ * C57BL/6) 		increased incidence of corneal inflammation J:85753
keratoconjunctivitis sicca J:85753
Nsmaftm1Mkr/Nsmaftm1Mkr
(B6.129P2-Nsmaftm1Mkr) 		decreased susceptibility to endotoxin shock J:89524
Nss1NOD/ShiLtJ/Nss1NOD/ShiLtJ
(involves: C57BL/10 * NOD) 		salivary gland inflammation J:73932
Ntan1tm1Avar/Ntan1tm1Avar
(involves: 129) 		increased acute inflammation J:62140
Nudt7em1Ejj/Nudt7em1Ejj
(involves: C57BL/6N) 		increased susceptibility to induced arthritis J:266261
osteoarthritis J:266261
Nudt21tm1.1Ejwpj/Nudt21tm1.1Ejwpj
Tg(Col1a1-cre/ERT2)1Crm/0
(involves: C57BL/6J * CBA/J) 		increased acute inflammation J:283035
Oca2p-8Btlr/Oca2p-8Btlr
(C57BL/6J-Oca2p-8Btlr) 		increased susceptibility to induced colitis J:264643
OclnGt(ROSA)39Tshi/OclnGt(ROSA)39Tshi
(involves: DBA/2) 		stomach inflammation J:110222
Oclntm1Sts/Oclntm1Sts
(involves: 129S4/SvJae * C57BL/6) 		stomach inflammation J:99467
Oclntm1Tshi/Oclntm1Tshi
(involves: C57BL/6 * DBA/2) 		stomach inflammation J:110222
Oclntm2Sts/Oclntm2Sts
(involves: 129S4/SvJae * C57BL/6) 		stomach inflammation J:99467
Odf2tm1.1Sats/Odf2tm1.2Sats
Tg(CAG-cre)13Miya/0
(involves: C57BL/6 * C57BL/6J) 		increased susceptibility to otitis media J:181294
sinus inflammation J:181294
Olfm4tm1Gpro/Olfm4tm1Gpro
(involves: 129X1/SvJ * Black Swiss) 		stomach inflammation J:161279
Oma1tm1Otin/Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		granulomatous inflammation J:184716
Onecut1tm1.1Mga/Onecut1tm1.1Mga
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		pancreas inflammation J:155058
Orai1Gt(XL922)Byg/Orai1Gt(XL922)Byg
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased susceptibility to type I hypersensitivity reaction J:130479
Orai1tm1Rao/Orai1tm1Rao
(involves: C57BL/6NTac * ICR) 		blepharitis J:139730
Orai2tm1.1Itl/Orai2tm1.1Itl
Tg(Cma1-cre)#Roer/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:278536
Orch4BALB/cByJ/Orch4BALB/cByJ
(involves: BALB/cByJ * DBA/2) 		testis inflammation J:35331
Orch4BALB/cByJ/Orch4DBA/2J
(involves: BALB/cByJ * DBA/2) 		decreased inflammatory response J:35331
Orch4DBA/2J/Orch4DBA/2J
(involves: BALB/cByJ * DBA/2) 		decreased inflammatory response J:35331
Orch5BALB/cByJ/Orch5BALB/cByJ
(involves: BALB/cByJ * DBA/2) 		testis inflammation J:35331
Orch5BALB/cByJ/Orch5DBA/2J
(involves: BALB/cByJ * DBA/2) 		decreased inflammatory response J:35331
Orch5DBA/2J/Orch5DBA/2J
(involves: BALB/cByJ * DBA/2) 		decreased inflammatory response J:35331
Orm2em1Bcgen/Orm2em1Bcgen
(involves: C57BL/6J) 		liver inflammation J:333118
Orm2tm1(KOMP)Vlcg/Orm2tm1(KOMP)Vlcg
(C57BL/6N-Orm2tm1(KOMP)Vlcg/Mmucd) 		kidney inflammation J:292194
Ormdl2em1Pdra/Ormdl2em1Pdra
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl2em1Pdra Ormdl3em1Pdra) 		abnormal type I hypersensitivity reaction J:328837
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl3em1Pdra) 		abnormal type I hypersensitivity reaction J:328837
Os/Os+
(ROP/GnLeJ) 		glomerulonephritis J:28323
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan) 		increased inflammatory response J:214124
white adipose tissue inflammation J:214124
Ostm1gl/Ostm1gl
(GL/Le Edardl-J +/+ Ostm1gl/J) 		eye inflammation J:13053
Otcspf-ash/Y
(B6EiC3Sn a/A-Otcspf-ash/J) 		increased susceptibility to endotoxin shock J:108979
Otud1em2Gpt/Otud1em2Gpt
(C57BL/6-Otud1em2Gpt) 		increased susceptibility to endotoxin shock J:287309
Otud5tm1Vmd/Otud5tm1Vmd
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		intestinal inflammation J:219495
Otulinem1Gvl/Otulintm1c(EUCOMM)Hmgu
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA/2) 		dermatitis J:312394
Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * DBA/2) 		dermatitis J:312394
P2rx2tm1Ckn/P2rx2tm1Ckn
P2rx3tm1Ckn/P2rx3tm1Ckn
(involves: 129P2/OlaHsd * C57BL/6) 		lung inflammation J:86890
P2rx7tm1Ipch/P2rx7tm1Ipch
(B6.Cg-P2rx7tm1Ipch) 		abnormal inflammatory response J:101945
P2ry6tm1Jabo/P2ry6tm1Jabo
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac) 		lung inflammation J:179177
P2ry6tm1Jabo/P2ry6tm1Jabo
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sortm9(cre/ESR1)Arte P2ry6tm1Jabo) 		lung inflammation J:179177
Panx3tm1c(KOMP)Wtsi/Panx3tm1c(KOMP)Wtsi
Tg(Col2a1-cre)1Star/0
(involves: C3H * C57BL/6 * C57BL/6J * C57BL/6N) 		decreased susceptibility to induced arthritis J:233542
Panx3tm1d(KOMP)Wtsi/Panx3tm1d(KOMP)Wtsi
(involves: BALB/cJ * C3H * C57BL/6 * C57BL/6N) 		decreased susceptibility to induced arthritis J:233542
Papss2bm/Papss2bm
(involves: C57BL/6J * LDJ/Le) 		autoimmune arthritis J:166514
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:92244
Parp1tm1Jmdm/Parp1tm1Jmdm
(involves: 129S2/SvPas * C57BL/6) 		abnormal inflammatory response J:117701
Parp1tm1Zqw/Parp1tm1Zqw
(involves: 129/Sv * C57BL/6) 		decreased inflammatory response J:94497
Parp1tm1Zqw/Parp1tm1Zqw
(129S-Parp1tm1Zqw/J) 		decreased inflammatory response J:95418
Parp1tm2Zqw/Parp1tm2Zqw
(either: (involves: 129P2/OlaHsd * 129/Sv) or (involves: 129P2/OlaHsd * C57BL/6)) 		abnormal inflammatory response J:93479
decreased inflammatory response J:93479
decreased susceptibility to endotoxin shock J:93479
Pax6Sey-4H/Pax6+
(involves: 101/H * C3H/HeCrj * C3H/HeH) 		increased susceptibility to induced pancreatitis J:124276
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+
(involves: C57BL/6) 		myositis J:180899
Pbxip1tm1Cya/Pbxip1tm1Cya
Tg(Col2a1-cre/ERT)KA3Smac/0
(involves: FVB/N) 		osteoarthritis J:270267
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J) 		increased susceptibility to endotoxin shock J:184882
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		insulitis J:153040
pancreas inflammation J:153040
Pdcd1tm1Hon/Pdcd1tm1Hon
(B6.129S2-Pdcd1tm1Hon) 		autoimmune arthritis J:78802
glomerulonephritis J:78802
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas) 		increased inflammatory response J:222944
Pdcd1tm1Hon/Pdcd1tm1Hon
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6) 		increased inflammatory response J:222944
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac) 		insulitis J:123785
Pdcd10tm1Kwhi/Pdcd10tm1.1Kwhi
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/?
(involves: C57BL/6 * CBA) 		CNS inflammation J:173947
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
Rag2tm1Fwa/Rag2tm1Fwa
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6) 		dermatitis J:226194
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129X1/SvJ * C57BL/6) 		dermatitis J:226194
Pdss2kd/Pdss2kd
(CBA/H-Pdss2kd) 		tubulointerstitial nephritis J:197578
Pdss2kd/Pdss2kd
(B6.CBACaH(CAST)-Pdss2kd) 		tubulointerstitial nephritis J:101779
Pdss2tm1Dalg/Pdss2tm1Dalg
Tg(NPHS2-cre)295Lbh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tubulointerstitial nephritis J:136670
Pdx1tm1Ted/Pdx1+
(involves: 129P2/OlaHsd) 		pancreas inflammation J:82969
Pecam1tm1Mak/Pecam1+
(D1.129P2-Pecam1tm1Mak) 		increased susceptibility to induced arthritis J:106275
Pecam1tm1Mak/Pecam1tm1Mak
(D1.129P2-Pecam1tm1Mak) 		increased susceptibility to induced arthritis J:106275
joint inflammation J:106275
Pecam1tm1Mak/Pecam1tm1Mak
(B6.129P2-Pecam1tm1Mak) 		liver inflammation J:95226
Pecam1tm1Mak/Pecam1tm1Mak
PitgpC57BL/6/PitgpC57BL/6
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		peritoneal inflammation J:144817
Peli1tm1Tigm/Peli1tm1Tigm
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to endotoxin shock J:152781
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig) 		lung inflammation J:62435
Perptm2Att/Perptm2Att
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S4/SvJae) 		skin inflammation J:167545
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac) 		liver inflammation J:278655
phlebitis J:278655
Pex5tm1Pec/Pex5tm1Pec
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal inflammatory response J:123503
Pex7tm1Nbra/Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6) 		liver inflammation J:158845
Pfdn1Gt(GTR1.3)1Rul/Pfdn1Gt(GTR1.3)1Rul
(involves: 129) 		sinus inflammation J:137415
Pgam1tm1.1Hiko/Pgam1tm1.1Hiko
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased acute inflammation J:293746
Pgdtm1.1Pse/Pgdtm1.1Pse
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		blepharitis J:313817
ear inflammation J:313817
increased susceptibility to type I hypersensitivity reaction J:313817
Pgftm1Pec/Pgftm1Pec
(involves: 129) 		decreased susceptibility to type IV hypersensitivity reaction J:81388
Pgia3DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased inflammatory response J:66460
Pgia5BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased inflammatory response J:66460
Pgia8DBA/2/Pgia8DBA/2
(C.D2-(D15Mit12-D15Mit267)) 		decreased susceptibility to induced arthritis J:137478
Pgia8DBA/2/Pgia8DBA/2
(involves: BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:137478
Pgia8DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased inflammatory response J:66460
Pgia9BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased inflammatory response J:66460
Pgia9DBA/2/Pgia9DBA/2
(C.D2-(D15Mit267-D15Mit41)) 		decreased susceptibility to induced arthritis J:137478
Pgia9DBA/2/Pgia9DBA/2
(involves: BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:137478
Pgia10BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased inflammatory response J:66460
Pgia12BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased inflammatory response J:66460
Pgia13C3H/HeJCr/Pgia13C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
Pgia14C3H/HeJCr/Pgia14C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
Pgia15C3H/HeJCr/Pgia15C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
Pgia26BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased inflammatory response J:84150
Pgia26DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl) 		abnormal inflammatory response J:84150
Pgia39DBA/2Crl/?
Pgia6BALB/cCrl/Pgia6DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl) 		decreased inflammatory response J:84150
Pgia39DBA/2Crl/Pgia39DBA/2Crl
Pgia6DBA/2Crl/Pgia6DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl) 		increased susceptibility to induced arthritis J:84150
Pgia39DBA/2Crl/Pgia39DBA/2Crl
Pgia26BALB/cCrl/Pgia26BALB/cCrl
(involves: BALB/cCrl * DBA/2Crl) 		increased susceptibility to induced arthritis J:84150
Pgis1DBA/2/Pgis1DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis1DBA/2/Pgis1DBA/2
Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis1DBA/2/Pgis1DBA/2
Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(C.129S-Pglyrp1tm1Rdz) 		increased susceptibility to induced arthritis J:178054
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(involves: 129S5/SvEvBrd * BALB/c) 		increased susceptibility to induced colitis J:178053
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp1tm1Rdz Pglyrp2tm1Rdz) 		decreased susceptibility to induced arthritis J:178054
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp2tm1Rdz) 		decreased susceptibility to induced arthritis J:178054
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(involves: 129S/SvEv * BALB/c) 		increased susceptibility to induced colitis J:178053
Pglyrp3tm1Rdz/Pglyrp3tm1Rdz
(involves: 129S6/SvEvTac * BALB/c) 		increased susceptibility to induced colitis J:178053
Pglyrp4tm1Rdz/Pglyrp4tm1Rdz
(involves: 129S6/SvEvTac * BALB/c) 		increased susceptibility to induced colitis J:178053
Pgm3Gt(W037B08)Wrst/Pgm3mld1
(involves: 129S1/Sv * C57BL/6) 		glomerulonephritis J:125094
Pgrtm1Bwo/Pgrtm1Bwo
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)) 		uterus inflammation J:28980
Pgrtm2(cre)Lyd/Pgr+
Criptotm2.2Mms/Criptotm2.2Mms
(involves: 129/Sv * C57BL/6N * CD-1) 		endometrium inflammation J:324146
Pgrmc1em1Ejho/Pgrmc1em1Ejho
(involves: C57BL/6N) 		liver inflammation J:268130
PhexHyp-Duk/Y
(involves: BALB/cAnBomUrd) 		ear inflammation J:132678
increased susceptibility to otitis media J:132678
PhexHyp/?
(involves: C57BL/6J) 		enthesitis J:192371
Phf11dm1H/Phf11dm1H
(C3H.CAnNCrl(C3)-Phf11dm1H) 		abnormal inflammatory response J:217094
Phlpp1tm1.1Saco/Phlpp1tm1.1Saco
Phlpp2tm1d(EUCOMM)Hmgu/Phlpp2tm1d(EUCOMM)Hmgu
(involves: 129 * C57BL/6N) 		decreased susceptibility to induced colitis J:231241
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N) 		liver inflammation J:142512
Pias1tm1Kes/Pias1tm1Kes
(involves: 129S/Sv * C57BL/6) 		increased susceptibility to endotoxin shock J:92167
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		glomerulonephritis J:169710
Pik3cdtm1.1Bvan/Pik3cdtm1.1Bvan
(involves: 129P2/OlaHsd * BALB/c) 		intestinal inflammation J:78412
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(B6.129S4-Pik3cdtm1Tnr) 		decreased inflammatory response J:134324
decreased susceptibility to induced arthritis J:134324
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129-Pik3cdtm1Tnr Pik3cgtm1Pngr) 		decreased inflammatory response J:134324
decreased susceptibility to induced arthritis J:134324
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129P2-Pik3cgtm1Pngr) 		decreased inflammatory response J:134324
decreased susceptibility to induced arthritis J:134324
Pik3cgtm2Ehi/Pik3cgtm2Ehi
(Not Specified) 		abnormal inflammatory response J:124856
Pik3r4tm1.1Mpnd/Pik3r4tm1.1Mpnd
Tg(ACTA1-cre)79Jme/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL) 		myositis J:198770
Pikfyvetm2.1Tssk/Pikfyvetm2.1Tssk
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		intestinal inflammation J:193689
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb) 		increased susceptibility to endotoxin shock J:191085
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		chronic inflammation J:234283
chronic liver inflammation J:234283
increased inflammatory response J:234283
intestinal inflammation J:234283
kidney inflammation J:234283
lung inflammation J:234283
salivary gland inflammation J:234283
Pip5k1btm1Tssk/Pip5k1btm1Tssk
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:97991
Piptm1Myal/Piptm1Myal
(involves: 129S/SvEv * C57BL/6) 		arteritis J:202016
colitis J:202016
Pja2tm1.2Afel/Pja2tm1.2Afel
(involves: 129S6/SvEvTac * C57BL/6J) 		kidney inflammation J:345592
Pkd1tm1Djmp/Pkd1tm1Djmp
(involves: 129P2/OlaHsd * C57BL/6) 		kidney inflammation J:94582
Pkd1tm1Jzh/Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)) 		bile duct inflammation J:52573
kidney inflammation J:52573
Pkhd1tm1.1Ggg/Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		bile duct inflammation J:125113
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik) 		glomerulonephritis J:193187
Pkp3tm1.1Fvr/Pkp3tm1.1Fvr
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL) 		dermatitis J:136451
Pla1aem1Appsc/Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc) 		decreased susceptibility to chemically induced skin inflammation J:333902
decreased susceptibility to induced arthritis J:333902
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg) 		increased susceptibility to type IV hypersensitivity reaction J:201008
Pla2g3tm1Murm/Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:197334
ear inflammation J:197334
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to type I hypersensitivity reaction J:39254
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(NOD.129P2(B6)-Pla2g4atm1Tksh) 		insulitis J:99775
Pla2g4eem1Murm/Pla2g4eem1Murm
(C57BL/6NSlc-Pla2g4eem1Murm) 		increased susceptibility to chemically induced skin inflammation J:333700
Pla2g5tm1Jarm/Pla2g5tm1Jarm
(involves: 129 * C57BL/6J) 		decreased acute inflammation J:89490
Pla2g10Gt712Lex/Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased inflammatory response J:125607
Pla2r1tm1Itoh/Pla2r1tm1Itoh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:44868
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg) 		autoimmune arthritis J:75303
chronic joint inflammation J:75303
Plautm1.1Bug/Plautm1.1Bug
(involves: C57BL/6) 		chronic inflammation J:164542
liver inflammation J:164542
trachea inflammation J:164542
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg) 		decreased inflammatory response J:68083
decreased susceptibility to induced arthritis J:75303
Plautm1Mlg/Plautm1Mlg
(B6.129S2-Plautm1Mlg) 		chronic inflammation J:164542
increased inflammatory response J:164542
liver inflammation J:164542
trachea inflammation J:164542
Plaurtm1Jld/Plaurtm1Jld
(B6.129P2-Plaurtm1Jld) 		chronic inflammation J:164542
increased inflammatory response J:164542
liver inflammation J:164542
trachea inflammation J:164542
Plaurtm1Jld/Plaurtm1Jld
Tg(MSR1-Plau)1Ddi/0
(B6.Cg-Plaurtm1Jld Tg(MSR1-Plau)1Ddi) 		heart inflammation J:113474
Plcd1tm1.1Kfu/Plcd1tm1.1Kfu
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA) 		increased susceptibility to type IV hypersensitivity reaction J:205633
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		dermatitis J:157757
ear inflammation J:157757
skin inflammation J:157757
Plcg2Ali5/Plcg2+
(C3HeB/FeJ-Plcg2Ali5) 		chronic inflammation J:97930
dermatitis J:97930
osteoarthritis J:97930
Plcg2Ali5/Plcg2+
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5) 		glomerulonephritis J:97930
Plcg2Ali5/Plcg2+
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C3HeB/FeJ * C3HeB/FeJ-Plcg2Ali5) 		chronic inflammation J:97930
dermatitis J:97930
osteoarthritis J:97930
Plcg2Ali5/Plcg2Ali5
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5) 		chronic inflammation J:97930
glomerulonephritis J:97930
Plcg2Ali14/Plcg2+
(C3HeB/FeJ-Plcg2Ali14) 		abnormal inflammatory response J:166106
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:157619
Pld3em1Nemz/Pld3em1Nemz
Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.Cg-Pld3em1Nemz Pld4tm1.1Nemz) 		liver inflammation J:281205
Plgtm1Dco/Plg+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:80114
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:80114
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss) 		proctitis J:39419
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld) 		conjunctivitis J:46096
eye inflammation J:46096
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss) 		colitis J:36591
Plgrkttm1Lmls/Plgrkt+
(B6.Cg-Plgrkttm1Lmls) 		dermatitis J:282437
Plgrkttm1Lmls/Plgrkttm1Lmls
(B6.Cg-Plgrkttm1Lmls) 		dermatitis J:282437
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg) 		decreased inflammatory response J:196302
Plp1tm1Kan/Y
Tspan2tm1Hbw/Tspan2tm1Hbw
(B6.Cg-Tspan2tm1Hbw Plp1tm1Kan) 		brain inflammation J:201143
Pls1tm1Fri/Pls1tm1Fri
(B6.129-Pls1tm1Fri) 		increased susceptibility to colitis induced morbidity/mortality J:216723
increased susceptibility to induced colitis J:216723
plt/plt
(either: B6.DDD-plt or C.DDD-plt) 		increased inflammatory response J:110910
lacrimal gland inflammation J:110910
parotid gland inflammation J:110910
salivary gland inflammation J:110910
submandibular gland inflammation J:110910
Pofut1tm2Pst/Pofut1tm1Pst
Shhtm2(cre/ERT2)Cjt/Shh+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL) 		lung inflammation J:150051
Polbtm1.1Jbsw/Polb+
(involves: 129/Sv * C57BL/6) 		dermatitis J:206872
glomerulonephritis J:206872
lymph node inflammation J:206872
salivary gland inflammation J:206872
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6) 		dermatitis J:206872
glomerulonephritis J:206872
lymph node inflammation J:206872
salivary gland inflammation J:206872
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh) 		liver inflammation J:234615
Postntm1Sjc/Postntm1Sjc
(involves: C57BL/6) 		periodontium inflammation J:103753
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae) 		heart inflammation J:63801
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N) 		skin inflammation J:63040
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		glomerulonephritis J:168799
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA * ICR) 		increased susceptibility to induced arthritis J:58222
Ppargtm2Rev/Ppargtm2Rev
Tg(Krt1-15-cre/PGR*)22Cot/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		skin inflammation J:150977
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		skin inflammation J:123403
Ppargc1atm1Brsp/Ppargc1a+
(involves: 129S4/SvJae * C57BL/6) 		increased inflammatory response J:264271
Ppiatm1Lubn/Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn) 		blepharitis J:93591
heart inflammation J:93591
increased inflammatory response J:93591
increased susceptibility to type I hypersensitivity reaction J:93591
liver inflammation J:93591
pancreas inflammation J:93591
Ppm1atm1.2Lavi/Ppm1atm1.2Lavi
(B.129(Cg)-Ppm1atm1.2Lavi) 		increased acute inflammation J:216372
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6) 		chronic inflammation J:74284
Ppp1r8tm1.1Itl/Ppp1r8tm1Ave
Tg(Alb1-cre)7Gsc/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NTac * FVB/N) 		liver inflammation J:238108
Ppp1r12atm1Mzhu/Ppp1r12atm1Mzhu
Tg(Acta2-cre)#Xya/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		small intestinal inflammation J:207752
Ppp1r13lwa3-J/Ppp1r13lwa3-J
(BALB/cJ-Ppp1r13lwa3-J/J) 		heart inflammation J:264272
Ppp6ctm1Shma/Ppp6ctm1Shma
Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6 * CBA * CD-1) 		increased susceptibility to chemically induced skin inflammation J:231809
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6) 		brain inflammation J:95522
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		brain inflammation J:177265
Prap1tm1Lex/Prap1tm1Lex
(B6.129S5-Prap1tm1Lex) 		increased inflammatory response J:304152
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		kidney inflammation J:178876
Prdx3Gt(Betageo-puro)711Lex/Prdx3Gt(Betageo-puro)711Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		lung inflammation J:118595
Prf1tm1Sdz/Prf1+
(NOD.B6-Prf1tm1Sdz) 		insulitis J:43468
periinsulitis J:43468
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz) 		abnormal inflammatory response J:17986
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz) 		insulitis J:43468
periinsulitis J:43468
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J) 		brain inflammation J:92260, J:120427
CNS inflammation J:120427
liver inflammation J:92260
lymph node inflammation J:92260
Prg2tm1Nal/Prg2tm1Nal
(involves: 129P2/OlaHsd * 129X1/SvJ) 		abnormal inflammatory response J:65655
respiratory system inflammation J:65655
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno) 		abnormal inflammatory response J:235379
white adipose tissue inflammation J:235379
Prkar1btm1Gsm/Prkar1btm1Gsm
(Not Specified) 		decreased inflammatory response J:43080
PrkcdM1Btlr/PrkcdM1Btlr
(C57BL/6J-PrkcdM1Btlr) 		increased susceptibility to induced colitis J:265145
Prkcdm2Btlr/Prkcdm2Btlr
(C57BL/6J-Prkcdm2Btlr) 		increased susceptibility to induced colitis J:265146
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:76135
increased acute inflammation J:76135
Prkcgtm1Stl/Prkcgtm1Stl
(Not Specified) 		decreased inflammatory response J:25061
Prkdchanky/Prkdchanky
(either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ)) 		cecum inflammation J:104190
colitis J:104190
interstitial pneumonia J:104190
liver inflammation J:104190
Prkdcscid/Prkdcscid
(C.BKa-Prkdcscid) 		salivary gland inflammation J:21965
Prkdcscid/Prkdcscid
(B6.Cg-Prkdcscid/Sz) 		stomach inflammation J:120556
Prmt3tm1a(EUCOMM)Wtsi/Prmt3tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		increased incidence of corneal inflammation J:213427
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		liver inflammation J:50527
Procrtm1.1Pcl/Procrtm1.1Pcl
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to endotoxin shock J:225914
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased inflammatory response J:102652
Prph2em1Sal/Prph2+
(C57BL/6J-Prph2em1Sal) 		eye inflammation J:342243
Prph2em1Sal/Prph2em1Sal
(C57BL/6J-Prph2em1Sal) 		eye inflammation J:342243
Prss3btm1.1Satom/Prss3b+
(B6(FVB)-Prss3btm1.1Satom) 		acute pancreas inflammation J:267764
chronic pancreas inflammation J:267764
Prss34tm1.1Hkar/Prss34tm1.1Hkar
(involves: C57BL/6) 		decreased inflammatory response J:238924
Prxl2atm1(KOMP)Vlcg/Prxl2atm1(KOMP)Vlcg
(C57BL/6N-Prxl2atm1(KOMP)Vlcg) 		white adipose tissue inflammation J:234040
Psaptm2Ggb/Psaptm2Ggb
(involves: 129S/SvEv * C57BL/6J) 		CNS inflammation J:137650
kidney inflammation J:137650
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J) 		CNS inflammation J:78223
Psen1tm1Bdes/Psen1+
Psen2tm1Bdes/Psen2tm1Bdes
(involves: 129P2/OlaHsd) 		arteritis J:91235
chronic inflammation J:91235
dermatitis J:91235
glomerulonephritis J:91235
increased incidence of corneal inflammation J:91235
increased inflammatory response J:91235
kidney inflammation J:91235
skin inflammation J:91235
Psip1Gt(betageo)1Hgs/Psip1Gt(betageo)1Hgs
(B6.129P2-Psip1Gt(betageo)1Hgs) 		blepharitis J:112975
Psip1Gt(betageo)1Hgs/Psip1Gt(betageo)1Hgs
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1)) 		blepharitis J:112975
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6) 		increased inflammatory response J:261081
skin inflammation J:261081
Pstpip2cmo/Pstpip2cmo
(C.D2-Qa2) 		chronic inflammation J:1534
Pstpip2cmo/Pstpip2cmo
(C.Cg-Pstpip2cmo/J) 		ear inflammation J:104476
osteomyelitis J:104476, J:105410
Pstpip2Lupo/Pstpip2Lupo
(either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J)) 		skin inflammation J:125785
Pstpip2Lupo/Pstpip2Lupo
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C3HeB/FeJ * C57BL/6J) 		skin inflammation J:125785
Pstpip2m1Bcs/Pstpip2m1Bcs
(involves: C57BL/6) 		abnormal inflammatory response J:196534
ear inflammation J:196534
skin inflammation J:196534
Ptafrtm1Tksh/Ptafrtm1Tksh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:87866
increased susceptibility to type I hypersensitivity reaction J:88505
Ptentm1Hwu/Ptentm1Hwu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		lung inflammation J:148947
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		prostate gland inflammation J:93902
pyelonephritis J:124208
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		liver inflammation J:138099
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(C.129-Ptgdr2tm1Tasa) 		abnormal inflammatory response J:131146
decreased inflammatory response J:131146
decreased susceptibility to type IV hypersensitivity reaction J:131146
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(B6.129-Ptgdr2tm1Tasa) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptgdrtm1Sna/Ptgdrtm1Sna
(involves: 129P2/OlaHsd * C57BL/6) 		brain inflammation J:243958
respiratory system inflammation J:61023
Ptgdrtm1Sna/Ptgdrtm1Sna
(B6.129P2-Ptgdrtm1Sna/Sna) 		decreased susceptibility to type I hypersensitivity reaction J:197334
Ptgdstm1Ohy/Ptgdstm1Ohy
(B6.129P2-Ptgdstm1Ohy) 		decreased susceptibility to type I hypersensitivity reaction J:197334
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna) 		decreased susceptibility to type IV hypersensitivity reaction J:128435
Ptger2tm1.1Kand/Ptger2tm1.1Kand
Tg(ITGAM-cre)2781Gkl/0
(involves: C57BL/6 * CBA) 		decreased susceptibility to endotoxin shock J:202677
Ptger3tm1Sna/Ptger3tm1Sna
(B6.129P2-Ptger3tm1Sna/Sna) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptger4tm1.1Matb/Ptger4tm1.1Matb
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N) 		heart inflammation J:158439
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased susceptibility to induced arthritis J:78964
rheumatoid arthritis J:78964
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:83725
Ptges2tm1Kymm/Ptges2tm1Kymm
(B6.Cg-Ptges2tm1Kymm) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptgestm1Aki/Ptgestm1Aki
(involves: 129X1/SvJ * C57BL/6) 		abnormal inflammatory response J:91821
chronic inflammation J:91821
Ptgestm1Aki/Ptgestm1Aki
(B6.129P2-Ptgestm1Aki) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptgestm1Lpa/Ptgestm1Lpa
(DBA/1LacJ-Ptgestm1Lpa) 		decreased inflammatory response J:89960, J:90980
Ptgirtm1Sna/Ptgirtm1Sna
(involves: 129P2/OlaHsd * C57BL/6) 		decreased acute inflammation J:42275
Ptgs1tm1Fun/Ptgs1tm1Fun
(involves: 129S6/SvEvTac * C57BL/6) 		decreased inflammatory response J:97351
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:29511
increased susceptibility to endotoxin shock J:75611
increased susceptibility to induced colitis J:158426, J:60668
Ptgs1tm1Unc/Ptgs1tm1Unc
(B6.129P2-Ptgs1tm1Unc) 		decreased susceptibility to induced arthritis J:110716
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun
(involves: 129S6/SvEvTac) 		kidney inflammation J:148699
Ptgs2tm1.1Wls/Ptgs2tm1.1Wls
(B6.129-Ptgs2tm1.1Wls) 		increased susceptibility to endotoxin shock J:156331
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd) 		pyelonephritis J:29974
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd * C57BL/6) 		peritoneal inflammation J:118171
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		peritoneal inflammation J:29510
tubulointerstitial nephritis J:29510
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:75611
increased susceptibility to induced colitis J:158426, J:60668
peritoneal inflammation J:60668
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc) 		decreased susceptibility to induced arthritis J:110716
Ptgs2tm1Unc/Ptgs2tm2.1Hahe
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased susceptibility to induced colitis J:158426
Ptgs2tm2.1(Ptgs1)Fun/Ptgs2tm2.1(Ptgs1)Fun
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB) 		kidney inflammation J:118171
peritoneal inflammation J:118171
Ptk2btm1Schl/Ptk2btm1Schl
(involves: 129S1/Sv * 129X1/SvJ) 		decreased acute inflammation J:99741
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c) 		abnormal inflammatory response J:90541
increased inflammatory response J:90541
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd) 		increased inflammatory response J:94077
lung inflammation J:142845
salivary gland inflammation J:142845
Ptpn6me-B2/Ptpn6me-B2
(involves: BALB/c) 		interstitial pneumonia J:169850
skin inflammation J:169850
Ptpn6me-v/Ptpn6me-v
(C57BL/6J-Ptpn6me-v) 		abnormal inflammatory response J:20845
chronic inflammation J:20845
interstitial pneumonia J:7531
rheumatoid arthritis J:20845
Ptpn6me/Ptpn6me
(either: (involves: C3H * C57BL/6J) or (involves: C57BL/6J * C57BL/6N)) 		lung inflammation J:5999
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased acute inflammation J:172422
liver inflammation J:172422
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Stat3tm1Vpo/Stat3tm1Vpo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		liver inflammation J:172422
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6) 		glomerulonephritis J:201448
increased inflammatory response J:201448
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn) 		glomerulonephritis J:147129
liver inflammation J:147129
lung inflammation J:147129
Ptprcm1Smv/Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J) 		CNS inflammation J:214487
Ptprctm1Mak/Ptprctm1Mak
(involves: 129) 		decreased susceptibility to type I hypersensitivity reaction J:110782
Ptprctm1Mak/Ptprctm1Mak
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(B6.Cg-Ptprctm1Mak Ptprjtm1.2Weis) 		liver inflammation J:131736
lung inflammation J:131736
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6) 		glomerulonephritis J:66501
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis) 		liver inflammation J:147129
lung inflammation J:147129
Ptprntm1Aln/Ptprntm1Aln
(NOD.129S4-Ptprntm1Aln) 		insulitis J:107161
Ptx3tm1Mant/Ptx3tm1Mant
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		lung inflammation J:85080
Pxdnmhdakta048/Pxdnmhdakta048
(involves: C3HeB/FeJ * C57BL/6J) 		eye inflammation J:213336
Pycardtm1Flv/Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased susceptibility to endotoxin shock J:113333
decreased susceptibility to type IV hypersensitivity reaction J:113333
Pycardtm1Flv/Pycardtm1Flv
(B6.129S5-Pycardtm1Flv) 		increased susceptibility to induced colitis J:173245
Pycardtm1Tno/Pycardtm1Tno
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to endotoxin shock J:100807
Pycardtm1Vmd/Pycardtm1Vmd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) 		decreased inflammatory response J:91292
Pycardtm1Vmd/Pycardtm1Vmd
(B6.129-Pycardtm1Vmd) 		decreased susceptibility to endotoxin shock J:193522
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi) 		liver inflammation J:284765
Pzptm1Vln/Pzptm1Vln
(involves: 129P2/OlaHsd * C57BL) 		increased susceptibility to induced pancreatitis J:28328
pancreas inflammation J:28328
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln) 		liver inflammation J:57485
Rab11atm1.1Ngao/Rab11atm1.1Ngao
Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6J * SJL) 		intestinal inflammation J:215917
Rab26em1Guwa/Rab26em1Guwa
(Not Specified) 		increased susceptibility to endotoxin shock J:306921
Rab32tm1c(KOMP)Wtsi/Rab32tm1c(KOMP)Wtsi
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA) 		increased susceptibility to colitis induced morbidity/mortality J:267497
increased susceptibility to induced colitis J:267497
Rab44em1Rbrc/Rab44em1Rbrc
(Not Specified) 		increased susceptibility to type I hypersensitivity reaction J:304506
Rabgef1tm1Glli/Rabgef1tm1Glli
(either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6)) 		abnormal inflammatory response J:91790
chronic inflammation J:91790
Rac1tm1Djk/Rac1tm1.1Djk
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased acute inflammation J:83457
Rad23btm1Gvh/Rad23btm1Gvh
(involves: 129P2/OlaHsd * C57BL/6) 		blepharitis J:74288
conjunctivitis J:74288
Rad50tm2.1Flv/Rad50tm2.2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased inflammatory response J:165055
Rag1tm1Bal/Rag1tm1Bal
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Rag1tm1Mom/Rag1tm1Mom
(B6.129S7-Rag1tm1Mom) 		dermatitis J:111828
ear inflammation J:111828
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to induced colitis J:194587
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd) 		decreased inflammatory response J:94420
Rag1tm1Mom/Rag1tm1Mom
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J) 		increased inflammatory response J:117880
Rag1tm1Mom/Rag1tm1Mom
Tg(CAG-Lyn*)#Paau/0
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased inflammatory response J:151886
Rag1tm1Mom/Rag1tm1Mom
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6) 		rheumatoid arthritis J:54056
small intestinal inflammation J:54056
Rag2tm1.1Cgn/Rag2tm1.1Cgn
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2) 		CNS inflammation J:134764
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6) 		colitis J:122108
erythroderma J:122108
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv) 		colitis J:116136
lung inflammation J:140483
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:165513
Rag2tm1Fwa/Rag2tm1Fwa
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S/SvEv * 129S6/SvEvTac) 		colitis J:141481
large intestinal inflammation J:141481
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6) 		thyroid gland inflammation J:78309
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified) 		insulitis J:201171
Raph1tm1.2Fbg/Raph1tm1.2Fbg
(involves: 129S4/SvJae * C57BL/6) 		increased inflammatory response J:238262
large intestinal inflammation J:238262
Rasa1tm1Wid/Rasa1tm1Wid
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6N) 		increased susceptibility to induced colitis J:189241
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6) 		glomerulonephritis J:85189
Rasgrp4tm1(cre)Rls/Rasgrp4tm1(cre)Rls
(C57BL/6-Rasgrp4tm1(cre)Rls) 		decreased susceptibility to induced arthritis J:186519
decreased susceptibility to induced colitis J:186519
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		glomerulonephritis J:168749
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/cJ) 		abnormal inflammatory response J:51060
Rbpjtm1Kyo/Rbpj+
(involves: 129S2/SvPas * CD-1) 		aortic valve inflammation J:187551
Rc3h1Gt(CC0753)Wtsi/Rc3h1Gt(CC0753)Wtsi
(B6.129P2-Rc3h1Gt(CC0753)Wtsi) 		chronic liver inflammation J:199407
ileum inflammation J:199407
intestinal inflammation J:199407
Rc3h1san/Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca)) 		glomerulonephritis J:98938
liver inflammation J:98938
Rc3h1san/Rc3h1san
(involves: C57BL/6JSfdAnu) 		cecum inflammation J:199407
chronic liver inflammation J:199407
colitis J:199407
granulomatous inflammation J:199407
ileum inflammation J:199407
small intestinal inflammation J:199407
Rc3h1san/Rc3h1san
Rc3h2tm1.2Cgv/Rc3h2tm1.2Cgv
(involves: C57BL/6 * C57BL/6JSfdAnu) 		increased inflammatory response J:196137
kidney inflammation J:196137
Rcan1tm1Fmc/Rcan1tm1Fmc
(involves: 129S4/SvJae) 		increased susceptibility to endotoxin shock J:152536
Rdns/Rdns+
(C57BL/6J-Rdns/GrsrJ) 		increased susceptibility to otitis media J:223062
Reltm1Brv/Reltm1Brv
(involves: 129S1/Sv) 		dermatitis J:46911
Relatm1Asba/Relatm1Asba
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6J * SJL) 		increased susceptibility to induced colitis J:131977
Relatm1Bal/Relatm1Bal
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S4/SvJae * C57BL/6) 		heart inflammation J:60742
liver inflammation J:60742
lung inflammation J:60742
Relatm1Mpa/Relatm1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: FVB/N) 		increased susceptibility to endotoxin shock J:137861
Relatm1Rsch/Relatm1Rsch
Ptf1atm1(cre)Hnak/?
(involves: C57BL/6) 		lung inflammation J:122194
pancreas inflammation J:122194
Relatm2.1Gho/Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6) 		increased inflammatory response J:163663
interstitial pneumonia J:163663
liver inflammation J:163663
lung inflammation J:163663
myositis J:163663
Relatm2.1Gho/Relatm2.1Gho
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased incidence of corneal inflammation J:163663
liver inflammation J:163663
Relbshep/Relbshep
(A;C-Relbshep/GrsrJ) 		liver inflammation J:171971
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri) 		glomerulonephritis J:76450
increased inflammatory response J:23081, J:76450
liver inflammation J:76450
lung inflammation J:76450
skin inflammation J:76450
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(involves: C57BL/6) 		increased inflammatory response J:120659
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:22675
epididymis inflammation J:22675
intestinal inflammation J:22675
liver inflammation J:22675
lung inflammation J:22675
myositis J:22675
ovary inflammation J:22675
salivary gland inflammation J:22675
stomach inflammation J:22675
Relbtm1Brv/Relbtm1Brv
(either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6)) 		dermatitis J:63950
lung inflammation J:63950
Ren1tm1Tkh/Ren1tm1Tkh
(C57BL/6-Ren1tm1Tkh) 		kidney inflammation J:110082
Retntm1Laz/Retntm1Laz
Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6) 		white adipose tissue inflammation J:171262
Retnlatm1Mer/Retnlatm1Mer
(C57BL/6-Retnlatm1Mer) 		decreased susceptibility to induced colitis J:144784, J:144927
Retnlatm1Mer/Retnlatm1Mer
(C.B6-Retnlatm1Mer) 		decreased susceptibility to induced colitis J:144784, J:144927
Retnlbtm1Gdw/Retnlbtm1Gdw
(involves: 129S/SvEv * C57BL/6) 		decreased inflammatory response J:114507
decreased susceptibility to induced colitis J:114507
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex) 		liver inflammation J:235058
white adipose tissue inflammation J:235058
Retnlbtm1Mer/Retnlbtm1Mer
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to induced colitis J:141524
increased susceptibility to induced colitis J:141524
Rgs3tm1Ndul/Rgs3tm1Ndul
(B6.129-Rgs3tm1Ndul) 		increased susceptibility to type I hypersensitivity reaction J:210195
lung inflammation J:210195
Rgs13tm1Drue/Rgs13tm1Drue
(B6.129S-Rgs13tm1Drue) 		increased susceptibility to type I hypersensitivity reaction J:130209
Rgs16tm1.1Drue/Rgs16tm1.1Drue
(involves: C57BL/6) 		granulomatous inflammation J:188966
Rgsc1547/Rgsc1547+
(involves: C3H * C57BL/6JJcl) 		increased susceptibility to otitis media J:133634
Rhbdd1tm1.1Mfm/Rhbdd1tm1.1Mfm
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to endotoxin shock J:346394
Rhbdd3tm1Caox/Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox) 		liver inflammation J:197348
Rhbdf2cub/Rhbdf2cub
(B6.Cg-Rhbdf2cub) 		white adipose tissue inflammation J:82006
Rhohtm1Hasu/Rhohtm1Hasu
(B6.Cg-Rhohtm1Hasu) 		decreased susceptibility to type I hypersensitivity reaction J:143491
Rigitm1Zgwg/Rigitm1Zgwg
(involves: 129S1/Sv) 		colitis J:139868
increased susceptibility to induced colitis J:139868
Riox2tm1Mtsun/Riox2tm1Mtsun
(B6CrSlc.Cg-Riox2tm1Mtsun) 		decreased inflammatory response J:201871
Ripk1tm1Led/Ripk1tm1Led
(involves: 129S6/SvEvTac) 		lymph node inflammation J:46522
Ripk3tm1Vmd/Ripk3tm1Vmd
(B6.129-Ripk3tm1Vmd) 		decreased inflammatory response J:179279
Rnase4em1Zpxu/Rnase4em1Zpxu
(Not Specified) 		increased susceptibility to induced colitis J:354138
Rnase4em2Zpxu/Rnase4em2Zpxu
Tg(Vil1-cre)DNju/0
(involves: C57BL/6 * C57BL/6J) 		increased susceptibility to induced colitis J:354138
Rnf20Gt(RRJ249)Byg/Rnf20+
(involves: 129P2/OlaHsd) 		increased susceptibility to induced colitis J:268221
Rnf40tm1.1Sajo/Rnf40tm1.1Sajo
Tg(Car1-cre)5Flt/0
(involves: 129S2/SvPas * C57BL/6J) 		decreased susceptibility to induced colitis J:311838
Rnf43em2Mage/Rnf43em2Mage
(Not Specified) 		stomach inflammation J:285428
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6) 		CNS inflammation J:160681
lung inflammation J:160681
Rnf139tm1(KOMP)Wtsi/Rnf139tm1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		liver inflammation J:231404
Rnf186em1Ktak/Rnf186em1Ktak
(involves: C57BL/6 * DBA/2) 		increased susceptibility to colitis induced morbidity/mortality J:258197
increased susceptibility to induced colitis J:258197
Rnf186tm1Ktak/Rnf186tm1Ktak
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to colitis induced morbidity/mortality J:258197
increased susceptibility to induced colitis J:258197
Ro60tm1Woln/Ro60tm1Woln
(involves: 129S1/Sv * C57BL/6) 		glomerulonephritis J:84627
Rock1tm1Sna/Rock1tm1Sna
(B6N.129X1-Rock1tm1Sna) 		blepharitis J:98250
Rorasg/Rorasg
(involves: C57BL/6) 		lung inflammation J:135863
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd) 		colitis J:158663
Rpap3tm1c(KOMP)Wtsi/Rpap3tm1c(KOMP)Wtsi
Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6N * DBA/2) 		small intestinal inflammation J:314346
Rpl22Gt(GST000137)Lex/Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd) 		glomerulonephritis J:123569
Rpl38Ts/Rpl38+
(TSJ/Le) 		increased susceptibility to otitis media J:168509
Rprd1btm1Tshu/Rprd1btm1Tshu
Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to colitis induced morbidity/mortality J:300857
Rps6ka4tm1Jsca/Rps6ka4tm1Jsca
Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(B6.Cg-Rps6ka5tm1Jsca Rps6ka4tm1Jsca) 		increased susceptibility to endotoxin shock J:139576
skin inflammation J:139576
Rptortm1Ahir/Rptortm1Ahir
Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Rptortm1Ahir Tg(Itgax-cre)1-1Reiz) 		increased susceptibility to induced colitis J:188676
Rsph9em1Jwji/Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji) 		sinus inflammation J:294184
Rtl5em1Tmki/Rtl5em1Tmki
Rtl6tm2.1Tmki/Rtl6tm2.1Tmki
(involves: C57BL/6NCrlj * C57BL/6NSlc * CBA/JNCrlj) 		abnormal inflammatory response J:329352
decreased susceptibility to endotoxin shock J:329352
Rtl5tm1.1Tmki/Rtl5tm1.1Tmki
Rtl6tm1.1Tmki/Rtl6tm1.1Tmki
(involves: C57BL/6NCrlj * C57BL/6NSlc * CBA/JNCrlj) 		abnormal inflammatory response J:329352
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N) 		glomerulonephritis J:235399
Runx1tm8Spe/Runx1tm8Spe
(involves: 129/Sv * C57BL/6) 		lung inflammation J:120100
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		lung inflammation J:125953
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1)) 		abnormal inflammatory response J:93240
colitis J:93240
intestinal inflammation J:93240
lung inflammation J:88424
small intestinal inflammation J:93240
stomach inflammation J:93240
Runx3tm3.1Yg/Runx3tm3.1Yg
(Not Specified) 		intestinal inflammation J:224898
Rxratm1Krc/Rxratm1Krc
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		glomerulonephritis J:168799
Rxratm2Ipc/Rxratm4Ipc
Tg(KRT14-cre)1Ipc/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		skin inflammation J:67149
Rxratm4Ipc/Rxratm4Ipc
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S2/SvPas) 		dermatitis J:102470
ear inflammation J:102470
Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs
Trp53tm1Sia/Trp53tm1Sia
(involves: 129X1/SvJ * C57BL/6 * CBA) 		myositis J:117828
S1pr3tm1Jch/S1pr3tm1Jch
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to endotoxin shock J:133917
S100a9tm1Nck/S100a9tm1Nck
(B6.129P2-S100a9tm1Nck) 		decreased susceptibility to endotoxin shock J:125179
Sall4tm1Brd/Sall4+
(involves: 129S7/SvEvBrd * C57BL/6J) 		ear inflammation J:117866
increased susceptibility to otitis media J:117866
Sash3tm1Hlz/Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz) 		abnormal inflammatory response J:102171
Satb1tm2Kos/Satb1tm2Kos
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		kidney inflammation J:252606
pancreas inflammation J:252606
salivary gland inflammation J:252606
Sbsnem1Ham/Sbsnem1Ham
(C57BL/6N-Sbsnem1Ham) 		decreased susceptibility to type IV hypersensitivity reaction J:296400
increased susceptibility to type IV hypersensitivity reaction J:296400
Scara5tm1Ktry/Scara5tm1Ktry
(B6N.129X1-Scara5tm1Ktry) 		adipose tissue inflammation J:195536
interstitial pneumonia J:195536
liver inflammation J:195536
lung inflammation J:195536
skin inflammation J:195536
urinary bladder inflammation J:195536
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6) 		glomerulonephritis J:208237
skin inflammation J:208237
Scd1ab-2J/Scd1ab-2J
(DBA/1LacJ-Scd1ab-2J/J) 		granulomatous inflammation J:62699
Scd2swty/Scd2swty
(C57BL/6JSfdAnu-Scd2swty/Anu) 		blepharitis J:104190
Scgnem1Ezb/Scgnem1Ezb
(C57BL/6-Scgnem1Ezb) 		increased susceptibility to colitis induced morbidity/mortality J:285572
Scgnem2Ezb/Scgnem2Ezb
(C57BL/6-Scgnem2Ezb) 		increased susceptibility to colitis induced morbidity/mortality J:285572
Scn3btm1a(KOMP)Wtsi/Scn3btm1a(KOMP)Wtsi
(C57BL/6N-Scn3btm1a(KOMP)Wtsi/Wtsi) 		myositis J:232539
Scn9atm1Dgen/Scn9atm1Dgen
(either: (involves: 129P2/OlaHsd * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1)) 		dermatitis J:223425
Scp2tm1Kier/Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr) 		liver inflammation J:124895
Sctrtm1Bkcc/Sctrtm1Bkcc
(B6.129S7-Sctrtm1Bkcc) 		kidney inflammation J:121376
Sdc1tm1Cma/Sdc1tm1Cma
(either: C.Cg-Sdc1tm1Cma or B6.Cg-Sdc1tm1Cma) 		increased inflammatory response J:80682
seb/seb
(Him:OF1) 		dermatitis J:64455
lymph node inflammation J:20987
skin inflammation J:8983
Sec23bGt(AD0407)Wtsi/Sec23bGt(AD0407)Wtsi
(B6J.129P2-Sec23bGt(AD0407)Wtsi) 		pancreas inflammation J:186391
Secia1DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia2DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia3FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia4DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia5DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia6DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia7FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia8FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Sectm1aem1Gcfa/Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa) 		heart inflammation J:317204
increased susceptibility to endotoxin shock J:317204
Seletm1Alb/Seletm1Alb
(involves: 129S7/SvEvBrd * C57BL/6J) 		eye inflammation J:101979
Seletm2Alb/Seletm2Alb
Selltm2Alb/Selltm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		lung inflammation J:70682
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		eye inflammation J:101979
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased acute inflammation J:112286
Seletm2Hyn/Seletm2Hyn
(B6.129S2-Seletm2Hyn) 		abnormal type IV hypersensitivity reaction J:121083
Selltm1.1Rpmc/Selltm1.1Rpmc
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		increased inflammatory response J:249558
Selltm1Flv/Sell+
(involves: C57BL/6 * NOD) 		pancreas inflammation J:88947
Selltm1Flv/Selltm1Flv
(involves: 129S2/SvPas * C57BL/6) 		abnormal type IV hypersensitivity reaction J:89253
Selltm1Flv/Selltm1Flv
(involves: C57BL/6 * NOD) 		pancreas inflammation J:88947
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		eye inflammation J:101979
Selptm1Bay/Selptm1Bay
(D1.129S7(B6J)-Selptm1Bay) 		increased susceptibility to induced arthritis J:57086
Selptm1Bay/Selptm1Bay
(B6.129S7-Selptm1Bay) 		decreased susceptibility to type IV hypersensitivity reaction J:121083
Sema4atm1Kik/Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik) 		decreased susceptibility to type IV hypersensitivity reaction J:97027
Senp1tm1Wami/Senp1tm1Wami
Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel) 		myocarditis J:228009
pancreas inflammation J:228009
Serpina1em#Chmu/Serpina1em#Chmu
(involves: C57BL/6J) 		increased susceptibility to endotoxin shock J:259615
respiratory system inflammation J:259615
Serpina3cem1Smoc/Serpina3cem1Smoc
(C57BL/6-Serpina3cem1Smoc) 		white adipose tissue inflammation J:343846
Serpina6tm1Tew/Serpina6tm1Tew
(involves: 129/SvEmcTer * C57BL/6N) 		increased susceptibility to endotoxin shock J:112974
Serpinb1atm1.1Cben/Serpinb1atm1.1Cben
(129S6/SvEvTac-Serpinb1atm1.1Cben) 		lung inflammation J:125918
Serpinb3atm1Gsil/Serpinb3atm1Gsil
(C.129-Serpinb3atm1Gsil) 		decreased susceptibility to type I hypersensitivity reaction J:189949
Serpinc1tm1Dwr/Serpinc1tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ) 		liver inflammation J:115658
Serpine1tm1.1Vlp/Serpine1tm1.1Vlp
(involves: 129 * C57BL/6) 		decreased susceptibility to endotoxin shock J:229191
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		abnormal acute inflammation J:133227
glomerulonephritis J:85989
increased acute inflammation J:133227
respiratory system inflammation J:66093
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S2-Serpine1tm1Mlg/J) 		heart inflammation J:101486
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas) 		decreased susceptibility to endotoxin shock J:229191
Sftpa1tm1Haw/Sftpa1tm1Haw
(involves: 129/Sv * C57BL/6 * CD-1) 		abnormal inflammatory response J:85432
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd * NIH Black Swiss) 		lung inflammation J:110382
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd) 		lung inflammation J:107841
Sftpctm1Swg/Sftpctm1Swg
(either: 129 or (involves: 129 * Black Swiss)) 		conjunctivitis J:82925
Sftpdtm1Jhf/Sftpdtm1Jhf
(involves: 129P2/OlaHsd * Black Swiss) 		lung inflammation J:62282, J:50436
Sgcatm1Kcam/Sgcatm1Kcam
(involves: 129S1/Sv * 129X1/SvJ) 		heart inflammation J:177563
Sgcatm1Kcam/Sgcatm1Kcam
Sgcetm1Vinni/Sgcetm1Vinni
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		heart inflammation J:177563
Sgcbtm1Oza/Sgcbtm1Oza
(involves: 129S4/SvJae * C57BL/6J) 		myositis J:57590
Sgk3fz-ica/Sgk3fz-ica
(Swiss albino) 		abnormal inflammatory response J:107373
sgl/sgl
(involves: C3H * C57BL/6J) 		conjunctivitis J:56826
Sgp5NZB/?
(involves: C57BL/6 * NZB * SB/Le) 		glomerulonephritis J:95829
increased susceptibility to type III hypersensitivity reaction J:95829
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor) 		kidney inflammation J:117491
Sh2d1atm1Lyin/Y
(involves: 129S2/SvPas * C57BL/6) 		chronic inflammation J:97346
Sh2d1atm1Lyin/Sh2d1atm1Lyin
(involves: 129S2/SvPas * C57BL/6) 		chronic inflammation J:97346
Sh3bp2tm1.1Ics/Sh3bp2tm1.1Ics
(involves: 129S2/SvPas * C57BL/6) 		increased inflammatory response J:221901
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J) 		blepharitis J:117880
dermatitis J:117880
increased inflammatory response J:117880
joint inflammation J:117880
liver inflammation J:117880
lung inflammation J:117880
myositis J:117880
osteomyelitis J:117880
spinal cord inflammation J:117880
stomach inflammation J:117880
Sh3pxd2bnee/Sh3pxd2bnee
(B10.Cg-H2h4 Sh3pxd2bnee/GrsrJ) 		eye inflammation J:262132
hypopyon J:262132
increased susceptibility to otitis media J:153369
Sh3yl1tm1Syb/Sh3yl1tm1Syb
(involves: C57BL/6N) 		decreased susceptibility to endotoxin shock J:298830
Sharpincpdm-Dem/Sharpincpdm-Dem
(CBy.OcB3-Sharpincpdm-Dem) 		dermatitis J:121810
skin inflammation J:121810
Sharpincpdm/Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm) 		dermatitis J:14539
esophageal inflammation J:31745
folliculitis J:31745
joint inflammation J:14539
lung inflammation J:31745
lymph node inflammation J:31745
stomach inflammation J:31745
Sharpincpdm/Sharpincpdm
(involves: C57BL/KaLawRij * FVB/NJ) 		skin inflammation J:121810
SialsMRL/MpJ/SialsMRL/MpJ
(involves: C3H/HeJ * MRL/MpJ) 		salivary gland inflammation J:66636
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J) 		liver inflammation J:236042
Sigirrtm1Lix/Sigirrtm1Lix
(involves: 129S6/SvEvTac * BALB/c) 		increased inflammatory response J:85151
increased susceptibility to endotoxin shock J:85151
Sigirrtm1Mant/Sigirrtm1Mant
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased susceptibility to induced colitis J:88907
Siglecftm1.2Avrk/Siglecftm1.2Avrk
(B6.129(FVB)-Siglecftm1.2Avrk) 		lung inflammation J:204811
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd) 		increased inflammatory response J:229999
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129) 		interstitial pneumonia J:81010
lung inflammation J:81010
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		glomerulonephritis J:160869
interstitial pneumonia J:81010
lung inflammation J:81010
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac) 		liver inflammation J:178653
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ) 		colitis J:112817
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv) 		liver inflammation J:205529
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL) 		heart inflammation J:43650
Slc2a6em1Kusu/Slc2a6em1Kusu
(involves: C57BL/6JCrlj) 		increased susceptibility to endotoxin shock J:270487
Slc2a9tm1.2Thor/Slc2a9tm1.2Thor
(involves: C57BL/6 * C57BL/6N) 		kidney inflammation J:153089
tubulointerstitial nephritis J:153089
Slc3a1pbl/Slc3a1pbl
(C3HeB/FeJ-Slc3a1pbl) 		tubulointerstitial nephritis J:85461
Slc3a1pbl/Slc3a1pbl
(involves: C3HeB/FeJ * MRL/MpJ) 		kidney inflammation J:85461
Slc3a2tm1.1Merl/Slc3a2+
Tg(Vil1-cre)997Gum/0
(B6.Cg-Slc3a2tm1.1Merl Tg(Vil1-cre)997Gum) 		decreased susceptibility to induced colitis J:173946
Slc5a2m2Btlr/Slc5a2m2Btlr
(C57BL/6J-Slc5a2m2Btlr) 		increased susceptibility to induced colitis J:265117
Slc5a6tm1.1Said/Slc5a6tm1.1Said
Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2) 		cecum inflammation J:307482
small intestinal inflammation J:307482
Slc7a9tm1Nune/Slc7a9tm1Nune
(involves: 129P2/OlaHsd * C57BL/6J) 		tubulointerstitial nephritis J:85462
Slc9a2tm1Ges/Slc9a2tm1Ges
(involves: 129X1/SvJ * Black Swiss) 		stomach inflammation J:65754
Slc9a4tm1Ges/Slc9a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss) 		stomach inflammation J:98566
Slc9a8m1Btlr/Slc9a8m1Btlr
(C57BL/6J-Slc9a8m1Btlr) 		increased susceptibility to induced colitis J:267481
Slc12a1urehr3/Slc12a1urehr3
(involves: C3HeB/FeJ) 		pyelitis J:159994
pyelonephritis J:159994
Slc12a2em1Dlp/Slc12a2em1Dlp
(involves: C57BL/6J * DBA/2J) 		large intestinal inflammation J:285398
Slc15a4tm1Tkyo/Slc15a4tm1Tkyo
(involves: C57BL/6) 		decreased susceptibility to induced colitis J:270965
Slc19a3tm1Said/Slc19a3tm1Said
(involves: C57BL/6) 		chronic liver inflammation J:170952
kidney inflammation J:170952
Slc22a4tm1Atsu/Slc22a4tm1Atsu
(involves: C57BL/6J) 		intestinal inflammation J:207006
Slc24a3em#Ebje/Slc24a3em#Ebje
(C57BL/6J-Slc24a3em#Ebje) 		increased susceptibility to induced colitis J:308448
Slc25a17Gt(XB686)Byg/Slc25a17Gt(XB686)Byg
(involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster) 		liver inflammation J:291257
Slc26a1tm1Mark/Slc26a1tm1Mark
(involves: 129X1/SvJ * CD-1) 		kidney inflammation J:158567
Slc26a4m2Btlr/Slc26a4m2Btlr
(C57BL/6J-Slc26a4m2Btlr) 		increased susceptibility to induced colitis J:236690
Slc30a4lm/Slc30a4lm
(C57BL/6J-Slc30a4lm) 		dermatitis J:5911, J:7690
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6) 		brain inflammation J:211266
conjunctivitis J:211266
dermatitis J:211266
increased inflammatory response J:211266
preputial gland inflammation J:211266
prostate gland inflammation J:211266
salivary gland inflammation J:211266
stomach inflammation J:211266
urinary bladder inflammation J:211266
Slc37a2tm1Dgen/Slc37a2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to endotoxin shock J:311521
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		abnormal inflammatory response J:86005
decreased inflammatory response J:86005
Slc39a5tm1.1Gka/Slc39a5tm1.1Gka
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased susceptibility to induced pancreatitis J:209760
Slc39a5tm1Gka/Slc39a5tm1Gka
Tg(Cela1-cre/ERT)1Lgdn/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced pancreatitis J:209760
Slc43a2Gt(258C1)Cmhd/Slc43a2Gt(258C1)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		liver inflammation J:237439
Slc44a4tm1.2Said/Slc44a4tm1.2Said
(involves: BALB/cJ * C57BL/6J * C57BL/6N) 		increased susceptibility to induced colitis J:351314
Sle1NZW/Sle1NZW
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW) 		glomerulonephritis J:134128
Sle1cNZB/Sle1cNZM2410/J
(involves: C57BL/6J * NZB * NZM2410/J) 		glomerulonephritis J:145133
Sle2NZM2410/Aeg/Sle2NZM2410/Aeg
(involves: C57BL/6J * NZM2410/Aeg) 		glomerulonephritis J:25006
Sle3NZM2410/Aeg/?
(involves: C57BL/6J * NZM2410/Aeg) 		glomerulonephritis J:52863
Sle7BXSB/J/Sle7BXSB/J
(involves: BXSB/J * C57BL/10Ola) 		glomerulonephritis J:60445
Sle8BXSB/J/Sle8BXSB/J
(involves: BXSB/J * C57BL/10Ola) 		glomerulonephritis J:60445
Sle12C57BL/6J/Sle12C57BL/6J
(involves: C57BL/6J * NZM2410/Aeg) 		glomerulonephritis J:52863
Sle12C57BL/6J/Sle12NZM2410/Aeg
(involves: C57BL/6J * NZM2410/Aeg) 		glomerulonephritis J:52863
Sle12NZM2410/Aeg/Sle12NZM2410/Aeg
(involves: C57BL/6J * NZM2410/Aeg) 		glomerulonephritis J:52863
Slpitm1Nkw/Slpitm1Nkw
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:82214
Smad2tm3Rob/Smad2tm3Rob
Smad3tm1Xfw/Smad3tm1Xfw
(involves: 129/Sv * 129S/SvEv * C57BL/6 * ICR) 		osteoarthritis J:95374
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		colitis J:53510
increased inflammatory response J:53510
pancreas inflammation J:53510
small intestinal inflammation J:53510
stomach inflammation J:53510
Smad3tm1Cxd/Smad3tm1Cxd
(B6.129S6-Smad3tm1Cxd) 		tubulointerstitial nephritis J:102084
Smad3tm1Cxd/Smad3tm1Cxd
(involves: 129S6/SvEvTac) 		osteoarthritis J:68792
Smad3tm1Par/Smad3tm1Par
(129-Smad3tm1Par/J) 		increased inflammatory response J:106572
Smad4tm1.1Gsu/Smad4tm1.1Gsu
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(MtTGFA)Lmb/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		chronic pancreas inflammation J:229184
Smad9tm3Jfm/Smad9tm3Jfm
(involves: 129S4/SvJaeSor) 		lung inflammation J:150213
Smcr8em1Btlr/Smcr8em1Btlr
(C57BL/6J-Smcr8em1Btlr) 		increased susceptibility to induced colitis J:268243
Smcr8em2Btlr/Smcr8em2Btlr
(C57BL/6J-Smcr8em2Btlr) 		increased susceptibility to induced colitis J:268243
Smcr8m1Btlr/Smcr8+
(C57BL/6J-Smcr8m1Btlr) 		increased susceptibility to induced colitis J:268243
Smcr8m1Btlr/Smcr8m1Btlr
(C57BL/6J-Smcr8m1Btlr) 		increased susceptibility to induced colitis J:268243
Smcr8m2Btlr/Smcr8m2Btlr
(C57BL/6J-Smcr8m2Btlr) 		increased susceptibility to induced colitis J:268243
Smcr8m3Btlr/Smcr8m3Btlr
(C57BL/6J-Smcr8m3Btlr) 		increased susceptibility to induced colitis J:268243
Smg1Gt(AG0297)Wtsi/Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		chronic inflammation J:193626
Smpdl3btm1a(EUCOMM)Wtsi/Smpdl3btm1a(EUCOMM)Wtsi
(C57BL/6-Smpdl3btm1a(EUCOMM)Wtsi) 		increased susceptibility to endotoxin shock J:224870
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6) 		intestinal inflammation J:104648
Smyd5tm1a(EUCOMM)Wtsi/Smyd5tm1a(EUCOMM)Wtsi
Tg(Vil1-cre)997Gum/0
(B6.Cg-Smyd5tm1a(EUCOMM)Wtsi Tg(Vil1-cre)997Gum) 		decreased susceptibility to induced colitis J:339411
Snai2tm1Look/Snai2tm1Look
(involves: 129X1/SvJ * C57BL/6) 		blepharitis J:80652
Snai2tm2Grid/Snai2tm2Grid
(involves: 129S1/Sv) 		blepharitis J:48521
conjunctivitis J:48521
Snrktm1.1Hxu/Snrktm1.1Hxu
Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr) 		brown adipose tissue inflammation J:257980
white adipose tissue inflammation J:257980
Snx10em1Ael/Snx10em1Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd) 		osteomyelitis J:289051
Snx10em2Ael/Snx10em2Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd) 		osteomyelitis J:289051
Socs1tm1Ayos/Socs1tm1Ayos
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		blepharitis J:167922
conjunctivitis J:167922
dermatitis J:167922
Socs1tm1Kish/Socs1tm1Kish
(B6.129P2-Socs1tm1Kish) 		liver inflammation J:69472
Socs1tm1Kish/Socs1tm1Kish
Stat1tm1Rds/Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		liver inflammation J:69472
Socs1tm1Kish/Socs1tm1Kish
Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		liver inflammation J:69472
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6) 		abnormal inflammatory response J:57474
heart inflammation J:51281
increased inflammatory response J:72528
liver inflammation J:51281
pancreas inflammation J:51281
Socs1tm2Wehi/Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi) 		glomerulonephritis J:72528
increased incidence of corneal inflammation J:72528
increased inflammatory response J:72528
intestinal inflammation J:72528
liver inflammation J:72528
myocarditis J:72528
myositis J:72528
pancreas inflammation J:72528
salivary gland inflammation J:72528
skin inflammation J:72528
Socs1tm3.1Wehi/Socs1tm3.1Wehi
(C57BL/6-Socs1tm3.1Wehi) 		abnormal inflammatory response J:83009
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J) 		liver inflammation J:186227
Socs3tm1Ayos/Socs3tm1Ayos
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6) 		decreased susceptibility to endotoxin shock J:92040
Socs3tm1Robb/Socs3tm1Robb
(involves: C57BL/6) 		increased susceptibility to induced arthritis J:145513
Socs3tm1Wsa/Socs3tm2Wsa
Tg(Vav1-cre)1Awr/0
(involves: C57BL/6) 		increased inflammatory response J:89785
liver inflammation J:89785
lung inflammation J:89785
peritoneal inflammation J:89785
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J) 		liver inflammation J:219360
Sod1tm1Leb/Sod1tm1Leb
(involves: 129S7/SvEvBrd * C57BL/6) 		blepharitis J:219024
Meibomian gland inflammation J:219024
Sod3tm1Mrkl/Sod3tm1Mrkl
(D1.129P2-Sod3tm1Mrkl) 		autoimmune arthritis J:106273
increased susceptibility to induced arthritis J:106273
Sod3tm1Svp/Sod3tm1Svp
(involves: 129S6/SvEvTac * C57BL/6NTac) 		decreased susceptibility to endotoxin shock J:285340
Sox2tm3(TK)Hoch/Sox2+
(involves: 129S4/SvJae * C57BL/6) 		stomach inflammation J:177655
tongue inflammation J:177655
Sox9em1(cre/ERT2)Smoc/Sox9+
Tnfsf18em1Pwan/Tnfsf18em1Pwan
(involves: C57BL/6J) 		decreased inflammatory response J:346395
Sox17tm1Ysk/Sox17+
(involves: 129S1/Sv * C57BL/6) 		liver inflammation J:194071
Sox17tm1Ysk/Sox17+
(B6.129S1-Sox17tm1Ysk) 		gallbladder inflammation J:241569
liver inflammation J:194071
Sox17tm2Sjm/Sox17+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		liver inflammation J:241569
Sparctm1Hwe/Sparctm1Hwe
(involves: 129S/SvEv * C57BL/6J) 		eye inflammation J:52120
vitreous body inflammation J:52120
Spata2tm1(KOMP)Vlcg/Spata2tm1(KOMP)Vlcg
(C57BL/6-Spata2tm1(KOMP)Vlcg) 		increased inflammatory response J:244164
Spdeftm1Shiv/Spdeftm1Shiv
(involves: 129S4/SvJae) 		small intestinal inflammation J:166876
stomach inflammation J:166876
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Trmutm1Tomik/Trmutm1Tomik
(involves: C57BL/6 * DBA) 		abnormal inflammatory response J:235644
Spef2bgh/Spef2bgh
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/10J) 		sinus inflammation J:176695
Sphk1tm1Rlp/Sphk1tm1Rlp
(involves: 129S6/SvEvTac) 		decreased susceptibility to endotoxin shock J:133917
Spink7em1Cya/Spink7em1Cya
(C57BL/6N-Spink7em1Cya/Cya) 		increased susceptibility to induced colitis J:310883
Spint1tm2.1Hk/Spint1tm2.1Hk
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to induced colitis J:179937
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		increased incidence of corneal inflammation J:213427
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss) 		granulomatous inflammation J:140014
Spp1tm1Blh/Spp1tm1Blh
(B6.129S6-Spp1tm1Blh) 		granulomatous inflammation J:116272
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal inflammatory response J:60284
decreased susceptibility to type IV hypersensitivity reaction J:60284
Spp1tm1Rit/Spp1tm1Rit
(B6.129S7-Spp1tm1Rit) 		decreased acute inflammation J:93915
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1) 		alveolitis J:12830
interstitial pneumonia J:12830
Spta1sph/Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1) 		glomerulonephritis J:44313
tubular nephritis J:44313
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1) 		glomerulonephritis J:44313
tubular nephritis J:44313
Sptbn4qv/Sptbn4qv
(either: (involves: BALB/c) or (involves: C57BL/10)) 		eye inflammation J:167
Sptlc2tm1Yhir/Sptlc2tm1Yhir
Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6) 		skin inflammation J:202388
Srctm1Sor/Srctm1Sor
(either: 129S7/SvEvBrd-Srctm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J)) 		increased inflammatory response J:67040
periodontium inflammation J:67040
Srxn1tm1Mtol/Srxn1tm1Mtol
(either: B6.129S2-Srxn1tm1Mtol or (involves: 129S2/SvPasCrl * C57BL/6)) 		increased susceptibility to endotoxin shock J:199277
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6) 		arteritis J:162035
Ssial1NOD/Ssial1NOD
(involves: C57BL/6J * NOD) 		periinsulitis J:11442
salivary gland inflammation J:75908
Ssial2NOD/?
(involves: C57BL/6J * NOD) 		salivary gland inflammation J:75908
Ssial3NOD/Ssial3NOD
(involves: C57BL/6J * NOD) 		salivary gland inflammation J:75908
Ssial4C57BL/6/Ssial4NOD
(involves: C57BL/6J * NOD) 		salivary gland inflammation J:75908
Ssial4NOD/Ssial4NOD
(involves: C57BL/6J * NOD) 		salivary gland inflammation J:75908
Sstr4tm1Szo/Sstr4tm1Szo
(B6.129P2-Sstr4tm1Szo) 		increased susceptibility to type IV hypersensitivity reaction J:152015
Ssu72tm1Cwl/Ssu72tm1Cwl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn) 		liver inflammation J:309624
St6gal1tm1Jlau/St6gal1tm1Jlau
(B6.129S4-St6gal1tm1Jlau) 		peritoneal inflammation J:140547
St6gal1tm1Jxm/St6gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ) 		peritoneal inflammation J:140547
St6galnac1em1Len/St6galnac1em1Len
(Not Specified) 		increased susceptibility to colitis induced morbidity/mortality J:324883
St13em1Gwzh/St13em1Gwzh
Tg(PRSS1/lacZ)#Gwzh/0
(Not Specified) 		increased susceptibility to induced pancreatitis J:345508
St14tm2Bug/St14tm3Bug
Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss) 		lacrimal gland inflammation J:213072
submandibular gland inflammation J:213072
St14tm2Bug/St14tm3Bug
Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * SJL) 		colitis J:153070
Stard7tm1a(EUCOMM)Wtsi/Stard7+
(involves: C57BL/6N) 		dermatitis J:242746
increased susceptibility to type I hypersensitivity reaction J:242746
lung inflammation J:242746
Stat1tm1Dlv/Stat1tm1Dlv
(involves: 129S/SvEv) 		decreased susceptibility to endotoxin shock J:130622
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac) 		bronchiolitis J:286237
lung inflammation J:286237
peritoneal inflammation J:286237
pleuritis J:286237
Stat1tm1Rds/Stat1tm1Rds
Stat3tm2Aki/Stat3tm2Aki
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		colitis J:83280
Stat1tm1Tdec/Stat1tm1Tdec
(involves: 129P2/OlaHsd * BALB/c) 		decreased susceptibility to endotoxin shock J:130622
Stat1tm2.1Uvin/Stat1tm2.1Uvin
(B6.129P2-Stat1tm2.1Uvin) 		decreased susceptibility to endotoxin shock J:209388
Stat3tm1Desi/Stat3tm1Desi
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to endotoxin shock J:77307
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Csf1r-icre)1Jwp/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal acute inflammation J:156593
abnormal inflammatory response J:156593
colitis J:156593
Stat3tm1Flv/Stat3tm1Flv
Tg(Tek-cre)1Xyfu/0
(involves: C57BL/6) 		increased susceptibility to endotoxin shock J:86655
Stat3tm1Flv/Stat3tm1Flv
Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6) 		abnormal inflammatory response J:81973
cecum inflammation J:81973
colitis J:81973
granulomatous inflammation J:81973
ileum inflammation J:81973
intestinal inflammation J:81973
liver inflammation J:81973
Stat3tm1Xyfu/Stat3+
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N) 		increased susceptibility to endotoxin shock J:86400
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N) 		increased susceptibility to endotoxin shock J:86400
Stat3tm2Aki/Stat3tm2Aki
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		colitis J:83280
Stat3tm2Aki/Stat3tm2Aki
Tg(KRT5-cre)1Tak/0
(involves: 129P2/OlaHsd * C3H * C57BL/6) 		conjunctivitis J:194832
dermatitis J:194832
lacrimal gland inflammation J:194832
Stat3tm2Aki/Stat3tm2Aki
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		lung inflammation J:87622
Stat3tm2Aki/Stat3tm2Aki
Tlr4tm1Aki/Tlr4tm1Aki
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		colitis J:83280
decreased susceptibility to endotoxin shock J:83280
Stat3tm2Aki/Stat3tm2Aki
Tnftm1Sek/Tnftm1Sek
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		colitis J:83280
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru) 		abnormal inflammatory response J:90600
Stat4tm1Gru/Stat4tm1Gru
Tg(Ins2-NP)25-3Olds/0
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		insulitis J:107047
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Lck-cre)I57Jxm/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR) 		abnormal acute inflammation J:122463
Stat5btm1Mam/Stat5btm1Mam
Tg(Lck-cre)I57Jxm/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR) 		abnormal acute inflammation J:122463
Stat6tm1Aki/Stat6tm1Aki
(C.129P2-Stat6tm1Aki Nfkbiztm1Aki) 		skin inflammation J:141704
Stat6tm1Aki/Stat6tm1Aki
Tg(KRT14-CASP1)1Miz/0
(involves: 129P2/OlaHsd * C57BL/6) 		dermatitis J:78602
Stat6tm1Gru/Stat6+
Tg(Scgb1a1-Il13)2Eli/?
(involves: 129S2/SvPas * C57BL/6 * CBA) 		respiratory system inflammation J:132385
Stat6tm1Gru/Stat6tm1Gru
(involves: 129S2/SvPas * BALB/c) 		abnormal acute inflammation J:85386
Stia1NOD/ShiLtDoi/?
(involves: C57BL/6J * NOD/LtDoi) 		increased inflammatory response J:70882
Stia2C57BL/6J/Stia2C57BL/6J
(involves: C57BL/6J * NOD/LtDoi) 		increased inflammatory response J:70882
Stia2C57BL/6J/Stia2NOD/ShiLtDoi
(involves: C57BL/6J * NOD/LtDoi) 		increased inflammatory response J:70882
Stim1tm1.1Kuro/Stim1+
(C57BL/6-Stim1tm1.1Kuro) 		decreased susceptibility to type I hypersensitivity reaction J:130477
Stim1tm1Rao/Stim1tm1Rao
Stim2tm1Rao/Stim2tm1Rao
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		blepharitis J:133262
dermatitis J:133262
Stim1tm3Ics/Stim1+
(involves: C57BL/6N) 		myositis J:277842
Sting1em1Jmin/Sting1+
(involves: C57BL/6N) 		lung inflammation J:251372
Stip1tm1.2Mamp/Stip1tm1.2Mamp
(involves: C57BL/6) 		increased acute inflammation J:201097
Stk3tm1.1Jav/Stk3tm1.1Jav
Stk4tm1Kina/Stk4tm1Kina
Tg(Nkx2-1-cre)2Sand/?
(involves: 129 * C57BL/6) 		lung inflammation J:197340
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR) 		pancreas inflammation J:134078
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Sprr2f-cre)1Dcas/0
(involves: 129S6/SvEvTac * FVB/N) 		peritoneal inflammation J:158190
Stk36tm1Fjs/Stk36tm1Fjs
(involves: 129S1/Sv * C57BL/6) 		rhinitis J:116391
Stk36tm1Lex/Stk36tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased susceptibility to otitis media J:185566
Stx2tm1Dcru/Stx2tm1Dcru
(involves: 129X1/SvJ * C57BL/6J) 		decreased susceptibility to induced colitis J:110376
Stxbp2tm1Bdic/Stxbp2+
(involves: 129S * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:188931
Sugcttm1.2Kald/Sugcttm1.2Kald
(B6.Cg-Sugcttm1.2Kald) 		kidney inflammation J:293423
white adipose tissue inflammation J:293423
Sumf1Gt(RST760)Byg/Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		CNS inflammation J:120146
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		lung inflammation J:144991
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6) 		lung inflammation J:144991
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		interstitial pneumonia J:144991
Suv39h1tm1Jnw/Suv39h1tm1Jnw
(involves: 129) 		decreased susceptibility to type I hypersensitivity reaction J:186702
Swrl1NZB/Swrl1NZB
(involves: NZB * SWR) 		abnormal type II hypersensitivity reaction J:73097
Swrl1NZB/Swrl1SWR
(involves: NZB * SWR) 		abnormal type II hypersensitivity reaction J:73097
Swrl2NZB/Swrl2SWR
(involves: NZB * SWR) 		glomerulonephritis J:73097
Swrl2SWR/Swrl2SWR
(involves: NZB * SWR) 		glomerulonephritis J:73097
Sycntm1Rja/Sycntm1Rja
(involves: 129P2/OlaHsd) 		increased susceptibility to induced pancreatitis J:74654
SykM2Btlr/Syk+
(C57BL/6J-SykM2Btlr) 		decreased inflammatory response J:231803
SykM2Btlr/SykM2Btlr
(C57BL/6J-SykM2Btlr) 		decreased inflammatory response J:231803
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr) 		glomerulonephritis J:188422
Syne1tm1.1Mcn/Syne1tm1.1Mcn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL) 		conjunctivitis J:144757
Syt7tm1Nan/Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6) 		increased inflammatory response J:85201
myositis J:85201
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		epididymis inflammation J:213427
meningitis J:213427
Syvn1tm1Tn/Syvn1+
(D1.Cg-Syvn1tm1Tn) 		decreased susceptibility to induced arthritis J:86009
Tacr1tm1Sph/Tacr1tm1Sph
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:46629
joint inflammation J:103700
Taf4tm1Idvd/Taf4tm1Idvd
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: C57BL/6 * SJL) 		chronic inflammation J:124111
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6) 		glomerulonephritis J:151757
liver inflammation J:151757
lung inflammation J:151757
TaprBALB/c/?
(involves: BALB/c * DBA/2) 		abnormal inflammatory response J:72894
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc) 		decreased susceptibility to induced arthritis J:301164
Tax1bp1tm1Ktj/Tax1bp1tm1Ktj
(B6.129P2-Tax1bp1tm1Ktj) 		cardiovalvulitis J:131849
skin inflammation J:131849
Tbc1d23Gt(BA0556)Wtsi/Tbc1d23Gt(BA0556)Wtsi
(B6.129P2-Tbc1d23Gt(BA0556)Wtsi) 		increased inflammatory response J:181861
Tbk1tm1.1Lex/Tbk1+
(involves: 129S4/SvJae * 129S5/SvEvBrd) 		abnormal inflammatory response J:166476
Tbk1tm1.1Lex/Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd) 		abnormal inflammatory response J:166476
increased susceptibility to endotoxin shock J:166476
skin inflammation J:166476
Tbx1tm1Bem/Tbx1+
(FVB.Cg-Tbx1tm1Bem) 		increased susceptibility to otitis media J:91664
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6) 		respiratory system inflammation J:73832
Tbx21tm1Glm/Tbx21tm1Glm
(C.129S6-Tbx21tm1Glm/J) 		CNS inflammation J:111932
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac) 		increased susceptibility to induced colitis J:141481
Tbxa2rtm1Sna/Tbxa2rtm1Sna
(either: (involves: 129/Ola * BALB/c) or (involves: 129/Ola * C57BL/6)) 		abnormal type I hypersensitivity reaction J:84085
Tbxa2rtm1Sna/Tbxa2rtm1Sna
(B6.Cg-Tbxa2rtm1Sna) 		increased susceptibility to type I hypersensitivity reaction J:197334
Tbxas1tm1Swl/Tbxas1tm1Swl
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J) 		decreased inflammatory response J:90922
Tcf7l2m1Btlr/Tcf7l2m1Btlr
(C57BL/6J-Tcf7l2m1Btlr) 		increased susceptibility to induced colitis J:267536
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi) 		decreased susceptibility to induced arthritis J:99107
increased incidence of corneal inflammation J:132503
liver inflammation J:135830
lung inflammation J:121037
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		liver inflammation J:105977
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		lung inflammation J:89695
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd) 		colitis J:37699
Tcratm1Mom/Tcratm1Mom
(B6.129S2-Tcratm1Mom) 		colitis J:135597
Tcratm1Mom/Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6) 		colitis J:15221
Tcratm1Mom/Tcratm1Mom
Tcrgtm1.1Hish/Tcrgtm1.1Hish
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		colitis J:135597
Tcratm1Mom/Tcratm1Mom
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		colitis J:181257
increased inflammatory response J:181257
myositis J:181257
skin inflammation J:181257
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c) 		colitis J:15221
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6) 		colitis J:15221
Tcrbtm1Mom/Tcrbtm1Mom
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N) 		skin inflammation J:100506
Tcrdtm1Mom/Tcrdtm1Mom
(FVB.129P2-Tcrdtm1Mom) 		dermatitis J:75915
increased susceptibility to type IV hypersensitivity reaction J:75915
Tcrdtm1Mom/Tcrdtm1Mom
(NOD.129P2-Tcrdtm1Mom) 		dermatitis J:75915
Tcrdtm1Mom/Tcrdtm1Mom
Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J) 		small intestinal inflammation J:108572
Tdrd7nmf166/Tdrd7nmf166
(involves: C3H * C57BL/6J) 		uveitis J:169836
Terf1tm1.1Blas/Terf1tm1.1Blas
Tg(KRT5-cre)1Tak/0
(involves: 129 * C3H * C57BL/6 * SJL) 		skin inflammation J:152077
Terf2ipGt(XD108)Byg/Terf2ip+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:163158
Tet2Gt(AN0709)Wtsi/Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi) 		liver inflammation J:174052
Tet2Gt(AN0709)Wtsi/Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi) 		liver inflammation J:174052
Tff3tm1Dkpy/Tff3tm1Dkpy
(involves: 129S4/SvJae) 		increased susceptibility to induced colitis J:35882
Tg(Ace2-ACE2)1Cqin/0
(involves: ICR) 		alveolitis J:141460
interstitial pneumonia J:141460, J:287631
pyelitis J:141460
submandibular gland inflammation J:141460
Tg(Acta2-cre/ERT2)#Pcn/0
Tgfbr2tm1Karl/Tgfbr2tm1Karl
Tg(H2-K-Fosl2,-EGFP)13Wag/0
(B6.Cg-Tgfbr2tm1Karl Tg(Acta2-cre/ERT2)#Pcn Tg(H2-K-Fosl2,-EGFP)13Wag) 		lung inflammation J:238723
Tg(ACTB-eGFP,-RAMP1)#Afru/0
Tg(Nes-cre)1Kln/0
(involves: C57BL/6J * SJL/J) 		increased inflammatory response J:120077
Tg(ACTB-Fpr2)#Jimw/0
(involves: FVB) 		respiratory system inflammation J:160074
Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu) 		abnormal type IV hypersensitivity reaction J:148162
Tg(Actb-Tnfsf4)1Nish/0
(B6.D2-Tg(Actb-Tnfsf4)1Nish) 		increased susceptibility to type IV hypersensitivity reaction J:80214
Tg(Adipoq-Apol6)#Hsul/0
(C57BL/6J-Tg(Adipoq-Apol6)#Hsul) 		white adipose tissue inflammation J:344362
Tg(Adipoq-cre)1Evdr/0
Tg(CAG-Jmjd8)#Kaso/0
(involves: C57BL/6 * FVB/NJ) 		white adipose tissue inflammation J:319518
Tg(AGER)#Eca/0
(C57BL/6J-Tg(AGER)#Eca) 		lung inflammation J:205092
Tg(AGT)2-5Afu/0
(involves: C57BL/6) 		heart inflammation J:194606
Tg(Alb1-GP33/H2-Kb)1Hpi/0
Tg(Alb1-HBV)66Bri/0
(involves: C57BL/6 * C57BL/10 * DBA/2) 		liver inflammation J:162605
Tg(Alb1-GP33/H2-Kb)1Hpi/0
Tg(Alb1-HBV)66Bri/0
Tg(TcrLCMV)318Sdz/0
(involves: C57BL/6 * C57BL/10 * DBA/2) 		liver inflammation J:162605
Tg(Alb1-Ren)1Unc/0
(involves: 129S6/SvEvTac * C57BL/6) 		kidney inflammation J:89252
Tg(Alb1-Ren)2Unc/0
(involves: 129S6/SvEvTac * C57BL/6) 		kidney inflammation J:89252
Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J) 		liver inflammation J:223921
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6) 		chronic liver inflammation J:211984
Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA) 		chronic liver inflammation J:242582
Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh) 		myocarditis J:92579
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL) 		liver inflammation J:249664
Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2) 		chronic liver inflammation J:135124
liver inflammation J:16979
myocarditis J:135124
pancreas inflammation J:135124
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh) 		dermatitis J:65036
folliculitis J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(involves: C57BL/6) 		dermatitis J:135501
skin inflammation J:135501
Tg(APOE-DGAT1)1Far/0
(involves: C57BL/6NHsd) 		liver inflammation J:124005
Tg(APOE-DGAT2)1Far/0
(involves: C57BL/6NHsd) 		liver inflammation J:124005
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA) 		enthesitis J:192371
Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/0
(involves: C57BL/6 * SJL) 		brain inflammation J:112949
Tg(ARR2/Pbsn-FGF8)3Prb/0
(involves: C57BL/6 * DBA/2) 		increased inflammatory response J:78918
prostate gland inflammation J:78918
Tg(BLG-STAT5A)15Itb/0
(involves: FVB/N) 		increased inflammatory response J:80588
Tg(CAG-ACE2)AC70Ctkt/0
(either: (involves: BALB/c * C3H/HeJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6 * C57BL/6J)) 		interstitial pneumonia J:117824
Tg(CAG-C1qtnf6)#Yiw/0
(involves: C57BL/6JJcl) 		decreased susceptibility to induced arthritis J:227217
Tg(CAG-cat,-Il18)#Thos/0
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6) 		interstitial pneumonia J:147547
Tg(CAG-DPP4)4Yuzh/0
(C57BL/6-Tg(CAG-DPP4)4Yuzh) 		brain inflammation J:286175
kidney inflammation J:286175
liver inflammation J:286175
lung inflammation J:286175
Tg(CAG-DPP4)52Ctkt/0
(involves: C3H/HeJ * C57BL/6J) 		brain inflammation J:227925
increased inflammatory response J:227925
interstitial pneumonia J:258199
lung inflammation J:227925
Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
(involves: C57BL/6 * DBA/2) 		myositis J:142253
Tg(CAG-Lyn*)#Paau/0
(B6.Cg-Tg(CAG-Lyn*)#Paau) 		skin inflammation J:151886
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB) 		lung inflammation J:80609
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB) 		lung inflammation J:80609
Tg(CAG-NRIP1)51Row/0
(involves: FVB/N) 		lung inflammation J:175885
Tg(CAG-Pgam2)#Hiko/0
(involves: C57BL/6) 		increased susceptibility to chemically induced skin inflammation J:306793
Tg(CAG-PGDS)1Groy/0
(involves: FVB/N) 		decreased inflammatory response J:107651
Tg(CAG-PLA2G3)#aMurm/0
(Not Specified) 		increased susceptibility to type I hypersensitivity reaction J:197334
Tg(CAG-Ptafr)1Tksh/0
(B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc) 		increased susceptibility to endotoxin shock J:38639
Tg(CAG-SYVN1)1Tn/?
(D1.Cg-Tg(CAG-SYVN1)1Tn) 		rheumatoid arthritis J:86009
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-APPSwInd)107Dbo/0
(involves: C3H/HeJ * C57BL/6 * CBA) 		CNS inflammation J:109829
Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro) 		decreased susceptibility to type IV hypersensitivity reaction J:134448
Tg(CD2-Ifngr2)2Pbro/?
(NOD.Cg-Tg(CD2-Ifngr2)2Pbro) 		insulitis J:81981
myositis J:81981
ovary inflammation J:81981
Tg(CD2-Ppp2ca)#Gct/0
(involves: C57BL/6J) 		glomerulonephritis J:184067
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6) 		lacrimal gland inflammation J:230700
lung inflammation J:230700
salivary gland inflammation J:230700
Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to type IV hypersensitivity reaction J:96558
Tg(CD2-Stat6*V625A*T626A)78Mhk/0
(involves: C3H * C57BL/6) 		dermatitis J:160119
Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J) 		peritoneal inflammation J:123440
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6) 		glomerulonephritis J:217939
kidney inflammation J:217939
liver inflammation J:217939
lung inflammation J:217939
skin inflammation J:217939
Tg(Cd4-CD4)2362Litt/0
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2 * SJL) 		CNS inflammation J:134764
Tg(Cd4-cre)1Cwi/0
Trmt61aem1Hbgl/Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J) 		colitis J:336736
Tg(CD4-HIV)F21380Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(CD4-HIV)F21388Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(CD4-HIV)F21407Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(CD4-HIV)F26605Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(CD4-HIV)F26622Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(CD4-HIV)F26990Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(CD4-HIV)F27011Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(CD4-HIV)F27367Pjo/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:78756
tubular nephritis J:78756
Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:158594
lung inflammation J:158594
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd) 		colitis J:97554
glomerulonephritis J:97554
increased inflammatory response J:97554
liver inflammation J:97554
lung inflammation J:97554
pancreas inflammation J:97554
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6) 		colitis J:134156
Tg(Cd68-BCL2)526Medz/0
(involves: 129 * C57BL/6) 		increased inflammatory response J:82809
Tg(Cd68-BCL2)535Medz/0
(involves: 129 * C57BL/6) 		increased inflammatory response J:82809
Tg(Cd68-Fem1a)1Seno/0
(C57BL/6-Tg(Cd68-Fem1a)1Seno) 		abnormal susceptibility to induced colitis J:228893
Tg(Cd74-Nlrc4*)1Kyas/0
(involves: C57BL/6N) 		autoimmune arthritis J:219652
dermatitis J:219652
increased inflammatory response J:219652
joint inflammation J:219652
skin inflammation J:219652
Tg(CD207-Dta)312Dhka/?
(FVB-Tg(CD207-Dta)312Dhka) 		increased susceptibility to type IV hypersensitivity reaction J:113309
Tg(Cga-LHB/CGB)94Jhn/?
(involves: C57BL/6 * SJL) 		pyelonephritis J:55157
tubulointerstitial nephritis J:55157
Tg(Ckm-APPSw)A2Lfa/0
(involves: C57BL/6 * SJL) 		myositis J:76338
Tg(Ckm-APPSw)A6Lfa/0
(involves: C57BL/6 * SJL) 		myositis J:76338
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl) 		myositis J:205907
Tg(Cma1-cre)ARoer/0
Tg(Kit*D814V)1Roer/0
(involves: C57BL/6) 		colitis J:169611
Tg(CMV-cre)1Cgn/0
Tg(Kit*D814V)1Roer/0
(involves: BALB/cJ * C57BL/6) 		large intestinal inflammation J:169611
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		pancreas inflammation J:94953
Tg(Col1a1-FGF2*,-Sapphire)203Mmh/Tg(Col1a1-FGF2*,-Sapphire)203Mmh
(involves: FVB/N) 		osteoarthritis J:240777
Tg(Col2a1-cre/ERT2)1Dic/0
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
(involves: 129 * C57BL/6) 		osteoarthritis J:271724
Tg(Col2a1-Mir140)#Asah/0
(C57BL/6-Tg(Col2a1-Mir140)#Asah) 		decreased susceptibility to induced arthritis J:160358
Tg(Col2a1-rtTA,tetO-COMP*)2Jath/0
(C57BL/6-Tg(Col2a1-rtTA,tetO-COMP*)2Jath) 		increased inflammatory response J:233238
Tg(Comp-tTA)#Yeli/0
Tg(tetO-DDR2)#Yeli/0
(Not Specified) 		osteoarthritis J:176308
Tg(Csf1r-Tnfsf15,-EGFP)#Targ/0
(involves: C57BL/6) 		small intestinal inflammation J:169462
Tg(CYP1A1-PPARD)#Jfoe/0
(involves: C57BL/6J * CBA) 		skin inflammation J:158907
Tg(DO11.10)10Dlo/0
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: 129 * BALB/c * C3H * C57BL/6) 		decreased inflammatory response J:107431
Tg(DPP4)2Nnag/0
(B6.Cg-Tg(DPP4)2Nnag) 		lung inflammation J:286321
Tg(DUX4*)1Maar/?
(involves: C57BL/6J * CBA/J) 		increased incidence of corneal inflammation J:195481
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw) 		esophageal inflammation J:180282
increased inflammatory response J:180282
Tg(EIF1AX-Il31ra)1Jagr/0
(involves: C3H * C57BL/6) 		conjunctivitis J:91124
dermatitis J:91124
Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * SJL) 		pancreas inflammation J:107545
Tg(Ela2a-Prss1*,-GFP)1Dbs/0
(C57BL/6-Tg(Ela2a-Prss1*,-GFP)1Dbs) 		chronic pancreas inflammation J:144663
increased susceptibility to induced pancreatitis J:144663
Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6 * FVB) 		pancreas inflammation J:231759
Tg(Ela-KRAS*G12D)9Eps/0
Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: C57BL/6 * FVB) 		pancreas inflammation J:231759
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr) 		interstitial pneumonia J:145185
kidney inflammation J:117018
lacrimal gland inflammation J:145185
parotid gland inflammation J:145185
salivary gland inflammation J:117018, J:145185
submandibular gland inflammation J:145185
Tg(F2RL1)1Mslb/0
(involves: FVB/NCrl) 		increased inflammatory response J:79757
respiratory system inflammation J:79757
Tg(Fabp1-cre)1Jig/0
Vhltm1Jae/Vhltm1Jae
(involves: 129S4/SvJae * BALB/c * FVB/N) 		decreased susceptibility to induced colitis J:93476
Tg(Fabp4-Angptl2)5Yo/0
(involves: C57BL/6) 		chronic inflammation J:152387
white adipose tissue inflammation J:152387
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul) 		white adipose tissue inflammation J:344362
Tg(FCGR2A)11Mkz/0
Tg(PF4)#Zcy/0
(involves: C57BL/6 * SJL) 		increased acute inflammation J:72220
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz
(involves: C57BL/6 * SJL) 		autoimmune arthritis J:136516
glomerulonephritis J:136516
increased susceptibility to induced arthritis J:136516
interstitial pneumonia J:136516
Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6) 		interstitial pneumonia J:288386
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0
(involves: C57BL/6NCrl) 		increased inflammatory response J:125295
increased susceptibility to type IV hypersensitivity reaction J:125295
insulitis J:125295
lung inflammation J:125295
skin inflammation J:125295
Tg(Gfap-Ifna1)12Ilc/0
(involves: BALB/c * C57BL/6J) 		CNS inflammation J:68811
meningoencephalitis J:68811
Tg(Gfap-Ifna1)39Ilc/0
(involves: BALB/c * C57BL/6J) 		CNS inflammation J:68811
meningoencephalitis J:68811
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP) 		abnormal inflammatory response J:104241
brain inflammation J:113202
small intestinal inflammation J:104241
Tg(Gfap-TNF*)K21Gkl/0
(involves: C57BL/6 * CBA) 		CNS inflammation J:106592
Tg(GFAP-tTA)78Pop/0
Tg(tetO-Ifng)184Pop/0
(B6.Cg-Tg(GFAP-tTA)78Pop Tg(tetO-Ifng)184Pop) 		CNS inflammation J:109838
Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr) 		abnormal inflammatory response J:67478
dermatitis J:67478
Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay) 		insulitis J:117352
Tg(H2-Ea-HA)HACIIAjca/0
Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo) 		autoimmune arthritis J:209872
heart inflammation J:209872
joint inflammation J:209872
kidney inflammation J:209872
Tg(H2-Ea-HA)HACIIAjca/0
Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca) 		autoimmune arthritis J:209872
joint inflammation J:209872
Tg(H2-Ea-Ins2)1Wehi/0
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi) 		salivary gland inflammation J:100232
Tg(H2-Ead)5Lt/0
(NOD/ShiLt-Tg(H2-Ead)5Lt) 		periinsulitis J:36435
Tg(H2-Ead)12Lt/0
(NOD/ShiLt-Tg(H2-Ead)12Lt) 		insulitis J:36435
Tg(H2-K1-HLA-A*)28Mpla/0
(B10.Cg-Tg(H2-K1-HLA-A*)28Mpla) 		choroid inflammation J:67871
eye inflammation J:67871
Tg(H2-K-Cd86)7All/0
(B6.Cg-Tg(H2-K-Cd86)7All) 		abnormal inflammatory response J:112266
Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA) 		dermatitis J:138077
skin inflammation J:138077
Tg(H2-K-Fosl2,-EGFP)13Wag/0
(B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag) 		lung inflammation J:238723
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs) 		brain inflammation J:149511
CNS inflammation J:149511
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish) 		glomerulonephritis J:128016, J:138762
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(C57BL/6-Tg(H2-L-IL6)46Kish) 		glomerulonephritis J:40405
Tg(HBB-Myc)#Cos/0
(involves: C57BL/6J * CBA/J) 		kidney inflammation J:276641
Tg(HIV)26Aln/0
(involves: FVB/N) 		kidney inflammation J:90297
myositis J:90297
uveitis J:136652
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2) 		CNS inflammation J:134764
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(involves: C57BL/6 * C57BL/10Sn * SJL/J) 		increased susceptibility to induced arthritis J:108635
Tg(HTT*)NXwy/0
(involves: FVB/NJ) 		CNS inflammation J:219890
Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ) 		insulitis J:131077
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		insulitis J:91865
Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V281)3Jwt) 		insulitis J:91865
Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6) 		peritoneal inflammation J:76574
Tg(Igh-V-CD40lg)#Tsub/0
(C57BL/6-Tg(Igh-V-CD40lg)#Tsub) 		glomerulonephritis J:128824
Tg(Igh-V-CD40lg)#Tsub/0
(involves: C57BL/6) 		colitis J:89855
glomerulonephritis J:89855
Tg(IghH280)48Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs/J) 		insulitis J:274578
Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IgkH280)934Dvs/J) 		insulitis J:274578
Tg(Il1rn)1Dih/0
(involves: C57BL/6 * CBA) 		decreased inflammatory response J:88605
decreased susceptibility to endotoxin shock J:36387
Tg(Il1rn)1Dih/Tg(Il1rn)1Dih
(involves: C57BL/6 * CBA) 		decreased susceptibility to endotoxin shock J:36387
Tg(ILK3mHEL)3Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd) 		insulitis J:78309
Tg(Ins1-Cd80)378Psoh/0
Tg(Ins2-GP)#Psoh/0
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		insulitis J:209714
periinsulitis J:209714
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		insulitis J:127015
Tg(Ins2-CD80)3B7Flv/?
(involves: C57BL/6 * CBA/Ca * NOD/Caj) 		insulitis J:26618
Tg(Ins2-CD80)3B7Flv/0
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		insulitis J:93555
Tg(Ins2-CD86)12B70Flv/0
(involves: C57BL/6 * CBA/Ca) 		periinsulitis J:93555
Tg(Ins2-CD86)12B70Flv/0
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		insulitis J:93555
Tg(Ins2-cre)5Lt/Tg(Ins2-cre)5Lt
(NOD/ShiLt-Tg(Ins2-cre)5Lt) 		insulitis J:127015
Tg(Ins2-GAD2)1Lt/0
(NOD/ShiLt-Tg(Ins2-GAD2)1Lt) 		insulitis J:100251
Tg(Ins2-GAD2)2Lt/0
(NOD/ShiLt-Tg(Ins2-GAD2)2Lt) 		insulitis J:100251
Tg(Ins2-GP)#Psoh/0
(involves: C57BL/6) 		insulitis J:81285
Tg(Ins2-HA)165Bri/0
Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2) 		insulitis J:99756
Tg(Ins2-HA)165Bri/?
Tg(TcraCl4,TcrbCl4)1Shrm/?
(involves: BALB/c * C57BL/6 * C57BL/10) 		insulitis J:99756
Tg(Ins2-Lta)#Flv/0
(involves: NOD) 		insulitis J:91820
kidney inflammation J:91820
periinsulitis J:91820
Tg(Ins2-Lta)#Flv/0
(involves: C57BL/6) 		insulitis J:91820
kidney inflammation J:91820
periinsulitis J:91820
Tg(Ins2-Lta)#Flv/0
(involves: C57BL/6 * CBA) 		insulitis J:127705
periinsulitis J:127705
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA * NOD) 		insulitis J:91820
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA) 		insulitis J:91820
Tg(INS-Il10)#Sar/0
(involves: BALB/c) 		pancreas inflammation J:107927
periinsulitis J:107927
Tg(ITGA2)1067Fmw/0
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1067Fmw/0
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1067Fmw/0
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1070Fmw/0
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1070Fmw/0
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1070Fmw/0
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1075Fmw/0
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1075Fmw/0
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA2)1075Fmw/0
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0794Fmw/0
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0794Fmw/0
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0794Fmw/0
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0844Fmw/0
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0844Fmw/0
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0844Fmw/0
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0858Fmw/0
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0858Fmw/0
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGA5)0858Fmw/0
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(Itgam-FCAR)83Rcmo/0
(involves: C57BL/6 * NOD) 		glomerulonephritis J:120534
Tg(ITGB1)0840Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGB1)0869Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(ITGB1)0870Fmw/0
(involves: C57BL/10 * CBA) 		dermatitis J:30249
eye inflammation J:30249
Tg(IVL-KLK5)#Hov/0
(involves: C57BL/6 * CBA) 		erythroderma J:210758
lymph node inflammation J:210758
skin inflammation J:210758
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J) 		blood vessel inflammation J:300960
brain inflammation J:294084
bronchiolitis J:302313
conjunctivitis J:294084
cytokine storm J:300960
interstitial pneumonia J:300960, J:302313
liver inflammation J:300960
lung inflammation J:294084, J:302313
meningitis J:294084, J:302313
meningoencephalitis J:300960, J:296067
rhinitis J:300960
Tg(Kit*D814V)1Roer/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		colitis J:169611
large intestinal inflammation J:169611
small intestinal inflammation J:169611
Tg(Kit*D814V)2Roer/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		colitis J:169611
large intestinal inflammation J:169611
small intestinal inflammation J:169611
Tg(Kit*D814V)3Roer/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		colitis J:169611
large intestinal inflammation J:169611
Tg(KRT5-IKBKB)2Armz/0
(involves: C57BL/6 * DBA/2) 		dermatitis J:160072
Tg(KRT5-Nfkbia*)3Rto/0
Tg(Krt5-Tnfr1)#Rsab/0
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6 * CBA) 		skin inflammation J:208995
Tg(KRT5-rtTA)1Glk/0
Tg(tetO-Tfrc/EGFP/Ova)#Sfz/0
Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N) 		respiratory system inflammation J:199558
skin inflammation J:199558
Tg(KRT5-rtTA)1Glk/0
Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N) 		dermatitis J:70670
skin inflammation J:70670
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N) 		conjunctivitis J:100506
dermatitis J:100506
Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR) 		skin inflammation J:90118
Tg(KRT5-tTA)1216Glk/0
Tg(tetO-Il13)1Tazh/0
(B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh) 		dermatitis J:150232
Tg(KRT5-tTA)1216Glk/0
Tg(tetO-LMNA*G608G,-EGFP)VF1-07Maer/0
(involves: FVB/N) 		periodontium inflammation J:145312
skin inflammation J:145312
Tg(KRT5-tTA)1216Glk/0
Tg(tetO-Tek)1Dmt/0
(involves: CD-1 * FVB/N) 		skin inflammation J:147438
Tg(KRT5-tTA)1216Glk/0
Tg(tetO-TGFB1*C223S*C225S)1Glk/0
(involves: FVB/N) 		dermatitis J:70670
skin inflammation J:70670
Tg(Krt14-Angptl2)1Yo/0
(C.Cg-Tg(Krt14-Angptl2)1Yo) 		skin inflammation J:152387, J:181261
Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6) 		dermatitis J:78602, J:79706
Tg(KRT14-cre)1Amc/0
Trpv3tm1.1Clph/Trpv3tm1.1Clph
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster) 		erythroderma J:164741
Tg(Krt14-Ifnk)#Cya/0
(C57BL/6N-Tg(Krt14-Ifnk)#Cya) 		increased susceptibility to chemically induced skin inflammation J:322130
Tg(KRT14-Il1f6)1Hblu/?
(involves: C57BL/6 * DBA/2) 		skin inflammation J:126327
Tg(KRT14-Il4)#Lsch/0
(involves: BALB/cBy * C57BL/6) 		blepharitis J:126285
conjunctivitis J:126285
dermatitis J:126285
skin inflammation J:126285
Tg(KRT14-Il7)1Tsk/0
(FVB/N-Tg(KRT14-Il7)1Tsk) 		blepharitis J:42565
skin inflammation J:42565
Tg(KRT14-Il7)1Tsk/Tg(KRT14-Il7)1Tsk
(FVB/N-Tg(KRT14-Il7)1Tsk) 		skin inflammation J:42565
Tg(KRT14-Il18)#Knak/0
(C57BL/6-Tg(KRT14-Il18)#Knak) 		dermatitis J:78602
Tg(Krt14-Rac1*G12V)#Mrnk/0
(involves: CBA/CaJ) 		joint inflammation J:237134
skin inflammation J:237134
Tg(KRT14-VP16/NR1I2)13Sdub/?
(involves: C57BL/6) 		dermatitis J:258435
skin inflammation J:258435
Tg(KRT18*R89C)22Rgo/0
(involves: FVB/N) 		chronic liver inflammation J:241700
Tg(KRT18*R89C)30Rgo/0
(involves: FVB/N) 		chronic liver inflammation J:241700
Tg(KRT18*R89C)50Rgo/0
(involves: FVB/N) 		chronic liver inflammation J:241700
Tg(KRT18-DPP4)3Pbmj/0
(involves: C57BL/6J * SJL/J) 		brain inflammation J:285467
interstitial pneumonia J:286231
lung inflammation J:286231, J:285467
Tg(Lck-cre)548Jxm/?
Tgfb1tm2.1Doe/Tgfb1tm2.1Doe
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA) 		increased inflammatory response J:150024
lung inflammation J:150024
salivary gland inflammation J:150024
Tg(Lck-Il31)1Jagr/0
(involves: C3H * C57BL/6) 		conjunctivitis J:91124
dermatitis J:91124
Tg(Lck-LMO1)11Sjk/0
Tg(STIL-TAL1)A5(3)Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros) 		abnormal inflammatory response J:40868
Tg(LCK-NFKBIA)5Dwb/?
(involves: BALB/c * C57BL/6 * DBA/2) 		decreased susceptibility to type I hypersensitivity reaction J:145531
decreased susceptibility to type IV hypersensitivity reaction J:145531
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish) 		increased susceptibility to type IV hypersensitivity reaction J:80214
lung inflammation J:194882
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf) 		abnormal inflammatory response J:128976
colitis J:129951
glomerulonephritis J:129951
intestinal inflammation J:128976
liver inflammation J:129951
lung inflammation J:129951
myositis J:129951
small intestinal inflammation J:120962
Tg(Lck-Tnfsf15,-EGFP)#Targ/0
(involves: C57BL/6) 		small intestinal inflammation J:169462
Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea) 		glomerulonephritis J:72982
liver inflammation J:72982
lung inflammation J:72982
Tg(Lck-VIPR2)1Ejg/0
(C57BL/6-Tg(Lck-VIPR2)1Ejg) 		decreased susceptibility to type IV hypersensitivity reaction J:127974
increased susceptibility to type I hypersensitivity reaction J:127974
Tg(Ly6a-GCSAM)102AIsg/0
(involves: C57BL/6J * CBA) 		increased inflammatory response J:221238
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon/0
(B6.Cg-Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon) 		decreased susceptibility to induced colitis J:184388
Tg(Mbp-SNCA)1Ema/0
(involves: C57BL/6 * DBA/2) 		brain inflammation J:207162
Tg(Mcpt8-cre)1Voeh/0
(involves: C57BL/6) 		decreased inflammatory response J:164432
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd) 		thyroid gland inflammation J:78309
Tg(MMTV-ENPP2)#Gbm/0
(FVB/N-Tg(MMTV-ENPP2)#Gbm) 		mastitis J:149661
Tg(MMTV-LPAR1)2Gbm/Tg(MMTV-LPAR1)2Gbm
(FVB/N-Tg(MMTV-LPAR1)2Gbm) 		mastitis J:149661
Tg(MMTV-LPAR1)7Gbm/Tg(MMTV-LPAR1)7Gbm
(FVB/N-Tg(MMTV-LPAR1)7Gbm) 		mastitis J:149661
Tg(MMTV-LPAR1)#Gbm/Tg(MMTV-LPAR1)#Gbm
(FVB/N-Tg(MMTV-LPAR1)#Gbm) 		mastitis J:149661
Tg(MMTV-LPAR2)3Gbm/Tg(MMTV-LPAR2)3Gbm
(FVB/N-Tg(MMTV-LPAR2)3Gbm) 		mastitis J:149661
Tg(MMTV-LPAR2)6Gbm/Tg(MMTV-LPAR2)6Gbm
(FVB/N-Tg(MMTV-LPAR2)6Gbm) 		mastitis J:149661
Tg(MMTV-LPAR2)#Gbm/Tg(MMTV-LPAR2)#Gbm
(FVB/N-Tg(MMTV-LPAR2)#Gbm) 		mastitis J:149661
Tg(MMTV-LPAR3)3Gbm/Tg(MMTV-LPAR3)3Gbm
(FVB/N-Tg(MMTV-LPAR3)3Gbm) 		mastitis J:149661
Tg(MMTV-LPAR3)#Gbm/Tg(MMTV-LPAR3)#Gbm
(FVB/N-Tg(MMTV-LPAR3)#Gbm) 		mastitis J:149661
Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J) 		increased inflammatory response J:182703
Tg(Msr1-MMP9)#Apar/0
(B6.Cg-Tg(Msr1-MMP9)#Apar) 		decreased inflammatory response J:129959
Tg(MSR1-Plau)1Ddi/0
(involves: C57BL/6 * SJL) 		heart inflammation J:101486
Tg(Mt1-Crry)26Quig/?
(involves: CD-1) 		abnormal inflammatory response J:117777
Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: FVB/N) 		pancreas inflammation J:76993
Tg(MT2A-TGFBR2)4Rser/0
(involves: C57BL/6 * DBA) 		osteoarthritis J:44579
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps) 		liver inflammation J:233146
Tg(Mx1-cre)1Cgn/0
Znrf1tm1Lchs/Znrf1tm1Lchs
(involves: C57BL/6) 		decreased susceptibility to endotoxin shock J:250572
Tg(Myh6*/tetO-Capn1)L3Gwd/0
(involves: FVB/N) 		heart inflammation J:133797
Tg(Myh6-BAG3*P209L)#Mswi/0
(involves: C57BL/6 * DBA/2) 		heart inflammation J:234278
Tg(Myh6-Grem2)1Akh/0
(involves: C57BL/6) 		decreased inflammatory response J:250034
Tg(Myh6-JUP*)1Dpju/0
(FVB/N-Tg(Myh6-JUP*)1Dpju) 		heart inflammation J:235770
Tg(Myh6-Tnf)1Brgi/?
(involves: C57BL/6J * SJL) 		myocarditis J:84829, J:100006
Tg(Myh6-Tnf)2Brgi/?
(involves: C57BL/6J * SJL) 		myocarditis J:84829, J:100006
Tg(Myh6-Tnnt2*R92Q)2Lnwd/0
(involves: C57BL/6) 		heart inflammation J:56911
Tg(Myh6-Tnnt2*R92Q)3Lnwd/0
(involves: C57BL/6) 		heart inflammation J:56911
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6 * CBA) 		heart inflammation J:131245
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6 * CBA) 		myocarditis J:81967
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-NOS2,-lacZ)240iMhus/0
(involves: C57BL/6 * CBA) 		heart inflammation J:132082
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-Spp1)5Gad/0
(involves: C57BL/6 * CBA) 		heart inflammation J:194810
myocarditis J:194810
Tg(Pcp2-TBP*)69Hmhl/0
(involves: FVB/N) 		brain inflammation J:174239
Tg(Pim1-Il9)5Jcrd/0
(involves: BALB/c * FVB/N) 		increased susceptibility to type I hypersensitivity reaction J:100568
Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N) 		increased susceptibility to type I hypersensitivity reaction J:100568
Tg(PLP1*)4Rsj/0
(involves: CD-1) 		CNS inflammation J:161344
Tg(Prnp-ATXN7*92Q)6529Als/Y
(involves: C3H/HeJ * C57BL/6J) 		colitis J:135615
Tg(Prnp-Immt/SOD1*G93A)7Gmnf/Tg(Prnp-Immt/SOD1*G93A)7Gmnf
(involves: C57BL/6 * CBA * SJL) 		dermatitis J:177846
Tg(Prnp-ITM2B*)1Ruvi/Tg(Prnp-ITM2B*)1Ruvi
Tg(Prnp-MAPT*P301L)#Ruvi/Tg(Prnp-MAPT*P301L)#Ruvi
(involves: C3HeB/FeJ * C57BL/6) 		increased inflammatory response J:197198
Tg(Prnp-MAPT*P301L)JNPL3Hlmc/?
(involves: C57BL/6 * DBA/2) 		eye inflammation J:63887
Tg(PRSS1/lacZ)#Gwzh/0
(Not Specified) 		increased susceptibility to induced pancreatitis J:345508
Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6) 		lacrimal gland inflammation J:141378
salivary gland inflammation J:141378
Tg(RIP1-Tag)5Dh/?
(C3HeB/FeJ-Tg(RIP1-Tag)5Dh) 		pancreas inflammation J:80168
Tg(Scgb1a1-IL6)9Flv/0
(involves: C57BL/6 * CBA) 		lung inflammation J:128762, J:156430
Tg(Scgb1a1-Il13)2Eli/?
(involves: C57BL/6 * CBA) 		respiratory system inflammation J:53612
Tg(Scgb1a1-Il17a)3Cdon/0
(C57BL/6-Tg(Scgb1a1-Il17a)3Cdon) 		lung inflammation J:112600
Tg(Scgb1a1-Il17f,GFP)1Cdon/?
(C57BL/6-Tg(Scgb1a1-Il17f,GFP)1Cdon) 		lung inflammation J:136279
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M*L858R)19Kkw/0
(involves: 129 * C57BL/6 * FVB/N) 		interstitial pneumonia J:122849
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-IL1B)KBry/0
(involves: 129 * C57BL/6) 		lung inflammation J:107601, J:130523
Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1*)1Eli/0
(involves: C57BL/6) 		lung inflammation J:92469
Tg(Scgb1a1-Scnn1b)6608Bouc/0
(involves: C3H * C57BL/6) 		bronchitis J:91139
Tg(Scgb1a1-Scnn1b)6608Bouc/0
(B6.Cg-Tg(Scgb1a1-Scnn1b)6608Bouc) 		respiratory system inflammation J:191673
Tg(Scgb1a1-Scnn1b)6608Bouc/0
(C.Cg-Tg(Scgb1a1-Scnn1b)6608Bouc) 		respiratory system inflammation J:191673
Tg(SERPINA1*E342K)#Slcw/0
(involves: C57BL/6 * ICR) 		liver inflammation J:149132
Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * ICR) 		liver inflammation J:90305
Tg(SFTPC-Il18)AThos/0
(B6N.Cg-Tg(SFTPC-Il18)AThos) 		lung inflammation J:147547
Tg(SFTPC-rtTA)2Jaw/0
Tg(tetO-CTGF)#Swu/0
(involves: 129 * C57BL/6 * C57BL/6J) 		lung inflammation J:171151
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: C57BL/6 * SJL) 		lung inflammation J:97297
Tg(SFTPC-Tnf)2Pva/0
(involves: C57BL/6 * DBA/2) 		alveolitis J:28120
interstitial pneumonia J:28120
Tg(Sirt1)ASrn/?
(involves: C57BL/6 * CBA) 		increased susceptibility to endotoxin shock J:137868
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J) 		CNS inflammation J:110437
Tg(Stat3*)9199Alau/0
(involves: C57BL/6) 		increased inflammatory response J:210877
increased susceptibility to endotoxin shock J:210877
intestinal inflammation J:210877
Tg(SV40-KLK7)1010Teg/0
(involves: C57BL/6J * CBA) 		dermatitis J:75714
Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57L * DBA/2 * SJL) 		seborrheic dermatitis J:95380
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6) 		blepharitis J:83278
CNS inflammation J:83278
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		insulitis J:52940
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: C57BL/6 * NOD * SJL) 		insulitis J:137009
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL) 		chronic joint inflammation J:36815
glomerulonephritis J:36815
kidney inflammation J:36815
rheumatoid arthritis J:36815
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp) 		liver inflammation J:72817
Tg(TcraTcrbNY4.1)1Pesa/0
(NOD.Cg-Tg(TcraTcrbNY4.1)1Pesa) 		insulitis J:108768
Tg(TcraTcrbNY8.3)1Pesa/?
(involves: C57BL/6 * NOD * SJL) 		pancreas inflammation J:44202
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
Tg(TcrbBL17)1Lmor/Tg(TcrbBL17)1Lmor
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		thyroid gland inflammation J:78309
Tg(Tek-Jam3)1Maal/?
(B6.Cg-Tg(Tek-Jam3)1Maal) 		lung inflammation J:99020
peritoneal inflammation J:99020
Tg(Tek-Procr)1Cte/0
(B6.FVB-Tg(Tek-Procr)1Cte) 		abnormal inflammatory response J:119637
Tg(Tek-Tnf*)5382Mcla/0
(B6.Cg-Tg(Tek-Tnf*)5382Mcla) 		chronic inflammation J:71622
chronic liver inflammation J:71622
decreased inflammatory response J:71622
kidney inflammation J:71622
lung inflammation J:71622
Tg(Tek-tTA)1Dmt/0
Tg(tetO-Tek)1Dmt/0
(involves: CD-1) 		skin inflammation J:96718, J:137745
Tg(TetOp-Polb/tTA)2Sbl/0
(B6.Cg-Tg(TetOp-Polb/tTA)2Sbl) 		glomerulonephritis J:152481
Tg(Tgfa)1Efu/0
(Not Specified) 		ear inflammation J:65045
Tg(THY1-APP)2Somm/0
(involves: C57BL/6J * DBA/2) 		brain inflammation J:44603
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2) 		brain inflammation J:44603
Tg(Thy1-MAPT*P301S)2541Godt/Tg(Thy1-MAPT*P301S)2541Godt
(involves: C57BL/6J * CBA/Ca) 		eye inflammation J:108870
Tg(Tk1-DPP4)27Ysj/0
(involves: C57BL/6 * FVB/N) 		lung inflammation J:290259
Tg(Tlr7)1Boll/0
(involves: C57BL/6) 		glomerulonephritis J:127600
liver inflammation J:127600
X/Tg(Tlr7)6Boll
(involves: C57BL/6) 		glomerulonephritis J:127600
liver inflammation J:127600
lung inflammation J:127600
Tg(TNF)197Gkl/0
(involves: C57BL/6 * CBA) 		autoimmune arthritis J:97992, J:92576
Tg(TNF)197Gkl/0
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129 * C57BL/6 * CBA) 		autoimmune arthritis J:92470
Tg(TNF)3647Gkl/0
(involves: C57BL/6 * CBA) 		autoimmune arthritis J:190204
Tg(Tnf)6074Gkl/0
(involves: C57BL/6 * CBA) 		brain inflammation J:106592
Tg(Tnf)6074Gkl/0
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6 * CBA) 		CNS inflammation J:106592
Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma) 		kidney inflammation J:73711
salivary gland inflammation J:73711
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma) 		glomerulonephritis J:113556
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma
(involves: C57BL/6 * DBA/2) 		kidney inflammation J:178227
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: BALB/c * C57BL/6J * DBA/2) 		skin inflammation J:98545
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: C57BL/6J * DBA/2) 		skin inflammation J:98545
Tg(Umod*C147W)958Lura/0
(involves: FVB) 		kidney inflammation J:161532
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6) 		abnormal inflammatory response J:189197
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J) 		glomerulonephritis J:88565
Tg(Vil1-cre)997Gum/?
Tlr4lps-del/Tlr4lps-del
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * C57BL/10ScN * SJL) 		large intestinal inflammation J:229155
Tg(Vil1-cre)997Gum/?
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * SJL/J) 		increased susceptibility to colitis induced morbidity/mortality J:229155
large intestinal inflammation J:229155
Tg(Vil-SLC3A2)HEMerl/0
(involves: FVB/N) 		colitis J:173946
increased susceptibility to induced colitis J:173946
Tg(VIM-Tag)3Pau/0
(either: (involves: C57BL/6 * CBA * SJL/J) or (involves: C57BL/6 * SJL/J)) 		glomerulonephritis J:92226
Tgm3Btlr/Tgm3Btlr
(C57BL/6J-Tgm3Btlr) 		increased susceptibility to induced colitis J:265197
Tgfatm1Ard/Tgfatm1Ard
(involves: 129P2/OlaHsd * C57BL/6) 		increased incidence of corneal inflammation J:4606
Tgfawa1/Tgfawa1
(Not Specified) 		conjunctivitis J:13115
keratoconjunctivitis J:13115
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1) 		abnormal inflammatory response J:2892
brain inflammation J:2892
conjunctivitis J:2892
diaphragmitis J:2892
eye inflammation J:2892
heart inflammation J:2892
lacrimal gland inflammation J:2892
liver inflammation J:2892
lung inflammation J:2892
myositis J:2892
pancreas inflammation J:2892
salivary gland inflammation J:2892
skin inflammation J:2892
stomach inflammation J:2892
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * BALB/c * CF-1) 		heart inflammation J:69346
liver inflammation J:69346
lung inflammation J:69346
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129S2-Tgfb1tm1Doe) 		heart inflammation J:69346
liver inflammation J:69346
Tgfb1tm1Doe/Tgfb1tm2.1Doe
Tg(Lck-cre)548Jxm/?
(involves: 129S2/SvPas * 129S6/SvEvTac * Black Swiss * BALB/c * C57BL/6 * CBA) 		lung inflammation J:150024
salivary gland inflammation J:150024
Tgfb1tm1Jmu/Tgfb1tm1Jmu
(involves: 129S6/SvEvTac * C57BL/6) 		heart inflammation J:120085
liver inflammation J:120085
lung inflammation J:120085
pancreas inflammation J:120085
stomach inflammation J:120085
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv) 		atrial endocarditis J:50848
increased inflammatory response J:50848
interstitial pneumonia J:50848
lymph node inflammation J:50848
myocarditis J:50848
pancreas inflammation J:50848
pericarditis J:50848
phlebitis J:50848
salivary gland inflammation J:50848
Tgfb1tm1Rif/Tgfb1tm1Rif
(either: (involves: 129) or (involves: 129S/SvEv * C57BL/6)) 		cecum inflammation J:142353
heart inflammation J:142353
increased inflammatory response J:142353
large intestinal inflammation J:142353
lung inflammation J:142353
proctitis J:142353
small intestinal inflammation J:142353
stomach inflammation J:142353
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		liver inflammation J:148747
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD) 		increased inflammatory response J:196160
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL) 		pancreas inflammation J:196160
Tgfbr2tm1Karl/Tgfbr2tm1Karl
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		eye inflammation J:77844
increased inflammatory response J:77844
liver inflammation J:77844
pancreas inflammation J:77844
stomach inflammation J:77844
Tgif1tm1.1Caw/Tgif1tm1.1Caw
(B6.129S-Tgif1tm1.1Caw) 		increased susceptibility to otitis media J:198238
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6) 		decreased susceptibility to endotoxin shock J:131975
Thbdtm1Wlr/Thbdtm1Wlr
(B6.129S2-Thbdtm1Wlr) 		increased susceptibility to endotoxin shock J:111502
Thbdtm2.1Emc/Thbdtm2.1Emc
(involves: 129/Sv * BALB/c * C57BL/6) 		increased susceptibility to endotoxin shock J:118000
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6)) 		lung inflammation J:46182, J:48446
pancreas inflammation J:48446
Thbs1tm1Hyn/Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		lacrimal gland inflammation J:153126
Thbs1tm1Hyn/Thbs1tm1Hyn
Thbs2tm1Bst/Thbs2tm1Bst
(involves: 129T2/SvEms * 129X1/SvJ) 		lung inflammation J:78876
thnh/thnh
(NOD.Cg-H2b thnh/J) 		folliculitis J:142872
Tia1tm1Andp/Tia1tm1Andp
(C.129S2-Tia1tm1Andp) 		increased susceptibility to endotoxin shock J:88770
Tia1tm1Andp/Tia1tm1Andp
(B6.Cg-Tia1tm1Andp) 		autoimmune arthritis J:88443
Tia1tm1Andp/Tia1tm1Andp
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Tia1tm1Andp Zfp36tm1Pjb) 		autoimmune arthritis J:88443
Ticam1Lps2/Ticam1Lps2
(involves: C57BL/6) 		decreased susceptibility to endotoxin shock J:84896
Ticam1Lps2/Ticam1Lps2
(C57BL/6J-Ticam1Lps2) 		decreased susceptibility to induced colitis J:167340
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd) 		decreased susceptibility to endotoxin shock J:84679
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:161445
myocarditis J:169158
TigarGt(EUCE0047g05)Hmgu/TigarGt(EUCE0047g05)Hmgu
(involves: 129P2/OlaHsd) 		increased susceptibility to induced colitis J:198650
Tigartm1.1Khv/Tigartm1.1Khv
Tg(CMV-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL) 		increased susceptibility to induced colitis J:198650
Timd2tm1(GAL4)Pdre/Timd2tm1(GAL4)Pdre
(C.129S4-Timd2tm1(GAL4)Pdre) 		abnormal inflammatory response J:125054
Timp1tm1Pds/Timp1tm1Pds
(involves: 129S4/SvJae * C57BL/6) 		lung inflammation J:112941
Timp3tm1Osya/Timp3tm1Osya
(B6.129P2-Timp3tm1Osya) 		aortitis J:193744
Timp3tm1Rkho/Timp3tm1Rkho
(B6.129-Timp3tm1Rkho) 		liver inflammation J:92948
Tinf2tm2.2Tdl/Tinf2+
(involves: BALB/cJ * C57BL/6) 		dermatitis J:207367
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor) 		kidney inflammation J:117491
Tk1tm1Vnd/Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6) 		arteritis J:101669
liver inflammation J:101669
lung inflammation J:101669
thyroid gland inflammation J:101669
Tktl1tm1Arte/Tktl1tm1Arte
(C57BL/6-Tktl1tm1Arte) 		increased susceptibility to induced colitis J:171154
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd) 		decreased inflammatory response J:146111
Tlr2tm1Aki/Tlr2tm1Aki
(NOD.129P2-Tlr2tm1Aki) 		insulitis J:124334
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir) 		increased susceptibility to induced colitis J:165105
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv * C57BL/6) 		decreased inflammatory response J:72167
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv) 		heart inflammation J:119967
Tlr4lps-2J/Tlr4lps-2J
(BXD29-Tlr4lps-2J/J) 		abnormal inflammatory response J:107391
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ) 		increased susceptibility to induced arthritis J:96356
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d) 		liver inflammation J:135830
lung inflammation J:96680
Tlr4lps-n/Tlr4lps-n
(C3H/HeN) 		decreased acute inflammation J:37271
Tlr4tm1.1Djh/Tlr4tm1.1Djh
(involves: FVB/N) 		decreased susceptibility to endotoxin shock J:192520
Tlr4tm1Aki/Tlr4lps-2J
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J) 		abnormal inflammatory response J:107391
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal acute inflammation J:98224
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:76115
Tlr4tm1Aki/Tlr4tm1Aki
(C.129P2-Tlr4tm1Aki) 		decreased susceptibility to induced arthritis J:178054
Tlr5tm1Aki/Tlr5tm1Aki
(involves: 129P2/OlaHsd) 		increased susceptibility to colitis induced morbidity/mortality J:229155
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to induced colitis J:158055
increased susceptibility to induced pancreatitis J:158055
lung inflammation J:111778
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		liver inflammation J:324448
lung inflammation J:324448
lymph node inflammation J:324448
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu) 		glomerulonephritis J:324448
increased inflammatory response J:324448
liver inflammation J:324448
lung inflammation J:324448
lymph node inflammation J:324448
pancreas inflammation J:324448
salivary gland inflammation J:324448
Tlr8tm1Vlcg/Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg) 		glomerulonephritis J:165267
Tlr9m6Btlr/Tlr9m6Btlr
(C57BL/6J-Tlr9m6Btlr) 		increased susceptibility to induced colitis J:155728
Tlr9tm1Aki/Tlr9tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:66049
Tmem30atm1.1Xjz/Tmem30atm1.1Xjz
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA) 		liver inflammation J:249038
Tmem79ma/Tmem79ma
(involves: C57BL/6JJcl * CBA/CaGr) 		dermatitis J:202316
Tmem79ma/Tmem79ma
(B6.CBACaGr-Tmem79ma/J) 		blepharitis J:202453
dermatitis J:202453
skin inflammation J:202453
Tmem178tm1Lex/Tmem178tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to induced arthritis J:228311
Tmem219tm1(KOMP)Vlcg/Tmem219tm1(KOMP)Vlcg
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA) 		lung inflammation J:236976
Tmem241em1Blsg/Tmem241em1Blsg
(involves: C57BL/6J) 		lung inflammation J:344360
Tmem258tm1.1(KOMP)Vlcg/Tmem258+
(involves: C57BL/6NTac) 		increased susceptibility to colitis induced morbidity/mortality J:240635
increased susceptibility to induced colitis J:240635
Tmprss2tm1(KOMP)Vlcg/Tmprss2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		lung inflammation J:214427
Tmprss2tm2.1(ETV1)Sho/Tmprss2tm2.1(ETV1)Sho
(involves: C57BL/6 * DBA/2) 		prostate gland inflammation J:212219
Tnbs1SJL/J/?
(involves: C57BL/6J * SJL/J) 		increased susceptibility to induced colitis J:82095
Tnbs2SJL/J/?
(involves: C57BL/6J * SJL/J) 		increased susceptibility to induced colitis J:82095
TnfBpsm1/Tnf+
(involves: C57BL/6) 		aortic valve inflammation J:226052
mitral valve inflammation J:226052
rheumatoid arthritis J:226052
TnfBpsm1/Tnf+
(C.Cg-TnfBpsm1) 		aortic valve inflammation J:226052
cardiovalvulitis J:226052
mitral valve inflammation J:226052
TnfBpsm1/TnfBpsm1
(involves: C57BL/6) 		accelerated temporomandibular joint osteoarthritis J:226052
aortic valve inflammation J:226052
mitral valve inflammation J:226052
rheumatoid arthritis J:226052
Tnfem4Boui/Tnf+
(C57BL/6-Tnfem4Boui) 		autoimmune arthritis J:306876
cardiovalvulitis J:306876
colitis J:306876
esophageal inflammation J:306876
ileum inflammation J:306876
Tnfem5Boui/Tnf+
Tnfrsf1atm1Mak/Tnfrsf1a+
(involves: 129S2/SvPas * C57BL/6) 		autoimmune arthritis J:306876
cardiovalvulitis J:306876
colitis J:306876
Tnftm1.1Sned/Tnftm1.1Sned
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to endotoxin shock J:95684
Tnftm1.1Sned/Tnftm1.1Sned
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2) 		decreased susceptibility to endotoxin shock J:95684
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		abnormal inflammatory response J:114740
decreased inflammatory response J:56068
decreased susceptibility to type IV hypersensitivity reaction J:47673
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv) 		decreased susceptibility to endotoxin shock J:95684
Tnftm1Gkl/Tnftm1Gkl
Tnfaip3tm1Ama/Tnfaip3tm1Ama
(involves: 129S/SvEv * C57BL/6J) 		abnormal inflammatory response J:92694
Tnftm1Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to endotoxin shock J:54056
rheumatoid arthritis J:54056
Tnftm1Jods/Tnftm1Jods
(involves: C57BL/6) 		decreased susceptibility to endotoxin shock J:98591
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv) 		decreased susceptibility to endotoxin shock J:95684, J:41992
Tnftm1Ljo/Tnftm1Ljo
(B6.129S1-Tnftm1Ljo) 		lung inflammation J:127028
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv * C57BL/6) 		skin inflammation J:127028
Tnftm1Sek/Tnftm1Sek
(B6.Cg-Tnftm1Sek) 		decreased susceptibility to endotoxin shock J:44841
Tnftm2.1Gkl/Tnftm2.1Gkl
Tg(Fabp1-cre)1Jig/0
(involves: 129S/SvEv * FVB/N) 		ileum inflammation J:204557
large intestinal inflammation J:204557
small intestinal inflammation J:204557
Tnftm2.1Gkl/Tnftm2.1Gkl
Tg(Lck-cre)I57Jxm/0
(involves: 129S/SvEv * ICR) 		small intestinal inflammation J:108572
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6) 		autoimmune arthritis J:92307, J:136667
decreased inflammatory response J:204922
ileum inflammation J:204922
intestinal inflammation J:136667
rheumatoid arthritis J:54056
small intestinal inflammation J:92307, J:54056, J:204922
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6 * SPRET/Ei) 		autoimmune arthritis J:92307
small intestinal inflammation J:92307
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J) 		small intestinal inflammation J:108572
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6 * CBA) 		autoimmune arthritis J:131930
Tnftm2Gkl/Tnf+
(B6.129S-Tnftm2Gkl/Jarn) 		ileum inflammation J:131978, J:145626
Tnftm2Gkl/Tnf+
Tnfrsf1atm2Gkl/Tnfrsf1atm2Gkl
Tg(Col6a1-cre)1Gkl/?
(involves: 129S/SvEv * C57BL/6 * CBA) 		autoimmune arthritis J:131930
small intestinal inflammation J:131930
Tnftm2Gkl/Tnf+
Tnfrsf1btm1.1Gkl/Tnfrsf1btm1.1Gkl
Tg(Col6a1-cre)1Gkl/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA) 		joint inflammation J:264147
Tnftm2Gkl/Tnf+
Tnfrsf1btm1.2Gkl/Tnfrsf1btm1.2Gkl
(involves: 129S/SvEv * C57BL/6 * C57BL/6J) 		aortic valve inflammation J:264147
autoimmune arthritis J:264147
Tnftm2Gkl/Tnf+
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		rheumatoid arthritis J:54056
small intestinal inflammation J:54056
Tnftm2Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		cardiovalvulitis J:226052
rheumatoid arthritis J:54056
small intestinal inflammation J:54056
Tnftm2Jods/Tnftm2Jods
(C57BL/6-Tnftm2Jods) 		decreased susceptibility to endotoxin shock J:98591
Tnftm3Gkl/Tnftm3Gkl
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to endotoxin shock J:114740
Tnfaip3m1Apb/Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb) 		CNS inflammation J:324062
uterus inflammation J:324062
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl
Tg(Vil1-cre)997Gum/0
(B6.Cg-Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum) 		increased susceptibility to induced colitis J:163410
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tg(Vil1-cre)997Gum/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		decreased susceptibility to induced colitis J:163410
increased susceptibility to induced colitis J:163410
Tnfaip3tm1Ama/Tnfaip3tm1Ama
(involves: C57BL/6J) 		abnormal inflammatory response J:92694
Tnfaip3tm1Ama/Tnfaip3tm1Ama
(Not Specified) 		increased inflammatory response J:92931
intestinal inflammation J:92931
joint inflammation J:92931
kidney inflammation J:92931
liver inflammation J:92931
Tnfaip3tm1Ama/Tnfaip3tm1Ama
Tnfrsf1atm1Imx/Tnfrsf1a+
(involves: C57BL/6J) 		abnormal inflammatory response J:92694
Tnfaip3tm1Ama/Tnfaip3tm1Ama
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: C57BL/6J) 		abnormal inflammatory response J:92694
Tnfaip3tm1Homy/Tnfaip3tm1Homy
Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		liver inflammation J:212681
lung inflammation J:212681
Tnfaip3tm3.1Ama/Tnfaip3tm3.1Ama
(C57BL/6J-Tnfaip3tm3.1Ama) 		increased susceptibility to induced colitis J:203160
Tnfaip3tm4.1Ama/Tnfaip3tm4.1Ama
(C57BL/6J-Tnfaip3tm4.1Ama) 		increased susceptibility to induced colitis J:203160
Tnfaip6tm1Cful/Tnfaip6tm1Cful
(involves: 129S6/SvEvTac * BALB/c) 		decreased inflammatory response J:193758
Tnfaip8Gt(IST13629C1)Tigm/Tnfaip8Gt(IST13629C1)Tigm
(involves: C57BL/6N) 		increased susceptibility to induced colitis J:223320
Tnfaip8Gt(IST13629C1)Tigm/Tnfaip8Gt(IST13629C1)Tigm
Tnfaip8l1em1Huwa/Tnfaip8l1em1Huwa
(involves: C57BL/6 * C57BL/6N) 		colitis J:342074
Tnfaip8l1em1Huwa/Tnfaip8l1em1Huwa
(C57BL/6-Tnfaip8l1em1Huwa) 		increased susceptibility to colitis induced morbidity/mortality J:342074
increased susceptibility to induced colitis J:342074
Tnfaip8l2tm1Yhcn/Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn) 		abnormal inflammatory response J:139785
chronic inflammation J:139785
increased susceptibility to endotoxin shock J:139785
intestinal inflammation J:139785
liver inflammation J:139785
lung inflammation J:139785
lymph node inflammation J:139785
Tnfrsf1atm1.1Gkl/Tnfrsf1a+
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:92307
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx) 		decreased inflammatory response J:45147
decreased susceptibility to endotoxin shock J:45147
lung inflammation J:120174
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx/J) 		decreased susceptibility to endotoxin shock J:160543
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased inflammatory response J:45147
decreased susceptibility to endotoxin shock J:45147
decreased susceptibility to induced arthritis J:120707
osteomyelitis J:58851
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * DBA/2J) 		granulomatous inflammation J:55889
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		glomerulonephritis J:180054
Tnfrsf1atm1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm1Rsie) 		increased susceptibility to endotoxin shock J:160543
Tnfrsf1atm1Rsie/Tnfrsf1atm1Rsie
(B6.Cg-Tnfrsf1atm1Rsie) 		decreased susceptibility to endotoxin shock J:160543
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm2.1Rsie) 		increased susceptibility to endotoxin shock J:160543
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(involves: 129S6/SvEvTac) 		increased susceptibility to endotoxin shock J:160543
Tnfrsf1atm2.1Rsie/Tnfrsf1atm2.1Rsie
(B6.Cg-Tnfrsf1atm2.1Rsie) 		decreased susceptibility to endotoxin shock J:160543
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		increased inflammatory response J:45147
lung inflammation J:120174
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD) 		periinsulitis J:64051
Tnfrsf4tm1Nik/Tnfrsf4tm1Nik
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to type I hypersensitivity reaction J:68588
Tnfrsf9em1Ygch/Tnfrsf9em1Ygch
(NOD/ShiLtDvs-Tnfrsf9em1Ygch) 		insulitis J:208927
Tnfrsf9em2Ygch/Tnfrsf9em2Ygch
(NOD/ShiLtDvs-Tnfrsf9em2Ygch) 		insulitis J:208927
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr
Tg(Gfap-cre)2Brn/0
(involves: 129 * C57BL/6 * C57BL/6NTac * FVB/N) 		decreased susceptibility to endotoxin shock J:155398
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6NTac * SJL) 		decreased susceptibility to endotoxin shock J:155398
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6) 		glomerulonephritis J:82331
kidney inflammation J:82331
liver inflammation J:82331
Tnfrsf14tm1Csj/Tnfrsf14tm1Csj
(B6.Cg-Tnfrsf14tm1Csj) 		decreased susceptibility to induced colitis J:169369
Tnfsf4tm1Shr/Tnfsf4tm1Shr
(involves: 129S4/SvJae) 		decreased susceptibility to type IV hypersensitivity reaction J:59203
Tnfsf4tm1Sug/Tnfsf4tm1Sug
(B6.129S4-Tnfsf4tm1Sug) 		decreased susceptibility to type IV hypersensitivity reaction J:80214
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs) 		liver inflammation J:87620
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs) 		increased susceptibility to induced arthritis J:82145
Tnfsf13tm1Pod/Tnfsf13tm1Pod
(B6.Cg-Tnfsf13tm1Pod) 		decreased susceptibility to induced arthritis J:141374
Tnfsf14tm1Lpc/Tnfsf14tm1Lpc
(involves: 129X1/SvJ * C57BL/6) 		decreased inflammatory response J:107803
Tnfsf15tm1Hluo/Tnfsf15tm1Hluo
(D1LacJ.129(B6)-Tnfsf15tm1Hluo) 		decreased susceptibility to induced arthritis J:207029
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:180054
Tnip1m1Btlr/Tnip1m1Btlr
(C57BL/6J-Tnip1m1Btlr) 		increased susceptibility to induced colitis J:265175
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:176826
Tns1tm1Efu/Tns1tm1Efu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tubulointerstitial nephritis J:39202
Tns2nph/Tns2nph
(involves: ICR) 		glomerulonephritis J:108691
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal inflammatory response J:133892
conjunctivitis J:133892
dermatitis J:133892
increased inflammatory response J:133892
Tomm5Gt(OST44663)Lex/Tomm5Gt(OST44663)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		lung inflammation J:186382
Top3btm1Jcw/Top3btm1Jcw
(involves: 129S6/SvEvTac * C57BL/6) 		dermatitis J:69405
glomerulonephritis J:69405
increased inflammatory response J:69405
pancreas inflammation J:69405
stomach inflammation J:69405
Tpsab1m1/Tpsab1m1
Tpsb2tm1(cre)Adch/Tpsb2tm1(cre)Adch
(B6.Cg-Tpsb2tm1(cre)Adch Tpsab1m1) 		decreased susceptibility to induced arthritis J:142880
Tpsb2tm1.1Mfg/Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg) 		decreased susceptibility to induced arthritis J:142880
Tpsg1tm1.2Rls/Tpsg1tm1.2Rls
(involves: C57BL/6 * C57BL/6NTac) 		decreased susceptibility to colitis induced morbidity/mortality J:243813
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		granulomatous inflammation J:184948
Traddtm1.1Mak/Tradd+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N)) 		decreased acute inflammation J:138824
Traddtm1.1Mak/Traddtm1.1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N)) 		decreased acute inflammation J:138824
decreased inflammatory response J:138824
Traf3ip2adjm/Traf3ip2adjm
(KOR-Traf3ip2adjm) 		dermatitis J:162859
Traf3ip2adjm/Traf3ip2adjm
(A.KOR-Traf3ip2adjm) 		dermatitis J:162859
Traf3ip2adjm/Traf3ip2adjm
(B6.KOR-Traf3ip2adjm) 		dermatitis J:162859
Traf3ip2adjm/Traf3ip2adjm
(C.KOR-Traf3ip2adjm) 		dermatitis J:162859
Traf3ip2adjm/Traf3ip2adjm
(AK.KOR-Traf3ip2adjm) 		dermatitis J:162859
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129/Sv * BALB/c) 		increased inflammatory response J:93923
respiratory system inflammation J:93923
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix) 		blepharitis J:138560
glomerulonephritis J:138560
increased inflammatory response J:138560
kidney inflammation J:138560
lacrimal gland inflammation J:138560
parotid gland inflammation J:138560
stomatitis J:138560
submandibular gland inflammation J:138560
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(involves: 129 * C57BL/6) 		decreased inflammatory response J:191090
Traf4tm1Lind/Traf4tm1Lind
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		lung inflammation J:74252
Traf4tm2Lind/Traf4tm2Lind
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		lung inflammation J:74252
Trafd1tm1Ayos/Trafd1tm1Ayos
(involves: 129 * C57BL/6J) 		increased susceptibility to endotoxin shock J:144594
Traj18tm1.1Kro/Traj18tm1.1Kro
(involves: C57BL/6NTac) 		decreased inflammatory response J:232957
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		decreased inflammatory response J:226880
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N) 		increased susceptibility to endotoxin shock J:242126
Treml1tm1Mcvic/Treml1tm1Mcvic
(C57BL/6-Treml1tm1Mcvic) 		increased susceptibility to endotoxin shock J:150578
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac) 		bronchiolitis J:220965
glomerulonephritis J:220965
heart inflammation J:220965
increased inflammatory response J:220965
lacrimal gland inflammation J:220965
pancreas inflammation J:220965
salivary gland inflammation J:220965
tubulointerstitial nephritis J:220965
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd) 		heart inflammation J:202757
myocarditis J:92264
skin inflammation J:202757
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6) 		dermatitis J:181257
folliculitis J:181257
glomerulonephritis J:181257
increased inflammatory response J:181257
kidney inflammation J:181257
myocarditis J:181257
myositis J:181257
skin inflammation J:181257
stomach inflammation J:181257
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		heart inflammation J:234263
increased inflammatory response J:234263
kidney inflammation J:234263
myositis J:234263
stomach inflammation J:234263
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6J) 		dermatitis J:243357
Trim8tm1Hbsh/Trim8tm1Hbsh
(involves: 129S6/SvEvTac) 		increased susceptibility to endotoxin shock J:251270
Trim21tm1Mwah/Trim21+
(C57BL/6-Trim21tm1Mwah) 		dermatitis J:151775
Trim21tm1Mwah/Trim21tm1Mwah
(C57BL/6-Trim21tm1Mwah) 		dermatitis J:151775
increased inflammatory response J:151775
Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		decreased inflammatory response J:349246
Trim31em1Cya/Trim31em1Cya
(involves: C57BL/6) 		decreased susceptibility to induced colitis J:243237
Trim58tm2313.1Arte/Trim58tm2313.1Arte
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to induced colitis J:279270
Trim58tm2313.2Arte/Trim58tm2313.2Arte
(involves: BALB/cJ * C57BL/6N) 		increased susceptibility to induced colitis J:279270
Trip10tm1.1Geha/Trip10tm1.1Geha
(B6.129S1-Trip10tm1.1Geha) 		decreased susceptibility to type IV hypersensitivity reaction J:164363
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6) 		increased inflammatory response J:173271
liver inflammation J:173271
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6) 		adipose tissue inflammation J:173271
increased inflammatory response J:173271
liver inflammation J:173271
lung inflammation J:173271
Trp53inp1tm1Acar/Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6) 		increased susceptibility to induced colitis J:118867
large intestinal inflammation J:118867
Trp63tm2Brd/Trp63+
(involves: 129S7/SvEvBrd) 		kidney inflammation J:100483
uterine cervix inflammation J:100483
Trp73tm1Fmc/Trp73tm1Fmc
(involves: 129S4/SvJae) 		chronic inflammation J:60896
conjunctivitis J:60896
increased susceptibility to otitis media J:60896
rhinitis J:60896
sinus inflammation J:60896
Trpa1tm1Jul/Trpa1+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal acute inflammation J:115886
Trpm2tm1Yamo/Trpm2tm1Yamo
(involves: 129S4/SvJae * C57BL/6J) 		decreased inflammatory response J:137676
Trpm4tm1.1Mfre/Trpm4tm1.1Mfre
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		increased susceptibility to type I hypersensitivity reaction J:118679
Trpm7tm1Agry/Trpm7+
(involves: 129) 		increased susceptibility to type IV hypersensitivity reaction J:205665
Trpv1tm1Jul/Trpv1tm1Jul
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to endotoxin shock J:104828
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul) 		kidney inflammation J:154624
Trpv3Nh/Trpv3+
(involves: DS) 		dermatitis J:42153
Trpv3tm1.2Clph/Trpv3tm1.2Clph
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA) 		erythroderma J:164741
Trpv5Hcalc1/Trpv5+
(involves: C3H/HeH * C57BL/6J) 		kidney inflammation J:196612
Trpv5Hcalc1/Trpv5Hcalc1
(involves: C3H/HeH * C57BL/6J) 		kidney inflammation J:196612
Trpv5m1Btlr/Trpv5m1Btlr
(C57BL/6J-Trpv5m1Btlr) 		increased susceptibility to induced colitis J:192586
intestinal inflammation J:192586
Tsc22d3tm1.2Efmd/Y
(Not Specified) 		increased susceptibility to type IV hypersensitivity reaction J:201728
Tslptm1(KOMP)Vlcg/Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac) 		decreased acute inflammation J:187770
respiratory system inflammation J:187770
Tslptm1Mak/Tslptm1Mak
(B6.Cg-Tslptm1Mak) 		colitis J:175844
Ttc7fsn-Jic/Ttc7fsn-Jic
(C3.INT-Ttc7fsn-Jic) 		liver inflammation J:115742
Ttc7fsn/Ttc7fsn
(involves: A/J) 		stomach inflammation J:2777
Ttc39aos1em1Bcgen/Ttc39aos1em1Bcgen
(involves: C57BL/6N) 		increased susceptibility to induced pancreatitis J:307097
Ttc39aos1tm1Kaf/Ttc39aos1tm1Kaf
(C57BL/6-Ttc39aos1tm1Kaf) 		increased susceptibility to endotoxin shock J:234649
Ttll1Gt(OST372941)Lex/Ttll1Gt(OST372941)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to otitis media J:186050
rhinitis J:186050
Ttll1tm1Seto/Ttll1tm1Seto
(involves: 129S/SvEv * C57BL/6) 		rhinosinusitis J:161297
Ttnmdm/Ttnmdm
(Not Specified) 		myositis J:14016
Ttntm1.1Isrd/Ttntm1.1Isrd
(involves: 129S2/SvPas * C57BL/6) 		myositis J:165576
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		arteritis J:119985
glomerulonephritis J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		arteritis J:119985
glomerulonephritis J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv) 		arteritis J:309768
chronic inflammation J:309768
Tvp23bem3Eetr/Tvp23bem3Eetr
(C57BL/6J-Tvp23bem3Eetr) 		increased susceptibility to induced colitis J:340685
Tvp23bm1Btlr/Tvp23bm1Btlr
(C57BL/6J-Tvp23bm1Btlr) 		increased susceptibility to induced colitis J:340685
Tyk2E775K/Tyk2E775K
(B10.D1-H2q/SgJ) 		decreased susceptibility to induced arthritis J:69051
Tymptm1Akiy/Tymptm1Akiy
Upp1tm1Akiy/Upp1tm1Akiy
(involves: 129X1/SvJ) 		brain inflammation J:78036
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:64764
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:158811
U90926em1Dnkv/U90926em1Dnkv
(C57BL6/J-U90926em1Dnkv) 		increased susceptibility to endotoxin shock J:340649
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy) 		liver inflammation J:157049
lung inflammation J:157049
Ube2nGt(OST374154)Lex/Ube2n+
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased susceptibility to endotoxin shock J:120846
Ube3bGt(RRJ142)Byg/Ube3bGt(RRJ142)Byg
(involves: 129P2/OlaHsd * CBA/Ca) 		eye inflammation J:203652
Ulk4tm1Lex/Ulk4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased susceptibility to otitis media J:185566
maxillary sinus inflammation J:185566
nasal inflammation J:185566
Umodem1Duf/Umod+
(C57BL/6J-Umodem1Duf) 		kidney inflammation J:252597
Umodtm1.1Rvt/Umod+
(either: B6J.129-Umodtm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ)) 		kidney inflammation J:242593
Umodtm1.1Rvt/Umodtm1.1Rvt
(either: B6J.129-Umodtm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ)) 		kidney inflammation J:242593
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:174308
liver inflammation J:174308
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli) 		kidney inflammation J:271949
Uoxin/Uoxin
(involves: C57BL/6J * DBA/2J) 		chronic inflammation J:70677
Uoxtm1Bay/Uoxtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		tubulointerstitial nephritis J:16490
Upk1aem2Mgef/Upk1aem2Mgef
(C57BL/6NJNcbs-Upk1aem2Mgef) 		epididymis inflammation J:345207
liver inflammation J:345207
lung inflammation J:345207
tubulointerstitial nephritis J:345207
urinary bladder inflammation J:345207
Uri1tm1.1Ndj/Uri1tm1.1Ndj
Albtm1(cre/ERT2)Mtz/Alb+
(B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj) 		liver inflammation J:217463
Usp13em1Nmw/Usp13em1Nmw
(B6.Cg-Usp13em1Nmw) 		lung inflammation J:285981
Usp18ity9/Usp18ity9
(involves: 129S1/SvImJ * C57BL/6) 		increased susceptibility to endotoxin shock J:163843
Usp25Gt(RRS805)Byg/Usp25Gt(RRS805)Byg
(involves: 129P2/OlaHsd) 		lung inflammation J:188557
Usp38em1Cya/Usp38em1Cya
(C57BL/6-Usp38em1Cya) 		lung inflammation J:321973
UvragTn(pb-Act-RFP)1.100107015-HRAZhu/UvragTn(pb-Act-RFP)1.100107015-HRAZhu
(involves: FVB/NJ) 		heart inflammation J:219546
Vamp8tm1Hong/Vamp8tm1Hong
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal type I hypersensitivity reaction J:133439
Varc/Varc+
(C3H/HeJ-Varc/J) 		increased susceptibility to otitis media J:241135
Varc/Varc+
(C3OuJ.C3-Varc/Kjn) 		increased susceptibility to otitis media J:241135
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to induced colitis J:130511
intestinal inflammation J:107077
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		dermatitis J:111828
Vdrtm2Ska/Vdrtm2Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		ear inflammation J:111828
Vegfatm2Gne/Vegfatm2Gne
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd) 		decreased inflammatory response J:107682
Vegfatm2Gne/Vegfatm2Gne
Tg(SFTPC-cre)#Mliu/0
(involves: 129/Sv * ICR) 		lung inflammation J:158566
Vhltm1Jae/Vhltm1Jae
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased inflammatory response J:107682
Viptm1Clw/Viptm1Clw
(involves: 129S/Sv * C57BL/6) 		lung inflammation J:132313
Vipr2tm1Ajh/Vipr2tm1Ajh
(B6.129P2-Vipr2tm1Ajh) 		decreased susceptibility to type I hypersensitivity reaction J:72933
increased susceptibility to type IV hypersensitivity reaction J:72933
Vms1A/J/Vms1A/J
(involves: A/J * C57BL/10SnSg) 		myocarditis J:121574
Vps13btm1.2Ics/Vps13btm1.2Ics
(involves: C57BL/6N) 		eye inflammation J:296007
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne) 		decreased susceptibility to induced colitis J:281762
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased inflammatory response J:222944
Vwftm1.1Geno/Vwf+
(involves: C57BL/6) 		increased acute inflammation J:250145
Vwftm1.1Geno/Vwftm1.1Geno
(involves: C57BL/6) 		increased acute inflammation J:250145
Wastm1Sbs/Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)) 		colitis J:48836
Wastm1Sbs/Wastm1Sbs
(129S6/SvEvTac-Wastm1Sbs/J) 		glomerulonephritis J:180407
Wastm1Sbs/Wastm1Sbs
Wasltm2Sbs/Wasltm2Sbs
Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6) 		colitis J:125309
Wasltm1.1Ttha/Wasltm1.1Ttha
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N * CBA) 		dermatitis J:271857
skin inflammation J:271857
Wdr1Gt(XN462)Byg/Wdr1rede
(involves: 129P2/OlaHsd * C57BL/6) 		ear inflammation J:134092
skin inflammation J:134092
Wdr1rede/Wdr1rede
(Not Specified) 		increased inflammatory response J:85113
Wdr1rede/Wdr1rede
(C57BL/6-Wdr1rede) 		ear inflammation J:134092
skin inflammation J:134092
Wdr41m1Btlr/Wdr41m1Btlr
(C57BL/6J-Wdr41m1Btlr) 		increased susceptibility to induced colitis J:268243
Wdr83tm1Guwo/Wdr83+
(involves: C57BL/6) 		kidney inflammation J:153983
Wfdc2tm1.1Ohbo/Wfdc2tm1.1Ohbo
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		lung inflammation J:282576
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6) 		colitis J:116168
glomerulonephritis J:116168
interstitial pneumonia J:116168
joint inflammation J:116168
lung inflammation J:116168
Wlstm1.1Arte/Wlstm1.1Arte
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6) 		skin inflammation J:202499
Wrntm1Led/Wrntm1Led
(involves: 129S6/SvEvTac * Black Swiss) 		heart inflammation J:106446
Wsb1tm1.1Jszh/Wsb1tm1.1Jszh
Ubcem1(cre/ERT2)Smoc/Ubc+
(involves: C57BL/6J * C57BL/6N) 		decreased inflammatory response J:358004
Wt1tm1Mlh/Wt1+
(involves: 129P2/OlaHsd * C57BL/6) 		glomerulonephritis J:135449
Wt1tm1Mlh/Wt1+
(129P2/OlaHsd-Wt1tm1Mlh) 		glomerulonephritis J:135449
Wt1tm1Mlh/Wt1+
(involves: 129P2/OlaHsd * C57BL/6 * MF1) 		glomerulonephritis J:135449
Wwc1tm1Arsc/Wwc1tm1Arsc
Wwc2tm1.1Arte/Wwc2tm1.1Arte
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * C57BL/6J * DBA) 		liver inflammation J:305034
Wwtr1tm1Benj/Wwtr1tm1Benj
(129S6/SvEvTac-Wwtr1tm1Benj) 		intestinal inflammation J:125326
lung inflammation J:125326
Wwtr1tm1Benj/Wwtr1tm1Benj
(129S-Wwtr1tm1Benj/J) 		intestinal inflammation J:156586
lung inflammation J:156586
Wwtr1tm1Hku/Wwtr1tm1Hku
(involves: 129 * C57BL/6 * ICR) 		alveolitis J:164957
lung inflammation J:164957
Wwtr1tm1Whun/Wwtr1tm1Whun
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)) 		tubular nephritis J:119488
Xbp1tm2Glm/Xbp1+
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL) 		small intestinal inflammation J:188627
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Defa6-icre)1Rsb/0
(involves: 129S6/SvEvTac * C57BL/6) 		small intestinal inflammation J:206084
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL) 		increased susceptibility to induced colitis J:188627
small intestinal inflammation J:188627
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		small intestinal inflammation J:206084
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		small intestinal inflammation J:206084
Xbp1tm2Glm/Xbp1tm2Glm
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		small intestinal inflammation J:206084
Xbp1tm3Glm/Xbp1tm3Glm
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		small intestinal inflammation J:188627
Xcl1tm1.1Dnax/Xcl1tm1.1Dnax
(either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6)) 		heart inflammation J:176844
increased inflammatory response J:176844
lacrimal gland inflammation J:176844
liver inflammation J:176844
salivary gland inflammation J:176844
stomach inflammation J:176844
Xdhtm1Fink/Xdhtm1Fink
(involves: 129X1/SvJ * C57BL/6J) 		tubulointerstitial nephritis J:166326
X/Yaa
(BXSB/MpJ) 		glomerulonephritis J:6235
X/Yaa
((NZW x SB)F1) 		glomerulonephritis J:7276
X/Yaa
(BXSB/MpJScr) 		glomerulonephritis J:10973
Yaa2BXSB/J/?
(involves: BXSB/J * C57BL/10Ola) 		kidney inflammation J:49868
Yaa3BXSB/J/?
(involves: BXSB/J * C57BL/10Ola) 		kidney inflammation J:49868
Yaa4BXSB/J/?
(involves: BXSB/J * C57BL/10Ola) 		kidney inflammation J:49868
YaailNZW/Ola/?
(involves: C57BL/6Ola * NZW/Ola) 		glomerulonephritis J:52110
Yap1M1Btlr/Yap1M1Btlr
(C57BL/6J-Yap1M1Btlr) 		increased susceptibility to induced colitis J:267549
Yap1tm1.1Dupa/Yap1tm1.1Dupa
Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		increased susceptibility to induced colitis J:165471
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		abnormal acute inflammation J:282740
Yipf6M1Btlr/Y
(C57BL/6J-Yipf6M1Btlr/Mmucd) 		colitis J:187584
increased susceptibility to induced colitis J:187584
Yipf6M1Btlr/Yipf6M1Btlr
(C57BL/6J-Yipf6M1Btlr/Mmucd) 		colitis J:187584
increased susceptibility to induced colitis J:187584
Yod1em1Smoc/Yod1em1Smoc
(C57BL/6JSmoc-Yod1em1Smoc/Smoc) 		increased inflammatory response J:350806
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c) 		chronic joint inflammation J:86607
increased susceptibility to induced arthritis J:154166
lung inflammation J:86607
rheumatoid arthritis J:86607
Zap70m1Saka/Zap70m1Saka
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: BALB/c * C57BL/6J * DBA/2J) 		autoimmune arthritis J:86607
Zap70m1Saka/Zap70tm1Dlo
(involves: 129P2/OlaHsd * BALB/c) 		autoimmune arthritis J:86607
Zap70m1Saka/Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c) 		decreased susceptibility to induced arthritis J:154166
Zc3h12atm1Aki/Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6) 		abnormal acute inflammation J:147868
granulomatous inflammation J:147868
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased inflammatory response J:304105
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		bile duct inflammation J:304105
granulomatous inflammation J:304105
liver inflammation J:304105
Zdhhc2em1Eko/Zdhhc2em1Eko
(C57BL/6-Zdhhc2em1Eko) 		decreased susceptibility to chemically induced skin inflammation J:303593
Zdhhc11tm1.1(KOMP)Vlcg/Zdhhc11tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased susceptibility to endotoxin shock J:310891
Zfp14tm1Xch/Zfp14+
(involves: C57BL/6) 		chronic pancreas inflammation J:331393
increased inflammatory response J:331393
Zfp14tm1Xch/Zfp14tm1Xch
(involves: C57BL/6) 		chronic pancreas inflammation J:331393
increased inflammatory response J:331393
Zfp36tm1Pjb/Zfp36tm1Pjb
(Not Specified) 		autoimmune arthritis J:33986
conjunctivitis J:33986
dermatitis J:33986
heart inflammation J:33986
liver inflammation J:33986
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb) 		autoimmune arthritis J:88443
blood vessel inflammation J:214114
Zfp36tm2.1Pjb/Zfp36tm2.1Pjb
(involves: C57BL/6) 		decreased inflammatory response J:229078
decreased susceptibility to induced arthritis J:229078
Zfp36tm4.1Pjb/Zfp36tm4.1Pjb
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		alveolitis J:188677
autoimmune arthritis J:188677
increased inflammatory response J:188677
increased susceptibility to endotoxin shock J:188677
Zfp148tm1.1Jmer/Zfp148tm1.1Jmer
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		increased inflammatory response J:198847
Zfp148tm1Djl/Zfp148tm1Djl
(involves: 129) 		increased susceptibility to induced colitis J:107441
Zfp871tm1a(EUCOMM)Wtsi/Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd) 		liver inflammation J:317166
Zfp950Gt(ROSA)76Sor/Zfp950Gt(ROSA)76Sor
(involves: 129S4/SvJaeSor) 		kidney inflammation J:117491
Zmynd10tm1(KOMP)Wtsi/Zmynd10tm1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		lung inflammation J:261915
Zranb1em1Shios/Zranb1em1Shios
(involves: C57BL/6) 		increased susceptibility to colitis induced morbidity/mortality J:333468
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory